data_2h0p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2h0p _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.1 mmm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.4 m -86.98 96.65 10.34 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -143.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.6 p -67.37 -10.74 54.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.895 1.678 . . . . 0.0 114.549 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 170.4 48.2 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.75 1.167 . . . . 0.0 113.726 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.18 158.04 27.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.446 1.498 . . . . 0.0 111.616 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -132.4 167.88 19.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.573 2.349 . . . . 0.0 110.616 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -108.46 139.7 42.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.387 1.075 . . . . 0.0 110.807 165.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tp -71.09 113.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 154.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.21 -14.11 9.29 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.807 0.843 . . . . 0.0 112.51 -162.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -147.82 141.19 25.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.575 1.55 . . . . 0.0 109.013 144.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.47 161.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.358 2.263 . . . . 0.0 114.287 170.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.95 131.35 37.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 130.04 46.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.549 1.54 . . . . 0.0 110.708 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -82.77 159.86 22.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.03 0.932 . . . . 0.0 113.127 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -115.54 168.27 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.175 1.39 . . . . 0.0 112.481 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.21 65.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.749 0.82 . . . . 0.0 112.581 166.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -67.21 -10.14 47.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.192 1.797 . . . . 0.0 112.152 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.92 78.15 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.19 1.376 . . . . 0.0 114.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -76.01 171.72 13.97 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.076 2.15 . . . . 0.0 110.582 167.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.54 154.33 43.99 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.107 0.963 . . . . 0.0 110.782 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.44 105.93 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.599 1.16 . . . . 0.0 109.637 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.93 164.3 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.662 1.185 . . . . 0.0 109.253 167.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tmmt? -132.29 128.39 37.68 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.238 -0.914 . . . . 0.0 109.891 155.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.0 161.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 111.033 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.81 145.64 51.69 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 107.949 161.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -81.66 155.26 25.68 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.778 1.172 . . . . 0.0 110.69 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -124.86 -63.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.696 0.799 . . . . 0.0 109.567 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -8.69 -77.7 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 130.233 3.778 . . . . 0.0 118.362 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.63 15.31 3.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -157.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.8 -54.56 4.68 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.701 -1.249 . . . . 0.0 112.842 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.74 164.3 3.21 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.747 2.419 . . . . 0.0 114.969 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.18 164.0 21.26 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.397 2.732 . . . . 0.0 113.979 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 70.7 m -141.55 148.43 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.072 1.749 . . . . 0.0 111.102 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -86.22 141.02 29.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.5 -1.28 . . . . 0.0 108.035 126.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.38 129.0 25.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.535 -168.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.64 117.41 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.082 1.855 . . . . 0.0 109.617 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.39 127.22 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.228 1.011 . . . . 0.0 109.107 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.05 170.04 11.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.657 0.783 . . . . 0.0 109.144 161.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.41 131.71 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 153.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -115.62 153.58 31.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.415 1.086 . . . . 0.0 111.015 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -62.76 176.03 0.74 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.364 1.466 . . . . 0.0 112.718 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.0 -39.62 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 120.803 -1.186 . . . . 0.0 112.711 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -72.14 -18.52 61.88 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.423 1.889 . . . . 0.0 113.399 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.27 20.6 mttm 74.19 4.84 4.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.426 3.09 . . . . 0.0 114.529 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.49 -43.34 63.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.259 2.224 . . . . 0.0 113.053 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -109.21 133.39 53.08 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.048 0.84 . . . . 0.0 110.997 -165.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -74.73 134.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.857 0.863 . . . . 0.0 110.256 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.67 -8.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.68 168.68 12.86 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.617 1.099 . . . . 0.0 114.759 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -131.25 122.18 26.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.724 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.02 138.07 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.895 0.77 . . . . 0.0 109.848 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.85 -34.98 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 111.798 -172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 80' ' ' GLU . 45.4 t -68.56 38.44 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.604 1.962 . . . . 0.0 114.866 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.8 t 57.12 -172.33 0.08 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.573 1.949 . . . . 0.0 112.889 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -64.23 109.54 2.85 Favored Pre-proline 0 C--O 1.246 0.889 0 C-N-CA 125.243 1.417 . . . . 0.0 110.175 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.04 136.38 60.92 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 124.465 3.444 . . . . 0.0 114.918 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.94 160.91 39.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.485 1.114 . . . . 0.0 112.806 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.64 123.5 11.98 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.52 1.528 . . . . 0.0 108.823 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -72.1 -22.49 61.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -170.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.38 169.68 10.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.871 2.468 . . . . 0.0 109.742 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -52.5 -45.64 66.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.294 1.038 . . . . 0.0 111.438 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -70.93 0.95 6.24 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 m -100.41 158.31 15.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.291 1.405 . . . . 0.0 112.376 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.74 154.23 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 125.079 1.352 . . . . 0.0 110.741 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -142.05 115.98 9.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.205 0.602 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -68.92 134.4 49.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.096 0.959 . . . . 0.0 110.341 164.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mm -132.04 104.62 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.803 1.241 . . . . 0.0 109.947 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' H ' ' HB2' ' A' ' 65' ' ' SER . 73.7 tt0 -68.51 131.17 44.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.793 0.837 . . . . 0.0 111.172 161.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 tp -150.12 145.16 26.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.063 1.745 . . . . 0.0 110.649 -163.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -119.72 94.62 48.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.523 1.529 . . . . 0.0 110.77 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.21 168.3 20.5 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.967 3.778 . . . . 0.0 112.712 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.92 165.65 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.183 1.922 . . . . 0.0 111.544 169.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -75.41 74.99 2.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.854 0.862 . . . . 0.0 111.702 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.43 -167.09 38.89 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.77 1.176 . . . . 0.0 112.374 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.17 140.28 52.52 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.688 1.195 . . . . 0.0 110.543 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.0 m -163.6 171.11 16.22 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.835 -1.166 . . . . 0.0 112.361 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -128.34 101.29 6.15 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.572 1.149 . . . . 0.0 109.867 -169.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.2 136.66 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.23 122.72 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.419 0.554 . . . . 0.0 109.61 174.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.6 mt -123.82 105.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.844 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.99 172.14 20.3 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.647 2.07 . . . . 0.0 111.097 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 m -95.8 129.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.3 1.05 . . . . 0.0 110.687 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 26.28 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 127.774 2.607 . . . . 0.0 116.081 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.95 -27.77 8.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.052 1.741 . . . . 0.0 115.474 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.8 m -101.29 -3.63 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.552 1.941 . . . . 0.0 112.932 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.31 109.83 16.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.288 1.035 . . . . 0.0 113.089 -166.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 mt -53.85 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.951 162.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.8 m -103.63 89.53 3.38 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -170.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -118.66 139.29 51.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.586 1.184 . . . . 0.0 113.484 -165.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 142.48 55.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.708 2.403 . . . . 0.0 114.208 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -145.53 153.81 41.51 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.888 0.875 . . . . 0.0 111.267 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -135.5 111.62 9.63 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.568 1.147 . . . . 0.0 108.973 168.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -68.49 144.1 54.75 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.929 -0.482 . . . . 0.0 111.647 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 129.653 3.181 . . . . 0.0 115.69 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.67 109.01 18.9 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -133.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -72.33 -13.33 61.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.746 1.618 . . . . 0.0 114.506 164.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.53 163.13 54.75 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.347 0.975 . . . . 0.0 113.317 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 158.93 34.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.967 0.907 . . . . 0.0 112.792 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -129.1 166.73 18.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.652 1.981 . . . . 0.0 110.239 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.39 137.2 54.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.58 1.952 . . . . 0.0 111.038 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 tp -80.15 95.47 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.941 1.296 . . . . 0.0 108.711 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.98 -11.71 28.0 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 112.633 -165.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.4 ttpp -152.71 137.77 17.28 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 109.379 151.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.62 168.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.073 2.949 . . . . 0.0 114.749 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 mtm -77.29 123.55 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.52 118.11 29.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.087 1.355 . . . . 0.0 110.256 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.11 161.79 21.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.312 1.045 . . . . 0.0 113.703 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 p -118.01 169.62 9.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 112.512 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -27.99 66.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.855 0.862 . . . . 0.0 112.387 166.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -65.06 -12.91 55.82 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.38 1.872 . . . . 0.0 112.469 168.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.32 -5.05 79.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.166 1.365 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -69.71 167.65 16.6 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 111.43 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -127.27 148.38 50.22 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.063 1.345 . . . . 0.0 110.072 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.51 116.25 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.526 1.13 . . . . 0.0 109.037 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.68 131.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.783 1.633 . . . . 0.0 108.946 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 5.9 ttmt -102.52 111.61 23.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.283 0.947 . . . . 0.0 109.606 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -87.6 157.0 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 122.585 0.354 . . . . 0.0 110.065 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -130.04 143.34 50.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.057 2.143 . . . . 0.0 107.491 160.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.85 154.74 26.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.586 1.085 . . . . 0.0 110.725 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.34 -63.13 1.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 110.712 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -18.73 -80.15 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 129.391 3.377 . . . . 0.0 117.793 -164.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.58 22.12 6.45 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.6 -49.15 3.82 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 120.917 -1.115 . . . . 0.0 114.327 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.6 178.73 1.71 Allowed Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 128.424 2.689 . . . . 0.0 114.761 -170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.75 166.28 14.18 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 124.255 3.303 . . . . 0.0 115.705 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.0 m -148.13 154.36 40.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.428 1.891 . . . . 0.0 111.286 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -92.12 138.67 31.34 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 128.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.29 125.11 44.57 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -66.14 101.19 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.305 2.003 . . . . 0.0 110.532 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.8 mt -106.84 130.94 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.099 0.96 . . . . 0.0 110.568 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.79 166.79 20.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.563 0.745 . . . . 0.0 110.461 157.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.49 130.61 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 146.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -111.83 162.67 15.03 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.615 1.166 . . . . 0.0 112.916 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -55.9 169.03 0.39 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.86 2.064 . . . . 0.0 113.351 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -58.25 -28.93 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.317 -0.864 . . . . 0.0 112.898 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -74.92 -17.07 60.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.235 1.814 . . . . 0.0 113.718 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 49.8 mttp 69.85 28.19 4.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.234 2.214 . . . . 0.0 113.205 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -115.26 -28.42 6.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.646 1.978 . . . . 0.0 113.173 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -132.6 138.19 47.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.694 1.134 . . . . 0.0 112.255 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.73 133.45 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.292 1.837 . . . . 0.0 111.213 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.51 -8.9 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 0.0 114.112 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.72 168.75 13.05 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 119.578 1.081 . . . . 0.0 115.257 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.55 114.1 14.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.068 1.747 . . . . 0.0 110.854 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.406 ' H ' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -74.92 102.38 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.08 0.952 . . . . 0.0 110.186 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.4 mm -76.36 -42.34 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.421 1.089 . . . . 0.0 111.767 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -70.49 36.94 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.649 1.98 . . . . 0.0 115.78 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t 62.66 -174.92 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.708 2.003 . . . . 0.0 113.588 -175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -59.5 107.01 0.84 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 127.584 2.354 . . . . 0.0 111.859 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.21 121.1 9.3 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.356 3.37 . . . . 0.0 114.57 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.05 165.93 26.17 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.89 148.59 34.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.82 1.648 . . . . 0.0 109.953 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -99.67 -21.46 15.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 112.173 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.6 165.03 19.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.76 1.624 . . . . 0.0 111.296 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -57.98 -28.56 64.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.328 1.051 . . . . 0.0 112.759 168.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -81.48 -4.24 55.34 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 m -83.79 155.97 22.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.621 1.1 . . . . 0.0 112.244 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.69 149.61 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 124.82 1.248 . . . . 0.0 110.204 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -138.62 107.42 5.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.39 0.676 . . . . 0.0 109.492 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.72 121.09 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.01 . . . . 0.0 110.939 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.88 111.84 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.716 1.606 . . . . 0.0 109.131 -168.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -67.42 126.57 29.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 110.765 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 tp -143.3 144.72 32.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.785 2.034 . . . . 0.0 109.527 -172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -114.46 100.21 52.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.413 1.485 . . . . 0.0 110.805 -170.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.19 175.31 10.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.472 3.448 . . . . 0.0 112.893 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -76.67 167.15 25.96 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.396 2.731 . . . . 0.0 111.518 165.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -76.97 78.43 3.52 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.841 -1.162 . . . . 0.0 111.679 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.57 -166.66 39.41 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.257 0.932 . . . . 0.0 112.3 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.66 143.79 54.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.153 0.501 . . . . 0.0 110.761 165.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.0 p -160.27 157.74 28.63 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.938 0.895 . . . . 0.0 111.64 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.494 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 96.1 m-85 -129.3 102.57 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.935 0.874 . . . . 0.0 111.446 -171.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.71 137.22 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.691 1.996 . . . . 0.0 107.568 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.37 129.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -130.86 97.91 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.649 1.18 . . . . 0.0 109.343 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.44 -175.78 15.9 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 127.11 2.29 . . . . 0.0 111.245 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.2 135.17 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 118.473 1.137 . . . . 0.0 111.418 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.27 -117.48 0.91 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.253 1.406 . . . . 0.0 114.158 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -70.43 -9.7 57.13 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.1 m -86.64 -11.23 51.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.518 1.127 . . . . 0.0 112.89 165.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.05 116.84 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.843 0.857 . . . . 0.0 112.583 -172.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.8 102.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 158.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.7 m -112.95 93.31 4.36 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -168.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -131.94 157.42 44.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.746 1.26 . . . . 0.0 114.018 -162.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 135.96 33.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.331 2.652 . . . . 0.0 114.355 -165.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -143.84 118.83 10.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 165.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -91.76 105.67 17.9 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.585 1.154 . . . . 0.0 110.148 164.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 139.09 58.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm . . . . . 0 N--CA 1.473 0.712 0 C-N-CA 126.471 1.908 . . . . 0.0 114.062 -179.617 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.38 113.02 20.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -135.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.7 p -68.67 -10.97 59.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.54 1.536 . . . . 0.0 114.564 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.3 170.68 44.58 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.279 0.942 . . . . 0.0 114.793 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 156.17 28.26 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.183 1.793 . . . . 0.0 111.484 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 82.6 m-85 -130.7 167.48 18.74 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.416 2.286 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -107.97 137.31 46.18 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.561 1.144 . . . . 0.0 111.054 167.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.8 tp -75.35 92.7 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 159.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.91 -13.2 25.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.754 1.222 . . . . 0.0 112.088 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -149.04 142.38 25.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.374 1.47 . . . . 0.0 109.535 148.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.36 162.68 0.13 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.211 2.204 . . . . 0.0 113.845 167.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.19 132.3 42.06 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 122.21 35.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.858 1.263 . . . . 0.0 110.418 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -80.82 160.89 24.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.5 p -113.65 169.56 8.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.655 1.582 . . . . 0.0 112.006 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.92 69.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.975 0.91 . . . . 0.0 112.287 165.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -68.67 -11.14 59.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.595 1.958 . . . . 0.0 112.764 171.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.42 -3.1 79.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.726 1.155 . . . . 0.0 113.818 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -72.7 165.35 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.445 1.898 . . . . 0.0 111.076 166.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -125.95 146.18 49.97 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.706 1.203 . . . . 0.0 110.405 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.98 118.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 109.164 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.39 124.96 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.607 1.563 . . . . 0.0 109.161 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -95.55 110.8 22.83 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.313 0.961 . . . . 0.0 109.233 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.88 161.53 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.151 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 152.54 49.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.272 1.829 . . . . 0.0 107.733 156.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -87.92 159.01 18.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.199 1.363 . . . . 0.0 110.966 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -130.95 -52.9 1.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.275 -0.891 . . . . 0.0 110.843 173.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.38 -11.21 46.27 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 120.252 2.861 . . . . 0.0 120.252 -151.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.31 2.64 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.61 2.705 . . . . 0.0 117.112 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.88 -56.77 4.29 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-N 120.522 1.51 . . . . 0.0 113.061 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.98 5.03 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 127.371 2.269 . . . . 0.0 114.269 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.66 164.81 22.63 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.031 3.154 . . . . 0.0 116.193 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -147.61 151.18 35.79 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.509 2.324 . . . . 0.0 111.391 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 142.61 28.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 129.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.25 1.0 OUTLIER -104.2 134.86 19.48 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.724 -169.576 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.84 106.42 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.247 1.965 . . . . 0.0 109.112 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 mt -115.14 130.69 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.548 0.739 . . . . 0.0 109.757 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -134.06 172.98 12.08 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.014 0.926 . . . . 0.0 110.048 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mt -126.42 125.71 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 156.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -109.15 162.89 13.85 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.922 0.868 . . . . 0.0 111.148 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -57.74 173.67 0.29 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.622 2.369 . . . . 0.0 113.487 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 m -56.57 -34.9 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.874 -1.141 . . . . 0.0 112.71 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -71.8 -14.07 61.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.563 1.945 . . . . 0.0 113.495 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 67.99 22.98 8.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.267 2.627 . . . . 0.0 113.662 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -108.74 -32.76 7.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.49 1.916 . . . . 0.0 112.692 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -127.15 135.82 51.24 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.249 1.386 . . . . 0.0 111.954 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.76 135.38 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.495 1.518 . . . . 0.0 111.625 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.93 -11.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.559 1.544 . . . . 0.0 114.622 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.97 171.01 13.65 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -170.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtm-85 -133.1 128.89 37.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.676 1.59 . . . . 0.0 110.729 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.72 124.09 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.52 -36.99 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.568 0.747 . . . . 0.0 111.282 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.8 t -68.63 35.29 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.296 1.838 . . . . 0.0 114.617 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.76 -170.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.899 2.08 . . . . 0.0 113.641 -175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -64.0 108.6 1.96 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.929 2.092 . . . . 0.0 111.157 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -55.05 143.78 72.05 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.31 3.34 . . . . 0.0 115.495 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -147.46 166.27 27.74 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.96 121.93 11.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.458 1.903 . . . . 0.0 108.168 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.52 -17.29 59.34 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.584 -0.697 . . . . 0.0 112.677 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.53 170.26 16.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.319 2.648 . . . . 0.0 109.419 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 m -50.5 -49.9 54.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.312 1.045 . . . . 0.0 110.464 163.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -67.03 -3.54 7.49 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 m -85.24 144.18 28.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.148 1.34 . . . . 0.0 112.093 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.02 150.96 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.045 1.338 . . . . 0.0 110.637 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 m -141.77 115.59 9.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.98 122.75 32.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 111.568 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.73 111.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 124.819 1.248 . . . . 0.0 109.827 -162.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.1 124.59 23.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.141 1.376 . . . . 0.0 111.42 165.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.4 tp -141.02 142.92 34.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.074 2.149 . . . . 0.0 110.013 -166.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -119.23 98.99 50.7 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -167.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.82 168.77 18.89 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.483 3.455 . . . . 0.0 113.573 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.49 165.13 32.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.946 2.431 . . . . 0.0 111.019 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -72.67 73.42 1.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.27 -0.894 . . . . 0.0 112.004 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -173.44 46.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.148 0.88 . . . . 0.0 113.789 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.54 129.61 41.39 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.13 0.972 . . . . 0.0 110.163 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 m -145.56 150.5 36.52 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.279 1.432 . . . . 0.0 111.011 -163.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.58 98.17 5.61 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.957 0.884 . . . . 0.0 111.317 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.82 126.44 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.391 1.876 . . . . 0.0 107.259 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.47 123.96 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.871 0.868 . . . . 0.0 109.039 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.1 mt -128.16 98.58 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.031 1.332 . . . . 0.0 109.256 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.93 -174.57 15.84 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 127.657 2.551 . . . . 0.0 110.649 -164.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.11 164.54 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.506 1.153 . . . . 0.0 110.585 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -10.14 -74.5 0.01 OUTLIER Glycine 0 CA--C 1.541 1.707 0 C-N-CA 127.55 2.5 . . . . 0.0 117.682 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.3 58.68 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.9 p -122.91 -10.29 8.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.295 1.838 . . . . 0.0 114.025 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.15 118.53 6.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.582 1.953 . . . . 0.0 112.67 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.5 mt -56.67 98.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 154.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 83.4 m -101.08 95.57 6.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.94 154.35 39.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.816 1.293 . . . . 0.0 113.735 -170.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.38 137.89 33.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.917 2.487 . . . . 0.0 114.267 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -134.64 156.48 48.67 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.201 1.0 . . . . 0.0 111.129 162.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -129.8 111.06 12.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 162.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -63.26 135.33 57.0 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 126.528 1.931 . . . . 0.0 113.705 -175.052 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.62 99.56 8.2 Favored 'General case' 0 N--CA 1.458 -0.056 0 O-C-N 121.106 -0.996 . . . . 0.0 113.36 -145.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -68.64 -6.44 25.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.517 166.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.24 53.83 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.045 1.307 . . . . 0.0 114.169 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 154.71 32.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.261 1.824 . . . . 0.0 112.459 -174.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.04 166.22 18.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.748 2.019 . . . . 0.0 110.794 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -101.39 137.45 39.71 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.579 1.151 . . . . 0.0 110.183 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.57 101.75 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -106.53 -14.37 15.07 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.319 1.448 . . . . 0.0 111.482 -163.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -149.38 137.84 20.86 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.686 1.595 . . . . 0.0 109.359 145.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.94 168.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.06 2.944 . . . . 0.0 114.351 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.9 mtm -79.88 136.36 36.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.39 122.57 21.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.013 1.725 . . . . 0.0 109.74 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.62 164.89 21.54 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -120.66 170.06 9.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.041 1.737 . . . . 0.0 111.778 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -27.56 66.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.117 0.967 . . . . 0.0 112.312 165.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -65.37 -9.15 22.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.338 1.855 . . . . 0.0 112.733 168.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.03 -7.4 55.96 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.477 1.513 . . . . 0.0 113.539 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -68.54 163.54 23.3 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.976 1.71 . . . . 0.0 111.067 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -126.71 148.29 49.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 109.503 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 t -114.65 115.3 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.127 0.971 . . . . 0.0 109.508 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.81 132.6 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 109.087 -171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -107.27 120.49 42.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.775 1.17 . . . . 0.0 110.47 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -93.75 165.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.656 1.182 . . . . 0.0 109.987 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.57 159.12 42.88 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.126 1.771 . . . . 0.0 108.183 156.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -104.31 139.04 39.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.724 1.602 . . . . 0.0 112.421 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -121.71 -27.82 4.63 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.87 -1.144 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.85 -18.13 79.51 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -157.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.34 2.57 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.31 -42.7 1.7 Allowed Glycine 0 CA--C 1.537 1.419 0 CA-C-N 120.765 1.62 . . . . 0.0 114.497 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.31 170.7 5.06 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 128.33 2.652 . . . . 0.0 115.107 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -67.64 166.24 24.77 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.926 3.084 . . . . 0.0 113.172 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.35 155.31 40.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.27 136.69 33.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 129.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.274 1.7 m -95.54 129.11 35.7 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -170.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.2 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.644 2.23 . . . . 0.0 109.091 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.7 mt -119.06 129.15 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.58 0.752 . . . . 0.0 110.833 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -132.83 169.06 17.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.525 1.13 . . . . 0.0 109.437 162.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -119.09 131.25 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 149.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -110.12 163.69 13.35 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.465 1.103 . . . . 0.0 112.209 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -59.64 175.52 0.35 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.706 1.603 . . . . 0.0 113.027 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -65.3 -22.77 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -79.72 -25.56 41.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.34 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 46.9 mttp 85.91 14.02 0.16 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.939 3.295 . . . . 0.0 112.565 169.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -83.09 -51.05 7.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.489 2.716 . . . . 0.0 112.815 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -122.68 151.48 41.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.127 1.33 . . . . 0.0 112.669 -167.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.32 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.938 1.695 . . . . 0.0 112.136 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.22 -28.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.188 1.795 . . . . 0.0 114.171 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.55 161.76 17.87 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.917 1.235 . . . . 0.0 114.429 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.52 HH21 ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -124.17 105.21 9.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.455 1.502 . . . . 0.0 110.354 -170.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.1 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.985 -1.072 . . . . 0.0 110.151 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.6 mm -108.73 -40.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.471 0.708 . . . . 0.0 111.603 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 t -66.41 10.14 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 98.13 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 130.588 3.555 . . . . 0.0 111.413 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 p -67.76 106.87 1.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.403 1.481 . . . . 0.0 109.375 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.94 147.21 64.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.635 2.89 . . . . 0.0 115.238 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 169.16 18.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.94 140.38 38.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.319 2.248 . . . . 0.0 108.914 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.12 -27.59 21.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.446 1.098 . . . . 0.0 112.283 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 177.73 7.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 130.163 3.385 . . . . 0.0 108.84 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.14 -43.71 61.26 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.085 -1.009 . . . . 0.0 112.342 170.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.37 -10.09 15.12 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 114.044 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -72.74 119.99 17.74 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 m -90.49 146.29 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.081 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -139.15 105.3 5.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -86.3 125.31 33.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 111.493 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.4 mt -131.69 115.47 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.309 1.444 . . . . 0.0 109.555 -159.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.11 126.51 29.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.103 0.961 . . . . 0.0 111.647 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.9 tp -145.5 143.13 29.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.021 1.728 . . . . 0.0 110.367 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CD ' HH21 ' A' ' 62' ' ' ARG . 5.2 tm-20 -118.19 92.63 43.17 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.619 1.568 . . . . 0.0 111.429 -165.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.85 170.47 19.99 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.288 3.325 . . . . 0.0 114.419 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.49 160.13 49.37 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.675 2.25 . . . . 0.0 111.17 165.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.85 92.18 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.456 0.702 . . . . 0.0 110.358 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.49 -172.38 34.24 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.218 1.389 . . . . 0.0 111.236 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.81 143.95 39.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.999 0.92 . . . . 0.0 111.512 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 162.18 24.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.064 0.946 . . . . 0.0 111.953 -171.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 91.8 m-85 -127.78 102.34 6.76 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.939 0.876 . . . . 0.0 111.747 -170.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.39 126.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 127.539 2.336 . . . . 0.0 106.968 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.32 120.36 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -124.28 98.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.075 1.35 . . . . 0.0 108.995 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.82 -174.04 15.01 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.85 2.167 . . . . 0.0 110.247 -161.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 m -114.76 161.53 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.569 1.184 . . . . 0.0 110.93 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 4.51 -85.57 0.0 OUTLIER Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.825 2.631 . . . . 0.0 117.406 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -4.43 58.67 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -119.41 -9.59 9.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.187 1.795 . . . . 0.0 113.853 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.93 8.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.716 2.006 . . . . 0.0 113.347 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.97 96.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 155.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.8 m -99.94 97.3 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -126.46 160.64 29.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.394 1.093 . . . . 0.0 113.307 -172.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 141.15 28.92 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 114.345 -162.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -146.24 129.45 16.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 166.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -105.93 108.76 20.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.548 1.539 . . . . 0.0 109.669 165.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -66.47 141.08 58.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 126.203 1.801 . . . . 0.0 113.624 -176.591 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . 0.289 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.08 106.65 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -139.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.3 p -70.66 -7.35 43.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.657 1.583 . . . . 0.0 114.2 162.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.01 168.67 54.79 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.655 1.121 . . . . 0.0 113.893 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 155.18 36.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.638 1.575 . . . . 0.0 112.332 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.53 166.22 21.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.049 2.14 . . . . 0.0 110.477 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -106.53 140.25 39.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.39 1.476 . . . . 0.0 110.667 166.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -76.45 94.28 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 159.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.48 -13.05 26.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.816 1.246 . . . . 0.0 112.267 -165.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -145.87 140.79 27.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.745 1.618 . . . . 0.0 108.684 146.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.61 167.66 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.48 2.312 . . . . 0.0 113.691 166.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 28.8 mtm -76.23 137.63 40.1 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.264 -0.897 . . . . 0.0 113.183 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.65 128.66 35.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.565 1.146 . . . . 0.0 110.137 171.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -85.15 161.3 19.69 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -111.52 168.63 9.4 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.896 1.678 . . . . 0.0 111.764 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -30.28 70.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.545 1.138 . . . . 0.0 111.965 164.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -62.12 -14.68 39.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.771 1.628 . . . . 0.0 112.645 166.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 1.98 90.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.989 1.28 . . . . 0.0 113.954 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -76.35 164.31 26.14 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.925 2.09 . . . . 0.0 110.916 166.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -119.86 146.07 46.08 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.186 0.994 . . . . 0.0 110.245 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.7 119.09 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.079 0.952 . . . . 0.0 109.044 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.49 130.7 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.553 1.541 . . . . 0.0 109.211 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -106.77 108.3 19.74 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.113 0.869 . . . . 0.0 110.229 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.5 162.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 110.156 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 145.6 41.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.201 1.8 . . . . 0.0 107.459 154.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.63 153.02 22.66 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.96 1.254 . . . . 0.0 111.115 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -124.28 -59.32 1.48 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.199 -0.938 . . . . 0.0 109.645 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -20.66 -64.65 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 130.192 3.758 . . . . 0.0 118.587 -167.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.86 11.64 2.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -158.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.74 -45.85 2.77 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 120.606 -1.309 . . . . 0.0 113.417 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 165.74 6.28 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 128.473 2.709 . . . . 0.0 115.559 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.06 167.82 20.7 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.513 3.475 . . . . 0.0 113.622 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.2 m -147.59 157.23 43.47 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.225 1.81 . . . . 0.0 111.611 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 137.73 32.07 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 128.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 1.9 m -100.29 128.15 31.26 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.381 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.03 105.71 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.599 2.199 . . . . 0.0 109.707 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.0 128.01 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 110.491 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -131.75 168.07 18.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 109.247 165.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.95 135.09 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 151.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -119.62 157.94 27.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.228 1.411 . . . . 0.0 110.929 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.1 177.67 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.03 0.932 . . . . 0.0 112.544 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -56.16 -34.82 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 120.902 -1.124 . . . . 0.0 113.354 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -82.29 -6.55 59.31 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.34 1.856 . . . . 0.0 112.592 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 66.12 -5.42 0.56 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.207 3.003 . . . . 0.0 115.272 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.06 -38.65 88.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.302 1.841 . . . . 0.0 114.658 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -118.13 140.09 50.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.424 1.465 . . . . 0.0 111.862 -168.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -73.68 139.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.291 1.436 . . . . 0.0 111.062 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.82 -7.93 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 114.955 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.99 13.09 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 119.982 1.264 . . . . 0.0 115.795 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -133.38 119.58 19.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.363 1.865 . . . . 0.0 111.513 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.96 99.72 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.029 0.932 . . . . 0.0 110.853 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 66' ' ' SER . 40.8 mm -71.61 -38.22 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 111.424 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -67.33 18.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.928 1.291 . . . . 0.0 114.242 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 64' ' ' ILE . 49.1 m 60.64 -176.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.531 2.332 . . . . 0.0 113.335 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.0 p -57.35 107.83 1.05 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.057 1.743 . . . . 0.0 110.827 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -59.29 159.81 21.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.26 3.307 . . . . 0.0 115.319 -172.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.88 167.17 22.74 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.75 143.97 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.671 1.589 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -92.56 -22.57 19.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.21 171.11 5.8 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.882 3.273 . . . . 0.0 109.399 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 m -51.68 -47.68 63.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.223 1.009 . . . . 0.0 110.989 164.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -66.48 1.36 1.71 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 m -104.28 130.42 52.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.535 1.061 . . . . 0.0 112.022 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.39 152.58 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.988 1.315 . . . . 0.0 111.579 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -142.7 111.49 6.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.726 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -76.59 130.38 37.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.614 1.166 . . . . 0.0 111.204 167.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mm -132.74 116.98 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.315 1.846 . . . . 0.0 110.023 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.8 128.24 34.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 111.303 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 tp -144.13 146.91 33.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.506 1.922 . . . . 0.0 110.695 -169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.4 100.3 41.92 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.397 1.479 . . . . 0.0 110.871 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.55 174.05 13.26 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.962 3.775 . . . . 0.0 113.314 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.71 165.53 32.04 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.631 2.22 . . . . 0.0 111.001 162.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.72 79.47 2.05 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.131 -0.981 . . . . 0.0 111.834 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.39 -168.53 41.5 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.766 1.174 . . . . 0.0 112.496 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.64 142.82 55.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.367 1.067 . . . . 0.0 110.357 170.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.7 m -164.6 168.52 18.08 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.675 -1.266 . . . . 0.0 112.531 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -126.31 100.77 6.43 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.214 1.006 . . . . 0.0 110.231 -171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.91 138.98 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 171.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.43 130.08 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.3 mt -127.12 101.93 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.255 . . . . 0.0 108.645 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.46 164.03 17.81 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.367 1.937 . . . . 0.0 111.071 -164.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.9 148.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.639 -0.918 . . . . 0.0 110.455 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 6.37 -92.1 0.01 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 128.457 2.932 . . . . 0.0 117.296 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -64.26 -13.81 51.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.7 m -108.54 -5.14 16.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.992 2.117 . . . . 0.0 112.507 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.87 127.03 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.515 1.126 . . . . 0.0 113.09 -168.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.87 82.01 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.9 m -79.01 104.95 10.0 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.756 0.822 . . . . 0.0 109.185 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.83 151.93 51.92 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 138.98 37.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.887 2.475 . . . . 0.0 114.976 -171.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -136.16 156.77 48.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.734 0.814 . . . . 0.0 111.785 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -128.87 109.47 11.29 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.843 1.257 . . . . 0.0 108.273 162.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -65.03 136.38 56.71 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.144 -0.347 . . . . 0.0 111.831 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 126.361 1.865 . . . . 0.0 114.156 -175.457 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.1 mmm . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 102.55 6.24 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -149.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 p -76.77 -15.36 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.55 173.37 35.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.741 1.163 . . . . 0.0 115.298 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 155.63 27.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.175 2.19 . . . . 0.0 112.792 -173.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -129.92 168.45 16.63 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.434 2.294 . . . . 0.0 112.009 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -104.1 138.46 40.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.247 1.419 . . . . 0.0 110.661 163.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 tp -75.9 82.24 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 122.783 1.278 . . . . 0.0 107.859 160.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.28 -14.56 59.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.331 1.452 . . . . 0.0 112.827 -170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -153.09 137.85 17.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.441 1.097 . . . . 0.0 110.282 154.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.73 168.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.875 2.47 . . . . 0.0 113.57 165.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.1 mtm -82.71 134.5 35.14 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.135 -0.978 . . . . 0.0 113.525 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.16 31.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.892 1.277 . . . . 0.0 110.546 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -83.27 159.75 21.87 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -111.39 169.24 8.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.105 1.762 . . . . 0.0 111.863 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -26.73 64.74 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.893 0.877 . . . . 0.0 112.283 164.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -63.7 -11.8 29.02 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.765 1.626 . . . . 0.0 112.261 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.8 76.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.249 1.404 . . . . 0.0 113.843 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 p -76.16 165.64 24.61 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.672 1.989 . . . . 0.0 110.658 165.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -125.44 147.4 49.22 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.994 0.918 . . . . 0.0 110.956 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.6 t -114.43 120.98 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.377 1.071 . . . . 0.0 109.363 -171.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.53 133.5 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.06 1.744 . . . . 0.0 109.102 -173.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -103.45 115.79 31.18 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.547 1.067 . . . . 0.0 110.034 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -88.76 161.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.207 0.603 . . . . 0.0 110.108 170.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.39 142.42 47.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.201 1.801 . . . . 0.0 107.237 154.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -78.41 155.1 30.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.451 1.478 . . . . 0.0 110.653 169.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -127.02 -62.34 1.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.869 0.868 . . . . 0.0 110.337 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -29.26 -59.74 0.17 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.956 3.17 . . . . 0.0 118.353 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.37 15.69 3.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -160.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -45.71 3.0 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.743 -1.223 . . . . 0.0 114.061 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.08 8.0 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 128.045 2.538 . . . . 0.0 115.539 -170.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -66.71 161.32 42.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.041 2.494 . . . . 0.0 112.414 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.3 m -156.25 155.7 32.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 0.0 111.179 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 137.57 38.46 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 142.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.291 1.7 m -99.74 134.38 21.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.767 -169.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.58 100.71 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.174 2.583 . . . . 0.0 109.256 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mt -112.22 124.41 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.76 0.824 . . . . 0.0 111.08 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.73 163.1 21.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.826 1.251 . . . . 0.0 110.225 164.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mt -118.78 126.69 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 146.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.23 163.94 12.59 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.61 1.164 . . . . 0.0 111.966 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -56.59 171.01 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 127.343 2.257 . . . . 0.0 113.803 173.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.75 -26.53 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.451 -0.78 . . . . 0.0 112.847 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -72.81 -17.25 61.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.614 1.565 . . . . 0.0 113.449 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HE3' ' CD2' ' A' ' 89' ' ' TYR . 42.8 mttp 71.73 23.62 3.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.734 2.413 . . . . 0.0 113.4 175.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -119.19 -31.6 4.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.148 1.779 . . . . 0.0 114.009 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -126.0 129.16 48.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.705 1.138 . . . . 0.0 110.917 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.53 133.74 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.358 1.463 . . . . 0.0 111.576 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -133.44 -10.5 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.149 1.78 . . . . 0.0 114.252 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.63 170.92 13.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.349 0.976 . . . . 0.0 114.599 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -131.35 138.22 49.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.812 1.645 . . . . 0.0 110.439 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.02 128.85 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.583 0.753 . . . . 0.0 109.616 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.59 -54.52 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 112.522 -162.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -60.41 -33.39 72.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -175.75 169.27 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.54 1.936 . . . . 0.0 110.135 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 p -66.52 105.13 0.73 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.334 157.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -58.44 145.52 93.93 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.528 2.819 . . . . 0.0 115.806 -163.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -144.7 167.68 21.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.13 0.972 . . . . 0.0 112.837 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.96 128.8 29.06 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.386 2.274 . . . . 0.0 108.334 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -75.2 -16.6 60.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.59 168.43 3.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.613 2.365 . . . . 0.0 110.429 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -58.47 -44.75 89.42 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.472 0.709 . . . . 0.0 110.065 156.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -69.88 40.13 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.453 1.901 . . . . 0.0 112.678 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -156.19 148.8 23.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 119.653 -1.904 . . . . 0.0 111.964 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.61 156.34 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.766 1.626 . . . . 0.0 111.078 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -142.98 107.76 4.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.101 0.56 . . . . 0.0 110.608 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -74.18 125.51 28.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.587 0.755 . . . . 0.0 110.852 164.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 mm -128.66 120.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.5 1.52 . . . . 0.0 110.022 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -71.04 130.66 42.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.4 1.08 . . . . 0.0 111.276 162.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 tp -143.94 151.55 39.93 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.308 2.243 . . . . 0.0 109.731 -168.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -125.7 94.37 42.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.901 1.68 . . . . 0.0 109.653 -165.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -76.07 172.59 15.98 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.606 3.537 . . . . 0.0 113.268 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.34 160.42 49.9 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.347 2.031 . . . . 0.0 110.692 162.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.26 72.61 2.33 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.221 -0.924 . . . . 0.0 111.097 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.33 42.42 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.318 1.913 . . . . 0.0 111.269 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.64 148.12 38.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.316 0.579 . . . . 0.0 111.045 169.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -163.97 161.3 22.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.929 0.891 . . . . 0.0 111.903 -167.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.506 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 86.5 m-85 -128.12 100.54 5.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 111.558 -169.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.57 126.56 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 127.668 2.387 . . . . 0.0 107.351 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.261 0.9 OUTLIER -119.08 120.95 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -122.04 97.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.498 1.519 . . . . 0.0 108.639 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.94 179.79 15.91 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.275 2.369 . . . . 0.0 110.493 -166.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.85 144.34 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.033 0.917 . . . . 0.0 111.169 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 38.0 -119.31 0.75 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.531 1.539 . . . . 0.0 113.858 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.44 -14.04 62.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.8 m -86.84 -10.79 52.64 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.226 1.011 . . . . 0.0 112.688 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.32 116.49 17.06 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.473 1.109 . . . . 0.0 113.467 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.7 mt -55.46 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 157.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.2 m -107.37 95.68 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.1 160.25 34.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.149 0.976 . . . . 0.0 113.38 -172.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.66 23.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.921 2.088 . . . . 0.0 114.521 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -151.64 132.01 13.74 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.157 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -103.88 109.31 21.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.003 1.321 . . . . 0.0 110.31 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.08 141.16 58.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 126.617 1.967 . . . . 0.0 114.353 -176.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 127.44 32.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -154.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.0 p -100.17 -7.58 24.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.0 113.708 163.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.72 170.26 34.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.91 1.243 . . . . 0.0 114.185 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 157.22 27.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.69 1.996 . . . . 0.0 112.734 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.5 m-85 -129.77 168.46 16.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.052 2.141 . . . . 0.0 111.732 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -105.51 141.3 37.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.611 1.565 . . . . 0.0 110.682 164.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 tp -77.01 95.09 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 156.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -93.15 -12.04 31.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.053 1.341 . . . . 0.0 112.613 -166.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -151.13 132.48 14.59 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.46 1.104 . . . . 0.0 109.62 149.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.7 153.61 0.57 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.694 1.998 . . . . 0.0 113.336 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -69.55 145.82 52.29 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.38 13.16 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.825 1.65 . . . . 0.0 109.519 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -78.41 156.91 29.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 113.272 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.1 p -108.53 170.24 8.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.636 1.574 . . . . 0.0 111.475 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -25.24 62.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.399 1.08 . . . . 0.0 112.248 164.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -64.57 -12.49 45.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.499 1.52 . . . . 0.0 112.023 164.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 1.63 84.28 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.421 1.486 . . . . 0.0 113.861 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -73.6 168.07 20.07 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.974 2.11 . . . . 0.0 110.847 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -125.0 148.61 48.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.262 1.025 . . . . 0.0 110.198 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 t -115.86 110.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.062 0.945 . . . . 0.0 109.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.64 124.27 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.6 1.16 . . . . 0.0 109.774 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -92.46 112.57 24.56 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.438 1.017 . . . . 0.0 110.018 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.01 165.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.978 0.511 . . . . 0.0 110.099 169.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 154.93 45.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.092 2.157 . . . . 0.0 108.113 156.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -98.79 139.15 34.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.934 1.697 . . . . 0.0 112.802 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -119.71 -33.26 4.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.692 -1.255 . . . . 0.0 113.101 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.81 -25.68 71.9 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -157.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.05 -47.1 3.07 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 120.678 1.581 . . . . 0.0 114.679 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.51 169.21 20.55 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 127.781 2.432 . . . . 0.0 113.964 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -68.01 160.19 49.7 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.905 2.404 . . . . 0.0 115.738 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 13.0 m -151.15 154.64 37.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.527 1.931 . . . . 0.0 110.733 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 136.07 36.73 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 144.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.295 1.1 m -96.85 141.81 23.62 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 118.308 0.504 . . . . 0.0 111.765 -165.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -88.16 96.89 0.4 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.999 2.466 . . . . 0.0 109.324 -168.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.28 129.41 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.6 0.76 . . . . 0.0 112.189 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.22 170.01 16.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.698 1.199 . . . . 0.0 110.147 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt -115.36 129.2 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 148.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.94 164.11 12.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.681 1.192 . . . . 0.0 111.995 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -58.62 172.0 0.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.226 2.21 . . . . 0.0 114.167 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.44 -31.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.081 -1.012 . . . . 0.0 112.464 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.46 -16.14 62.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.608 1.963 . . . . 0.0 113.255 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 mttm 67.23 20.18 10.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.498 2.719 . . . . 0.0 113.436 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -101.57 -40.35 7.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 112.09 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 32.9 mtmm -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.93 1.241 . . . . 0.0 112.879 -165.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.1 137.63 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.989 1.716 . . . . 0.0 112.442 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.35 -14.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.05 169.04 14.73 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-N 119.745 1.157 . . . . 0.0 114.977 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -129.95 122.87 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.266 1.426 . . . . 0.0 112.216 -172.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.08 100.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.561 1.144 . . . . 0.0 111.398 176.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.8 mm -71.7 -44.03 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 110.642 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -62.87 -3.2 1.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m 62.92 -26.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 129.398 3.079 . . . . 0.0 118.785 155.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.2 p -128.25 69.6 78.23 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.21 1.368 . . . . 0.0 112.223 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -54.12 106.97 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.671 2.914 . . . . 0.0 113.211 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 169.6 17.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 166.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.84 116.98 13.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.418 2.687 . . . . 0.0 107.837 171.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -72.08 -16.46 62.02 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.42 173.48 3.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.144 3.378 . . . . 0.0 108.384 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.6 -45.36 77.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.333 -0.855 . . . . 0.0 111.653 166.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.17 0.63 2.57 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.8 m -96.6 112.07 23.96 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 m -80.46 152.66 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.244 1.017 . . . . 0.0 111.717 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m -144.58 110.44 5.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.283 0.633 . . . . 0.0 110.754 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.3 124.0 28.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.457 0.703 . . . . 0.0 111.741 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.05 109.46 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.997 1.319 . . . . 0.0 109.197 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -67.53 127.64 33.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.05 0.94 . . . . 0.0 111.025 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.7 tp -147.08 145.73 29.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.108 1.763 . . . . 0.0 110.154 -167.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -120.16 97.48 49.2 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.581 1.552 . . . . 0.0 110.496 -165.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.94 170.83 19.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.265 3.31 . . . . 0.0 113.423 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.88 161.16 47.05 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.548 2.165 . . . . 0.0 111.062 163.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -72.63 90.55 1.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.369 -0.832 . . . . 0.0 110.548 168.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.04 -171.91 37.19 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.041 1.305 . . . . 0.0 111.147 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.82 147.97 31.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.536 0.734 . . . . 0.0 111.048 170.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 90.4 p -162.57 159.94 25.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 112.325 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -128.72 96.91 4.51 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.545 1.164 . . . . 0.0 110.923 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.8 128.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 127.704 2.402 . . . . 0.0 106.918 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.23 120.76 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.5 mt -122.48 94.32 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.136 1.374 . . . . 0.0 108.064 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 177.69 15.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.669 2.08 . . . . 0.0 110.543 -166.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 m -114.1 149.85 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.804 0.842 . . . . 0.0 110.763 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 32.72 -111.71 0.06 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 126.047 1.784 . . . . 0.0 114.971 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -70.41 -12.95 61.92 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 m -98.59 -9.32 24.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.626 1.571 . . . . 0.0 112.455 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.84 123.52 20.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.785 1.234 . . . . 0.0 112.934 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.99 90.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 151.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.6 m -84.68 101.25 12.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 168.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -125.63 154.66 41.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.701 1.239 . . . . 0.0 113.552 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 138.97 32.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.054 2.541 . . . . 0.0 114.618 -170.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -144.43 129.44 18.51 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 161.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -101.15 112.43 24.91 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.523 1.129 . . . . 0.0 109.656 165.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -66.58 134.46 52.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 126.435 1.894 . . . . 0.0 112.707 -172.253 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.9 mmm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 100.38 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -138.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 p -79.15 -10.85 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.298 1.839 . . . . 0.0 114.86 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.57 171.93 14.31 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.327 1.441 . . . . 0.0 114.63 -172.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 39' ' ' GLU . 12.0 ttpp -74.0 159.04 33.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.743 1.217 . . . . 0.0 114.023 -168.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -124.02 171.57 9.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.316 2.646 . . . . 0.0 109.741 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.18 139.63 45.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.969 1.708 . . . . 0.0 109.696 166.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.14 100.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.64 -10.0 20.42 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.179 1.391 . . . . 0.0 112.131 -165.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -153.42 143.57 22.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.149 1.38 . . . . 0.0 110.077 150.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.47 166.68 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 113.869 166.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -89.78 136.29 33.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.74 30.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 109.843 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.55 158.53 23.08 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -110.69 170.6 7.98 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.315 1.846 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.6 68.9 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.047 -1.033 . . . . 0.0 112.737 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -67.97 -10.77 56.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.096 1.758 . . . . 0.0 112.236 167.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.95 4.64 72.63 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.427 1.489 . . . . 0.0 114.052 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -74.6 166.12 24.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.446 1.898 . . . . 0.0 110.292 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -119.21 152.88 35.85 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.48 1.112 . . . . 0.0 110.15 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -115.04 113.26 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.024 0.929 . . . . 0.0 109.871 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.24 116.55 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.566 1.546 . . . . 0.0 109.27 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.83 117.5 29.84 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.876 0.762 . . . . 0.0 110.572 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.57 160.03 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 110.234 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -141.17 150.43 42.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.636 1.974 . . . . 0.0 108.227 164.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -98.55 150.85 21.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.27 1.395 . . . . 0.0 112.982 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 17' ' ' LYS . 53.5 mt-10 -128.09 -63.87 0.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 110.971 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -7.66 -72.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 129.649 3.499 . . . . 0.0 117.106 -169.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.39 18.62 3.66 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.578 1.551 . . . . 0.0 113.446 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.46 -43.64 1.1 Allowed Glycine 0 CA--C 1.539 1.593 0 N-CA-C 116.557 1.383 . . . . 0.0 116.557 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 165.43 4.47 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.713 2.805 . . . . 0.0 114.761 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.03 157.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.647 2.231 . . . . 0.0 113.831 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.0 m -151.76 157.22 41.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.277 1.431 . . . . 0.0 112.014 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 138.05 36.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 139.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 m -97.53 123.75 51.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.873 -171.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.86 124.24 13.7 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.557 2.171 . . . . 0.0 110.072 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mt -132.8 130.99 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 109.73 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.21 167.98 16.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 166.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.7 mt -124.25 128.8 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 147.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.52 164.11 13.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.704 1.202 . . . . 0.0 112.088 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.97 175.5 0.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.466 2.306 . . . . 0.0 113.492 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.0 -32.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.45 -8.04 58.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.583 1.553 . . . . 0.0 113.177 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 66.82 32.42 6.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.188 2.195 . . . . 0.0 113.0 171.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -130.85 -20.72 2.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.409 1.484 . . . . 0.0 114.64 -175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -121.65 121.65 37.84 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.685 1.129 . . . . 0.0 110.359 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.07 133.84 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 111.624 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -137.35 -7.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.794 1.638 . . . . 0.0 114.537 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.5 170.01 13.22 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.682 1.128 . . . . 0.0 114.679 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -131.71 119.58 21.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.12 1.768 . . . . 0.0 110.947 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -72.11 122.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.857 0.863 . . . . 0.0 109.78 176.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.1 mm -97.36 -33.24 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.499 0.719 . . . . 0.0 111.707 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.7 t -62.2 20.28 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.386 2.274 . . . . 0.0 116.84 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.1 p 60.01 -169.01 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.805 2.042 . . . . 0.0 112.535 -163.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.4 p -60.87 106.38 0.77 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.246 1.818 . . . . 0.0 111.083 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.59 144.4 97.38 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.645 2.896 . . . . 0.0 113.46 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.02 167.21 22.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.87 123.7 18.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.87 2.068 . . . . 0.0 108.358 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -75.3 -26.46 58.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.933 0.893 . . . . 0.0 113.135 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.62 172.86 4.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.139 2.575 . . . . 0.0 109.916 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -39.28 63.76 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 171.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -72.8 -2.65 21.37 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -94.86 155.44 16.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 111.749 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.5 147.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.514 1.126 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.7 m -139.35 105.34 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.592 0.357 . . . . 0.0 110.644 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.79 89.56 4.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.204 1.801 . . . . 0.0 111.837 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.52 117.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.931 1.692 . . . . 0.0 111.201 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -69.13 126.88 31.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.054 0.942 . . . . 0.0 111.466 159.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.5 tp -143.04 147.01 34.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.679 1.991 . . . . 0.0 110.268 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -118.65 97.48 50.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.395 1.478 . . . . 0.0 110.528 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.05 172.08 16.67 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.752 3.635 . . . . 0.0 113.666 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.61 163.14 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.498 2.132 . . . . 0.0 111.1 164.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.83 74.01 4.39 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.322 -0.861 . . . . 0.0 111.688 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.65 -168.14 40.94 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.053 1.311 . . . . 0.0 111.632 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -67.24 144.35 56.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.476 0.655 . . . . 0.0 111.085 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.6 p -161.73 160.14 28.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.083 0.953 . . . . 0.0 111.502 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.47 98.03 4.73 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.493 0.717 . . . . 0.0 110.333 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.89 135.45 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.764 1.626 . . . . 0.0 107.305 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.87 123.45 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.2 mt -125.31 109.85 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.719 1.207 . . . . 0.0 109.488 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.49 163.63 26.28 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.963 1.744 . . . . 0.0 111.422 -162.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.88 166.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.708 -0.878 . . . . 0.0 111.872 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -30.17 -59.81 0.21 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.456 2.455 . . . . 0.0 116.885 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.99 3.24 0.87 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.848 1.659 . . . . 0.0 115.232 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -161.93 12.09 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.269 -1.519 . . . . 0.0 114.29 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.31 108.34 7.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.349 1.459 . . . . 0.0 112.286 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.08 101.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 160.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.5 m -112.31 95.2 5.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.317 1.047 . . . . 0.0 108.386 -167.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -130.44 146.45 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 137.95 45.75 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.037 2.935 . . . . 0.0 114.872 -172.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -149.22 121.02 8.12 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.943 0.897 . . . . 0.0 112.539 165.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -92.3 108.05 19.66 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.443 0.697 . . . . 0.0 109.754 164.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -64.05 131.78 48.59 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.978 0.511 . . . . 0.0 111.038 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 mttp . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.946 1.699 . . . . 0.0 112.728 -171.414 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.99 108.56 10.13 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -153.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.7 p -69.39 -4.52 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.25 1.42 . . . . 0.0 114.315 165.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.65 172.15 46.14 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.506 1.527 . . . . 0.0 114.339 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.56 163.17 27.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.59 1.556 . . . . 0.0 113.799 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.48 174.38 10.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.444 2.298 . . . . 0.0 109.76 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 p -112.13 145.46 39.76 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.259 1.024 . . . . 0.0 110.983 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.2 103.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 156.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 -14.71 14.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.905 0.882 . . . . 0.0 111.45 -159.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.7 ttpp -143.83 136.91 27.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.635 1.574 . . . . 0.0 108.615 149.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.29 156.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.917 2.087 . . . . 0.0 113.628 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 mtm -70.69 132.78 45.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.1 122.74 36.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.034 1.333 . . . . 0.0 109.996 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 152.61 34.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.581 0.705 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.7 p -101.27 167.54 10.13 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 111.105 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -24.69 64.12 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.244 -0.91 . . . . 0.0 112.27 163.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -64.94 -9.22 19.7 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.232 1.813 . . . . 0.0 112.419 165.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.89 -3.82 63.48 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.764 1.65 . . . . 0.0 114.17 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -69.58 168.35 14.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.73 2.012 . . . . 0.0 110.736 165.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 t -125.8 154.06 43.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.758 0.823 . . . . 0.0 110.481 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -118.72 118.95 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.43 1.092 . . . . 0.0 109.663 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.16 116.81 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.49 1.516 . . . . 0.0 110.125 -173.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 tmmt? -89.59 109.9 20.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.376 0.989 . . . . 0.0 109.822 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -86.75 165.66 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.205 1.002 . . . . 0.0 110.495 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 150.99 45.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.941 1.696 . . . . 0.0 108.544 153.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -94.15 129.96 40.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.289 0.95 . . . . 0.0 113.024 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -131.21 1.82 4.22 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.09 -61.82 2.76 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.102 0.858 . . . . 0.0 114.561 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.19 19.35 1.4 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -165.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.1 -43.77 2.52 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.612 -1.305 . . . . 0.0 115.553 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.18 174.33 2.95 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 127.16 2.184 . . . . 0.0 114.31 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.07 162.82 33.84 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.515 2.81 . . . . 0.0 114.22 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.2 m -145.35 151.59 38.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.684 1.994 . . . . 0.0 110.284 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 131.78 34.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 131.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.276 0.9 OUTLIER -90.43 137.91 27.22 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 118.561 0.618 . . . . 0.0 110.824 -168.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.07 97.3 0.56 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.845 2.363 . . . . 0.0 109.569 -168.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.66 124.57 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.781 0.832 . . . . 0.0 111.384 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.64 168.63 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.23 1.412 . . . . 0.0 110.242 164.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.23 133.03 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 147.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -112.17 162.87 14.98 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.533 1.133 . . . . 0.0 111.921 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -56.6 171.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.809 2.043 . . . . 0.0 113.138 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -57.49 -28.83 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 112.701 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -75.63 -12.62 60.24 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.03 2.132 . . . . 0.0 113.772 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 68.04 25.88 7.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.637 2.375 . . . . 0.0 113.452 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -120.59 -27.42 5.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.403 1.481 . . . . 0.0 114.04 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -124.07 129.05 50.23 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.676 1.125 . . . . 0.0 111.364 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.79 131.39 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.826 1.65 . . . . 0.0 111.535 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.51 -7.37 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.962 1.705 . . . . 0.0 114.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.49 166.04 15.0 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.637 1.108 . . . . 0.0 114.745 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -129.54 109.87 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.017 1.727 . . . . 0.0 109.837 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -70.14 114.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 0.0 109.645 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.5 mm -87.58 -33.9 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.887 . . . . 0.0 111.977 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.9 t -64.27 23.19 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.551 1.94 . . . . 0.0 116.062 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p 74.63 -101.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 129.997 3.319 . . . . 0.0 113.134 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.7 p -131.39 99.03 17.72 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.705 1.602 . . . . 0.0 109.072 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.46 137.71 31.82 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.86 3.04 . . . . 0.0 113.797 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -141.94 168.16 20.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 137.18 37.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.909 2.084 . . . . 0.0 108.256 168.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -91.59 -17.0 26.27 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.256 -0.903 . . . . 0.0 112.852 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.98 176.42 1.79 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 130.939 3.695 . . . . 0.0 108.167 173.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -40.88 64.52 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.816 -1.178 . . . . 0.0 112.848 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -65.31 -6.69 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.41 1.084 . . . . 0.0 113.852 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -78.49 123.82 27.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.227 0.922 . . . . 0.0 111.398 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.25 154.51 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.116 159.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.3 109.14 4.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.833 0.453 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 107.35 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.179 0.992 . . . . 0.0 112.004 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -104.27 114.08 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 125.455 1.502 . . . . 0.0 110.684 -172.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.36 129.96 41.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.868 0.842 . . . . 0.0 111.137 161.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.7 147.61 29.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.066 1.746 . . . . 0.0 110.217 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.98 94.13 43.77 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.645 1.578 . . . . 0.0 110.433 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -66.95 171.38 11.27 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.581 3.521 . . . . 0.0 112.826 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.53 155.59 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.005 1.803 . . . . 0.0 110.634 162.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -70.68 90.63 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.511 -0.743 . . . . 0.0 110.246 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.51 -170.62 32.92 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.849 1.214 . . . . 0.0 111.352 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.77 143.18 44.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.594 0.758 . . . . 0.0 111.607 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -160.68 158.06 28.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 112.36 -166.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -126.23 97.0 4.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.151 0.976 . . . . 0.0 110.972 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 132.42 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.424 2.29 . . . . 0.0 107.231 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.263 1.9 m -125.87 118.13 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mt -122.97 100.09 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.062 1.345 . . . . 0.0 108.97 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.65 -178.4 16.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.047 2.261 . . . . 0.0 110.285 -165.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.93 148.29 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.181 0.991 . . . . 0.0 111.06 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.92 -121.65 2.04 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.852 1.215 . . . . 0.0 113.523 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -69.69 -12.84 61.95 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.1 m -87.53 -9.86 53.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.485 1.114 . . . . 0.0 112.898 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.35 112.14 10.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.705 1.202 . . . . 0.0 113.072 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.49 95.84 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.838 0.855 . . . . 0.0 108.907 159.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -102.87 98.76 8.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.8 157.7 43.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.382 1.086 . . . . 0.0 113.766 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 143.07 28.95 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.098 2.159 . . . . 0.0 114.693 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -149.56 136.94 19.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.572 0.749 . . . . 0.0 112.86 160.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -104.28 108.07 19.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.719 1.208 . . . . 0.0 109.402 165.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -70.4 142.44 52.05 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.904 -0.498 . . . . 0.0 111.704 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 126.442 1.897 . . . . 0.0 112.217 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.472 ' HB2' ' H ' ' A' ' 46' ' ' LYS . 56.3 mmm . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -83.82 154.63 23.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -134.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.9 p -125.24 1.56 7.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.918 1.687 . . . . 0.0 114.069 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.79 174.45 49.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.92 1.247 . . . . 0.0 113.452 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -74.48 161.53 29.69 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.933 1.293 . . . . 0.0 112.514 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 47' ' ' VAL . 86.0 m-85 -130.05 177.06 7.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.014 2.126 . . . . 0.0 109.373 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.8 p -107.32 151.58 25.29 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.914 0.779 . . . . 0.0 111.183 155.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 tp -83.59 100.33 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -15.17 15.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.062 1.345 . . . . 0.0 112.233 -160.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -147.57 141.8 26.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.774 2.43 . . . . 0.0 107.381 151.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.62 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.069 2.948 . . . . 0.0 115.006 167.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -86.01 129.88 34.71 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.155 -0.966 . . . . 0.0 112.563 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.78 118.17 24.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -80.31 156.1 26.95 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.1 p -112.68 171.77 7.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.578 1.551 . . . . 0.0 112.832 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.12 66.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.129 0.972 . . . . 0.0 113.316 166.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.07 -6.66 58.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.997 2.119 . . . . 0.0 111.597 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.0 6.7 60.8 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 120.832 -1.167 . . . . 0.0 113.705 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -76.36 169.67 17.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.972 2.109 . . . . 0.0 110.103 164.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -129.31 147.65 51.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.073 0.949 . . . . 0.0 111.149 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.85 102.25 13.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.519 1.128 . . . . 0.0 110.312 -171.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.45 144.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.45 1.9 . . . . 0.0 109.2 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -111.85 125.28 53.85 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.238 1.381 . . . . 0.0 109.228 168.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 m -104.15 169.39 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.422 1.089 . . . . 0.0 110.44 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.28 155.5 44.49 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.43 1.892 . . . . 0.0 108.523 158.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -97.78 130.1 44.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.087 1.312 . . . . 0.0 112.836 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -132.19 13.98 4.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.099 -1.0 . . . . 0.0 112.679 -169.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.04 -50.04 2.53 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.227 0.918 . . . . 0.0 115.103 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.83 9.88 1.02 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -166.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.46 -41.97 1.91 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 120.112 1.324 . . . . 0.0 114.783 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.24 177.42 2.81 Favored Pre-proline 0 CA--C 1.561 1.365 0 C-N-CA 127.719 2.408 . . . . 0.0 114.188 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 166.25 24.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.241 3.294 . . . . 0.0 115.161 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.2 m -149.14 155.22 40.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.749 2.02 . . . . 0.0 110.798 172.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' H ' ' HB2' ' A' ' 13' ' ' MET . 8.0 ptpt -83.3 134.1 34.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 118.79 -1.164 . . . . 0.0 107.925 127.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 18' ' ' PHE 0.287 1.9 m -93.87 131.06 32.77 Favored Pre-proline 0 N--CA 1.468 0.434 0 O-C-N 123.551 0.532 . . . . 0.0 110.258 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.82 105.18 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.89 2.393 . . . . 0.0 108.859 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.91 124.9 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.914 0.886 . . . . 0.0 111.092 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 52' ' ' ARG . 63.5 mt-10 -136.2 169.45 17.62 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 109.768 168.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.4 mt -119.78 124.6 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 50' ' ' GLU . 61.5 mtt-85 -107.79 162.22 14.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 111.048 171.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -59.84 176.22 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.956 2.102 . . . . 0.0 113.967 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.06 -33.59 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.841 -1.162 . . . . 0.0 112.766 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -74.22 -11.44 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.279 1.832 . . . . 0.0 113.543 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 63.43 28.85 15.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.243 2.617 . . . . 0.0 113.606 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.21 -40.1 5.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.88 1.672 . . . . 0.0 112.563 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -124.32 138.0 54.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.874 1.215 . . . . 0.0 111.677 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.63 133.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.783 1.233 . . . . 0.0 111.38 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.27 -11.38 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.079 1.752 . . . . 0.0 114.072 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.35 168.03 14.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.541 1.067 . . . . 0.0 114.659 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -133.42 121.83 22.85 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.176 1.79 . . . . 0.0 111.274 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 122.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.963 0.802 . . . . 0.0 110.177 174.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.2 mm -95.85 -37.05 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 0.0 111.596 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 t -64.24 -7.51 9.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.7 m 117.82 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 1 C-N-CA 132.944 4.497 . . . . 0.0 108.961 -166.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 m -65.41 117.57 41.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.178 -0.915 . . . . 0.0 108.733 159.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.29 156.59 20.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.589 3.526 . . . . 0.0 115.261 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.16 169.08 18.87 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 172.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.64 139.37 31.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.457 2.303 . . . . 0.0 108.583 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -97.95 -17.6 19.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.006 0.923 . . . . 0.0 112.717 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.81 174.94 7.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.643 3.177 . . . . 0.0 108.072 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -44.65 62.54 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.309 -0.869 . . . . 0.0 112.369 173.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -65.65 -7.49 15.52 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.117 1.367 . . . . 0.0 113.917 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -71.62 106.42 4.04 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.32 0.964 . . . . 0.0 110.834 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.05 149.19 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.625 154.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 m -141.41 117.7 10.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.049 0.54 . . . . 0.0 110.134 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.25 119.66 29.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.753 0.821 . . . . 0.0 111.669 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 mm -120.82 110.87 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.877 1.671 . . . . 0.0 110.683 -167.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -69.01 123.79 21.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.536 1.134 . . . . 0.0 111.165 162.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.4 tp -142.35 141.66 32.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.782 2.033 . . . . 0.0 109.943 -169.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -113.78 100.58 52.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.853 1.661 . . . . 0.0 110.564 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -78.06 173.36 14.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.391 3.394 . . . . 0.0 113.77 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.74 161.92 43.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.522 2.148 . . . . 0.0 110.878 162.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -72.7 102.63 3.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.984 166.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.47 -169.82 25.78 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.87 1.224 . . . . 0.0 111.964 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.64 139.52 39.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.165 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -159.59 164.48 34.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.105 0.962 . . . . 0.0 112.261 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -129.11 104.93 7.84 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.224 1.011 . . . . 0.0 111.526 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.33 123.82 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.261 2.224 . . . . 0.0 107.102 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.68 122.63 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.33 100.38 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.994 1.317 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.19 176.28 18.59 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.714 2.102 . . . . 0.0 110.216 -161.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.6 m -107.25 139.71 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.16 0.98 . . . . 0.0 110.3 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 23.14 -100.17 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 127.902 2.667 . . . . 0.0 115.563 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -59.02 -16.37 18.01 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -110.09 -2.9 16.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.738 1.615 . . . . 0.0 112.767 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.17 111.33 16.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.103 0.961 . . . . 0.0 112.963 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.9 mt -56.22 100.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 93.03 4.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.37 156.27 34.29 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.293 1.044 . . . . 0.0 113.51 -172.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 147.0 33.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.444 1.898 . . . . 0.0 114.495 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -146.1 144.08 29.77 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.33 1.052 . . . . 0.0 110.725 157.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -114.42 116.84 29.53 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -70.03 138.68 52.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 126.035 1.734 . . . . 0.0 115.401 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.422 ' HB2' ' H ' ' A' ' 46' ' ' LYS . 84.7 mmm . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.82 105.51 7.93 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -133.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -72.45 -3.52 24.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.09 1.756 . . . . 0.0 114.547 166.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 170.49 51.22 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.888 1.232 . . . . 0.0 113.67 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -73.66 160.66 31.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.146 1.378 . . . . 0.0 113.014 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -131.31 175.0 9.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.093 2.157 . . . . 0.0 109.901 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p -114.71 144.66 43.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 111.382 160.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.59 93.57 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 159.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.4 -16.49 21.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.264 -159.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -145.74 139.42 26.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.85 2.06 . . . . 0.0 108.105 148.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.1 162.05 0.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.779 2.432 . . . . 0.0 114.602 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 mtm -69.88 127.39 32.73 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 123.4 37.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.898 1.279 . . . . 0.0 110.245 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.93 155.16 27.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 p -105.21 170.82 7.66 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.252 1.821 . . . . 0.0 111.448 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -27.34 67.78 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.196 -0.94 . . . . 0.0 112.416 165.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.55 -9.73 37.99 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.555 1.942 . . . . 0.0 112.256 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.39 1.44 60.83 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.317 1.436 . . . . 0.0 114.014 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.25 166.12 22.22 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.157 1.783 . . . . 0.0 110.262 164.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -122.79 148.0 45.87 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 110.5 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.84 113.57 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 109.4 -173.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -110.41 116.08 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 109.792 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -96.09 105.04 17.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.42 0.555 . . . . 0.0 109.688 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.27 166.22 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.506 1.122 . . . . 0.0 110.655 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 146.63 30.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.914 1.685 . . . . 0.0 108.716 160.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -91.09 134.96 34.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.795 0.725 . . . . 0.0 112.496 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -133.38 3.15 3.6 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.135 -0.978 . . . . 0.0 113.583 -171.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.78 -36.5 7.28 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.216 1.247 . . . . 0.0 116.216 -170.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.96 7.88 0.41 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.16 -43.07 1.96 Allowed Glycine 0 CA--C 1.535 1.322 0 CA-C-N 120.211 1.369 . . . . 0.0 114.928 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.46 167.66 6.54 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 127.696 2.399 . . . . 0.0 115.025 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.94 163.42 22.32 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.657 2.904 . . . . 0.0 113.478 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -147.29 154.5 41.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.733 1.613 . . . . 0.0 111.59 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 13' ' ' MET . 7.8 ptpt -87.27 140.49 29.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 127.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 1.4 m -100.74 120.53 55.49 Favored Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.06 115.59 3.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.28 1.987 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mt -126.1 129.64 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 110.712 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.09 165.32 18.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.392 1.077 . . . . 0.0 110.154 162.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.94 130.74 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 146.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -112.12 164.9 12.64 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.431 1.492 . . . . 0.0 112.435 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -58.14 171.32 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.591 1.956 . . . . 0.0 113.508 172.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.9 -36.13 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.367 -0.833 . . . . 0.0 112.932 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.87 -12.33 60.64 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.876 2.07 . . . . 0.0 113.988 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 67.09 27.76 8.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 113.419 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.17 -27.96 7.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.084 2.154 . . . . 0.0 113.012 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -131.72 132.92 44.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.214 0.916 . . . . 0.0 111.041 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.98 134.22 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.204 1.402 . . . . 0.0 110.89 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.61 -8.46 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.921 1.688 . . . . 0.0 114.19 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.9 163.59 18.42 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 119.555 1.07 . . . . 0.0 114.686 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -127.21 112.87 15.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.889 1.675 . . . . 0.0 110.36 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -72.31 109.77 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.607 0.763 . . . . 0.0 109.947 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.01 -38.23 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.971 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -67.44 30.71 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.73 2.012 . . . . 0.0 114.558 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.34 -173.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.943 2.097 . . . . 0.0 113.095 -169.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -66.93 111.72 7.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.371 1.068 . . . . 0.0 109.238 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -55.82 152.99 32.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.476 3.451 . . . . 0.0 115.544 -169.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.26 167.26 22.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.6 143.71 31.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.008 1.723 . . . . 0.0 109.127 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -96.4 -18.53 19.84 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.79 174.03 5.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.844 2.858 . . . . 0.0 108.547 173.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -45.75 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.608 -0.682 . . . . 0.0 112.018 169.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -66.36 -3.39 5.88 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.3 m -87.41 119.81 28.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 111.459 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.58 156.12 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 159.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.51 119.05 10.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.069 0.548 . . . . 0.0 110.87 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.67 106.11 18.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.66 109.06 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.085 1.754 . . . . 0.0 110.526 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -67.14 126.55 29.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.385 0.612 . . . . 0.0 110.875 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.8 tp -146.65 140.73 26.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 110.235 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.94 94.14 23.8 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.011 1.324 . . . . 0.0 110.727 -172.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.83 169.95 20.82 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.641 3.561 . . . . 0.0 112.865 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 163.47 39.07 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.815 2.343 . . . . 0.0 111.664 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -75.22 72.11 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.852 0.861 . . . . 0.0 111.442 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.49 -169.34 41.42 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.233 1.397 . . . . 0.0 111.813 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.82 145.05 50.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.273 0.559 . . . . 0.0 111.11 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -161.02 154.68 22.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.574 0.749 . . . . 0.0 112.138 -166.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -127.78 101.92 6.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.157 0.98 . . . . 0.0 111.656 -171.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.89 139.53 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.966 2.106 . . . . 0.0 107.647 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.4 125.04 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 170.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 mt -125.67 103.34 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.685 1.194 . . . . 0.0 109.099 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.27 178.13 20.84 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.109 1.814 . . . . 0.0 111.117 -162.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 145.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.074 0.937 . . . . 0.0 110.786 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 22.03 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.683 2.563 . . . . 0.0 116.063 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.05 -11.28 28.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -107.98 -7.74 16.09 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.276 1.83 . . . . 0.0 112.639 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 127.41 32.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 112.171 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.54 87.12 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 157.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.8 m -79.39 98.26 6.68 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -125.05 176.62 6.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.207 1.403 . . . . 0.0 113.008 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 139.9 53.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -154.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -154.86 131.27 10.46 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -106.22 109.84 21.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.02 1.328 . . . . 0.0 109.327 165.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -63.82 148.35 49.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.649 0.78 . . . . 0.0 111.775 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 129.079 2.952 . . . . 0.0 116.214 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.446 ' HB2' ' H ' ' A' ' 46' ' ' LYS . 66.0 mmm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.3 m -79.83 107.67 12.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -138.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 p -69.36 -9.45 53.51 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 164.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 171.93 52.48 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.701 1.619 . . . . 0.0 114.337 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -77.22 160.82 28.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.447 1.499 . . . . 0.0 114.301 -169.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CE2' ' HB ' ' A' ' 47' ' ' VAL . 87.7 m-85 -130.46 173.64 10.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.535 2.334 . . . . 0.0 109.954 173.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.0 p -119.75 142.93 48.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.073 0.949 . . . . 0.0 112.037 159.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 101.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 163.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -106.52 -13.19 15.39 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.809 1.243 . . . . 0.0 111.046 -164.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -149.23 140.82 23.43 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.872 2.069 . . . . 0.0 108.883 148.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.15 170.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.464 2.706 . . . . 0.0 114.477 166.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.0 mtm -80.89 133.8 35.63 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.95 114.76 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.945 1.698 . . . . 0.0 110.718 176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.49 151.45 43.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p -106.36 168.89 8.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.976 1.711 . . . . 0.0 111.72 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -26.21 66.97 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.291 -0.881 . . . . 0.0 112.559 166.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -67.21 -8.64 33.08 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.311 2.244 . . . . 0.0 112.422 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.08 0.48 65.56 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.405 1.479 . . . . 0.0 114.205 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -73.31 173.29 9.73 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.126 2.17 . . . . 0.0 110.263 164.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -133.44 146.06 50.83 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 111.133 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.37 103.95 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.855 1.262 . . . . 0.0 110.385 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.58 168.4 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.599 1.96 . . . . 0.0 110.144 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -133.86 124.97 27.38 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.472 -0.767 . . . . 0.0 111.054 159.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.75 165.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.434 1.093 . . . . 0.0 110.524 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.03 145.33 39.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.952 1.701 . . . . 0.0 108.564 156.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -84.81 143.69 28.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.797 1.181 . . . . 0.0 111.654 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -136.27 -9.37 1.98 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -36.0 62.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.162 -1.355 . . . . 0.0 116.344 -170.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.86 12.78 0.25 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -166.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 -43.89 2.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 120.9 1.682 . . . . 0.0 114.416 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.57 175.44 4.68 Favored Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 127.4 2.28 . . . . 0.0 114.743 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.18 167.89 17.16 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.352 3.368 . . . . 0.0 115.388 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -148.21 160.84 42.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.624 1.969 . . . . 0.0 110.911 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' H ' ' HB2' ' A' ' 13' ' ' MET . 7.0 ptpt -88.1 136.29 33.04 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 129.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HB ' ' CE2' ' A' ' 18' ' ' PHE 0.332 2.0 m -96.29 135.52 22.51 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.355 0.409 . . . . 0.0 111.158 -169.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -87.14 89.39 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.019 2.479 . . . . 0.0 107.888 -163.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.1 125.69 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.725 0.81 . . . . 0.0 111.342 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.81 162.77 24.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.32 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' CG2' ' HB3' ' A' ' 88' ' ' SER . 4.1 mt -118.62 126.91 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 151.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -110.84 162.99 14.24 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.323 1.014 . . . . 0.0 112.452 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -58.39 171.94 0.53 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.136 2.174 . . . . 0.0 113.079 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.86 -31.99 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -74.69 -12.85 60.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.186 1.794 . . . . 0.0 113.515 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 mttm 67.84 26.56 7.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.122 2.169 . . . . 0.0 113.171 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.47 4.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.995 2.118 . . . . 0.0 113.165 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.3 131.07 57.05 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.347 0.976 . . . . 0.0 110.624 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.1 138.72 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.991 0.916 . . . . 0.0 111.447 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.36 -10.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.617 1.567 . . . . 0.0 115.083 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.83 169.77 13.86 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.994 1.27 . . . . 0.0 115.715 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.59 107.82 9.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.081 2.152 . . . . 0.0 110.553 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.42 108.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.296 0.638 . . . . 0.0 110.07 175.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 66' ' ' SER . 31.3 mm -78.95 -36.54 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.215 1.006 . . . . 0.0 111.408 -174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -67.43 26.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.85 1.66 . . . . 0.0 114.658 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 64' ' ' ILE . 6.1 t 63.43 -178.5 0.15 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.946 2.498 . . . . 0.0 113.168 -168.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.5 m -61.64 110.68 3.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.428 1.091 . . . . 0.0 108.925 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.57 159.2 11.48 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.315 3.343 . . . . 0.0 115.431 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -141.98 168.2 20.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.22 38.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.935 1.694 . . . . 0.0 108.286 171.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -93.84 -14.37 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.09 172.9 2.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 130.483 3.513 . . . . 0.0 108.451 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -57.74 -50.35 73.51 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 110.967 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -66.44 3.09 1.03 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 m -97.84 124.79 42.39 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.479 1.111 . . . . 0.0 111.077 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 m -86.91 162.15 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.426 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.32 107.02 4.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.689 0.795 . . . . 0.0 109.111 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -73.28 136.27 44.52 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.991 -0.443 . . . . 0.0 109.978 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -135.64 109.55 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.497 1.119 . . . . 0.0 110.094 -168.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -73.0 130.3 40.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.272 1.029 . . . . 0.0 110.746 163.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.8 tp -151.9 144.56 24.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.995 1.318 . . . . 0.0 110.986 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -117.39 96.91 50.13 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.747 1.619 . . . . 0.0 110.77 -171.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.73 171.1 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.803 3.668 . . . . 0.0 112.564 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.94 164.33 32.15 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.477 2.118 . . . . 0.0 111.483 168.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.25 87.55 1.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.77 166.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.01 -173.47 44.09 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.856 1.217 . . . . 0.0 112.051 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.97 159.15 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.755 0.822 . . . . 0.0 110.21 165.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.422 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 18.7 m -171.39 158.3 5.23 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.475 1.11 . . . . 0.0 112.784 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.97 102.94 7.49 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.663 1.22 . . . . 0.0 110.328 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.71 125.31 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 128.599 2.759 . . . . 0.0 106.746 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.19 130.53 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.1 mt -129.16 94.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.209 1.404 . . . . 0.0 108.577 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.24 -170.52 18.07 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.421 1.963 . . . . 0.0 109.767 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.61 179.11 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.231 1.015 . . . . 0.0 110.721 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.74 -20.17 17.24 Favored Glycine 0 CA--C 1.541 1.705 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 -168.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.51 0.26 49.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -154.32 -8.46 0.14 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.62 128.08 34.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.692 1.197 . . . . 0.0 113.942 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.09 98.61 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 152.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -96.41 100.94 12.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.93 165.83 18.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 112.381 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 153.11 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.115 1.766 . . . . 0.0 114.552 -167.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -150.37 147.57 27.75 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.098 0.559 . . . . 0.0 111.843 162.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -124.19 111.88 16.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -66.97 144.13 56.39 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 111.392 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 129.102 2.961 . . . . 0.0 116.928 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mmm . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -85.24 95.99 9.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -140.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.0 p -65.87 -2.5 3.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 162.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.67 176.56 53.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.255 1.407 . . . . 0.0 113.925 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 154.01 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.69 2.396 . . . . 0.0 111.797 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -135.15 174.06 11.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.199 1.8 . . . . 0.0 110.77 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.449 ' HG ' ' CD ' ' A' ' 39' ' ' GLU . 8.4 m -123.46 144.19 49.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.601 0.76 . . . . 0.0 112.172 161.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.4 91.48 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 107.249 159.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -94.29 -13.41 26.51 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.913 1.285 . . . . 0.0 111.857 -163.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -150.25 135.83 18.22 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.415 1.886 . . . . 0.0 109.431 148.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.76 162.81 0.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.884 2.874 . . . . 0.0 115.169 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 32.3 mtm -70.41 122.41 19.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.3 119.61 36.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.597 1.159 . . . . 0.0 110.975 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.14 157.65 34.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 0.0 112.368 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -117.37 168.48 10.32 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.783 1.233 . . . . 0.0 112.802 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -25.03 67.2 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.419 -0.801 . . . . 0.0 112.835 166.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -71.9 -7.63 49.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.485 1.914 . . . . 0.0 112.275 168.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.78 71.29 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.068 1.318 . . . . 0.0 113.964 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 p -76.61 174.44 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.314 2.246 . . . . 0.0 110.667 168.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.73 154.26 44.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.851 0.86 . . . . 0.0 110.932 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.41 125.01 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.864 1.266 . . . . 0.0 109.613 -174.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.76 127.43 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.803 1.641 . . . . 0.0 109.482 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -100.56 115.43 30.13 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.717 1.144 . . . . 0.0 110.081 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.2 m -98.8 159.05 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.482 0.713 . . . . 0.0 111.707 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.86 147.95 37.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.903 2.081 . . . . 0.0 109.357 169.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -100.95 137.53 39.2 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.593 1.088 . . . . 0.0 112.552 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.449 ' CD ' ' HG ' ' A' ' 19' ' ' SER . 62.2 mt-10 -135.51 1.74 2.89 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -173.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.25 -46.62 15.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.033 -0.871 . . . . 0.0 115.129 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.89 11.35 0.48 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.9 -46.96 2.74 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.591 -1.318 . . . . 0.0 114.584 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.01 163.89 3.89 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 128.098 2.559 . . . . 0.0 114.703 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.06 162.82 36.5 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.293 2.662 . . . . 0.0 113.803 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.6 m -144.26 154.96 43.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.54 1.936 . . . . 0.0 111.183 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -90.69 141.07 29.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 128.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.73 123.33 44.41 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 115.52 3.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.993 1.795 . . . . 0.0 109.687 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mt -125.81 134.54 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.88 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -132.96 169.12 17.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.771 1.228 . . . . 0.0 109.579 163.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mt -120.04 129.04 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 146.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -109.65 164.62 12.37 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.542 1.137 . . . . 0.0 112.508 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -54.84 170.26 0.18 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.386 2.275 . . . . 0.0 113.428 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.4 m -58.46 -33.0 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.232 -0.918 . . . . 0.0 112.919 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -70.6 -15.61 62.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.991 2.116 . . . . 0.0 113.759 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.4 mttm 66.74 33.73 6.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.275 2.23 . . . . 0.0 113.254 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.27 -27.67 5.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.504 1.922 . . . . 0.0 113.698 -174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -133.98 135.27 43.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.811 1.187 . . . . 0.0 111.726 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.76 136.34 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.0 111.876 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.51 -10.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.872 1.669 . . . . 0.0 114.733 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.87 169.14 12.75 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.585 1.084 . . . . 0.0 114.72 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -130.52 111.79 12.6 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.145 1.778 . . . . 0.0 110.911 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.58 131.63 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.734 -0.603 . . . . 0.0 109.533 172.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.61 -32.14 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.302 0.641 . . . . 0.0 111.392 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 38.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.262 1.825 . . . . 0.0 115.27 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 t 59.26 -172.68 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.964 2.106 . . . . 0.0 113.077 -171.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -70.26 108.94 3.99 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.311 1.445 . . . . 0.0 110.661 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.01 139.41 61.26 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.644 3.562 . . . . 0.0 116.035 -171.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.76 166.3 24.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.22 1.008 . . . . 0.0 113.605 177.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.88 130.36 21.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.891 1.677 . . . . 0.0 108.914 171.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -83.58 -17.55 41.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.09 172.95 3.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.919 2.888 . . . . 0.0 109.181 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -51.72 -48.63 63.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.67 -0.55 13.38 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -83.01 152.05 25.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.295 0.952 . . . . 0.0 111.023 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.84 148.45 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.151 0.98 . . . . 0.0 110.451 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -137.77 108.05 6.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.803 0.441 . . . . 0.0 109.865 -174.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.91 111.94 19.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.086 1.355 . . . . 0.0 111.2 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.5 mt -115.38 112.99 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.487 1.915 . . . . 0.0 109.88 -163.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -69.93 127.81 34.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.312 1.045 . . . . 0.0 111.543 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.9 tp -146.68 144.07 29.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.442 1.897 . . . . 0.0 110.242 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -116.69 94.03 42.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.744 1.617 . . . . 0.0 110.49 -170.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -73.93 170.38 20.22 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.759 3.64 . . . . 0.0 113.158 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.11 161.78 44.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.543 2.162 . . . . 0.0 111.271 167.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.44 74.89 3.19 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.335 -0.853 . . . . 0.0 111.25 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.76 -170.66 43.09 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.647 1.594 . . . . 0.0 111.382 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -69.62 142.21 53.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.388 0.613 . . . . 0.0 111.069 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.9 p -160.0 159.39 32.05 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.137 0.975 . . . . 0.0 111.354 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -130.73 103.65 6.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.88 137.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.42 125.18 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.41 98.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.801 1.24 . . . . 0.0 109.517 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.66 -169.22 14.1 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.735 1.635 . . . . 0.0 111.331 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.9 -174.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.896 0.879 . . . . 0.0 111.881 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.71 -14.76 5.49 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.96 4.57 23.45 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 113.822 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 p -153.29 -9.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.58 107.64 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.85 1.66 . . . . 0.0 114.062 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 mt -54.75 104.97 0.13 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 159.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -111.53 88.01 2.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -168.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -119.87 140.46 50.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.712 1.244 . . . . 0.0 113.801 -160.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 136.6 54.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.601 3.16 . . . . 0.0 115.092 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -153.11 120.42 5.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -100.72 104.87 16.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.463 1.105 . . . . 0.0 109.819 166.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -60.67 140.97 57.27 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.726 -0.609 . . . . 0.0 111.31 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 128.205 2.602 . . . . 0.0 116.545 -169.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mmm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 m -73.6 102.94 4.04 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -140.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 p -66.01 -12.12 52.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.422 1.489 . . . . 0.0 113.782 166.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.38 169.41 43.44 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.268 1.413 . . . . 0.0 114.398 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 157.08 37.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.492 1.917 . . . . 0.0 113.87 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.05 167.25 19.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.253 2.621 . . . . 0.0 109.78 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -102.7 139.6 38.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.469 1.108 . . . . 0.0 110.416 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 tp -73.97 103.93 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 155.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -106.8 -14.15 15.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.743 -165.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.6 ttpp -153.08 138.73 17.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.324 1.85 . . . . 0.0 109.615 146.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.13 165.55 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.44 2.696 . . . . 0.0 114.454 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.5 mtm -70.65 135.01 48.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.13 119.29 21.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.171 1.389 . . . . 0.0 111.349 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 160.89 30.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -116.54 168.03 10.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.667 1.587 . . . . 0.0 111.992 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -26.15 64.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.198 0.999 . . . . 0.0 112.435 165.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -65.73 -10.57 38.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.735 1.614 . . . . 0.0 112.494 165.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.99 89.18 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 124.895 1.236 . . . . 0.0 113.976 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.6 p -82.0 171.18 14.71 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.905 2.482 . . . . 0.0 110.553 168.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t -125.41 148.73 48.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.256 1.022 . . . . 0.0 111.02 169.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.21 119.68 61.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.96 1.304 . . . . 0.0 108.928 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.79 146.45 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.65 1.58 . . . . 0.0 108.469 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -115.12 115.89 27.51 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 109.686 170.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -93.87 164.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 109.903 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 149.61 49.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.24 1.816 . . . . 0.0 107.406 157.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -86.05 157.85 19.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.469 1.486 . . . . 0.0 111.055 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.59 -63.23 0.84 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.155 -0.966 . . . . 0.0 110.198 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -15.5 -75.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 129.88 3.61 . . . . 0.0 117.655 -167.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -130.75 15.16 5.35 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -162.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 -44.01 2.56 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.627 -1.296 . . . . 0.0 113.809 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.4 170.3 3.07 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 128.591 2.756 . . . . 0.0 115.208 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -66.7 163.23 33.9 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.52 2.814 . . . . 0.0 113.611 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.27 151.32 38.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.241 1.816 . . . . 0.0 110.488 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -88.72 126.33 35.27 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 134.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.6 m -86.12 129.98 51.81 Favored Pre-proline 0 N--CA 1.472 0.63 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -166.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.36 111.92 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.935 1.757 . . . . 0.0 109.109 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.98 131.37 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.572 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.28 169.12 16.92 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.095 164.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 mt -122.56 123.63 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 152.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -102.62 157.39 16.97 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.979 0.8 . . . . 0.0 110.211 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -58.54 174.48 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.465 1.906 . . . . 0.0 113.37 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.93 -35.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.995 -1.066 . . . . 0.0 113.037 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -72.57 -16.71 61.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.891 2.076 . . . . 0.0 113.597 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttm 68.28 27.44 6.62 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.057 2.543 . . . . 0.0 113.512 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.89 -38.74 7.26 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.616 1.966 . . . . 0.0 111.823 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -124.17 137.37 54.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.707 1.14 . . . . 0.0 111.632 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -68.87 134.16 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.597 1.159 . . . . 0.0 110.666 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.34 -9.16 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.242 1.417 . . . . 0.0 114.618 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.94 167.98 12.72 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.438 1.017 . . . . 0.0 114.928 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -130.81 110.83 11.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.224 1.81 . . . . 0.0 110.403 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.54 115.63 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.635 0.774 . . . . 0.0 109.501 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 mm -93.53 -39.87 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.199 1.0 . . . . 0.0 111.711 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -63.64 8.73 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t 97.7 179.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.504 3.522 . . . . 0.0 110.149 -163.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.3 p -65.07 114.58 15.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.793 1.237 . . . . 0.0 109.74 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.05 136.18 44.73 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.323 2.682 . . . . 0.0 114.057 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.14 166.97 23.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -140.37 131.64 26.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.084 2.153 . . . . 0.0 108.279 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -85.29 -18.41 33.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.93 172.41 5.55 Favored 'General case' 0 CA--C 1.549 0.912 1 C-N-CA 131.769 4.027 . . . . 0.0 108.639 175.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -54.81 7.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.19 1.396 . . . . 0.0 112.216 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -66.87 -1.07 3.51 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 m -74.37 121.59 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.813 1.188 . . . . 0.0 111.057 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -90.34 146.63 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.34 0.656 . . . . 0.0 110.758 162.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 m -139.5 110.99 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.637 0.775 . . . . 0.0 109.57 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.52 134.71 37.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 110.548 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.6 mt -139.36 106.85 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.965 1.306 . . . . 0.0 109.599 -166.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -65.5 127.84 33.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.923 1.289 . . . . 0.0 111.955 161.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 tp -147.75 146.08 29.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.978 2.111 . . . . 0.0 110.111 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.18 96.6 50.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 111.524 -171.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.17 170.0 19.26 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.437 3.424 . . . . 0.0 113.108 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.27 166.55 28.92 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.456 2.104 . . . . 0.0 111.157 166.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -74.8 77.43 2.09 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.327 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.59 -169.18 42.1 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.746 1.165 . . . . 0.0 112.149 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.86 143.12 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.073 0.949 . . . . 0.0 110.481 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 m -164.57 169.26 17.29 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.997 -1.064 . . . . 0.0 112.698 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -125.97 107.55 10.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 110.736 -169.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.0 124.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 127.922 2.489 . . . . 0.0 107.055 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.69 123.23 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.5 mt -125.35 99.88 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.318 1.447 . . . . 0.0 108.719 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.6 -169.15 13.37 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 127.07 2.272 . . . . 0.0 110.242 -161.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.52 -177.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.636 1.218 . . . . 0.0 111.675 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.32 -18.29 6.79 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.95 2.91 44.05 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.18 1.49 . . . . 0.0 114.267 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 p -157.97 -11.36 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.2 117.45 6.07 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.665 1.186 . . . . 0.0 114.106 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 mt -52.54 104.73 0.1 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 156.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.4 m -110.66 94.54 5.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.97 160.35 27.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.276 1.031 . . . . 0.0 112.455 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.7 148.38 25.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.425 1.49 . . . . 0.0 114.292 -161.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -149.77 147.39 27.96 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 171.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.04 107.15 11.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.32 1.048 . . . . 0.0 108.885 164.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -63.32 140.01 58.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.257 0.623 . . . . 0.0 111.559 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 128.534 2.734 . . . . 0.0 116.228 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mmm . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.79 138.69 52.92 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -143.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -132.04 13.3 4.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.659 1.184 . . . . 0.0 113.388 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.34 175.03 15.64 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.868 1.699 . . . . 0.0 112.549 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.456 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 11.8 ttpp -71.45 157.86 37.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -169.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -127.5 173.86 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.119 2.568 . . . . 0.0 110.332 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.97 139.1 47.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.066 1.746 . . . . 0.0 109.927 165.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tp -75.81 89.51 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 160.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.48 -12.84 41.83 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.789 1.235 . . . . 0.0 112.379 -164.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -149.38 142.95 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.647 1.579 . . . . 0.0 109.663 149.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 167.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.777 2.431 . . . . 0.0 113.701 166.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 141.89 31.85 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 120.78 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.913 1.285 . . . . 0.0 110.654 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.44 162.01 23.47 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 p -116.9 178.65 4.27 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.792 1.637 . . . . 0.0 112.528 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -17.01 63.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.141 0.976 . . . . 0.0 113.444 166.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -75.87 -10.73 59.67 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.906 1.23 . . . . 0.0 112.118 164.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.84 8.13 32.78 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.485 -1.384 . . . . 0.0 113.306 -164.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.1 p -66.23 160.3 24.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.996 1.398 . . . . 0.0 108.879 162.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -126.67 144.04 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.893 0.877 . . . . 0.0 110.627 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -105.03 118.91 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.523 1.129 . . . . 0.0 109.172 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.19 129.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -104.13 110.03 22.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.341 0.973 . . . . 0.0 110.253 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -86.05 163.78 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.533 0.733 . . . . 0.0 110.375 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.2 155.61 43.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.581 1.952 . . . . 0.0 108.156 157.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -108.95 142.4 39.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.367 1.439 . . . . 0.0 113.177 -170.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CD ' ' HZ3' ' A' ' 17' ' ' LYS . 48.2 mt-10 -128.96 -24.29 2.94 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.29 73.37 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 117.406 1.722 . . . . 0.0 117.406 -163.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.61 1.51 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.95 -41.1 1.04 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 120.177 1.353 . . . . 0.0 115.193 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.04 171.5 6.42 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.288 2.635 . . . . 0.0 114.146 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.28 159.3 35.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.608 2.872 . . . . 0.0 114.39 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.52 152.73 29.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.122 1.769 . . . . 0.0 110.476 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 132.88 35.82 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 142.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -94.29 124.74 54.76 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -170.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -67.11 114.05 3.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 109.374 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.8 mt -120.43 123.34 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.256 1.022 . . . . 0.0 108.769 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.49 174.47 10.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.561 0.744 . . . . 0.0 109.931 167.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 mt -124.1 130.01 73.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 153.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -110.83 160.32 16.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.133 0.968 . . . . 0.0 111.126 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -58.63 176.07 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.852 2.461 . . . . 0.0 114.083 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.32 -29.96 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.007 -1.058 . . . . 0.0 112.945 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -71.96 -17.7 62.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.215 1.406 . . . . 0.0 112.974 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 45.7 mttp 67.66 29.9 6.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.304 2.641 . . . . 0.0 112.954 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.15 -29.99 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.763 1.625 . . . . 0.0 113.487 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -122.45 131.4 53.85 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.896 1.225 . . . . 0.0 110.894 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.79 135.68 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.346 1.458 . . . . 0.0 111.656 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.53 -7.01 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.78 168.63 12.61 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.855 1.207 . . . . 0.0 115.27 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -131.31 118.1 19.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.756 1.622 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.423 ' H ' HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -77.87 99.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.348 1.059 . . . . 0.0 111.101 -177.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.81 -49.49 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.033 0.933 . . . . 0.0 111.876 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.2 t -63.03 -4.97 2.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m 62.82 -12.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.935 2.494 . . . . 0.0 117.692 158.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.6 p -120.16 59.71 6.6 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.481 1.512 . . . . 0.0 113.663 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -58.04 84.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.832 3.022 . . . . 0.0 113.786 163.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.42 166.99 23.2 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.67 137.31 36.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.445 2.698 . . . . 0.0 108.32 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -102.77 -7.49 21.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.662 1.185 . . . . 0.0 112.962 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.25 170.77 11.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 130.17 3.388 . . . . 0.0 108.258 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -44.62 41.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.319 0.648 . . . . 0.0 111.794 167.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -66.76 -6.08 14.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.112 1.765 . . . . 0.0 114.429 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -73.58 101.56 3.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.42 1.009 . . . . 0.0 111.345 174.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 m -73.88 135.46 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.434 158.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -137.95 108.06 6.4 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.779 0.432 . . . . 0.0 110.828 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.58 121.63 25.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.283 1.433 . . . . 0.0 111.833 170.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mm -124.49 115.84 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 126.129 1.772 . . . . 0.0 110.188 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.58 127.95 34.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.405 1.082 . . . . 0.0 110.898 161.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 tp -141.4 145.19 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.359 2.263 . . . . 0.0 109.561 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -113.73 101.05 53.39 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.162 1.385 . . . . 0.0 110.901 -171.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.66 168.91 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.348 3.365 . . . . 0.0 113.135 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.31 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.261 1.974 . . . . 0.0 110.857 162.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -76.32 75.4 3.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.087 -1.008 . . . . 0.0 111.748 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.94 -166.94 39.27 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.987 1.279 . . . . 0.0 112.492 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.99 135.67 47.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.961 1.304 . . . . 0.0 110.626 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -163.38 173.5 13.14 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.075 -1.015 . . . . 0.0 112.098 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 90.5 m-85 -125.67 105.0 8.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.743 0.817 . . . . 0.0 110.765 -165.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.95 129.86 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.976 1.711 . . . . 0.0 106.841 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.69 122.66 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.79 98.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.575 1.15 . . . . 0.0 109.223 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.56 -176.99 16.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.025 2.25 . . . . 0.0 111.279 -162.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.95 177.21 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.638 1.175 . . . . 0.0 111.57 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.27 -17.18 5.42 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 117.675 1.83 . . . . 0.0 117.675 -170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.39 6.36 44.47 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.514 1.657 . . . . 0.0 113.992 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -162.75 -1.23 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.57 114.88 3.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.512 1.525 . . . . 0.0 114.282 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.63 103.35 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 157.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 m -112.32 92.83 4.17 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -126.51 148.73 49.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.814 1.292 . . . . 0.0 113.908 -166.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 139.84 47.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.683 2.393 . . . . 0.0 114.132 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -140.03 153.57 46.86 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.417 0.687 . . . . 0.0 110.718 156.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -124.48 115.45 20.92 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 165.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -66.65 134.35 52.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.24 0.473 . . . . 0.0 111.865 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.46 -52.59 1.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.129 2.971 . . . . 0.0 115.566 165.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -140.62 -36.21 0.48 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 128.461 2.704 . . . . 0.0 110.992 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.11 87.13 1.89 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.58 1.152 . . . . 0.0 107.922 163.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -159.5 174.33 14.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.924 2.09 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -71.55 82.45 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.806 0.842 . . . . 0.0 110.387 168.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -51.0 -56.59 11.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.077 2.151 . . . . 0.0 114.497 -167.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.6 -21.79 74.84 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.819 0.723 . . . . 0.0 114.144 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -89.76 -70.43 0.66 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 0.0 109.466 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.2 p -70.08 14.62 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.861 2.464 . . . . 0.0 117.164 -161.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -121.99 156.6 33.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.517 1.127 . . . . 0.0 111.537 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -149.75 93.72 2.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.097 2.559 . . . . 0.0 106.122 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.1 mmm -120.9 -92.51 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -151.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.4 m -86.98 96.65 10.34 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -143.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.6 p -67.37 -10.74 54.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.895 1.678 . . . . 0.0 114.549 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 170.4 48.2 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.75 1.167 . . . . 0.0 113.726 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.18 158.04 27.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.446 1.498 . . . . 0.0 111.616 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -132.4 167.88 19.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.573 2.349 . . . . 0.0 110.616 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -108.46 139.7 42.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.387 1.075 . . . . 0.0 110.807 165.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tp -71.09 113.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 154.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.21 -14.11 9.29 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.807 0.843 . . . . 0.0 112.51 -162.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -147.82 141.19 25.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.575 1.55 . . . . 0.0 109.013 144.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -50.47 161.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.358 2.263 . . . . 0.0 114.287 170.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.95 131.35 37.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 130.04 46.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.549 1.54 . . . . 0.0 110.708 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -82.77 159.86 22.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.03 0.932 . . . . 0.0 113.127 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -115.54 168.27 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.175 1.39 . . . . 0.0 112.481 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.21 65.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.749 0.82 . . . . 0.0 112.581 166.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -67.21 -10.14 47.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.192 1.797 . . . . 0.0 112.152 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.92 78.15 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.19 1.376 . . . . 0.0 114.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -76.01 171.72 13.97 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.076 2.15 . . . . 0.0 110.582 167.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.54 154.33 43.99 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.107 0.963 . . . . 0.0 110.782 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.44 105.93 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.599 1.16 . . . . 0.0 109.637 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.93 164.3 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.662 1.185 . . . . 0.0 109.253 167.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tmmt? -132.29 128.39 37.68 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.238 -0.914 . . . . 0.0 109.891 155.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.0 161.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 111.033 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.81 145.64 51.69 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 107.949 161.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -81.66 155.26 25.68 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.778 1.172 . . . . 0.0 110.69 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -124.86 -63.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.696 0.799 . . . . 0.0 109.567 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -8.69 -77.7 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 130.233 3.778 . . . . 0.0 118.362 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.63 15.31 3.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -157.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.8 -54.56 4.68 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.701 -1.249 . . . . 0.0 112.842 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.74 164.3 3.21 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.747 2.419 . . . . 0.0 114.969 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.18 164.0 21.26 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.397 2.732 . . . . 0.0 113.979 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 70.7 m -141.55 148.43 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.072 1.749 . . . . 0.0 111.102 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -86.22 141.02 29.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.5 -1.28 . . . . 0.0 108.035 126.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.38 129.0 25.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.535 -168.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.64 117.41 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.082 1.855 . . . . 0.0 109.617 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.39 127.22 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.228 1.011 . . . . 0.0 109.107 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.05 170.04 11.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.657 0.783 . . . . 0.0 109.144 161.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.41 131.71 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 153.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -115.62 153.58 31.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.415 1.086 . . . . 0.0 111.015 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -62.76 176.03 0.74 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.364 1.466 . . . . 0.0 112.718 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.0 -39.62 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 120.803 -1.186 . . . . 0.0 112.711 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -72.14 -18.52 61.88 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.423 1.889 . . . . 0.0 113.399 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.27 20.6 mttm 74.19 4.84 4.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.426 3.09 . . . . 0.0 114.529 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.49 -43.34 63.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.259 2.224 . . . . 0.0 113.053 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -109.21 133.39 53.08 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.048 0.84 . . . . 0.0 110.997 -165.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -74.73 134.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.857 0.863 . . . . 0.0 110.256 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.67 -8.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.68 168.68 12.86 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.617 1.099 . . . . 0.0 114.759 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -131.25 122.18 26.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.724 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.02 138.07 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.895 0.77 . . . . 0.0 109.848 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.85 -34.98 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 111.798 -172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 80' ' ' GLU . 45.4 t -68.56 38.44 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.604 1.962 . . . . 0.0 114.866 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.8 t 57.12 -172.33 0.08 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.573 1.949 . . . . 0.0 112.889 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -64.23 109.54 2.85 Favored Pre-proline 0 C--O 1.246 0.889 0 C-N-CA 125.243 1.417 . . . . 0.0 110.175 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.04 136.38 60.92 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 124.465 3.444 . . . . 0.0 114.918 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.94 160.91 39.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.485 1.114 . . . . 0.0 112.806 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.64 123.5 11.98 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.52 1.528 . . . . 0.0 108.823 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -72.1 -22.49 61.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -170.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.38 169.68 10.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.871 2.468 . . . . 0.0 109.742 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -52.5 -45.64 66.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.294 1.038 . . . . 0.0 111.438 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -70.93 0.95 6.24 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 m -100.41 158.31 15.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.291 1.405 . . . . 0.0 112.376 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.74 154.23 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 125.079 1.352 . . . . 0.0 110.741 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -142.05 115.98 9.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.205 0.602 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -68.92 134.4 49.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.096 0.959 . . . . 0.0 110.341 164.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mm -132.04 104.62 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.803 1.241 . . . . 0.0 109.947 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' H ' ' HB2' ' A' ' 65' ' ' SER . 73.7 tt0 -68.51 131.17 44.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.793 0.837 . . . . 0.0 111.172 161.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 tp -150.12 145.16 26.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.063 1.745 . . . . 0.0 110.649 -163.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -119.72 94.62 48.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.523 1.529 . . . . 0.0 110.77 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.21 168.3 20.5 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.967 3.778 . . . . 0.0 112.712 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.92 165.65 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.183 1.922 . . . . 0.0 111.544 169.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -75.41 74.99 2.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.854 0.862 . . . . 0.0 111.702 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.43 -167.09 38.89 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.77 1.176 . . . . 0.0 112.374 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.17 140.28 52.52 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.688 1.195 . . . . 0.0 110.543 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.0 m -163.6 171.11 16.22 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.835 -1.166 . . . . 0.0 112.361 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -128.34 101.29 6.15 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.572 1.149 . . . . 0.0 109.867 -169.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.2 136.66 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.23 122.72 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.419 0.554 . . . . 0.0 109.61 174.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.6 mt -123.82 105.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.844 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.99 172.14 20.3 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.647 2.07 . . . . 0.0 111.097 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 m -95.8 129.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.3 1.05 . . . . 0.0 110.687 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 26.28 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 127.774 2.607 . . . . 0.0 116.081 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.95 -27.77 8.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.052 1.741 . . . . 0.0 115.474 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.8 m -101.29 -3.63 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.552 1.941 . . . . 0.0 112.932 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.31 109.83 16.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.288 1.035 . . . . 0.0 113.089 -166.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 mt -53.85 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.951 162.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.8 m -103.63 89.53 3.38 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -170.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -118.66 139.29 51.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.586 1.184 . . . . 0.0 113.484 -165.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 142.48 55.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.708 2.403 . . . . 0.0 114.208 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -145.53 153.81 41.51 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.888 0.875 . . . . 0.0 111.267 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -135.5 111.62 9.63 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.568 1.147 . . . . 0.0 108.973 168.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -68.49 144.1 54.75 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.929 -0.482 . . . . 0.0 111.647 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 129.653 3.181 . . . . 0.0 115.69 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.97 50.93 4.25 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.896 1.236 . . . . 0.0 111.209 158.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.0 m -59.54 20.06 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 131.611 3.964 . . . . 0.0 118.59 -154.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 m -157.51 9.99 0.19 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.43 -1.419 . . . . 0.0 114.537 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -28.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.531 1.059 . . . . 0.0 111.249 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.13 158.4 15.39 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 156.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 23' ' ' GLU . 26.4 mmmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.182 2.193 . . . . 0.0 112.52 -170.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -132.04 -86.93 0.47 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.108 2.963 . . . . 0.0 108.99 -160.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 8.2 mtmp? -66.85 -40.97 88.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.587 1.155 . . . . 0.0 110.531 157.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 mt -81.04 69.21 7.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.217 0.462 . . . . 0.0 110.145 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -167.17 177.54 6.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.636 2.375 . . . . 0.0 111.46 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.36 77.17 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.835 1.302 . . . . 0.0 110.575 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.76 -52.32 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.045 2.538 . . . . 0.0 115.11 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.8 -34.62 61.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.133 0.873 . . . . 0.0 114.816 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -99.78 -39.37 8.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.963 0.882 . . . . 0.0 112.818 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -82.48 2.58 32.08 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -103.8 149.4 25.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.535 1.061 . . . . 0.0 111.952 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -146.73 90.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.913 2.485 . . . . 0.0 106.465 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.56 -104.69 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 -145.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.67 109.01 18.9 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -133.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -72.33 -13.33 61.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.746 1.618 . . . . 0.0 114.506 164.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.53 163.13 54.75 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.347 0.975 . . . . 0.0 113.317 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 158.93 34.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.967 0.907 . . . . 0.0 112.792 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -129.1 166.73 18.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.652 1.981 . . . . 0.0 110.239 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.39 137.2 54.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.58 1.952 . . . . 0.0 111.038 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 tp -80.15 95.47 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.941 1.296 . . . . 0.0 108.711 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.98 -11.71 28.0 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 112.633 -165.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.4 ttpp -152.71 137.77 17.28 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 109.379 151.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.62 168.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.073 2.949 . . . . 0.0 114.749 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 mtm -77.29 123.55 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.52 118.11 29.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.087 1.355 . . . . 0.0 110.256 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.11 161.79 21.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.312 1.045 . . . . 0.0 113.703 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 p -118.01 169.62 9.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 112.512 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -27.99 66.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.855 0.862 . . . . 0.0 112.387 166.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -65.06 -12.91 55.82 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.38 1.872 . . . . 0.0 112.469 168.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.32 -5.05 79.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.166 1.365 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -69.71 167.65 16.6 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 111.43 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -127.27 148.38 50.22 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.063 1.345 . . . . 0.0 110.072 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.51 116.25 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.526 1.13 . . . . 0.0 109.037 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.68 131.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.783 1.633 . . . . 0.0 108.946 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 5.9 ttmt -102.52 111.61 23.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.283 0.947 . . . . 0.0 109.606 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -87.6 157.0 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 122.585 0.354 . . . . 0.0 110.065 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -130.04 143.34 50.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.057 2.143 . . . . 0.0 107.491 160.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.85 154.74 26.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.586 1.085 . . . . 0.0 110.725 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.34 -63.13 1.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 110.712 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -18.73 -80.15 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 129.391 3.377 . . . . 0.0 117.793 -164.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.58 22.12 6.45 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.6 -49.15 3.82 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 120.917 -1.115 . . . . 0.0 114.327 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.6 178.73 1.71 Allowed Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 128.424 2.689 . . . . 0.0 114.761 -170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.75 166.28 14.18 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 124.255 3.303 . . . . 0.0 115.705 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.0 m -148.13 154.36 40.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.428 1.891 . . . . 0.0 111.286 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -92.12 138.67 31.34 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 128.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.29 125.11 44.57 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -66.14 101.19 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.305 2.003 . . . . 0.0 110.532 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.8 mt -106.84 130.94 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.099 0.96 . . . . 0.0 110.568 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.79 166.79 20.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.563 0.745 . . . . 0.0 110.461 157.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.49 130.61 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 146.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -111.83 162.67 15.03 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.615 1.166 . . . . 0.0 112.916 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -55.9 169.03 0.39 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.86 2.064 . . . . 0.0 113.351 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -58.25 -28.93 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.317 -0.864 . . . . 0.0 112.898 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -74.92 -17.07 60.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.235 1.814 . . . . 0.0 113.718 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 49.8 mttp 69.85 28.19 4.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.234 2.214 . . . . 0.0 113.205 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -115.26 -28.42 6.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.646 1.978 . . . . 0.0 113.173 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -132.6 138.19 47.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.694 1.134 . . . . 0.0 112.255 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.73 133.45 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.292 1.837 . . . . 0.0 111.213 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.51 -8.9 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 0.0 114.112 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.72 168.75 13.05 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 119.578 1.081 . . . . 0.0 115.257 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.55 114.1 14.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.068 1.747 . . . . 0.0 110.854 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.406 ' H ' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -74.92 102.38 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.08 0.952 . . . . 0.0 110.186 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.4 mm -76.36 -42.34 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.421 1.089 . . . . 0.0 111.767 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -70.49 36.94 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.649 1.98 . . . . 0.0 115.78 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t 62.66 -174.92 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.708 2.003 . . . . 0.0 113.588 -175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -59.5 107.01 0.84 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 127.584 2.354 . . . . 0.0 111.859 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.21 121.1 9.3 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.356 3.37 . . . . 0.0 114.57 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.05 165.93 26.17 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.89 148.59 34.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.82 1.648 . . . . 0.0 109.953 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -99.67 -21.46 15.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 112.173 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.6 165.03 19.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.76 1.624 . . . . 0.0 111.296 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -57.98 -28.56 64.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.328 1.051 . . . . 0.0 112.759 168.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -81.48 -4.24 55.34 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 m -83.79 155.97 22.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.621 1.1 . . . . 0.0 112.244 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.69 149.61 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 124.82 1.248 . . . . 0.0 110.204 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -138.62 107.42 5.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.39 0.676 . . . . 0.0 109.492 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.72 121.09 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.01 . . . . 0.0 110.939 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.88 111.84 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.716 1.606 . . . . 0.0 109.131 -168.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -67.42 126.57 29.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 110.765 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 tp -143.3 144.72 32.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.785 2.034 . . . . 0.0 109.527 -172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -114.46 100.21 52.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.413 1.485 . . . . 0.0 110.805 -170.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.19 175.31 10.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.472 3.448 . . . . 0.0 112.893 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -76.67 167.15 25.96 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.396 2.731 . . . . 0.0 111.518 165.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -76.97 78.43 3.52 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.841 -1.162 . . . . 0.0 111.679 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.57 -166.66 39.41 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.257 0.932 . . . . 0.0 112.3 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.66 143.79 54.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.153 0.501 . . . . 0.0 110.761 165.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.0 p -160.27 157.74 28.63 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.938 0.895 . . . . 0.0 111.64 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.494 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 96.1 m-85 -129.3 102.57 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.935 0.874 . . . . 0.0 111.446 -171.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.71 137.22 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.691 1.996 . . . . 0.0 107.568 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.37 129.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -130.86 97.91 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.649 1.18 . . . . 0.0 109.343 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.44 -175.78 15.9 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 127.11 2.29 . . . . 0.0 111.245 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.2 135.17 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 118.473 1.137 . . . . 0.0 111.418 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.27 -117.48 0.91 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.253 1.406 . . . . 0.0 114.158 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -70.43 -9.7 57.13 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.1 m -86.64 -11.23 51.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.518 1.127 . . . . 0.0 112.89 165.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.05 116.84 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.843 0.857 . . . . 0.0 112.583 -172.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.8 102.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 158.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.7 m -112.95 93.31 4.36 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -168.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -131.94 157.42 44.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.746 1.26 . . . . 0.0 114.018 -162.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 135.96 33.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.331 2.652 . . . . 0.0 114.355 -165.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -143.84 118.83 10.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 165.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -91.76 105.67 17.9 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.585 1.154 . . . . 0.0 110.148 164.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 139.09 58.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 56.26 22.81 6.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.471 1.908 . . . . 0.0 114.062 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.63 -24.14 0.04 OUTLIER Glycine 0 CA--C 1.534 1.249 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t 58.78 8.04 0.87 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.598 2.199 . . . . 0.0 114.779 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.5 p -47.81 -42.96 27.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.536 2.335 . . . . 0.0 115.382 -165.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -126.87 16.8 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 126.15 1.78 . . . . 0.0 110.958 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.36 130.71 7.4 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.069 1.319 . . . . 0.0 113.074 -165.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.752 2.021 . . . . 0.0 112.048 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.69 -52.2 11.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.883 2.473 . . . . 0.0 113.983 166.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 7.9 mtmp? -127.43 -39.96 1.82 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 128.219 2.608 . . . . 0.0 111.347 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.52 89.5 1.28 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 169.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -161.05 173.02 15.82 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.381 2.272 . . . . 0.0 110.165 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -73.4 82.29 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.531 0.732 . . . . 0.0 109.322 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -55.14 -27.99 49.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.359 1.464 . . . . 0.0 113.428 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.82 -53.81 12.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 127.224 2.345 . . . . 0.0 113.852 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -128.34 -15.57 4.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -81.86 3.16 27.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.748 1.158 . . . . 0.0 114.081 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -124.35 139.7 53.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.235 1.814 . . . . 0.0 109.117 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 p -140.98 92.15 2.47 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.84 2.056 . . . . 0.0 106.955 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 87.6 mmm -124.49 -109.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -148.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.38 113.02 20.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -135.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.7 p -68.67 -10.97 59.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.54 1.536 . . . . 0.0 114.564 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.3 170.68 44.58 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.279 0.942 . . . . 0.0 114.793 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 156.17 28.26 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.183 1.793 . . . . 0.0 111.484 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 82.6 m-85 -130.7 167.48 18.74 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.416 2.286 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -107.97 137.31 46.18 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.561 1.144 . . . . 0.0 111.054 167.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.8 tp -75.35 92.7 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 159.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.91 -13.2 25.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.754 1.222 . . . . 0.0 112.088 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -149.04 142.38 25.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.374 1.47 . . . . 0.0 109.535 148.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.36 162.68 0.13 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.211 2.204 . . . . 0.0 113.845 167.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.19 132.3 42.06 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 122.21 35.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.858 1.263 . . . . 0.0 110.418 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -80.82 160.89 24.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.5 p -113.65 169.56 8.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.655 1.582 . . . . 0.0 112.006 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.92 69.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.975 0.91 . . . . 0.0 112.287 165.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -68.67 -11.14 59.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.595 1.958 . . . . 0.0 112.764 171.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.42 -3.1 79.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.726 1.155 . . . . 0.0 113.818 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -72.7 165.35 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.445 1.898 . . . . 0.0 111.076 166.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -125.95 146.18 49.97 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.706 1.203 . . . . 0.0 110.405 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.98 118.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 109.164 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.39 124.96 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.607 1.563 . . . . 0.0 109.161 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -95.55 110.8 22.83 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.313 0.961 . . . . 0.0 109.233 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.88 161.53 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.151 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 152.54 49.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.272 1.829 . . . . 0.0 107.733 156.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -87.92 159.01 18.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.199 1.363 . . . . 0.0 110.966 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -130.95 -52.9 1.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.275 -0.891 . . . . 0.0 110.843 173.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.38 -11.21 46.27 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 120.252 2.861 . . . . 0.0 120.252 -151.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.31 2.64 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.61 2.705 . . . . 0.0 117.112 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.88 -56.77 4.29 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-N 120.522 1.51 . . . . 0.0 113.061 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.98 5.03 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 127.371 2.269 . . . . 0.0 114.269 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.66 164.81 22.63 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.031 3.154 . . . . 0.0 116.193 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -147.61 151.18 35.79 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.509 2.324 . . . . 0.0 111.391 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 142.61 28.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 129.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.416 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.25 1.0 OUTLIER -104.2 134.86 19.48 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.724 -169.576 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.84 106.42 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.247 1.965 . . . . 0.0 109.112 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 mt -115.14 130.69 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.548 0.739 . . . . 0.0 109.757 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -134.06 172.98 12.08 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.014 0.926 . . . . 0.0 110.048 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mt -126.42 125.71 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 156.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -109.15 162.89 13.85 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.922 0.868 . . . . 0.0 111.148 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -57.74 173.67 0.29 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.622 2.369 . . . . 0.0 113.487 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 m -56.57 -34.9 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.874 -1.141 . . . . 0.0 112.71 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -71.8 -14.07 61.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.563 1.945 . . . . 0.0 113.495 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 67.99 22.98 8.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.267 2.627 . . . . 0.0 113.662 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -108.74 -32.76 7.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.49 1.916 . . . . 0.0 112.692 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -127.15 135.82 51.24 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.249 1.386 . . . . 0.0 111.954 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.76 135.38 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.495 1.518 . . . . 0.0 111.625 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.93 -11.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.559 1.544 . . . . 0.0 114.622 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.97 171.01 13.65 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -170.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtm-85 -133.1 128.89 37.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.676 1.59 . . . . 0.0 110.729 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.72 124.09 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.52 -36.99 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.568 0.747 . . . . 0.0 111.282 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.8 t -68.63 35.29 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.296 1.838 . . . . 0.0 114.617 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.76 -170.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.899 2.08 . . . . 0.0 113.641 -175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -64.0 108.6 1.96 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.929 2.092 . . . . 0.0 111.157 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -55.05 143.78 72.05 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.31 3.34 . . . . 0.0 115.495 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -147.46 166.27 27.74 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.96 121.93 11.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.458 1.903 . . . . 0.0 108.168 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.52 -17.29 59.34 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.584 -0.697 . . . . 0.0 112.677 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.53 170.26 16.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.319 2.648 . . . . 0.0 109.419 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 m -50.5 -49.9 54.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.312 1.045 . . . . 0.0 110.464 163.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -67.03 -3.54 7.49 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 m -85.24 144.18 28.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.148 1.34 . . . . 0.0 112.093 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.02 150.96 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.045 1.338 . . . . 0.0 110.637 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 m -141.77 115.59 9.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.98 122.75 32.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 111.568 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.73 111.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 124.819 1.248 . . . . 0.0 109.827 -162.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.1 124.59 23.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.141 1.376 . . . . 0.0 111.42 165.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.4 tp -141.02 142.92 34.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.074 2.149 . . . . 0.0 110.013 -166.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -119.23 98.99 50.7 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -167.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.82 168.77 18.89 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.483 3.455 . . . . 0.0 113.573 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.49 165.13 32.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.946 2.431 . . . . 0.0 111.019 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -72.67 73.42 1.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.27 -0.894 . . . . 0.0 112.004 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -173.44 46.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.148 0.88 . . . . 0.0 113.789 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.54 129.61 41.39 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.13 0.972 . . . . 0.0 110.163 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 m -145.56 150.5 36.52 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.279 1.432 . . . . 0.0 111.011 -163.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.58 98.17 5.61 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.957 0.884 . . . . 0.0 111.317 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.82 126.44 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.391 1.876 . . . . 0.0 107.259 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.47 123.96 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.871 0.868 . . . . 0.0 109.039 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.1 mt -128.16 98.58 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.031 1.332 . . . . 0.0 109.256 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.93 -174.57 15.84 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 127.657 2.551 . . . . 0.0 110.649 -164.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.11 164.54 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.506 1.153 . . . . 0.0 110.585 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -10.14 -74.5 0.01 OUTLIER Glycine 0 CA--C 1.541 1.707 0 C-N-CA 127.55 2.5 . . . . 0.0 117.682 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.3 58.68 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.9 p -122.91 -10.29 8.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.295 1.838 . . . . 0.0 114.025 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.15 118.53 6.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.582 1.953 . . . . 0.0 112.67 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.5 mt -56.67 98.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 154.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 83.4 m -101.08 95.57 6.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.94 154.35 39.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.816 1.293 . . . . 0.0 113.735 -170.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.38 137.89 33.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.917 2.487 . . . . 0.0 114.267 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -134.64 156.48 48.67 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.201 1.0 . . . . 0.0 111.129 162.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -129.8 111.06 12.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 162.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -63.26 135.33 57.0 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm 55.46 30.9 15.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.528 1.931 . . . . 0.0 113.705 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.53 -25.71 0.03 OUTLIER Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 t 52.35 -96.2 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.83 1.815 . . . . 0.0 112.144 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.3 p 55.87 -101.34 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.197 1.799 . . . . 0.0 113.067 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.19 -21.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.368 1.867 . . . . 0.0 113.125 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.9 113.69 4.71 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.479 1.514 . . . . 0.0 112.387 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 3.2 mmpt? . . . . . 0 C--O 1.251 1.139 0 C-N-CA 126.982 2.113 . . . . 0.0 112.674 173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.73 -0.1 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.08 -54.07 0.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 130.05 3.34 . . . . 0.0 115.009 166.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -144.31 -28.15 0.5 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.8 2.04 . . . . 0.0 112.519 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.2 mt -69.31 80.11 0.37 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 108.465 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -159.4 171.48 19.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.975 2.91 . . . . 0.0 108.88 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 81.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.621 162.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -40.88 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.481 2.712 . . . . 0.0 114.199 -163.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.24 -58.22 12.61 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.243 1.402 . . . . 0.0 113.008 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -49.92 75.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.94 0.87 . . . . 0.0 113.001 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.9 p -81.95 -10.34 59.3 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -168.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -76.46 159.69 30.19 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.759 1.163 . . . . 0.0 112.484 171.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.4 p -139.42 91.17 2.47 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.367 1.867 . . . . 0.0 106.474 161.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.44 -110.03 0.33 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -145.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.62 99.56 8.2 Favored 'General case' 0 N--CA 1.458 -0.056 0 O-C-N 121.106 -0.996 . . . . 0.0 113.36 -145.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -68.64 -6.44 25.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.517 166.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.24 53.83 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.045 1.307 . . . . 0.0 114.169 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 154.71 32.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.261 1.824 . . . . 0.0 112.459 -174.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.04 166.22 18.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.748 2.019 . . . . 0.0 110.794 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -101.39 137.45 39.71 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.579 1.151 . . . . 0.0 110.183 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.57 101.75 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -106.53 -14.37 15.07 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.319 1.448 . . . . 0.0 111.482 -163.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -149.38 137.84 20.86 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.686 1.595 . . . . 0.0 109.359 145.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.94 168.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.06 2.944 . . . . 0.0 114.351 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.9 mtm -79.88 136.36 36.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.39 122.57 21.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.013 1.725 . . . . 0.0 109.74 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.62 164.89 21.54 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -120.66 170.06 9.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.041 1.737 . . . . 0.0 111.778 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -27.56 66.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.117 0.967 . . . . 0.0 112.312 165.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -65.37 -9.15 22.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.338 1.855 . . . . 0.0 112.733 168.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.03 -7.4 55.96 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.477 1.513 . . . . 0.0 113.539 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -68.54 163.54 23.3 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.976 1.71 . . . . 0.0 111.067 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -126.71 148.29 49.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 109.503 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 t -114.65 115.3 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.127 0.971 . . . . 0.0 109.508 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.81 132.6 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 109.087 -171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -107.27 120.49 42.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.775 1.17 . . . . 0.0 110.47 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -93.75 165.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.656 1.182 . . . . 0.0 109.987 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.57 159.12 42.88 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.126 1.771 . . . . 0.0 108.183 156.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -104.31 139.04 39.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.724 1.602 . . . . 0.0 112.421 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -121.71 -27.82 4.63 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.87 -1.144 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.85 -18.13 79.51 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -157.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.34 2.57 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.31 -42.7 1.7 Allowed Glycine 0 CA--C 1.537 1.419 0 CA-C-N 120.765 1.62 . . . . 0.0 114.497 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.31 170.7 5.06 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 128.33 2.652 . . . . 0.0 115.107 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -67.64 166.24 24.77 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.926 3.084 . . . . 0.0 113.172 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.35 155.31 40.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.27 136.69 33.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 129.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.274 1.7 m -95.54 129.11 35.7 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -170.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.2 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.644 2.23 . . . . 0.0 109.091 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.7 mt -119.06 129.15 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.58 0.752 . . . . 0.0 110.833 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -132.83 169.06 17.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.525 1.13 . . . . 0.0 109.437 162.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -119.09 131.25 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 149.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -110.12 163.69 13.35 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.465 1.103 . . . . 0.0 112.209 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -59.64 175.52 0.35 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.706 1.603 . . . . 0.0 113.027 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -65.3 -22.77 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -79.72 -25.56 41.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.34 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 46.9 mttp 85.91 14.02 0.16 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.939 3.295 . . . . 0.0 112.565 169.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -83.09 -51.05 7.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.489 2.716 . . . . 0.0 112.815 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -122.68 151.48 41.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.127 1.33 . . . . 0.0 112.669 -167.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.32 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.938 1.695 . . . . 0.0 112.136 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.22 -28.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.188 1.795 . . . . 0.0 114.171 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.55 161.76 17.87 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.917 1.235 . . . . 0.0 114.429 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.52 HH21 ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -124.17 105.21 9.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.455 1.502 . . . . 0.0 110.354 -170.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.1 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.985 -1.072 . . . . 0.0 110.151 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.6 mm -108.73 -40.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.471 0.708 . . . . 0.0 111.603 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 t -66.41 10.14 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 98.13 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 130.588 3.555 . . . . 0.0 111.413 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 p -67.76 106.87 1.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.403 1.481 . . . . 0.0 109.375 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.94 147.21 64.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.635 2.89 . . . . 0.0 115.238 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 169.16 18.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.94 140.38 38.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.319 2.248 . . . . 0.0 108.914 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.12 -27.59 21.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.446 1.098 . . . . 0.0 112.283 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 177.73 7.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 130.163 3.385 . . . . 0.0 108.84 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.14 -43.71 61.26 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.085 -1.009 . . . . 0.0 112.342 170.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.37 -10.09 15.12 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 114.044 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -72.74 119.99 17.74 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 m -90.49 146.29 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.081 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -139.15 105.3 5.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -86.3 125.31 33.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 111.493 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.4 mt -131.69 115.47 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.309 1.444 . . . . 0.0 109.555 -159.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.11 126.51 29.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.103 0.961 . . . . 0.0 111.647 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.9 tp -145.5 143.13 29.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.021 1.728 . . . . 0.0 110.367 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CD ' HH21 ' A' ' 62' ' ' ARG . 5.2 tm-20 -118.19 92.63 43.17 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.619 1.568 . . . . 0.0 111.429 -165.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.85 170.47 19.99 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.288 3.325 . . . . 0.0 114.419 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.49 160.13 49.37 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.675 2.25 . . . . 0.0 111.17 165.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.85 92.18 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.456 0.702 . . . . 0.0 110.358 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.49 -172.38 34.24 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.218 1.389 . . . . 0.0 111.236 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.81 143.95 39.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.999 0.92 . . . . 0.0 111.512 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 162.18 24.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.064 0.946 . . . . 0.0 111.953 -171.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 91.8 m-85 -127.78 102.34 6.76 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.939 0.876 . . . . 0.0 111.747 -170.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.39 126.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 127.539 2.336 . . . . 0.0 106.968 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.32 120.36 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -124.28 98.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.075 1.35 . . . . 0.0 108.995 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.82 -174.04 15.01 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.85 2.167 . . . . 0.0 110.247 -161.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 m -114.76 161.53 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.569 1.184 . . . . 0.0 110.93 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 4.51 -85.57 0.0 OUTLIER Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.825 2.631 . . . . 0.0 117.406 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -4.43 58.67 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -119.41 -9.59 9.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.187 1.795 . . . . 0.0 113.853 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.93 8.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.716 2.006 . . . . 0.0 113.347 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.97 96.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 155.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.8 m -99.94 97.3 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -126.46 160.64 29.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.394 1.093 . . . . 0.0 113.307 -172.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 141.15 28.92 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 114.345 -162.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -146.24 129.45 16.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 166.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -105.93 108.76 20.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.548 1.539 . . . . 0.0 109.669 165.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -66.47 141.08 58.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm 51.54 33.36 10.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.203 1.801 . . . . 0.0 113.624 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.67 -29.29 0.02 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 115.621 1.009 . . . . 0.0 115.621 172.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.9 t 54.66 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.443 1.897 . . . . 0.0 113.381 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.3 p 54.07 -104.26 0.2 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.969 1.708 . . . . 0.0 112.378 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.2 tt -69.04 -27.92 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.094 1.358 . . . . 0.0 112.568 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.87 102.67 1.09 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.652 1.12 . . . . 0.0 111.082 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.485 2.714 . . . . 0.0 112.079 -176.787 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.85 -58.86 0.5 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.916 2.886 . . . . 0.0 114.66 165.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -141.52 -21.61 0.74 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.374 1.869 . . . . 0.0 113.004 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.7 tp -71.18 84.84 0.75 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.793 1.179 . . . . 0.0 108.611 159.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -161.31 176.17 11.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.511 2.725 . . . . 0.0 109.386 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -73.46 79.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.444 -0.785 . . . . 0.0 109.951 162.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -48.86 -58.54 4.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.65 2.38 . . . . 0.0 113.406 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.0 -56.09 20.57 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.584 1.088 . . . . 0.0 112.172 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.34 -58.66 6.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.039 0.936 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.0 p -82.95 6.89 17.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -160.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -102.6 165.78 10.88 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.847 1.203 . . . . 0.0 111.445 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -141.11 91.29 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.151 1.78 . . . . 0.0 107.117 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . 0.289 0.0 OUTLIER -129.1 -116.53 0.25 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -147.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.08 106.65 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -139.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.3 p -70.66 -7.35 43.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.657 1.583 . . . . 0.0 114.2 162.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.01 168.67 54.79 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.655 1.121 . . . . 0.0 113.893 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 155.18 36.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.638 1.575 . . . . 0.0 112.332 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.53 166.22 21.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.049 2.14 . . . . 0.0 110.477 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -106.53 140.25 39.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.39 1.476 . . . . 0.0 110.667 166.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -76.45 94.28 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 159.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.48 -13.05 26.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.816 1.246 . . . . 0.0 112.267 -165.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -145.87 140.79 27.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.745 1.618 . . . . 0.0 108.684 146.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.61 167.66 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.48 2.312 . . . . 0.0 113.691 166.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 28.8 mtm -76.23 137.63 40.1 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.264 -0.897 . . . . 0.0 113.183 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.65 128.66 35.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.565 1.146 . . . . 0.0 110.137 171.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -85.15 161.3 19.69 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -111.52 168.63 9.4 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.896 1.678 . . . . 0.0 111.764 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -30.28 70.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.545 1.138 . . . . 0.0 111.965 164.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -62.12 -14.68 39.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.771 1.628 . . . . 0.0 112.645 166.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 1.98 90.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.989 1.28 . . . . 0.0 113.954 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -76.35 164.31 26.14 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.925 2.09 . . . . 0.0 110.916 166.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -119.86 146.07 46.08 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.186 0.994 . . . . 0.0 110.245 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.7 119.09 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.079 0.952 . . . . 0.0 109.044 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.49 130.7 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.553 1.541 . . . . 0.0 109.211 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -106.77 108.3 19.74 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.113 0.869 . . . . 0.0 110.229 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.5 162.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 110.156 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 145.6 41.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.201 1.8 . . . . 0.0 107.459 154.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.63 153.02 22.66 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.96 1.254 . . . . 0.0 111.115 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -124.28 -59.32 1.48 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.199 -0.938 . . . . 0.0 109.645 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -20.66 -64.65 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 130.192 3.758 . . . . 0.0 118.587 -167.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.86 11.64 2.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -158.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.74 -45.85 2.77 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 120.606 -1.309 . . . . 0.0 113.417 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 165.74 6.28 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 128.473 2.709 . . . . 0.0 115.559 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.06 167.82 20.7 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.513 3.475 . . . . 0.0 113.622 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.2 m -147.59 157.23 43.47 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.225 1.81 . . . . 0.0 111.611 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 137.73 32.07 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 128.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 1.9 m -100.29 128.15 31.26 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.381 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.03 105.71 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.599 2.199 . . . . 0.0 109.707 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.0 128.01 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 110.491 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -131.75 168.07 18.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 109.247 165.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.95 135.09 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 151.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -119.62 157.94 27.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.228 1.411 . . . . 0.0 110.929 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.1 177.67 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.03 0.932 . . . . 0.0 112.544 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -56.16 -34.82 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 120.902 -1.124 . . . . 0.0 113.354 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -82.29 -6.55 59.31 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.34 1.856 . . . . 0.0 112.592 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 66.12 -5.42 0.56 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.207 3.003 . . . . 0.0 115.272 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.06 -38.65 88.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.302 1.841 . . . . 0.0 114.658 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -118.13 140.09 50.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.424 1.465 . . . . 0.0 111.862 -168.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -73.68 139.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.291 1.436 . . . . 0.0 111.062 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.82 -7.93 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 114.955 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.99 13.09 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 119.982 1.264 . . . . 0.0 115.795 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -133.38 119.58 19.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.363 1.865 . . . . 0.0 111.513 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.96 99.72 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.029 0.932 . . . . 0.0 110.853 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 66' ' ' SER . 40.8 mm -71.61 -38.22 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 111.424 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -67.33 18.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.928 1.291 . . . . 0.0 114.242 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 64' ' ' ILE . 49.1 m 60.64 -176.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.531 2.332 . . . . 0.0 113.335 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.0 p -57.35 107.83 1.05 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.057 1.743 . . . . 0.0 110.827 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -59.29 159.81 21.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.26 3.307 . . . . 0.0 115.319 -172.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.88 167.17 22.74 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.75 143.97 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.671 1.589 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -92.56 -22.57 19.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.21 171.11 5.8 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.882 3.273 . . . . 0.0 109.399 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 m -51.68 -47.68 63.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.223 1.009 . . . . 0.0 110.989 164.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -66.48 1.36 1.71 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 m -104.28 130.42 52.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.535 1.061 . . . . 0.0 112.022 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.39 152.58 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.988 1.315 . . . . 0.0 111.579 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -142.7 111.49 6.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.726 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -76.59 130.38 37.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.614 1.166 . . . . 0.0 111.204 167.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mm -132.74 116.98 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.315 1.846 . . . . 0.0 110.023 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.8 128.24 34.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 111.303 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 tp -144.13 146.91 33.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.506 1.922 . . . . 0.0 110.695 -169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.4 100.3 41.92 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.397 1.479 . . . . 0.0 110.871 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.55 174.05 13.26 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.962 3.775 . . . . 0.0 113.314 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.71 165.53 32.04 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.631 2.22 . . . . 0.0 111.001 162.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.72 79.47 2.05 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.131 -0.981 . . . . 0.0 111.834 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.39 -168.53 41.5 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.766 1.174 . . . . 0.0 112.496 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.64 142.82 55.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.367 1.067 . . . . 0.0 110.357 170.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.7 m -164.6 168.52 18.08 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.675 -1.266 . . . . 0.0 112.531 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -126.31 100.77 6.43 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.214 1.006 . . . . 0.0 110.231 -171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.91 138.98 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 171.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.43 130.08 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.3 mt -127.12 101.93 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.255 . . . . 0.0 108.645 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.46 164.03 17.81 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.367 1.937 . . . . 0.0 111.071 -164.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.9 148.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.639 -0.918 . . . . 0.0 110.455 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 6.37 -92.1 0.01 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 128.457 2.932 . . . . 0.0 117.296 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -64.26 -13.81 51.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.7 m -108.54 -5.14 16.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.992 2.117 . . . . 0.0 112.507 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.87 127.03 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.515 1.126 . . . . 0.0 113.09 -168.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.87 82.01 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.9 m -79.01 104.95 10.0 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.756 0.822 . . . . 0.0 109.185 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.83 151.93 51.92 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 138.98 37.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.887 2.475 . . . . 0.0 114.976 -171.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -136.16 156.77 48.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.734 0.814 . . . . 0.0 111.785 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -128.87 109.47 11.29 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.843 1.257 . . . . 0.0 108.273 162.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -65.03 136.38 56.71 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.144 -0.347 . . . . 0.0 111.831 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 58.61 24.43 12.04 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.361 1.865 . . . . 0.0 114.156 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -153.72 -17.48 0.05 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.5 t 43.34 -104.3 0.06 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.502 1.921 . . . . 0.0 111.758 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m 58.18 -76.21 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.051 2.54 . . . . 0.0 114.26 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.08 -22.01 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.03 1.332 . . . . 0.0 112.289 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.4 124.57 7.5 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.968 1.747 . . . . 0.0 112.695 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 4.7 mmpt? . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.359 2.664 . . . . 0.0 112.159 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.193 0.044 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.02 -54.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.877 3.271 . . . . 0.0 115.075 167.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.42 -29.77 0.74 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.599 2.36 . . . . 0.0 111.851 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.25 85.96 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.911 0.884 . . . . 0.0 108.737 164.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -163.26 172.57 14.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.298 3.039 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 pt -73.21 82.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.332 -0.855 . . . . 0.0 109.852 163.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -47.3 -55.41 8.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.327 1.851 . . . . 0.0 113.318 -168.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.66 -52.91 38.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.938 1.256 . . . . 0.0 113.918 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.0 ttt -82.53 -45.19 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.466 0.633 . . . . 0.0 112.682 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.6 p -83.78 -9.18 58.98 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -167.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -85.88 146.7 26.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.249 1.386 . . . . 0.0 111.381 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 p -137.66 90.49 2.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.726 2.01 . . . . 0.0 106.842 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.1 mmm -119.12 -81.68 0.63 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -150.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 102.55 6.24 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -149.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 p -76.77 -15.36 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.55 173.37 35.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.741 1.163 . . . . 0.0 115.298 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 155.63 27.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.175 2.19 . . . . 0.0 112.792 -173.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -129.92 168.45 16.63 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.434 2.294 . . . . 0.0 112.009 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -104.1 138.46 40.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.247 1.419 . . . . 0.0 110.661 163.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 tp -75.9 82.24 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 122.783 1.278 . . . . 0.0 107.859 160.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.28 -14.56 59.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.331 1.452 . . . . 0.0 112.827 -170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -153.09 137.85 17.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.441 1.097 . . . . 0.0 110.282 154.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.73 168.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.875 2.47 . . . . 0.0 113.57 165.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.1 mtm -82.71 134.5 35.14 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.135 -0.978 . . . . 0.0 113.525 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.16 31.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.892 1.277 . . . . 0.0 110.546 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -83.27 159.75 21.87 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -111.39 169.24 8.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.105 1.762 . . . . 0.0 111.863 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -26.73 64.74 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.893 0.877 . . . . 0.0 112.283 164.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -63.7 -11.8 29.02 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.765 1.626 . . . . 0.0 112.261 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.8 76.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.249 1.404 . . . . 0.0 113.843 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 p -76.16 165.64 24.61 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.672 1.989 . . . . 0.0 110.658 165.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -125.44 147.4 49.22 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.994 0.918 . . . . 0.0 110.956 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.6 t -114.43 120.98 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.377 1.071 . . . . 0.0 109.363 -171.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.53 133.5 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.06 1.744 . . . . 0.0 109.102 -173.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -103.45 115.79 31.18 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.547 1.067 . . . . 0.0 110.034 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -88.76 161.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.207 0.603 . . . . 0.0 110.108 170.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.39 142.42 47.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.201 1.801 . . . . 0.0 107.237 154.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -78.41 155.1 30.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.451 1.478 . . . . 0.0 110.653 169.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -127.02 -62.34 1.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.869 0.868 . . . . 0.0 110.337 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -29.26 -59.74 0.17 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.956 3.17 . . . . 0.0 118.353 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.37 15.69 3.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -160.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -45.71 3.0 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.743 -1.223 . . . . 0.0 114.061 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.08 8.0 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 128.045 2.538 . . . . 0.0 115.539 -170.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -66.71 161.32 42.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.041 2.494 . . . . 0.0 112.414 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.3 m -156.25 155.7 32.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 0.0 111.179 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 137.57 38.46 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 142.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.291 1.7 m -99.74 134.38 21.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.767 -169.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.58 100.71 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.174 2.583 . . . . 0.0 109.256 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mt -112.22 124.41 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.76 0.824 . . . . 0.0 111.08 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.73 163.1 21.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.826 1.251 . . . . 0.0 110.225 164.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mt -118.78 126.69 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 146.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.23 163.94 12.59 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.61 1.164 . . . . 0.0 111.966 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -56.59 171.01 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 127.343 2.257 . . . . 0.0 113.803 173.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.75 -26.53 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.451 -0.78 . . . . 0.0 112.847 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -72.81 -17.25 61.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.614 1.565 . . . . 0.0 113.449 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.506 ' HE3' ' CD2' ' A' ' 89' ' ' TYR . 42.8 mttp 71.73 23.62 3.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.734 2.413 . . . . 0.0 113.4 175.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -119.19 -31.6 4.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.148 1.779 . . . . 0.0 114.009 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -126.0 129.16 48.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.705 1.138 . . . . 0.0 110.917 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.53 133.74 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.358 1.463 . . . . 0.0 111.576 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -133.44 -10.5 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.149 1.78 . . . . 0.0 114.252 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.63 170.92 13.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.349 0.976 . . . . 0.0 114.599 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -131.35 138.22 49.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.812 1.645 . . . . 0.0 110.439 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.02 128.85 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.583 0.753 . . . . 0.0 109.616 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.59 -54.52 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 112.522 -162.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -60.41 -33.39 72.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -175.75 169.27 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.54 1.936 . . . . 0.0 110.135 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 p -66.52 105.13 0.73 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.334 157.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -58.44 145.52 93.93 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.528 2.819 . . . . 0.0 115.806 -163.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -144.7 167.68 21.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.13 0.972 . . . . 0.0 112.837 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.96 128.8 29.06 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.386 2.274 . . . . 0.0 108.334 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -75.2 -16.6 60.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.59 168.43 3.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.613 2.365 . . . . 0.0 110.429 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -58.47 -44.75 89.42 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.472 0.709 . . . . 0.0 110.065 156.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -69.88 40.13 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.453 1.901 . . . . 0.0 112.678 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -156.19 148.8 23.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 119.653 -1.904 . . . . 0.0 111.964 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.61 156.34 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.766 1.626 . . . . 0.0 111.078 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -142.98 107.76 4.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.101 0.56 . . . . 0.0 110.608 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -74.18 125.51 28.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.587 0.755 . . . . 0.0 110.852 164.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 mm -128.66 120.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.5 1.52 . . . . 0.0 110.022 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -71.04 130.66 42.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.4 1.08 . . . . 0.0 111.276 162.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.5 tp -143.94 151.55 39.93 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.308 2.243 . . . . 0.0 109.731 -168.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -125.7 94.37 42.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.901 1.68 . . . . 0.0 109.653 -165.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -76.07 172.59 15.98 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.606 3.537 . . . . 0.0 113.268 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.34 160.42 49.9 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.347 2.031 . . . . 0.0 110.692 162.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.26 72.61 2.33 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.221 -0.924 . . . . 0.0 111.097 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.33 42.42 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.318 1.913 . . . . 0.0 111.269 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.64 148.12 38.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.316 0.579 . . . . 0.0 111.045 169.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -163.97 161.3 22.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.929 0.891 . . . . 0.0 111.903 -167.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.506 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 86.5 m-85 -128.12 100.54 5.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 111.558 -169.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.57 126.56 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 127.668 2.387 . . . . 0.0 107.351 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.261 0.9 OUTLIER -119.08 120.95 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -122.04 97.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.498 1.519 . . . . 0.0 108.639 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.94 179.79 15.91 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.275 2.369 . . . . 0.0 110.493 -166.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.85 144.34 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.033 0.917 . . . . 0.0 111.169 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 38.0 -119.31 0.75 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.531 1.539 . . . . 0.0 113.858 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.44 -14.04 62.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.8 m -86.84 -10.79 52.64 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.226 1.011 . . . . 0.0 112.688 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.32 116.49 17.06 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.473 1.109 . . . . 0.0 113.467 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.7 mt -55.46 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 157.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.2 m -107.37 95.68 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.1 160.25 34.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.149 0.976 . . . . 0.0 113.38 -172.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.66 23.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.921 2.088 . . . . 0.0 114.521 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -151.64 132.01 13.74 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.157 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -103.88 109.31 21.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.003 1.321 . . . . 0.0 110.31 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.08 141.16 58.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.13 26.23 11.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.617 1.967 . . . . 0.0 114.353 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.81 -16.19 0.02 OUTLIER Glycine 0 CA--C 1.535 1.308 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.8 t 39.5 -94.83 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.267 2.227 . . . . 0.0 113.755 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m 63.28 -54.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 129.153 2.981 . . . . 0.0 115.382 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.21 -17.1 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.402 1.881 . . . . 0.0 112.657 170.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.7 108.57 3.69 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.388 1.475 . . . . 0.0 114.108 -164.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.9 -0.037 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.3 -57.38 0.33 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.514 3.126 . . . . 0.0 115.057 166.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -139.34 -32.06 0.67 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.685 2.394 . . . . 0.0 111.73 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 93.26 4.18 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -155.96 164.69 38.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 110.406 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mm -76.27 82.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.711 0.804 . . . . 0.0 109.077 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -55.04 -27.98 48.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.117 1.767 . . . . 0.0 113.724 -170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.54 -37.37 75.1 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.571 1.558 . . . . 0.0 114.015 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -136.94 -20.82 1.26 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 9.62 1.24 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -143.15 139.35 30.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.183 2.193 . . . . 0.0 108.858 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -142.83 77.03 1.56 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.78 2.032 . . . . 0.0 107.597 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 tpt -115.89 -75.83 0.58 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -130.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 127.44 32.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -154.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.0 p -100.17 -7.58 24.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.0 113.708 163.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.72 170.26 34.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.91 1.243 . . . . 0.0 114.185 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 157.22 27.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.69 1.996 . . . . 0.0 112.734 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.5 m-85 -129.77 168.46 16.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.052 2.141 . . . . 0.0 111.732 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -105.51 141.3 37.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.611 1.565 . . . . 0.0 110.682 164.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 tp -77.01 95.09 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 156.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -93.15 -12.04 31.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.053 1.341 . . . . 0.0 112.613 -166.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -151.13 132.48 14.59 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.46 1.104 . . . . 0.0 109.62 149.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.7 153.61 0.57 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.694 1.998 . . . . 0.0 113.336 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -69.55 145.82 52.29 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.38 13.16 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.825 1.65 . . . . 0.0 109.519 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -78.41 156.91 29.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 113.272 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.1 p -108.53 170.24 8.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.636 1.574 . . . . 0.0 111.475 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -25.24 62.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.399 1.08 . . . . 0.0 112.248 164.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -64.57 -12.49 45.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.499 1.52 . . . . 0.0 112.023 164.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 1.63 84.28 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.421 1.486 . . . . 0.0 113.861 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -73.6 168.07 20.07 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.974 2.11 . . . . 0.0 110.847 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -125.0 148.61 48.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.262 1.025 . . . . 0.0 110.198 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 t -115.86 110.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.062 0.945 . . . . 0.0 109.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.64 124.27 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.6 1.16 . . . . 0.0 109.774 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -92.46 112.57 24.56 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.438 1.017 . . . . 0.0 110.018 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.01 165.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.978 0.511 . . . . 0.0 110.099 169.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 154.93 45.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.092 2.157 . . . . 0.0 108.113 156.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -98.79 139.15 34.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.934 1.697 . . . . 0.0 112.802 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -119.71 -33.26 4.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.692 -1.255 . . . . 0.0 113.101 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.81 -25.68 71.9 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -157.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.05 -47.1 3.07 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 120.678 1.581 . . . . 0.0 114.679 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.51 169.21 20.55 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 127.781 2.432 . . . . 0.0 113.964 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -68.01 160.19 49.7 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.905 2.404 . . . . 0.0 115.738 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 13.0 m -151.15 154.64 37.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.527 1.931 . . . . 0.0 110.733 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 136.07 36.73 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 144.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.295 1.1 m -96.85 141.81 23.62 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 118.308 0.504 . . . . 0.0 111.765 -165.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -88.16 96.89 0.4 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.999 2.466 . . . . 0.0 109.324 -168.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.28 129.41 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.6 0.76 . . . . 0.0 112.189 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.22 170.01 16.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.698 1.199 . . . . 0.0 110.147 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt -115.36 129.2 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 148.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.94 164.11 12.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.681 1.192 . . . . 0.0 111.995 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -58.62 172.0 0.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.226 2.21 . . . . 0.0 114.167 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.44 -31.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.081 -1.012 . . . . 0.0 112.464 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.46 -16.14 62.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.608 1.963 . . . . 0.0 113.255 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 mttm 67.23 20.18 10.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.498 2.719 . . . . 0.0 113.436 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -101.57 -40.35 7.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 112.09 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 32.9 mtmm -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.93 1.241 . . . . 0.0 112.879 -165.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.1 137.63 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.989 1.716 . . . . 0.0 112.442 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.35 -14.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.05 169.04 14.73 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-N 119.745 1.157 . . . . 0.0 114.977 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -129.95 122.87 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.266 1.426 . . . . 0.0 112.216 -172.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.08 100.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.561 1.144 . . . . 0.0 111.398 176.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.8 mm -71.7 -44.03 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 110.642 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -62.87 -3.2 1.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m 62.92 -26.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 129.398 3.079 . . . . 0.0 118.785 155.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.2 p -128.25 69.6 78.23 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.21 1.368 . . . . 0.0 112.223 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -54.12 106.97 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.671 2.914 . . . . 0.0 113.211 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 169.6 17.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 166.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.84 116.98 13.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.418 2.687 . . . . 0.0 107.837 171.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -72.08 -16.46 62.02 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.42 173.48 3.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.144 3.378 . . . . 0.0 108.384 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.6 -45.36 77.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.333 -0.855 . . . . 0.0 111.653 166.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.17 0.63 2.57 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.8 m -96.6 112.07 23.96 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 m -80.46 152.66 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.244 1.017 . . . . 0.0 111.717 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m -144.58 110.44 5.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.283 0.633 . . . . 0.0 110.754 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.3 124.0 28.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.457 0.703 . . . . 0.0 111.741 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.05 109.46 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.997 1.319 . . . . 0.0 109.197 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -67.53 127.64 33.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.05 0.94 . . . . 0.0 111.025 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.7 tp -147.08 145.73 29.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.108 1.763 . . . . 0.0 110.154 -167.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -120.16 97.48 49.2 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.581 1.552 . . . . 0.0 110.496 -165.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.94 170.83 19.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.265 3.31 . . . . 0.0 113.423 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.88 161.16 47.05 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.548 2.165 . . . . 0.0 111.062 163.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -72.63 90.55 1.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.369 -0.832 . . . . 0.0 110.548 168.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.04 -171.91 37.19 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.041 1.305 . . . . 0.0 111.147 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.82 147.97 31.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.536 0.734 . . . . 0.0 111.048 170.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 90.4 p -162.57 159.94 25.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 112.325 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -128.72 96.91 4.51 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.545 1.164 . . . . 0.0 110.923 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.8 128.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 127.704 2.402 . . . . 0.0 106.918 176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.23 120.76 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.5 mt -122.48 94.32 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.136 1.374 . . . . 0.0 108.064 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 177.69 15.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.669 2.08 . . . . 0.0 110.543 -166.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 m -114.1 149.85 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.804 0.842 . . . . 0.0 110.763 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 32.72 -111.71 0.06 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 126.047 1.784 . . . . 0.0 114.971 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -70.41 -12.95 61.92 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 m -98.59 -9.32 24.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.626 1.571 . . . . 0.0 112.455 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.84 123.52 20.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.785 1.234 . . . . 0.0 112.934 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.99 90.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 151.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.6 m -84.68 101.25 12.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 168.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -125.63 154.66 41.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.701 1.239 . . . . 0.0 113.552 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 138.97 32.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.054 2.541 . . . . 0.0 114.618 -170.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -144.43 129.44 18.51 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 161.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -101.15 112.43 24.91 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.523 1.129 . . . . 0.0 109.656 165.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -66.58 134.46 52.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm 52.72 47.2 25.19 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.435 1.894 . . . . 0.0 112.707 -172.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.284 -1.287 . . . . 0.0 116.264 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.7 t 46.39 -110.35 0.27 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.6 1.7 . . . . 0.0 111.22 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.3 m 60.42 -77.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 114.0 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.1 tt -76.54 -22.19 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.343 1.057 . . . . 0.0 112.087 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.04 8.3 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.438 1.971 . . . . 0.0 111.201 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.366 0 C-N-CA 126.122 1.769 . . . . 0.0 111.501 -169.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 tpp . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.63 -51.03 0.64 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.414 3.486 . . . . 0.0 115.55 167.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -147.9 -28.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.126 2.17 . . . . 0.0 112.088 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.07 84.51 0.52 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 162.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -164.34 170.99 15.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 108.324 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 tp -74.98 84.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 O-C-N 121.131 -0.98 . . . . 0.0 109.385 165.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -46.05 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.524 2.329 . . . . 0.0 114.564 -161.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.12 -46.37 56.4 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.415 1.007 . . . . 0.0 112.823 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.7 ttm -64.14 -59.93 3.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.262 1.025 . . . . 0.0 111.749 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.0 p -86.82 -9.53 55.58 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.932 1.826 . . . . 0.0 115.932 -164.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -68.55 156.44 38.03 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.436 1.471 . . . . 0.0 111.064 165.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -143.81 90.2 2.12 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.896 1.679 . . . . 0.0 107.276 165.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.9 mmm -129.79 -87.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -151.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 100.38 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -138.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 p -79.15 -10.85 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.298 1.839 . . . . 0.0 114.86 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.57 171.93 14.31 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.327 1.441 . . . . 0.0 114.63 -172.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 39' ' ' GLU . 12.0 ttpp -74.0 159.04 33.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.743 1.217 . . . . 0.0 114.023 -168.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -124.02 171.57 9.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.316 2.646 . . . . 0.0 109.741 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.18 139.63 45.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.969 1.708 . . . . 0.0 109.696 166.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.14 100.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.64 -10.0 20.42 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.179 1.391 . . . . 0.0 112.131 -165.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -153.42 143.57 22.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.149 1.38 . . . . 0.0 110.077 150.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.47 166.68 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 113.869 166.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -89.78 136.29 33.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.74 30.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 109.843 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.55 158.53 23.08 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -110.69 170.6 7.98 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.315 1.846 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.6 68.9 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.047 -1.033 . . . . 0.0 112.737 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -67.97 -10.77 56.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.096 1.758 . . . . 0.0 112.236 167.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.95 4.64 72.63 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.427 1.489 . . . . 0.0 114.052 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -74.6 166.12 24.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.446 1.898 . . . . 0.0 110.292 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -119.21 152.88 35.85 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.48 1.112 . . . . 0.0 110.15 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -115.04 113.26 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.024 0.929 . . . . 0.0 109.871 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.24 116.55 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.566 1.546 . . . . 0.0 109.27 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.83 117.5 29.84 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.876 0.762 . . . . 0.0 110.572 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.57 160.03 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 110.234 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -141.17 150.43 42.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.636 1.974 . . . . 0.0 108.227 164.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -98.55 150.85 21.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.27 1.395 . . . . 0.0 112.982 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 17' ' ' LYS . 53.5 mt-10 -128.09 -63.87 0.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 110.971 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -7.66 -72.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 129.649 3.499 . . . . 0.0 117.106 -169.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.39 18.62 3.66 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.578 1.551 . . . . 0.0 113.446 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.46 -43.64 1.1 Allowed Glycine 0 CA--C 1.539 1.593 0 N-CA-C 116.557 1.383 . . . . 0.0 116.557 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 165.43 4.47 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.713 2.805 . . . . 0.0 114.761 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.03 157.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.647 2.231 . . . . 0.0 113.831 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.0 m -151.76 157.22 41.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.277 1.431 . . . . 0.0 112.014 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 138.05 36.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 139.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 m -97.53 123.75 51.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.873 -171.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.86 124.24 13.7 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.557 2.171 . . . . 0.0 110.072 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mt -132.8 130.99 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 109.73 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.21 167.98 16.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 166.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.7 mt -124.25 128.8 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 147.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.52 164.11 13.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.704 1.202 . . . . 0.0 112.088 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.97 175.5 0.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.466 2.306 . . . . 0.0 113.492 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.0 -32.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.45 -8.04 58.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.583 1.553 . . . . 0.0 113.177 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 66.82 32.42 6.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.188 2.195 . . . . 0.0 113.0 171.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -130.85 -20.72 2.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.409 1.484 . . . . 0.0 114.64 -175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -121.65 121.65 37.84 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.685 1.129 . . . . 0.0 110.359 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.07 133.84 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 111.624 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -137.35 -7.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.794 1.638 . . . . 0.0 114.537 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.5 170.01 13.22 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.682 1.128 . . . . 0.0 114.679 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -131.71 119.58 21.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.12 1.768 . . . . 0.0 110.947 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -72.11 122.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.857 0.863 . . . . 0.0 109.78 176.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.1 mm -97.36 -33.24 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.499 0.719 . . . . 0.0 111.707 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.7 t -62.2 20.28 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.386 2.274 . . . . 0.0 116.84 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.1 p 60.01 -169.01 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.805 2.042 . . . . 0.0 112.535 -163.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.4 p -60.87 106.38 0.77 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.246 1.818 . . . . 0.0 111.083 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.59 144.4 97.38 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.645 2.896 . . . . 0.0 113.46 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.02 167.21 22.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.87 123.7 18.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.87 2.068 . . . . 0.0 108.358 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -75.3 -26.46 58.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.933 0.893 . . . . 0.0 113.135 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.62 172.86 4.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.139 2.575 . . . . 0.0 109.916 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -39.28 63.76 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 171.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -72.8 -2.65 21.37 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -94.86 155.44 16.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 111.749 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.5 147.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.514 1.126 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.7 m -139.35 105.34 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.592 0.357 . . . . 0.0 110.644 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.79 89.56 4.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.204 1.801 . . . . 0.0 111.837 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.52 117.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.931 1.692 . . . . 0.0 111.201 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -69.13 126.88 31.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.054 0.942 . . . . 0.0 111.466 159.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.5 tp -143.04 147.01 34.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.679 1.991 . . . . 0.0 110.268 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -118.65 97.48 50.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.395 1.478 . . . . 0.0 110.528 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.05 172.08 16.67 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.752 3.635 . . . . 0.0 113.666 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.61 163.14 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.498 2.132 . . . . 0.0 111.1 164.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.83 74.01 4.39 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.322 -0.861 . . . . 0.0 111.688 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.65 -168.14 40.94 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.053 1.311 . . . . 0.0 111.632 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -67.24 144.35 56.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.476 0.655 . . . . 0.0 111.085 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.6 p -161.73 160.14 28.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.083 0.953 . . . . 0.0 111.502 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.47 98.03 4.73 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.493 0.717 . . . . 0.0 110.333 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.89 135.45 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.764 1.626 . . . . 0.0 107.305 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.87 123.45 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.2 mt -125.31 109.85 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.719 1.207 . . . . 0.0 109.488 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.49 163.63 26.28 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.963 1.744 . . . . 0.0 111.422 -162.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.88 166.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.708 -0.878 . . . . 0.0 111.872 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -30.17 -59.81 0.21 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.456 2.455 . . . . 0.0 116.885 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.99 3.24 0.87 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.848 1.659 . . . . 0.0 115.232 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -161.93 12.09 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.269 -1.519 . . . . 0.0 114.29 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.31 108.34 7.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.349 1.459 . . . . 0.0 112.286 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.08 101.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 160.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.5 m -112.31 95.2 5.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.317 1.047 . . . . 0.0 108.386 -167.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -130.44 146.45 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 137.95 45.75 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.037 2.935 . . . . 0.0 114.872 -172.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -149.22 121.02 8.12 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.943 0.897 . . . . 0.0 112.539 165.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -92.3 108.05 19.66 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.443 0.697 . . . . 0.0 109.754 164.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -64.05 131.78 48.59 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.978 0.511 . . . . 0.0 111.038 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 mttp 49.23 55.31 9.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.946 1.699 . . . . 0.0 112.728 -171.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.04 -37.52 0.04 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.528 1.061 . . . . 0.0 112.301 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m 54.7 22.77 4.3 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 149.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.0 m -122.84 -48.29 2.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.404 1.482 . . . . 0.0 111.498 -167.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.5 tt -74.07 -10.33 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.161 0.984 . . . . 0.0 112.653 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.51 141.67 10.01 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 124.444 1.021 . . . . 0.0 112.191 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt . . . . . 0 C--O 1.254 1.337 0 C-N-CA 130.015 3.326 . . . . 0.0 111.05 -173.36 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -58.41 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.583 1.953 . . . . 0.0 110.302 -163.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -106.51 -37.65 6.41 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 129.324 3.05 . . . . 0.0 109.457 163.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -76.46 81.44 3.17 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.521 1.528 . . . . 0.0 108.262 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -163.75 156.44 17.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.689 2.396 . . . . 0.0 108.642 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 tt -73.11 93.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 122.014 0.911 . . . . 0.0 110.096 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.7 -25.71 67.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.717 1.607 . . . . 0.0 114.386 -170.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.02 -23.51 77.88 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 119.546 -0.586 . . . . 0.0 114.05 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -114.75 -47.83 2.87 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.239 1.02 . . . . 0.0 111.655 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 81.0 p -75.75 7.44 3.85 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.072 1.749 . . . . 0.0 115.206 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -132.35 150.67 52.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.172 1.389 . . . . 0.0 110.715 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -148.01 85.34 1.54 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.984 2.114 . . . . 0.0 107.534 166.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 tpt -115.65 -102.81 0.42 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -128.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.99 108.56 10.13 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -153.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.7 p -69.39 -4.52 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.25 1.42 . . . . 0.0 114.315 165.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.65 172.15 46.14 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.506 1.527 . . . . 0.0 114.339 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.56 163.17 27.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.59 1.556 . . . . 0.0 113.799 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.48 174.38 10.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.444 2.298 . . . . 0.0 109.76 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 p -112.13 145.46 39.76 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.259 1.024 . . . . 0.0 110.983 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.2 103.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 156.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 -14.71 14.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.905 0.882 . . . . 0.0 111.45 -159.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.7 ttpp -143.83 136.91 27.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.635 1.574 . . . . 0.0 108.615 149.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.29 156.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.917 2.087 . . . . 0.0 113.628 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 mtm -70.69 132.78 45.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.1 122.74 36.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.034 1.333 . . . . 0.0 109.996 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 152.61 34.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.581 0.705 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.7 p -101.27 167.54 10.13 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 111.105 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -24.69 64.12 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.244 -0.91 . . . . 0.0 112.27 163.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -64.94 -9.22 19.7 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.232 1.813 . . . . 0.0 112.419 165.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.89 -3.82 63.48 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.764 1.65 . . . . 0.0 114.17 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -69.58 168.35 14.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.73 2.012 . . . . 0.0 110.736 165.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 t -125.8 154.06 43.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.758 0.823 . . . . 0.0 110.481 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -118.72 118.95 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.43 1.092 . . . . 0.0 109.663 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.16 116.81 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.49 1.516 . . . . 0.0 110.125 -173.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 tmmt? -89.59 109.9 20.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.376 0.989 . . . . 0.0 109.822 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -86.75 165.66 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.205 1.002 . . . . 0.0 110.495 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 150.99 45.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.941 1.696 . . . . 0.0 108.544 153.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -94.15 129.96 40.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.289 0.95 . . . . 0.0 113.024 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -131.21 1.82 4.22 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.09 -61.82 2.76 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.102 0.858 . . . . 0.0 114.561 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.19 19.35 1.4 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -165.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.1 -43.77 2.52 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.612 -1.305 . . . . 0.0 115.553 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.18 174.33 2.95 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 127.16 2.184 . . . . 0.0 114.31 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.07 162.82 33.84 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.515 2.81 . . . . 0.0 114.22 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.2 m -145.35 151.59 38.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.684 1.994 . . . . 0.0 110.284 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 131.78 34.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 131.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.276 0.9 OUTLIER -90.43 137.91 27.22 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 118.561 0.618 . . . . 0.0 110.824 -168.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.07 97.3 0.56 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.845 2.363 . . . . 0.0 109.569 -168.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.66 124.57 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.781 0.832 . . . . 0.0 111.384 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.64 168.63 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.23 1.412 . . . . 0.0 110.242 164.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.23 133.03 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 147.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -112.17 162.87 14.98 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.533 1.133 . . . . 0.0 111.921 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -56.6 171.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.809 2.043 . . . . 0.0 113.138 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -57.49 -28.83 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 112.701 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -75.63 -12.62 60.24 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.03 2.132 . . . . 0.0 113.772 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 68.04 25.88 7.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.637 2.375 . . . . 0.0 113.452 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -120.59 -27.42 5.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.403 1.481 . . . . 0.0 114.04 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -124.07 129.05 50.23 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.676 1.125 . . . . 0.0 111.364 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.79 131.39 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.826 1.65 . . . . 0.0 111.535 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.51 -7.37 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.962 1.705 . . . . 0.0 114.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.49 166.04 15.0 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.637 1.108 . . . . 0.0 114.745 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -129.54 109.87 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.017 1.727 . . . . 0.0 109.837 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -70.14 114.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 0.0 109.645 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.5 mm -87.58 -33.9 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.887 . . . . 0.0 111.977 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.9 t -64.27 23.19 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.551 1.94 . . . . 0.0 116.062 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p 74.63 -101.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 129.997 3.319 . . . . 0.0 113.134 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.7 p -131.39 99.03 17.72 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.705 1.602 . . . . 0.0 109.072 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.46 137.71 31.82 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.86 3.04 . . . . 0.0 113.797 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -141.94 168.16 20.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 137.18 37.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.909 2.084 . . . . 0.0 108.256 168.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -91.59 -17.0 26.27 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.256 -0.903 . . . . 0.0 112.852 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.98 176.42 1.79 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 130.939 3.695 . . . . 0.0 108.167 173.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -40.88 64.52 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.816 -1.178 . . . . 0.0 112.848 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -65.31 -6.69 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.41 1.084 . . . . 0.0 113.852 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -78.49 123.82 27.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.227 0.922 . . . . 0.0 111.398 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.25 154.51 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.116 159.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.3 109.14 4.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.833 0.453 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 107.35 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.179 0.992 . . . . 0.0 112.004 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -104.27 114.08 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 125.455 1.502 . . . . 0.0 110.684 -172.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.36 129.96 41.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.868 0.842 . . . . 0.0 111.137 161.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.7 147.61 29.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.066 1.746 . . . . 0.0 110.217 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.98 94.13 43.77 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.645 1.578 . . . . 0.0 110.433 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -66.95 171.38 11.27 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.581 3.521 . . . . 0.0 112.826 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.53 155.59 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.005 1.803 . . . . 0.0 110.634 162.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -70.68 90.63 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.511 -0.743 . . . . 0.0 110.246 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.51 -170.62 32.92 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.849 1.214 . . . . 0.0 111.352 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.77 143.18 44.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.594 0.758 . . . . 0.0 111.607 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -160.68 158.06 28.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 112.36 -166.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -126.23 97.0 4.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.151 0.976 . . . . 0.0 110.972 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 132.42 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.424 2.29 . . . . 0.0 107.231 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.263 1.9 m -125.87 118.13 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mt -122.97 100.09 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.062 1.345 . . . . 0.0 108.97 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.65 -178.4 16.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.047 2.261 . . . . 0.0 110.285 -165.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.93 148.29 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.181 0.991 . . . . 0.0 111.06 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.92 -121.65 2.04 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.852 1.215 . . . . 0.0 113.523 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -69.69 -12.84 61.95 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.1 m -87.53 -9.86 53.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.485 1.114 . . . . 0.0 112.898 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.35 112.14 10.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.705 1.202 . . . . 0.0 113.072 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.49 95.84 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.838 0.855 . . . . 0.0 108.907 159.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -102.87 98.76 8.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.8 157.7 43.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.382 1.086 . . . . 0.0 113.766 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 143.07 28.95 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.098 2.159 . . . . 0.0 114.693 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -149.56 136.94 19.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.572 0.749 . . . . 0.0 112.86 160.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -104.28 108.07 19.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.719 1.208 . . . . 0.0 109.402 165.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -70.4 142.44 52.05 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.904 -0.498 . . . . 0.0 111.704 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.99 46.53 25.36 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.442 1.897 . . . . 0.0 112.217 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.19 -33.07 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.124 1.345 . . . . 0.0 111.705 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m 63.66 19.22 11.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.201 1.401 . . . . 0.0 114.108 147.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.7 m -126.56 -54.53 1.44 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.31 1.844 . . . . 0.0 112.984 -162.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.1 tt -70.86 -11.51 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.199 0.999 . . . . 0.0 113.263 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.12 154.75 22.45 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.257 1.408 . . . . 0.0 110.298 165.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 129.097 2.959 . . . . 0.0 111.142 -173.414 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.53 -55.55 0.84 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.654 3.182 . . . . 0.0 114.802 166.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -133.05 -34.24 1.11 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 128.285 2.634 . . . . 0.0 111.714 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.53 81.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.455 1.102 . . . . 0.0 108.264 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -159.63 167.71 27.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.074 2.55 . . . . 0.0 108.867 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.06 79.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.863 0.839 . . . . 0.0 109.706 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -67.91 0.24 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.531 1.932 . . . . 0.0 114.796 -161.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.54 -37.48 67.4 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.568 0.604 . . . . 0.0 112.925 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.09 -5.62 54.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -144.68 -7.5 0.67 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -167.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -82.65 167.1 18.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 121.004 1.729 . . . . 0.0 112.455 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 p -147.53 107.08 3.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.565 2.746 . . . . 0.0 107.133 162.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.472 ' HB2' ' H ' ' A' ' 46' ' ' LYS . 56.3 mmm -135.16 -107.27 0.22 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -161.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -83.82 154.63 23.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -134.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.9 p -125.24 1.56 7.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.918 1.687 . . . . 0.0 114.069 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.79 174.45 49.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.92 1.247 . . . . 0.0 113.452 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -74.48 161.53 29.69 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.933 1.293 . . . . 0.0 112.514 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 47' ' ' VAL . 86.0 m-85 -130.05 177.06 7.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.014 2.126 . . . . 0.0 109.373 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.8 p -107.32 151.58 25.29 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.914 0.779 . . . . 0.0 111.183 155.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 tp -83.59 100.33 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -15.17 15.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.062 1.345 . . . . 0.0 112.233 -160.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -147.57 141.8 26.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.774 2.43 . . . . 0.0 107.381 151.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.62 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.069 2.948 . . . . 0.0 115.006 167.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -86.01 129.88 34.71 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.155 -0.966 . . . . 0.0 112.563 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.78 118.17 24.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -80.31 156.1 26.95 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.1 p -112.68 171.77 7.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.578 1.551 . . . . 0.0 112.832 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.12 66.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.129 0.972 . . . . 0.0 113.316 166.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.07 -6.66 58.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.997 2.119 . . . . 0.0 111.597 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.0 6.7 60.8 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 120.832 -1.167 . . . . 0.0 113.705 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -76.36 169.67 17.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.972 2.109 . . . . 0.0 110.103 164.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -129.31 147.65 51.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.073 0.949 . . . . 0.0 111.149 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.85 102.25 13.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.519 1.128 . . . . 0.0 110.312 -171.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.45 144.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.45 1.9 . . . . 0.0 109.2 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -111.85 125.28 53.85 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.238 1.381 . . . . 0.0 109.228 168.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 m -104.15 169.39 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.422 1.089 . . . . 0.0 110.44 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.28 155.5 44.49 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.43 1.892 . . . . 0.0 108.523 158.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -97.78 130.1 44.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.087 1.312 . . . . 0.0 112.836 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -132.19 13.98 4.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.099 -1.0 . . . . 0.0 112.679 -169.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.04 -50.04 2.53 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.227 0.918 . . . . 0.0 115.103 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.83 9.88 1.02 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -166.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.46 -41.97 1.91 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 120.112 1.324 . . . . 0.0 114.783 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.24 177.42 2.81 Favored Pre-proline 0 CA--C 1.561 1.365 0 C-N-CA 127.719 2.408 . . . . 0.0 114.188 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 166.25 24.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.241 3.294 . . . . 0.0 115.161 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.2 m -149.14 155.22 40.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.749 2.02 . . . . 0.0 110.798 172.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' H ' ' HB2' ' A' ' 13' ' ' MET . 8.0 ptpt -83.3 134.1 34.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 118.79 -1.164 . . . . 0.0 107.925 127.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 18' ' ' PHE 0.287 1.9 m -93.87 131.06 32.77 Favored Pre-proline 0 N--CA 1.468 0.434 0 O-C-N 123.551 0.532 . . . . 0.0 110.258 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.82 105.18 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.89 2.393 . . . . 0.0 108.859 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.91 124.9 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.914 0.886 . . . . 0.0 111.092 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 52' ' ' ARG . 63.5 mt-10 -136.2 169.45 17.62 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 109.768 168.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.4 mt -119.78 124.6 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 50' ' ' GLU . 61.5 mtt-85 -107.79 162.22 14.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 111.048 171.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -59.84 176.22 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.956 2.102 . . . . 0.0 113.967 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.06 -33.59 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.841 -1.162 . . . . 0.0 112.766 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -74.22 -11.44 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.279 1.832 . . . . 0.0 113.543 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 63.43 28.85 15.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.243 2.617 . . . . 0.0 113.606 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.21 -40.1 5.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.88 1.672 . . . . 0.0 112.563 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -124.32 138.0 54.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.874 1.215 . . . . 0.0 111.677 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.63 133.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.783 1.233 . . . . 0.0 111.38 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.27 -11.38 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.079 1.752 . . . . 0.0 114.072 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.35 168.03 14.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.541 1.067 . . . . 0.0 114.659 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -133.42 121.83 22.85 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.176 1.79 . . . . 0.0 111.274 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 122.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.963 0.802 . . . . 0.0 110.177 174.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.2 mm -95.85 -37.05 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 0.0 111.596 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 t -64.24 -7.51 9.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.7 m 117.82 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 1 C-N-CA 132.944 4.497 . . . . 0.0 108.961 -166.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 m -65.41 117.57 41.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.178 -0.915 . . . . 0.0 108.733 159.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.29 156.59 20.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.589 3.526 . . . . 0.0 115.261 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.16 169.08 18.87 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 172.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.64 139.37 31.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.457 2.303 . . . . 0.0 108.583 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -97.95 -17.6 19.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.006 0.923 . . . . 0.0 112.717 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.81 174.94 7.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.643 3.177 . . . . 0.0 108.072 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -44.65 62.54 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.309 -0.869 . . . . 0.0 112.369 173.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -65.65 -7.49 15.52 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.117 1.367 . . . . 0.0 113.917 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -71.62 106.42 4.04 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.32 0.964 . . . . 0.0 110.834 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.05 149.19 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.625 154.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 m -141.41 117.7 10.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.049 0.54 . . . . 0.0 110.134 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.25 119.66 29.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.753 0.821 . . . . 0.0 111.669 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 mm -120.82 110.87 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.877 1.671 . . . . 0.0 110.683 -167.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -69.01 123.79 21.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.536 1.134 . . . . 0.0 111.165 162.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.4 tp -142.35 141.66 32.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.782 2.033 . . . . 0.0 109.943 -169.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -113.78 100.58 52.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.853 1.661 . . . . 0.0 110.564 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -78.06 173.36 14.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.391 3.394 . . . . 0.0 113.77 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.74 161.92 43.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.522 2.148 . . . . 0.0 110.878 162.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -72.7 102.63 3.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.984 166.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.47 -169.82 25.78 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.87 1.224 . . . . 0.0 111.964 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.64 139.52 39.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.165 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -159.59 164.48 34.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.105 0.962 . . . . 0.0 112.261 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -129.11 104.93 7.84 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.224 1.011 . . . . 0.0 111.526 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.33 123.82 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.261 2.224 . . . . 0.0 107.102 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.68 122.63 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.33 100.38 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.994 1.317 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.19 176.28 18.59 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.714 2.102 . . . . 0.0 110.216 -161.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.6 m -107.25 139.71 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.16 0.98 . . . . 0.0 110.3 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 23.14 -100.17 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 127.902 2.667 . . . . 0.0 115.563 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -59.02 -16.37 18.01 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -110.09 -2.9 16.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.738 1.615 . . . . 0.0 112.767 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.17 111.33 16.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.103 0.961 . . . . 0.0 112.963 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.9 mt -56.22 100.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 93.03 4.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.37 156.27 34.29 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.293 1.044 . . . . 0.0 113.51 -172.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 147.0 33.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.444 1.898 . . . . 0.0 114.495 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -146.1 144.08 29.77 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.33 1.052 . . . . 0.0 110.725 157.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -114.42 116.84 29.53 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -70.03 138.68 52.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.31 17.48 4.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.035 1.734 . . . . 0.0 115.401 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.02 42.56 0.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.809 1.195 . . . . 0.0 113.042 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.5 m -68.35 34.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.845 2.858 . . . . 0.0 117.238 -157.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.3 t -72.75 -1.27 15.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.591 1.556 . . . . 0.0 114.877 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.3 tt -131.96 -1.48 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.04 1.336 . . . . 0.0 113.467 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.97 143.8 9.81 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 121.305 -0.872 . . . . 0.0 112.281 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 C--O 1.252 1.215 0 C-N-CA 128.154 2.582 . . . . 0.0 112.615 -170.042 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.9 mmm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -43.13 -59.54 2.01 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 130.834 3.653 . . . . 0.0 115.257 164.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -135.63 -33.3 0.87 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.37 3.068 . . . . 0.0 111.018 -167.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.9 84.91 0.96 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.861 1.264 . . . . 0.0 108.378 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -166.52 165.34 16.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.593 2.757 . . . . 0.0 109.668 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.99 84.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.903 0.859 . . . . 0.0 110.0 167.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -64.0 -34.18 77.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.582 1.553 . . . . 0.0 113.675 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.49 -34.1 63.28 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.157 0.884 . . . . 0.0 112.963 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -92.58 -66.16 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.17 0.985 . . . . 0.0 110.366 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -73.2 8.34 1.72 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -159.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -109.66 156.5 20.16 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.663 1.12 . . . . 0.0 110.418 165.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -145.16 91.34 2.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.482 1.913 . . . . 0.0 106.997 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.422 ' HB2' ' H ' ' A' ' 46' ' ' LYS . 84.7 mmm -128.59 -115.01 0.26 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -152.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.82 105.51 7.93 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -133.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -72.45 -3.52 24.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.09 1.756 . . . . 0.0 114.547 166.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 170.49 51.22 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.888 1.232 . . . . 0.0 113.67 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -73.66 160.66 31.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.146 1.378 . . . . 0.0 113.014 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -131.31 175.0 9.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.093 2.157 . . . . 0.0 109.901 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p -114.71 144.66 43.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 111.382 160.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.59 93.57 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 159.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.4 -16.49 21.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.264 -159.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -145.74 139.42 26.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.85 2.06 . . . . 0.0 108.105 148.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.1 162.05 0.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.779 2.432 . . . . 0.0 114.602 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 mtm -69.88 127.39 32.73 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 123.4 37.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.898 1.279 . . . . 0.0 110.245 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.93 155.16 27.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 p -105.21 170.82 7.66 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.252 1.821 . . . . 0.0 111.448 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -27.34 67.78 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.196 -0.94 . . . . 0.0 112.416 165.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.55 -9.73 37.99 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.555 1.942 . . . . 0.0 112.256 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.39 1.44 60.83 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.317 1.436 . . . . 0.0 114.014 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.25 166.12 22.22 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.157 1.783 . . . . 0.0 110.262 164.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -122.79 148.0 45.87 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 110.5 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.84 113.57 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 109.4 -173.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -110.41 116.08 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 109.792 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -96.09 105.04 17.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.42 0.555 . . . . 0.0 109.688 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.27 166.22 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.506 1.122 . . . . 0.0 110.655 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 146.63 30.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.914 1.685 . . . . 0.0 108.716 160.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -91.09 134.96 34.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.795 0.725 . . . . 0.0 112.496 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -133.38 3.15 3.6 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.135 -0.978 . . . . 0.0 113.583 -171.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.78 -36.5 7.28 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.216 1.247 . . . . 0.0 116.216 -170.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.96 7.88 0.41 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.16 -43.07 1.96 Allowed Glycine 0 CA--C 1.535 1.322 0 CA-C-N 120.211 1.369 . . . . 0.0 114.928 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.46 167.66 6.54 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 127.696 2.399 . . . . 0.0 115.025 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.94 163.42 22.32 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.657 2.904 . . . . 0.0 113.478 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -147.29 154.5 41.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.733 1.613 . . . . 0.0 111.59 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 13' ' ' MET . 7.8 ptpt -87.27 140.49 29.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 127.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 1.4 m -100.74 120.53 55.49 Favored Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.06 115.59 3.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.28 1.987 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mt -126.1 129.64 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 110.712 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.09 165.32 18.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.392 1.077 . . . . 0.0 110.154 162.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.94 130.74 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 146.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -112.12 164.9 12.64 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.431 1.492 . . . . 0.0 112.435 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -58.14 171.32 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.591 1.956 . . . . 0.0 113.508 172.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.9 -36.13 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.367 -0.833 . . . . 0.0 112.932 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.87 -12.33 60.64 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.876 2.07 . . . . 0.0 113.988 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 67.09 27.76 8.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 113.419 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.17 -27.96 7.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.084 2.154 . . . . 0.0 113.012 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -131.72 132.92 44.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.214 0.916 . . . . 0.0 111.041 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.98 134.22 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.204 1.402 . . . . 0.0 110.89 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.61 -8.46 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.921 1.688 . . . . 0.0 114.19 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.9 163.59 18.42 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 119.555 1.07 . . . . 0.0 114.686 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -127.21 112.87 15.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.889 1.675 . . . . 0.0 110.36 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 63' ' ' ILE . 0.6 OUTLIER -72.31 109.77 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.607 0.763 . . . . 0.0 109.947 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.01 -38.23 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.971 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -67.44 30.71 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.73 2.012 . . . . 0.0 114.558 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.34 -173.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.943 2.097 . . . . 0.0 113.095 -169.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -66.93 111.72 7.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.371 1.068 . . . . 0.0 109.238 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -55.82 152.99 32.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.476 3.451 . . . . 0.0 115.544 -169.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.26 167.26 22.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.6 143.71 31.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.008 1.723 . . . . 0.0 109.127 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -96.4 -18.53 19.84 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.79 174.03 5.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.844 2.858 . . . . 0.0 108.547 173.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -45.75 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.608 -0.682 . . . . 0.0 112.018 169.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -66.36 -3.39 5.88 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.3 m -87.41 119.81 28.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 111.459 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.58 156.12 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 159.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.51 119.05 10.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.069 0.548 . . . . 0.0 110.87 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.67 106.11 18.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.66 109.06 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.085 1.754 . . . . 0.0 110.526 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -67.14 126.55 29.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.385 0.612 . . . . 0.0 110.875 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.8 tp -146.65 140.73 26.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 110.235 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.94 94.14 23.8 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.011 1.324 . . . . 0.0 110.727 -172.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.83 169.95 20.82 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.641 3.561 . . . . 0.0 112.865 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 163.47 39.07 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.815 2.343 . . . . 0.0 111.664 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -75.22 72.11 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.852 0.861 . . . . 0.0 111.442 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.49 -169.34 41.42 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.233 1.397 . . . . 0.0 111.813 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.82 145.05 50.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.273 0.559 . . . . 0.0 111.11 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -161.02 154.68 22.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.574 0.749 . . . . 0.0 112.138 -166.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -127.78 101.92 6.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.157 0.98 . . . . 0.0 111.656 -171.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.89 139.53 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.966 2.106 . . . . 0.0 107.647 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.4 125.04 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 170.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 mt -125.67 103.34 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.685 1.194 . . . . 0.0 109.099 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.27 178.13 20.84 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.109 1.814 . . . . 0.0 111.117 -162.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 145.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.074 0.937 . . . . 0.0 110.786 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 22.03 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.683 2.563 . . . . 0.0 116.063 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.05 -11.28 28.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -107.98 -7.74 16.09 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.276 1.83 . . . . 0.0 112.639 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 127.41 32.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 112.171 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.54 87.12 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 157.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.8 m -79.39 98.26 6.68 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -125.05 176.62 6.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.207 1.403 . . . . 0.0 113.008 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 139.9 53.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -154.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -154.86 131.27 10.46 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -106.22 109.84 21.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.02 1.328 . . . . 0.0 109.327 165.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -63.82 148.35 49.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.649 0.78 . . . . 0.0 111.775 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -25.83 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 129.079 2.952 . . . . 0.0 116.214 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.98 43.47 3.24 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.298 1.428 . . . . 0.0 111.7 160.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.1 m -63.33 29.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 131.494 3.918 . . . . 0.0 118.194 -151.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 m -156.26 1.85 0.15 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.9 tt -68.63 -19.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.278 1.399 . . . . 0.0 112.5 170.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -121.23 160.8 15.47 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.971 1.748 . . . . 0.0 109.276 156.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 5.2 mmpt? . . . . . 0 C--O 1.256 1.441 0 C-N-CA 125.934 1.694 . . . . 0.0 112.413 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -111.48 -88.24 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 130.399 3.48 . . . . 0.0 111.32 -163.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -77.25 -40.51 44.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.066 2.146 . . . . 0.0 109.719 162.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.54 76.77 1.07 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.291 1.036 . . . . 0.0 111.156 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -164.7 162.35 21.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 127.501 2.321 . . . . 0.0 110.268 167.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -70.98 96.96 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.758 0.79 . . . . 0.0 109.337 168.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -60.32 -55.62 31.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.411 1.885 . . . . 0.0 112.847 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.2 -28.27 54.05 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.342 0.972 . . . . 0.0 114.001 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -85.52 -68.58 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.395 1.097 . . . . 0.0 110.263 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.6 p -79.08 -4.91 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -161.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.82 165.7 12.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.585 1.538 . . . . 0.0 112.827 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 p -148.51 104.67 3.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.724 2.81 . . . . 0.0 106.44 158.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.446 ' HB2' ' H ' ' A' ' 46' ' ' LYS . 66.0 mmm -129.95 -110.39 0.26 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -152.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.3 m -79.83 107.67 12.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -138.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 p -69.36 -9.45 53.51 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 164.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 171.93 52.48 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.701 1.619 . . . . 0.0 114.337 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -77.22 160.82 28.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.447 1.499 . . . . 0.0 114.301 -169.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CE2' ' HB ' ' A' ' 47' ' ' VAL . 87.7 m-85 -130.46 173.64 10.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.535 2.334 . . . . 0.0 109.954 173.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.0 p -119.75 142.93 48.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.073 0.949 . . . . 0.0 112.037 159.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 101.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 163.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -106.52 -13.19 15.39 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.809 1.243 . . . . 0.0 111.046 -164.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -149.23 140.82 23.43 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.872 2.069 . . . . 0.0 108.883 148.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.15 170.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.464 2.706 . . . . 0.0 114.477 166.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.0 mtm -80.89 133.8 35.63 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.95 114.76 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.945 1.698 . . . . 0.0 110.718 176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.49 151.45 43.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p -106.36 168.89 8.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.976 1.711 . . . . 0.0 111.72 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -26.21 66.97 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.291 -0.881 . . . . 0.0 112.559 166.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -67.21 -8.64 33.08 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.311 2.244 . . . . 0.0 112.422 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.08 0.48 65.56 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.405 1.479 . . . . 0.0 114.205 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -73.31 173.29 9.73 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.126 2.17 . . . . 0.0 110.263 164.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -133.44 146.06 50.83 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 111.133 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.37 103.95 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.855 1.262 . . . . 0.0 110.385 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.58 168.4 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.599 1.96 . . . . 0.0 110.144 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -133.86 124.97 27.38 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.472 -0.767 . . . . 0.0 111.054 159.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.75 165.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.434 1.093 . . . . 0.0 110.524 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.03 145.33 39.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.952 1.701 . . . . 0.0 108.564 156.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -84.81 143.69 28.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.797 1.181 . . . . 0.0 111.654 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -136.27 -9.37 1.98 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -36.0 62.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.162 -1.355 . . . . 0.0 116.344 -170.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.86 12.78 0.25 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -166.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 -43.89 2.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 120.9 1.682 . . . . 0.0 114.416 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.57 175.44 4.68 Favored Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 127.4 2.28 . . . . 0.0 114.743 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.18 167.89 17.16 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.352 3.368 . . . . 0.0 115.388 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -148.21 160.84 42.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.624 1.969 . . . . 0.0 110.911 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' H ' ' HB2' ' A' ' 13' ' ' MET . 7.0 ptpt -88.1 136.29 33.04 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 129.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HB ' ' CE2' ' A' ' 18' ' ' PHE 0.332 2.0 m -96.29 135.52 22.51 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.355 0.409 . . . . 0.0 111.158 -169.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -87.14 89.39 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.019 2.479 . . . . 0.0 107.888 -163.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.1 125.69 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.725 0.81 . . . . 0.0 111.342 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.81 162.77 24.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.32 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' CG2' ' HB3' ' A' ' 88' ' ' SER . 4.1 mt -118.62 126.91 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 151.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -110.84 162.99 14.24 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.323 1.014 . . . . 0.0 112.452 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -58.39 171.94 0.53 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.136 2.174 . . . . 0.0 113.079 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.86 -31.99 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -74.69 -12.85 60.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.186 1.794 . . . . 0.0 113.515 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 mttm 67.84 26.56 7.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.122 2.169 . . . . 0.0 113.171 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.47 4.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.995 2.118 . . . . 0.0 113.165 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.3 131.07 57.05 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.347 0.976 . . . . 0.0 110.624 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.1 138.72 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.991 0.916 . . . . 0.0 111.447 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.36 -10.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.617 1.567 . . . . 0.0 115.083 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.83 169.77 13.86 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.994 1.27 . . . . 0.0 115.715 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.59 107.82 9.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.081 2.152 . . . . 0.0 110.553 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.42 108.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.296 0.638 . . . . 0.0 110.07 175.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 66' ' ' SER . 31.3 mm -78.95 -36.54 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.215 1.006 . . . . 0.0 111.408 -174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -67.43 26.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.85 1.66 . . . . 0.0 114.658 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 64' ' ' ILE . 6.1 t 63.43 -178.5 0.15 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.946 2.498 . . . . 0.0 113.168 -168.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.5 m -61.64 110.68 3.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.428 1.091 . . . . 0.0 108.925 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.57 159.2 11.48 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.315 3.343 . . . . 0.0 115.431 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -141.98 168.2 20.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.22 38.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.935 1.694 . . . . 0.0 108.286 171.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -93.84 -14.37 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.09 172.9 2.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 130.483 3.513 . . . . 0.0 108.451 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -57.74 -50.35 73.51 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 110.967 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -66.44 3.09 1.03 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 m -97.84 124.79 42.39 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.479 1.111 . . . . 0.0 111.077 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 m -86.91 162.15 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.426 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.32 107.02 4.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.689 0.795 . . . . 0.0 109.111 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -73.28 136.27 44.52 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.991 -0.443 . . . . 0.0 109.978 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -135.64 109.55 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.497 1.119 . . . . 0.0 110.094 -168.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -73.0 130.3 40.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.272 1.029 . . . . 0.0 110.746 163.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.8 tp -151.9 144.56 24.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.995 1.318 . . . . 0.0 110.986 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -117.39 96.91 50.13 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.747 1.619 . . . . 0.0 110.77 -171.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.73 171.1 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.803 3.668 . . . . 0.0 112.564 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.94 164.33 32.15 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.477 2.118 . . . . 0.0 111.483 168.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.25 87.55 1.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.77 166.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.01 -173.47 44.09 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.856 1.217 . . . . 0.0 112.051 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.97 159.15 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.755 0.822 . . . . 0.0 110.21 165.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.422 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 18.7 m -171.39 158.3 5.23 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.475 1.11 . . . . 0.0 112.784 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.97 102.94 7.49 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.663 1.22 . . . . 0.0 110.328 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.71 125.31 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 128.599 2.759 . . . . 0.0 106.746 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.19 130.53 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.1 mt -129.16 94.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.209 1.404 . . . . 0.0 108.577 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.24 -170.52 18.07 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.421 1.963 . . . . 0.0 109.767 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.61 179.11 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.231 1.015 . . . . 0.0 110.721 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.74 -20.17 17.24 Favored Glycine 0 CA--C 1.541 1.705 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 -168.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.51 0.26 49.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -154.32 -8.46 0.14 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.62 128.08 34.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.692 1.197 . . . . 0.0 113.942 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.09 98.61 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 152.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -96.41 100.94 12.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.93 165.83 18.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 112.381 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 153.11 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.115 1.766 . . . . 0.0 114.552 -167.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -150.37 147.57 27.75 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.098 0.559 . . . . 0.0 111.843 162.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -124.19 111.88 16.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -66.97 144.13 56.39 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 111.392 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER 62.5 -24.28 0.05 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.102 2.961 . . . . 0.0 116.928 -175.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.24 52.19 1.86 Allowed Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.842 1.201 . . . . 0.0 110.521 161.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -64.6 28.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 131.408 3.883 . . . . 0.0 117.508 -153.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 m -154.16 9.77 0.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.317 -1.489 . . . . 0.0 114.27 165.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.489 1.041 . . . . 0.0 110.965 163.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.39 165.82 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.481 1.515 . . . . 0.0 110.187 162.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 5.5 mmpt? . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.812 2.045 . . . . 0.0 112.015 -174.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -30.95 -58.49 0.22 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.044 2.537 . . . . 0.0 114.977 165.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -132.98 -31.96 1.25 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.174 2.989 . . . . 0.0 110.813 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.58 87.62 2.69 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.31 0.959 . . . . 0.0 108.563 166.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -161.65 165.87 27.63 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.574 1.949 . . . . 0.0 111.765 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 tp -72.61 83.92 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.506 1.122 . . . . 0.0 110.278 164.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -59.96 -35.98 76.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.51 1.124 . . . . 0.0 113.319 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.36 62.17 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.941 0.781 . . . . 0.0 113.407 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ttt -102.59 -69.45 0.79 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 110.209 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.0 p -65.73 9.78 0.12 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.739 2.816 . . . . 0.0 117.401 -162.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -121.53 152.7 38.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.873 1.269 . . . . 0.0 110.4 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.1 p -145.13 86.41 1.77 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 163.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mmm -117.67 -92.92 0.52 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -147.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -85.24 95.99 9.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -140.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.0 p -65.87 -2.5 3.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 162.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.67 176.56 53.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.255 1.407 . . . . 0.0 113.925 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 154.01 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.69 2.396 . . . . 0.0 111.797 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -135.15 174.06 11.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.199 1.8 . . . . 0.0 110.77 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.449 ' HG ' ' CD ' ' A' ' 39' ' ' GLU . 8.4 m -123.46 144.19 49.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.601 0.76 . . . . 0.0 112.172 161.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.4 91.48 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 107.249 159.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -94.29 -13.41 26.51 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.913 1.285 . . . . 0.0 111.857 -163.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -150.25 135.83 18.22 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.415 1.886 . . . . 0.0 109.431 148.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.76 162.81 0.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.884 2.874 . . . . 0.0 115.169 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 32.3 mtm -70.41 122.41 19.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.3 119.61 36.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.597 1.159 . . . . 0.0 110.975 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.14 157.65 34.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 0.0 112.368 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -117.37 168.48 10.32 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.783 1.233 . . . . 0.0 112.802 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -25.03 67.2 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.419 -0.801 . . . . 0.0 112.835 166.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -71.9 -7.63 49.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.485 1.914 . . . . 0.0 112.275 168.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.78 71.29 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.068 1.318 . . . . 0.0 113.964 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 p -76.61 174.44 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.314 2.246 . . . . 0.0 110.667 168.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.73 154.26 44.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.851 0.86 . . . . 0.0 110.932 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.41 125.01 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.864 1.266 . . . . 0.0 109.613 -174.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.76 127.43 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.803 1.641 . . . . 0.0 109.482 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -100.56 115.43 30.13 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.717 1.144 . . . . 0.0 110.081 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.2 m -98.8 159.05 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.482 0.713 . . . . 0.0 111.707 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.86 147.95 37.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.903 2.081 . . . . 0.0 109.357 169.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -100.95 137.53 39.2 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.593 1.088 . . . . 0.0 112.552 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.449 ' CD ' ' HG ' ' A' ' 19' ' ' SER . 62.2 mt-10 -135.51 1.74 2.89 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -173.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.25 -46.62 15.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.033 -0.871 . . . . 0.0 115.129 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.89 11.35 0.48 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.9 -46.96 2.74 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.591 -1.318 . . . . 0.0 114.584 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.01 163.89 3.89 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 128.098 2.559 . . . . 0.0 114.703 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.06 162.82 36.5 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.293 2.662 . . . . 0.0 113.803 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.6 m -144.26 154.96 43.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.54 1.936 . . . . 0.0 111.183 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -90.69 141.07 29.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 128.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.73 123.33 44.41 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 115.52 3.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.993 1.795 . . . . 0.0 109.687 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mt -125.81 134.54 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.88 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -132.96 169.12 17.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.771 1.228 . . . . 0.0 109.579 163.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mt -120.04 129.04 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 146.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -109.65 164.62 12.37 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.542 1.137 . . . . 0.0 112.508 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -54.84 170.26 0.18 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.386 2.275 . . . . 0.0 113.428 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.4 m -58.46 -33.0 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.232 -0.918 . . . . 0.0 112.919 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -70.6 -15.61 62.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.991 2.116 . . . . 0.0 113.759 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.4 mttm 66.74 33.73 6.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.275 2.23 . . . . 0.0 113.254 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.27 -27.67 5.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.504 1.922 . . . . 0.0 113.698 -174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -133.98 135.27 43.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.811 1.187 . . . . 0.0 111.726 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.76 136.34 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.0 111.876 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.51 -10.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.872 1.669 . . . . 0.0 114.733 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.87 169.14 12.75 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.585 1.084 . . . . 0.0 114.72 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -130.52 111.79 12.6 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.145 1.778 . . . . 0.0 110.911 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.58 131.63 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.734 -0.603 . . . . 0.0 109.533 172.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.61 -32.14 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.302 0.641 . . . . 0.0 111.392 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 38.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.262 1.825 . . . . 0.0 115.27 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 t 59.26 -172.68 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.964 2.106 . . . . 0.0 113.077 -171.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -70.26 108.94 3.99 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.311 1.445 . . . . 0.0 110.661 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.01 139.41 61.26 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.644 3.562 . . . . 0.0 116.035 -171.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.76 166.3 24.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.22 1.008 . . . . 0.0 113.605 177.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.88 130.36 21.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.891 1.677 . . . . 0.0 108.914 171.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -83.58 -17.55 41.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.09 172.95 3.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.919 2.888 . . . . 0.0 109.181 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -51.72 -48.63 63.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.67 -0.55 13.38 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -83.01 152.05 25.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.295 0.952 . . . . 0.0 111.023 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.84 148.45 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.151 0.98 . . . . 0.0 110.451 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -137.77 108.05 6.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.803 0.441 . . . . 0.0 109.865 -174.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.91 111.94 19.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.086 1.355 . . . . 0.0 111.2 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.5 mt -115.38 112.99 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.487 1.915 . . . . 0.0 109.88 -163.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -69.93 127.81 34.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.312 1.045 . . . . 0.0 111.543 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.9 tp -146.68 144.07 29.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.442 1.897 . . . . 0.0 110.242 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -116.69 94.03 42.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.744 1.617 . . . . 0.0 110.49 -170.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -73.93 170.38 20.22 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.759 3.64 . . . . 0.0 113.158 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.11 161.78 44.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.543 2.162 . . . . 0.0 111.271 167.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.44 74.89 3.19 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.335 -0.853 . . . . 0.0 111.25 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.76 -170.66 43.09 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.647 1.594 . . . . 0.0 111.382 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -69.62 142.21 53.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.388 0.613 . . . . 0.0 111.069 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.9 p -160.0 159.39 32.05 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.137 0.975 . . . . 0.0 111.354 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -130.73 103.65 6.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.88 137.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.42 125.18 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.41 98.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.801 1.24 . . . . 0.0 109.517 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.66 -169.22 14.1 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.735 1.635 . . . . 0.0 111.331 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.9 -174.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.896 0.879 . . . . 0.0 111.881 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.71 -14.76 5.49 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.96 4.57 23.45 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 113.822 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 p -153.29 -9.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.58 107.64 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.85 1.66 . . . . 0.0 114.062 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 mt -54.75 104.97 0.13 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 159.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -111.53 88.01 2.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -168.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -119.87 140.46 50.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.712 1.244 . . . . 0.0 113.801 -160.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 136.6 54.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.601 3.16 . . . . 0.0 115.092 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -153.11 120.42 5.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -100.72 104.87 16.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.463 1.105 . . . . 0.0 109.819 166.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -60.67 140.97 57.27 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.726 -0.609 . . . . 0.0 111.31 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER 61.22 -19.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.205 2.602 . . . . 0.0 116.545 -169.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.44 47.64 3.89 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.134 1.35 . . . . 0.0 110.786 158.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -60.02 17.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 130.856 3.663 . . . . 0.0 118.253 -152.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.0 m -154.96 7.7 0.28 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.188 -1.57 . . . . 0.0 114.657 164.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.78 -26.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.76 1.164 . . . . 0.0 111.358 170.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -116.02 160.59 13.28 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 156.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 5.3 mmpt? . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.475 1.91 . . . . 0.0 111.628 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 mmt . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -28.5 -50.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.656 3.182 . . . . 0.0 115.575 167.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -137.76 -21.36 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.288 1.835 . . . . 0.0 113.322 161.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.77 80.58 1.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.572 1.078 . . . . 0.0 109.84 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -165.46 -170.62 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 130.399 3.48 . . . . 0.0 108.731 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -68.35 78.83 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 O-C-N 121.072 -1.017 . . . . 0.0 112.209 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.65 -69.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.181 2.192 . . . . 0.0 114.016 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.14 -30.35 63.87 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.16 -12.47 40.88 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.636 1.174 . . . . 0.0 113.731 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.8 p -128.03 16.09 6.78 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.11 151.06 41.33 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.849 1.66 . . . . 0.0 110.057 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.6 p -144.78 89.54 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.272 2.229 . . . . 0.0 105.882 163.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mmm -114.44 -111.95 0.34 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -149.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 m -73.6 102.94 4.04 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -140.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 p -66.01 -12.12 52.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.422 1.489 . . . . 0.0 113.782 166.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.38 169.41 43.44 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.268 1.413 . . . . 0.0 114.398 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 157.08 37.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.492 1.917 . . . . 0.0 113.87 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.05 167.25 19.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.253 2.621 . . . . 0.0 109.78 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -102.7 139.6 38.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.469 1.108 . . . . 0.0 110.416 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 tp -73.97 103.93 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 155.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -106.8 -14.15 15.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.743 -165.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.6 ttpp -153.08 138.73 17.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.324 1.85 . . . . 0.0 109.615 146.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.13 165.55 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.44 2.696 . . . . 0.0 114.454 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.5 mtm -70.65 135.01 48.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.13 119.29 21.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.171 1.389 . . . . 0.0 111.349 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 160.89 30.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -116.54 168.03 10.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.667 1.587 . . . . 0.0 111.992 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -26.15 64.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.198 0.999 . . . . 0.0 112.435 165.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -65.73 -10.57 38.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.735 1.614 . . . . 0.0 112.494 165.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.99 89.18 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 124.895 1.236 . . . . 0.0 113.976 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.6 p -82.0 171.18 14.71 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.905 2.482 . . . . 0.0 110.553 168.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t -125.41 148.73 48.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.256 1.022 . . . . 0.0 111.02 169.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.21 119.68 61.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.96 1.304 . . . . 0.0 108.928 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.79 146.45 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.65 1.58 . . . . 0.0 108.469 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -115.12 115.89 27.51 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 109.686 170.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -93.87 164.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 109.903 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 149.61 49.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.24 1.816 . . . . 0.0 107.406 157.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -86.05 157.85 19.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.469 1.486 . . . . 0.0 111.055 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.59 -63.23 0.84 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.155 -0.966 . . . . 0.0 110.198 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -15.5 -75.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 129.88 3.61 . . . . 0.0 117.655 -167.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -130.75 15.16 5.35 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -162.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 -44.01 2.56 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.627 -1.296 . . . . 0.0 113.809 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.4 170.3 3.07 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 128.591 2.756 . . . . 0.0 115.208 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -66.7 163.23 33.9 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.52 2.814 . . . . 0.0 113.611 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.27 151.32 38.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.241 1.816 . . . . 0.0 110.488 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -88.72 126.33 35.27 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 134.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.6 m -86.12 129.98 51.81 Favored Pre-proline 0 N--CA 1.472 0.63 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -166.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -72.36 111.92 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.935 1.757 . . . . 0.0 109.109 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.98 131.37 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.572 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.28 169.12 16.92 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.095 164.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 mt -122.56 123.63 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 152.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -102.62 157.39 16.97 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.979 0.8 . . . . 0.0 110.211 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -58.54 174.48 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.465 1.906 . . . . 0.0 113.37 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.93 -35.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.995 -1.066 . . . . 0.0 113.037 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -72.57 -16.71 61.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.891 2.076 . . . . 0.0 113.597 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttm 68.28 27.44 6.62 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.057 2.543 . . . . 0.0 113.512 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.89 -38.74 7.26 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.616 1.966 . . . . 0.0 111.823 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -124.17 137.37 54.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.707 1.14 . . . . 0.0 111.632 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -68.87 134.16 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.597 1.159 . . . . 0.0 110.666 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.34 -9.16 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.242 1.417 . . . . 0.0 114.618 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.94 167.98 12.72 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.438 1.017 . . . . 0.0 114.928 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -130.81 110.83 11.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.224 1.81 . . . . 0.0 110.403 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.54 115.63 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.635 0.774 . . . . 0.0 109.501 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 mm -93.53 -39.87 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.199 1.0 . . . . 0.0 111.711 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -63.64 8.73 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t 97.7 179.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.504 3.522 . . . . 0.0 110.149 -163.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.3 p -65.07 114.58 15.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.793 1.237 . . . . 0.0 109.74 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.05 136.18 44.73 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.323 2.682 . . . . 0.0 114.057 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.14 166.97 23.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -140.37 131.64 26.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.084 2.153 . . . . 0.0 108.279 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -85.29 -18.41 33.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.93 172.41 5.55 Favored 'General case' 0 CA--C 1.549 0.912 1 C-N-CA 131.769 4.027 . . . . 0.0 108.639 175.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -54.81 7.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.19 1.396 . . . . 0.0 112.216 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -66.87 -1.07 3.51 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 m -74.37 121.59 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.813 1.188 . . . . 0.0 111.057 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -90.34 146.63 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.34 0.656 . . . . 0.0 110.758 162.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 m -139.5 110.99 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.637 0.775 . . . . 0.0 109.57 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.52 134.71 37.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 110.548 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.6 mt -139.36 106.85 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.965 1.306 . . . . 0.0 109.599 -166.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -65.5 127.84 33.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.923 1.289 . . . . 0.0 111.955 161.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 tp -147.75 146.08 29.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.978 2.111 . . . . 0.0 110.111 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.18 96.6 50.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 111.524 -171.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.17 170.0 19.26 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.437 3.424 . . . . 0.0 113.108 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.27 166.55 28.92 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.456 2.104 . . . . 0.0 111.157 166.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -74.8 77.43 2.09 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.327 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.59 -169.18 42.1 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.746 1.165 . . . . 0.0 112.149 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.86 143.12 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.073 0.949 . . . . 0.0 110.481 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 m -164.57 169.26 17.29 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.997 -1.064 . . . . 0.0 112.698 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -125.97 107.55 10.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 110.736 -169.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.0 124.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 127.922 2.489 . . . . 0.0 107.055 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.69 123.23 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.5 mt -125.35 99.88 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.318 1.447 . . . . 0.0 108.719 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.6 -169.15 13.37 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 127.07 2.272 . . . . 0.0 110.242 -161.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.52 -177.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.636 1.218 . . . . 0.0 111.675 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.32 -18.29 6.79 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.95 2.91 44.05 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.18 1.49 . . . . 0.0 114.267 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 p -157.97 -11.36 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.2 117.45 6.07 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.665 1.186 . . . . 0.0 114.106 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 mt -52.54 104.73 0.1 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 156.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.4 m -110.66 94.54 5.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.97 160.35 27.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.276 1.031 . . . . 0.0 112.455 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.7 148.38 25.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.425 1.49 . . . . 0.0 114.292 -161.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -149.77 147.39 27.96 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 171.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.04 107.15 11.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.32 1.048 . . . . 0.0 108.885 164.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -63.32 140.01 58.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.257 0.623 . . . . 0.0 111.559 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.49 -4.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.534 2.734 . . . . 0.0 116.228 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.5 50.09 0.81 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.219 1.866 . . . . 0.0 109.924 162.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.4 m -61.68 22.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.651 1 C-N-CA 132.582 4.353 . . . . 0.0 117.726 -157.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.6 t -140.41 1.99 1.81 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 114.313 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -25.2 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 120.097 1.317 . . . . 0.0 111.826 167.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.28 171.18 21.57 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.664 1.602 . . . . 0.0 110.534 166.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 6.5 mmpt? . . . . . 0 C--O 1.258 1.518 0 C-N-CA 127.805 2.442 . . . . 0.0 111.456 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -23.62 -58.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.991 3.316 . . . . 0.0 115.627 167.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -128.79 -28.9 2.4 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.894 2.478 . . . . 0.0 111.222 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.68 84.63 7.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.518 1.053 . . . . 0.0 110.477 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -164.94 174.0 11.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.42 1.888 . . . . 0.0 111.83 168.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 tp -71.51 77.75 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 125.53 1.532 . . . . 0.0 112.02 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -67.84 -13.0 61.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.037 1.735 . . . . 0.0 114.583 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.28 93.79 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.406 0.548 . . . . 0.0 112.006 169.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.32 -56.27 2.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.163 1.385 . . . . 0.0 110.757 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.9 p -74.68 36.37 0.11 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 115.08 -172.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.71 146.53 24.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.497 1.919 . . . . 0.0 109.336 162.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.1 p -139.22 93.6 2.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.623 1.969 . . . . 0.0 106.599 163.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mmm -120.15 -87.23 0.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -155.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.79 138.69 52.92 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -143.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -132.04 13.3 4.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.659 1.184 . . . . 0.0 113.388 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.34 175.03 15.64 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.868 1.699 . . . . 0.0 112.549 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 11.8 ttpp -71.45 157.86 37.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -169.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -127.5 173.86 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.119 2.568 . . . . 0.0 110.332 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.97 139.1 47.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.066 1.746 . . . . 0.0 109.927 165.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tp -75.81 89.51 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 160.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.48 -12.84 41.83 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.789 1.235 . . . . 0.0 112.379 -164.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -149.38 142.95 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.647 1.579 . . . . 0.0 109.663 149.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 167.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.777 2.431 . . . . 0.0 113.701 166.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 141.89 31.85 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 120.78 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.913 1.285 . . . . 0.0 110.654 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.44 162.01 23.47 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 p -116.9 178.65 4.27 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.792 1.637 . . . . 0.0 112.528 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -17.01 63.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.141 0.976 . . . . 0.0 113.444 166.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -75.87 -10.73 59.67 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.906 1.23 . . . . 0.0 112.118 164.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.84 8.13 32.78 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.485 -1.384 . . . . 0.0 113.306 -164.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.1 p -66.23 160.3 24.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.996 1.398 . . . . 0.0 108.879 162.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -126.67 144.04 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.893 0.877 . . . . 0.0 110.627 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -105.03 118.91 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.523 1.129 . . . . 0.0 109.172 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.19 129.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -104.13 110.03 22.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.341 0.973 . . . . 0.0 110.253 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -86.05 163.78 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.533 0.733 . . . . 0.0 110.375 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.2 155.61 43.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.581 1.952 . . . . 0.0 108.156 157.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -108.95 142.4 39.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.367 1.439 . . . . 0.0 113.177 -170.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CD ' ' HZ3' ' A' ' 17' ' ' LYS . 48.2 mt-10 -128.96 -24.29 2.94 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.29 73.37 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 117.406 1.722 . . . . 0.0 117.406 -163.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.61 1.51 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.95 -41.1 1.04 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 120.177 1.353 . . . . 0.0 115.193 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.04 171.5 6.42 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.288 2.635 . . . . 0.0 114.146 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.28 159.3 35.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.608 2.872 . . . . 0.0 114.39 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.52 152.73 29.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.122 1.769 . . . . 0.0 110.476 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 132.88 35.82 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 142.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -94.29 124.74 54.76 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -170.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -67.11 114.05 3.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 109.374 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.8 mt -120.43 123.34 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.256 1.022 . . . . 0.0 108.769 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.49 174.47 10.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.561 0.744 . . . . 0.0 109.931 167.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 mt -124.1 130.01 73.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 153.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -110.83 160.32 16.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.133 0.968 . . . . 0.0 111.126 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -58.63 176.07 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.852 2.461 . . . . 0.0 114.083 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.32 -29.96 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.007 -1.058 . . . . 0.0 112.945 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -71.96 -17.7 62.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.215 1.406 . . . . 0.0 112.974 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 45.7 mttp 67.66 29.9 6.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.304 2.641 . . . . 0.0 112.954 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.15 -29.99 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.763 1.625 . . . . 0.0 113.487 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -122.45 131.4 53.85 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.896 1.225 . . . . 0.0 110.894 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.79 135.68 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.346 1.458 . . . . 0.0 111.656 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.53 -7.01 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.78 168.63 12.61 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.855 1.207 . . . . 0.0 115.27 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -131.31 118.1 19.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.756 1.622 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.423 ' H ' HD11 ' A' ' 63' ' ' ILE . 0.5 OUTLIER -77.87 99.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.348 1.059 . . . . 0.0 111.101 -177.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.81 -49.49 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.033 0.933 . . . . 0.0 111.876 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.2 t -63.03 -4.97 2.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m 62.82 -12.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.935 2.494 . . . . 0.0 117.692 158.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.6 p -120.16 59.71 6.6 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.481 1.512 . . . . 0.0 113.663 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -58.04 84.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.832 3.022 . . . . 0.0 113.786 163.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.42 166.99 23.2 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.67 137.31 36.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.445 2.698 . . . . 0.0 108.32 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -102.77 -7.49 21.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.662 1.185 . . . . 0.0 112.962 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.25 170.77 11.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 130.17 3.388 . . . . 0.0 108.258 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -44.62 41.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.319 0.648 . . . . 0.0 111.794 167.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -66.76 -6.08 14.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.112 1.765 . . . . 0.0 114.429 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -73.58 101.56 3.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.42 1.009 . . . . 0.0 111.345 174.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 m -73.88 135.46 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.434 158.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -137.95 108.06 6.4 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.779 0.432 . . . . 0.0 110.828 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.58 121.63 25.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.283 1.433 . . . . 0.0 111.833 170.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mm -124.49 115.84 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 126.129 1.772 . . . . 0.0 110.188 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.58 127.95 34.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.405 1.082 . . . . 0.0 110.898 161.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 tp -141.4 145.19 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.359 2.263 . . . . 0.0 109.561 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -113.73 101.05 53.39 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.162 1.385 . . . . 0.0 110.901 -171.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.66 168.91 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.348 3.365 . . . . 0.0 113.135 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.31 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.261 1.974 . . . . 0.0 110.857 162.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -76.32 75.4 3.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.087 -1.008 . . . . 0.0 111.748 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.94 -166.94 39.27 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.987 1.279 . . . . 0.0 112.492 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.99 135.67 47.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.961 1.304 . . . . 0.0 110.626 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -163.38 173.5 13.14 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.075 -1.015 . . . . 0.0 112.098 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 90.5 m-85 -125.67 105.0 8.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.743 0.817 . . . . 0.0 110.765 -165.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.95 129.86 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.976 1.711 . . . . 0.0 106.841 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.69 122.66 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.79 98.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.575 1.15 . . . . 0.0 109.223 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.56 -176.99 16.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.025 2.25 . . . . 0.0 111.279 -162.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.95 177.21 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.638 1.175 . . . . 0.0 111.57 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.27 -17.18 5.42 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 117.675 1.83 . . . . 0.0 117.675 -170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.39 6.36 44.47 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.514 1.657 . . . . 0.0 113.992 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -162.75 -1.23 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.57 114.88 3.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.512 1.525 . . . . 0.0 114.282 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.63 103.35 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 157.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 m -112.32 92.83 4.17 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -126.51 148.73 49.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.814 1.292 . . . . 0.0 113.908 -166.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 139.84 47.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.683 2.393 . . . . 0.0 114.132 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -140.03 153.57 46.86 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.417 0.687 . . . . 0.0 110.718 156.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -124.48 115.45 20.92 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 165.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -66.65 134.35 52.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.24 0.473 . . . . 0.0 111.865 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.26 -29.94 0.05 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.56 30.18 10.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.747 2.118 . . . . 0.0 113.39 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -57.26 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 128.413 2.685 . . . . 0.0 113.42 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 p -143.42 -67.49 0.35 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.889 1.676 . . . . 0.0 110.472 -165.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.7 tp -67.56 -9.88 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.522 1.529 . . . . 0.0 113.576 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.02 144.46 16.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.734 1.159 . . . . 0.0 112.591 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 127.955 2.502 . . . . 0.0 111.346 -171.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.1 mmm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.4 m -86.98 96.65 10.34 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -143.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.6 p -67.37 -10.74 54.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.895 1.678 . . . . 0.0 114.549 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 170.4 48.2 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.75 1.167 . . . . 0.0 113.726 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.18 158.04 27.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.446 1.498 . . . . 0.0 111.616 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -132.4 167.88 19.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.573 2.349 . . . . 0.0 110.616 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -108.46 139.7 42.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.387 1.075 . . . . 0.0 110.807 165.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tp -71.09 113.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 154.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.21 -14.11 9.29 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.807 0.843 . . . . 0.0 112.51 -162.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.1 ttpp -147.82 141.19 25.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.575 1.55 . . . . 0.0 109.013 144.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.47 161.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.358 2.263 . . . . 0.0 114.287 170.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.95 131.35 37.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 130.04 46.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.549 1.54 . . . . 0.0 110.708 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -82.77 159.86 22.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.03 0.932 . . . . 0.0 113.127 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -115.54 168.27 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.175 1.39 . . . . 0.0 112.481 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.21 65.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.749 0.82 . . . . 0.0 112.581 166.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -67.21 -10.14 47.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.192 1.797 . . . . 0.0 112.152 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.92 78.15 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.19 1.376 . . . . 0.0 114.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -76.01 171.72 13.97 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.076 2.15 . . . . 0.0 110.582 167.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.54 154.33 43.99 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.107 0.963 . . . . 0.0 110.782 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.44 105.93 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.599 1.16 . . . . 0.0 109.637 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.93 164.3 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.662 1.185 . . . . 0.0 109.253 167.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.6 tmmt? -132.29 128.39 37.68 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.238 -0.914 . . . . 0.0 109.891 155.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.0 161.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 111.033 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.81 145.64 51.69 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 107.949 161.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -81.66 155.26 25.68 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.778 1.172 . . . . 0.0 110.69 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -124.86 -63.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.696 0.799 . . . . 0.0 109.567 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -8.69 -77.7 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 130.233 3.778 . . . . 0.0 118.362 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.63 15.31 3.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -157.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.8 -54.56 4.68 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.701 -1.249 . . . . 0.0 112.842 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.74 164.3 3.21 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.747 2.419 . . . . 0.0 114.969 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.18 164.0 21.26 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.397 2.732 . . . . 0.0 113.979 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 70.7 m -141.55 148.43 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.072 1.749 . . . . 0.0 111.102 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -86.22 141.02 29.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.5 -1.28 . . . . 0.0 108.035 126.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.38 129.0 25.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.535 -168.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.64 117.41 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.082 1.855 . . . . 0.0 109.617 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.39 127.22 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.228 1.011 . . . . 0.0 109.107 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.05 170.04 11.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.657 0.783 . . . . 0.0 109.144 161.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.41 131.71 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 153.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -115.62 153.58 31.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.415 1.086 . . . . 0.0 111.015 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -62.76 176.03 0.74 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.364 1.466 . . . . 0.0 112.718 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.0 -39.62 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 120.803 -1.186 . . . . 0.0 112.711 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -72.14 -18.52 61.88 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.423 1.889 . . . . 0.0 113.399 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.27 20.6 mttm 74.19 4.84 4.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.426 3.09 . . . . 0.0 114.529 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.49 -43.34 63.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.259 2.224 . . . . 0.0 113.053 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -109.21 133.39 53.08 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.048 0.84 . . . . 0.0 110.997 -165.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -74.73 134.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.857 0.863 . . . . 0.0 110.256 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.67 -8.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.68 168.68 12.86 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.617 1.099 . . . . 0.0 114.759 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -131.25 122.18 26.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.724 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.455 HD12 ' H ' ' A' ' 63' ' ' ILE . 1.2 mp -76.02 138.07 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.895 0.77 . . . . 0.0 109.848 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.85 -34.98 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 111.798 -172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 t -68.56 38.44 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.604 1.962 . . . . 0.0 114.866 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.8 t 57.12 -172.33 0.08 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.573 1.949 . . . . 0.0 112.889 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -64.23 109.54 2.85 Favored Pre-proline 0 C--O 1.246 0.889 0 C-N-CA 125.243 1.417 . . . . 0.0 110.175 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.04 136.38 60.92 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 124.465 3.444 . . . . 0.0 114.918 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.94 160.91 39.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.485 1.114 . . . . 0.0 112.806 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.64 123.5 11.98 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.52 1.528 . . . . 0.0 108.823 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -72.1 -22.49 61.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -170.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.38 169.68 10.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.871 2.468 . . . . 0.0 109.742 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -52.5 -45.64 66.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.294 1.038 . . . . 0.0 111.438 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -70.93 0.95 6.24 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 m -100.41 158.31 15.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.291 1.405 . . . . 0.0 112.376 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.74 154.23 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 125.079 1.352 . . . . 0.0 110.741 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -142.05 115.98 9.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.205 0.602 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -68.92 134.4 49.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.096 0.959 . . . . 0.0 110.341 164.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mm -132.04 104.62 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.803 1.241 . . . . 0.0 109.947 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.51 131.17 44.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.793 0.837 . . . . 0.0 111.172 161.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 tp -150.12 145.16 26.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.063 1.745 . . . . 0.0 110.649 -163.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -119.72 94.62 48.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.523 1.529 . . . . 0.0 110.77 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.21 168.3 20.5 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.967 3.778 . . . . 0.0 112.712 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.92 165.65 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.183 1.922 . . . . 0.0 111.544 169.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -75.41 74.99 2.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.854 0.862 . . . . 0.0 111.702 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.43 -167.09 38.89 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.77 1.176 . . . . 0.0 112.374 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.17 140.28 52.52 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.688 1.195 . . . . 0.0 110.543 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.0 m -163.6 171.11 16.22 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.835 -1.166 . . . . 0.0 112.361 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -128.34 101.29 6.15 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.572 1.149 . . . . 0.0 109.867 -169.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.2 136.66 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.23 122.72 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.419 0.554 . . . . 0.0 109.61 174.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.6 mt -123.82 105.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.844 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.99 172.14 20.3 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.647 2.07 . . . . 0.0 111.097 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 m -95.8 129.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.3 1.05 . . . . 0.0 110.687 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 26.28 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 127.774 2.607 . . . . 0.0 116.081 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.95 -27.77 8.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.052 1.741 . . . . 0.0 115.474 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.8 m -101.29 -3.63 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.552 1.941 . . . . 0.0 112.932 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.31 109.83 16.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.288 1.035 . . . . 0.0 113.089 -166.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 mt -53.85 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.951 162.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.8 m -103.63 89.53 3.38 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -170.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -118.66 139.29 51.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.586 1.184 . . . . 0.0 113.484 -165.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 142.48 55.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.708 2.403 . . . . 0.0 114.208 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -145.53 153.81 41.51 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.888 0.875 . . . . 0.0 111.267 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -135.5 111.62 9.63 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.568 1.147 . . . . 0.0 108.973 168.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -68.49 144.1 54.75 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.929 -0.482 . . . . 0.0 111.647 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 129.653 3.181 . . . . 0.0 115.69 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.67 109.01 18.9 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -133.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -72.33 -13.33 61.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.746 1.618 . . . . 0.0 114.506 164.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.53 163.13 54.75 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.347 0.975 . . . . 0.0 113.317 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 158.93 34.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.967 0.907 . . . . 0.0 112.792 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -129.1 166.73 18.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.652 1.981 . . . . 0.0 110.239 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.39 137.2 54.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.58 1.952 . . . . 0.0 111.038 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 tp -80.15 95.47 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.941 1.296 . . . . 0.0 108.711 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.98 -11.71 28.0 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 112.633 -165.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.4 ttpp -152.71 137.77 17.28 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 109.379 151.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.62 168.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.073 2.949 . . . . 0.0 114.749 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 mtm -77.29 123.55 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.52 118.11 29.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.087 1.355 . . . . 0.0 110.256 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.11 161.79 21.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.312 1.045 . . . . 0.0 113.703 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 p -118.01 169.62 9.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 112.512 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -27.99 66.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.855 0.862 . . . . 0.0 112.387 166.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -65.06 -12.91 55.82 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.38 1.872 . . . . 0.0 112.469 168.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.32 -5.05 79.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.166 1.365 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -69.71 167.65 16.6 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 111.43 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -127.27 148.38 50.22 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.063 1.345 . . . . 0.0 110.072 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.51 116.25 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.526 1.13 . . . . 0.0 109.037 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.68 131.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.783 1.633 . . . . 0.0 108.946 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 5.9 ttmt -102.52 111.61 23.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.283 0.947 . . . . 0.0 109.606 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -87.6 157.0 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 122.585 0.354 . . . . 0.0 110.065 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -130.04 143.34 50.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.057 2.143 . . . . 0.0 107.491 160.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.85 154.74 26.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.586 1.085 . . . . 0.0 110.725 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.34 -63.13 1.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 110.712 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -18.73 -80.15 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 129.391 3.377 . . . . 0.0 117.793 -164.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.58 22.12 6.45 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.6 -49.15 3.82 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 120.917 -1.115 . . . . 0.0 114.327 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.6 178.73 1.71 Allowed Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 128.424 2.689 . . . . 0.0 114.761 -170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.75 166.28 14.18 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 124.255 3.303 . . . . 0.0 115.705 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.0 m -148.13 154.36 40.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.428 1.891 . . . . 0.0 111.286 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -92.12 138.67 31.34 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 128.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.29 125.11 44.57 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -66.14 101.19 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.305 2.003 . . . . 0.0 110.532 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.8 mt -106.84 130.94 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.099 0.96 . . . . 0.0 110.568 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.79 166.79 20.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.563 0.745 . . . . 0.0 110.461 157.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.49 130.61 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 146.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -111.83 162.67 15.03 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.615 1.166 . . . . 0.0 112.916 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -55.9 169.03 0.39 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.86 2.064 . . . . 0.0 113.351 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -58.25 -28.93 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.317 -0.864 . . . . 0.0 112.898 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -74.92 -17.07 60.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.235 1.814 . . . . 0.0 113.718 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 49.8 mttp 69.85 28.19 4.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.234 2.214 . . . . 0.0 113.205 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -115.26 -28.42 6.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.646 1.978 . . . . 0.0 113.173 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -132.6 138.19 47.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.694 1.134 . . . . 0.0 112.255 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.73 133.45 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.292 1.837 . . . . 0.0 111.213 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.51 -8.9 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 0.0 114.112 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.72 168.75 13.05 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 119.578 1.081 . . . . 0.0 115.257 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.55 114.1 14.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.068 1.747 . . . . 0.0 110.854 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -74.92 102.38 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.08 0.952 . . . . 0.0 110.186 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.4 mm -76.36 -42.34 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.421 1.089 . . . . 0.0 111.767 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -70.49 36.94 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.649 1.98 . . . . 0.0 115.78 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t 62.66 -174.92 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.708 2.003 . . . . 0.0 113.588 -175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -59.5 107.01 0.84 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 127.584 2.354 . . . . 0.0 111.859 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.21 121.1 9.3 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.356 3.37 . . . . 0.0 114.57 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.05 165.93 26.17 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.89 148.59 34.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.82 1.648 . . . . 0.0 109.953 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -99.67 -21.46 15.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 112.173 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.6 165.03 19.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.76 1.624 . . . . 0.0 111.296 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -57.98 -28.56 64.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.328 1.051 . . . . 0.0 112.759 168.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -81.48 -4.24 55.34 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 m -83.79 155.97 22.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.621 1.1 . . . . 0.0 112.244 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.69 149.61 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 124.82 1.248 . . . . 0.0 110.204 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -138.62 107.42 5.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.39 0.676 . . . . 0.0 109.492 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.72 121.09 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.01 . . . . 0.0 110.939 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.88 111.84 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.716 1.606 . . . . 0.0 109.131 -168.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -67.42 126.57 29.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 110.765 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 tp -143.3 144.72 32.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.785 2.034 . . . . 0.0 109.527 -172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -114.46 100.21 52.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.413 1.485 . . . . 0.0 110.805 -170.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.19 175.31 10.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.472 3.448 . . . . 0.0 112.893 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -76.67 167.15 25.96 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.396 2.731 . . . . 0.0 111.518 165.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -76.97 78.43 3.52 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.841 -1.162 . . . . 0.0 111.679 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.57 -166.66 39.41 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.257 0.932 . . . . 0.0 112.3 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.66 143.79 54.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.153 0.501 . . . . 0.0 110.761 165.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.0 p -160.27 157.74 28.63 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.938 0.895 . . . . 0.0 111.64 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.489 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 96.1 m-85 -129.3 102.57 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.935 0.874 . . . . 0.0 111.446 -171.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.71 137.22 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.691 1.996 . . . . 0.0 107.568 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.37 129.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -130.86 97.91 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.649 1.18 . . . . 0.0 109.343 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.44 -175.78 15.9 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 127.11 2.29 . . . . 0.0 111.245 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.2 135.17 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 118.473 1.137 . . . . 0.0 111.418 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.27 -117.48 0.91 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.253 1.406 . . . . 0.0 114.158 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -70.43 -9.7 57.13 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.1 m -86.64 -11.23 51.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.518 1.127 . . . . 0.0 112.89 165.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.05 116.84 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.843 0.857 . . . . 0.0 112.583 -172.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.8 102.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 158.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.7 m -112.95 93.31 4.36 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -168.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -131.94 157.42 44.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.746 1.26 . . . . 0.0 114.018 -162.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 135.96 33.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.331 2.652 . . . . 0.0 114.355 -165.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -143.84 118.83 10.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 165.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -91.76 105.67 17.9 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.585 1.154 . . . . 0.0 110.148 164.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 139.09 58.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm . . . . . 0 N--CA 1.473 0.712 0 C-N-CA 126.471 1.908 . . . . 0.0 114.062 -179.617 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.38 113.02 20.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -135.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.7 p -68.67 -10.97 59.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.54 1.536 . . . . 0.0 114.564 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.3 170.68 44.58 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.279 0.942 . . . . 0.0 114.793 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 156.17 28.26 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.183 1.793 . . . . 0.0 111.484 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 82.6 m-85 -130.7 167.48 18.74 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.416 2.286 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -107.97 137.31 46.18 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.561 1.144 . . . . 0.0 111.054 167.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.8 tp -75.35 92.7 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 159.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.91 -13.2 25.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.754 1.222 . . . . 0.0 112.088 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -149.04 142.38 25.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.374 1.47 . . . . 0.0 109.535 148.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.36 162.68 0.13 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.211 2.204 . . . . 0.0 113.845 167.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.19 132.3 42.06 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 122.21 35.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.858 1.263 . . . . 0.0 110.418 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -80.82 160.89 24.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.5 p -113.65 169.56 8.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.655 1.582 . . . . 0.0 112.006 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.92 69.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.975 0.91 . . . . 0.0 112.287 165.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -68.67 -11.14 59.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.595 1.958 . . . . 0.0 112.764 171.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.42 -3.1 79.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.726 1.155 . . . . 0.0 113.818 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -72.7 165.35 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.445 1.898 . . . . 0.0 111.076 166.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -125.95 146.18 49.97 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.706 1.203 . . . . 0.0 110.405 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.98 118.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 109.164 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.39 124.96 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.607 1.563 . . . . 0.0 109.161 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -95.55 110.8 22.83 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.313 0.961 . . . . 0.0 109.233 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.88 161.53 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.151 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 152.54 49.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.272 1.829 . . . . 0.0 107.733 156.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -87.92 159.01 18.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.199 1.363 . . . . 0.0 110.966 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -130.95 -52.9 1.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.275 -0.891 . . . . 0.0 110.843 173.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.38 -11.21 46.27 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 120.252 2.861 . . . . 0.0 120.252 -151.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.31 2.64 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.61 2.705 . . . . 0.0 117.112 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.88 -56.77 4.29 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-N 120.522 1.51 . . . . 0.0 113.061 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.98 5.03 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 127.371 2.269 . . . . 0.0 114.269 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.66 164.81 22.63 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.031 3.154 . . . . 0.0 116.193 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -147.61 151.18 35.79 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.509 2.324 . . . . 0.0 111.391 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 142.61 28.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 129.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.25 1.0 OUTLIER -104.2 134.86 19.48 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.724 -169.576 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.84 106.42 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.247 1.965 . . . . 0.0 109.112 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 mt -115.14 130.69 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.548 0.739 . . . . 0.0 109.757 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -134.06 172.98 12.08 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.014 0.926 . . . . 0.0 110.048 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' HG ' ' A' ' 81' ' ' LEU . 5.0 mt -126.42 125.71 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 156.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -109.15 162.89 13.85 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.922 0.868 . . . . 0.0 111.148 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -57.74 173.67 0.29 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.622 2.369 . . . . 0.0 113.487 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 m -56.57 -34.9 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.874 -1.141 . . . . 0.0 112.71 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -71.8 -14.07 61.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.563 1.945 . . . . 0.0 113.495 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 67.99 22.98 8.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.267 2.627 . . . . 0.0 113.662 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -108.74 -32.76 7.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.49 1.916 . . . . 0.0 112.692 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -127.15 135.82 51.24 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.249 1.386 . . . . 0.0 111.954 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.76 135.38 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.495 1.518 . . . . 0.0 111.625 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.93 -11.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.559 1.544 . . . . 0.0 114.622 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.97 171.01 13.65 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -170.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtm-85 -133.1 128.89 37.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.676 1.59 . . . . 0.0 110.729 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 63' ' ' ILE . 1.9 mp -79.72 124.09 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.52 -36.99 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.568 0.747 . . . . 0.0 111.282 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.8 t -68.63 35.29 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.296 1.838 . . . . 0.0 114.617 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.76 -170.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.899 2.08 . . . . 0.0 113.641 -175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -64.0 108.6 1.96 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.929 2.092 . . . . 0.0 111.157 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -55.05 143.78 72.05 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.31 3.34 . . . . 0.0 115.495 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -147.46 166.27 27.74 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.96 121.93 11.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.458 1.903 . . . . 0.0 108.168 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.52 -17.29 59.34 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.584 -0.697 . . . . 0.0 112.677 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.53 170.26 16.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.319 2.648 . . . . 0.0 109.419 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 m -50.5 -49.9 54.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.312 1.045 . . . . 0.0 110.464 163.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -67.03 -3.54 7.49 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 m -85.24 144.18 28.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.148 1.34 . . . . 0.0 112.093 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.02 150.96 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.045 1.338 . . . . 0.0 110.637 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 m -141.77 115.59 9.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.98 122.75 32.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 111.568 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.73 111.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 124.819 1.248 . . . . 0.0 109.827 -162.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.1 124.59 23.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.141 1.376 . . . . 0.0 111.42 165.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 51' ' ' ILE . 57.4 tp -141.02 142.92 34.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.074 2.149 . . . . 0.0 110.013 -166.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -119.23 98.99 50.7 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -167.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.82 168.77 18.89 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.483 3.455 . . . . 0.0 113.573 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.49 165.13 32.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.946 2.431 . . . . 0.0 111.019 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -72.67 73.42 1.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.27 -0.894 . . . . 0.0 112.004 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -173.44 46.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.148 0.88 . . . . 0.0 113.789 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.54 129.61 41.39 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.13 0.972 . . . . 0.0 110.163 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 m -145.56 150.5 36.52 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.279 1.432 . . . . 0.0 111.011 -163.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.58 98.17 5.61 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.957 0.884 . . . . 0.0 111.317 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.82 126.44 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.391 1.876 . . . . 0.0 107.259 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.47 123.96 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.871 0.868 . . . . 0.0 109.039 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.1 mt -128.16 98.58 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.031 1.332 . . . . 0.0 109.256 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.93 -174.57 15.84 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 127.657 2.551 . . . . 0.0 110.649 -164.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.11 164.54 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.506 1.153 . . . . 0.0 110.585 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -10.14 -74.5 0.01 OUTLIER Glycine 0 CA--C 1.541 1.707 0 C-N-CA 127.55 2.5 . . . . 0.0 117.682 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.3 58.68 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.9 p -122.91 -10.29 8.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.295 1.838 . . . . 0.0 114.025 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.15 118.53 6.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.582 1.953 . . . . 0.0 112.67 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.5 mt -56.67 98.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 154.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 83.4 m -101.08 95.57 6.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.94 154.35 39.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.816 1.293 . . . . 0.0 113.735 -170.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.38 137.89 33.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.917 2.487 . . . . 0.0 114.267 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -134.64 156.48 48.67 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.201 1.0 . . . . 0.0 111.129 162.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -129.8 111.06 12.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 162.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -63.26 135.33 57.0 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 126.528 1.931 . . . . 0.0 113.705 -175.052 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.62 99.56 8.2 Favored 'General case' 0 N--CA 1.458 -0.056 0 O-C-N 121.106 -0.996 . . . . 0.0 113.36 -145.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -68.64 -6.44 25.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.517 166.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.24 53.83 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.045 1.307 . . . . 0.0 114.169 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 154.71 32.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.261 1.824 . . . . 0.0 112.459 -174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.04 166.22 18.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.748 2.019 . . . . 0.0 110.794 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -101.39 137.45 39.71 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.579 1.151 . . . . 0.0 110.183 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.57 101.75 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -106.53 -14.37 15.07 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.319 1.448 . . . . 0.0 111.482 -163.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.5 ttpp -149.38 137.84 20.86 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.686 1.595 . . . . 0.0 109.359 145.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.94 168.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.06 2.944 . . . . 0.0 114.351 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 34' ' ' VAL . 24.9 mtm -79.88 136.36 36.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.39 122.57 21.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.013 1.725 . . . . 0.0 109.74 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.62 164.89 21.54 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -120.66 170.06 9.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.041 1.737 . . . . 0.0 111.778 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -27.56 66.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.117 0.967 . . . . 0.0 112.312 165.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -65.37 -9.15 22.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.338 1.855 . . . . 0.0 112.733 168.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.03 -7.4 55.96 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.477 1.513 . . . . 0.0 113.539 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -68.54 163.54 23.3 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.976 1.71 . . . . 0.0 111.067 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -126.71 148.29 49.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 109.503 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 t -114.65 115.3 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.127 0.971 . . . . 0.0 109.508 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.6 t -117.81 132.6 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 109.087 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 25.7 ttpp -107.27 120.49 42.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.775 1.17 . . . . 0.0 110.47 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -93.75 165.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.656 1.182 . . . . 0.0 109.987 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.57 159.12 42.88 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.126 1.771 . . . . 0.0 108.183 156.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -104.31 139.04 39.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.724 1.602 . . . . 0.0 112.421 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -121.71 -27.82 4.63 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.87 -1.144 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.85 -18.13 79.51 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -157.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.34 2.57 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.31 -42.7 1.7 Allowed Glycine 0 CA--C 1.537 1.419 0 CA-C-N 120.765 1.62 . . . . 0.0 114.497 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.31 170.7 5.06 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 128.33 2.652 . . . . 0.0 115.107 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -67.64 166.24 24.77 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.926 3.084 . . . . 0.0 113.172 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.35 155.31 40.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.27 136.69 33.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 129.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.274 1.7 m -95.54 129.11 35.7 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -170.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.2 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.644 2.23 . . . . 0.0 109.091 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.7 mt -119.06 129.15 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.58 0.752 . . . . 0.0 110.833 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -132.83 169.06 17.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.525 1.13 . . . . 0.0 109.437 162.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -119.09 131.25 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 149.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -110.12 163.69 13.35 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.465 1.103 . . . . 0.0 112.209 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -59.64 175.52 0.35 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.706 1.603 . . . . 0.0 113.027 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -65.3 -22.77 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -79.72 -25.56 41.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.34 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 46.9 mttp 85.91 14.02 0.16 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.939 3.295 . . . . 0.0 112.565 169.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -83.09 -51.05 7.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.489 2.716 . . . . 0.0 112.815 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -122.68 151.48 41.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.127 1.33 . . . . 0.0 112.669 -167.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.32 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.938 1.695 . . . . 0.0 112.136 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.22 -28.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.188 1.795 . . . . 0.0 114.171 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.55 161.76 17.87 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.917 1.235 . . . . 0.0 114.429 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -124.17 105.21 9.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.455 1.502 . . . . 0.0 110.354 -170.021 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.1 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.985 -1.072 . . . . 0.0 110.151 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.6 mm -108.73 -40.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.471 0.708 . . . . 0.0 111.603 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 t -66.41 10.14 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 98.13 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 130.588 3.555 . . . . 0.0 111.413 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 p -67.76 106.87 1.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.403 1.481 . . . . 0.0 109.375 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.94 147.21 64.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.635 2.89 . . . . 0.0 115.238 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 169.16 18.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.94 140.38 38.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.319 2.248 . . . . 0.0 108.914 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.12 -27.59 21.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.446 1.098 . . . . 0.0 112.283 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 177.73 7.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 130.163 3.385 . . . . 0.0 108.84 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.14 -43.71 61.26 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.085 -1.009 . . . . 0.0 112.342 170.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.37 -10.09 15.12 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 114.044 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -72.74 119.99 17.74 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 m -90.49 146.29 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.081 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -139.15 105.3 5.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -86.3 125.31 33.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 111.493 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.4 mt -131.69 115.47 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.309 1.444 . . . . 0.0 109.555 -159.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.11 126.51 29.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.103 0.961 . . . . 0.0 111.647 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.9 tp -145.5 143.13 29.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.021 1.728 . . . . 0.0 110.367 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 62' ' ' ARG . 5.2 tm-20 -118.19 92.63 43.17 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.619 1.568 . . . . 0.0 111.429 -165.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.85 170.47 19.99 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.288 3.325 . . . . 0.0 114.419 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.49 160.13 49.37 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.675 2.25 . . . . 0.0 111.17 165.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.85 92.18 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.456 0.702 . . . . 0.0 110.358 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.49 -172.38 34.24 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.218 1.389 . . . . 0.0 111.236 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.81 143.95 39.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.999 0.92 . . . . 0.0 111.512 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 162.18 24.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.064 0.946 . . . . 0.0 111.953 -171.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 91.8 m-85 -127.78 102.34 6.76 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.939 0.876 . . . . 0.0 111.747 -170.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.39 126.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 127.539 2.336 . . . . 0.0 106.968 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.32 120.36 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -124.28 98.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.075 1.35 . . . . 0.0 108.995 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.82 -174.04 15.01 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.85 2.167 . . . . 0.0 110.247 -161.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 m -114.76 161.53 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.569 1.184 . . . . 0.0 110.93 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 4.51 -85.57 0.0 OUTLIER Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.825 2.631 . . . . 0.0 117.406 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -4.43 58.67 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -119.41 -9.59 9.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.187 1.795 . . . . 0.0 113.853 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.93 8.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.716 2.006 . . . . 0.0 113.347 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.97 96.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 155.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.8 m -99.94 97.3 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -126.46 160.64 29.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.394 1.093 . . . . 0.0 113.307 -172.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 141.15 28.92 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 114.345 -162.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -146.24 129.45 16.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 166.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -105.93 108.76 20.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.548 1.539 . . . . 0.0 109.669 165.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -66.47 141.08 58.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 126.203 1.801 . . . . 0.0 113.624 -176.591 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . 0.289 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.08 106.65 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -139.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.3 p -70.66 -7.35 43.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.657 1.583 . . . . 0.0 114.2 162.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.01 168.67 54.79 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.655 1.121 . . . . 0.0 113.893 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 155.18 36.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.638 1.575 . . . . 0.0 112.332 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.53 166.22 21.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.049 2.14 . . . . 0.0 110.477 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -106.53 140.25 39.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.39 1.476 . . . . 0.0 110.667 166.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -76.45 94.28 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 159.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.48 -13.05 26.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.816 1.246 . . . . 0.0 112.267 -165.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.9 ttpp -145.87 140.79 27.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.745 1.618 . . . . 0.0 108.684 146.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.61 167.66 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.48 2.312 . . . . 0.0 113.691 166.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.434 ' HG2' HG22 ' A' ' 34' ' ' VAL . 28.8 mtm -76.23 137.63 40.1 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.264 -0.897 . . . . 0.0 113.183 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.65 128.66 35.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.565 1.146 . . . . 0.0 110.137 171.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -85.15 161.3 19.69 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -111.52 168.63 9.4 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.896 1.678 . . . . 0.0 111.764 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -30.28 70.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.545 1.138 . . . . 0.0 111.965 164.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -62.12 -14.68 39.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.771 1.628 . . . . 0.0 112.645 166.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 1.98 90.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.989 1.28 . . . . 0.0 113.954 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -76.35 164.31 26.14 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.925 2.09 . . . . 0.0 110.916 166.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -119.86 146.07 46.08 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.186 0.994 . . . . 0.0 110.245 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.7 119.09 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.079 0.952 . . . . 0.0 109.044 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.5 t -117.49 130.7 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.553 1.541 . . . . 0.0 109.211 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.5 ttmt -106.77 108.3 19.74 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.113 0.869 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.5 162.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 110.156 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 145.6 41.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.201 1.8 . . . . 0.0 107.459 154.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.63 153.02 22.66 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.96 1.254 . . . . 0.0 111.115 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -124.28 -59.32 1.48 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.199 -0.938 . . . . 0.0 109.645 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -20.66 -64.65 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 130.192 3.758 . . . . 0.0 118.587 -167.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.86 11.64 2.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -158.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.74 -45.85 2.77 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 120.606 -1.309 . . . . 0.0 113.417 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 165.74 6.28 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 128.473 2.709 . . . . 0.0 115.559 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.06 167.82 20.7 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.513 3.475 . . . . 0.0 113.622 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.2 m -147.59 157.23 43.47 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.225 1.81 . . . . 0.0 111.611 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 137.73 32.07 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 128.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 1.9 m -100.29 128.15 31.26 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.381 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.03 105.71 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.599 2.199 . . . . 0.0 109.707 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.0 128.01 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 110.491 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -131.75 168.07 18.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 109.247 165.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.95 135.09 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 151.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -119.62 157.94 27.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.228 1.411 . . . . 0.0 110.929 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.1 177.67 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.03 0.932 . . . . 0.0 112.544 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -56.16 -34.82 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 120.902 -1.124 . . . . 0.0 113.354 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -82.29 -6.55 59.31 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.34 1.856 . . . . 0.0 112.592 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 66.12 -5.42 0.56 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.207 3.003 . . . . 0.0 115.272 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.06 -38.65 88.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.302 1.841 . . . . 0.0 114.658 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -118.13 140.09 50.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.424 1.465 . . . . 0.0 111.862 -168.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -73.68 139.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.291 1.436 . . . . 0.0 111.062 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.82 -7.93 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 114.955 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.99 13.09 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 119.982 1.264 . . . . 0.0 115.795 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -133.38 119.58 19.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.363 1.865 . . . . 0.0 111.513 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.96 99.72 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.029 0.932 . . . . 0.0 110.853 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.61 -38.22 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 111.424 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -67.33 18.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.928 1.291 . . . . 0.0 114.242 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.1 m 60.64 -176.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.531 2.332 . . . . 0.0 113.335 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.0 p -57.35 107.83 1.05 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.057 1.743 . . . . 0.0 110.827 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -59.29 159.81 21.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.26 3.307 . . . . 0.0 115.319 -172.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.88 167.17 22.74 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.75 143.97 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.671 1.589 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -92.56 -22.57 19.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.21 171.11 5.8 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.882 3.273 . . . . 0.0 109.399 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 m -51.68 -47.68 63.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.223 1.009 . . . . 0.0 110.989 164.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -66.48 1.36 1.71 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 m -104.28 130.42 52.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.535 1.061 . . . . 0.0 112.022 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.39 152.58 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.988 1.315 . . . . 0.0 111.579 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -142.7 111.49 6.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.726 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -76.59 130.38 37.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.614 1.166 . . . . 0.0 111.204 167.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mm -132.74 116.98 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.315 1.846 . . . . 0.0 110.023 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.8 128.24 34.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 111.303 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 tp -144.13 146.91 33.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.506 1.922 . . . . 0.0 110.695 -169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.4 100.3 41.92 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.397 1.479 . . . . 0.0 110.871 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.55 174.05 13.26 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.962 3.775 . . . . 0.0 113.314 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.71 165.53 32.04 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.631 2.22 . . . . 0.0 111.001 162.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.72 79.47 2.05 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.131 -0.981 . . . . 0.0 111.834 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.39 -168.53 41.5 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.766 1.174 . . . . 0.0 112.496 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.64 142.82 55.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.367 1.067 . . . . 0.0 110.357 170.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.7 m -164.6 168.52 18.08 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.675 -1.266 . . . . 0.0 112.531 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -126.31 100.77 6.43 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.214 1.006 . . . . 0.0 110.231 -171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.91 138.98 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 171.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.43 130.08 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.3 mt -127.12 101.93 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.255 . . . . 0.0 108.645 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.46 164.03 17.81 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.367 1.937 . . . . 0.0 111.071 -164.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.9 148.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.639 -0.918 . . . . 0.0 110.455 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 6.37 -92.1 0.01 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 128.457 2.932 . . . . 0.0 117.296 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -64.26 -13.81 51.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.7 m -108.54 -5.14 16.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.992 2.117 . . . . 0.0 112.507 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.87 127.03 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.515 1.126 . . . . 0.0 113.09 -168.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.87 82.01 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.9 m -79.01 104.95 10.0 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.756 0.822 . . . . 0.0 109.185 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.83 151.93 51.92 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 138.98 37.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.887 2.475 . . . . 0.0 114.976 -171.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -136.16 156.77 48.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.734 0.814 . . . . 0.0 111.785 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -128.87 109.47 11.29 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.843 1.257 . . . . 0.0 108.273 162.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -65.03 136.38 56.71 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.144 -0.347 . . . . 0.0 111.831 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 126.361 1.865 . . . . 0.0 114.156 -175.457 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.1 mmm . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 102.55 6.24 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -149.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 p -76.77 -15.36 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.55 173.37 35.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.741 1.163 . . . . 0.0 115.298 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 155.63 27.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.175 2.19 . . . . 0.0 112.792 -173.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -129.92 168.45 16.63 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.434 2.294 . . . . 0.0 112.009 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -104.1 138.46 40.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.247 1.419 . . . . 0.0 110.661 163.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 tp -75.9 82.24 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 122.783 1.278 . . . . 0.0 107.859 160.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.28 -14.56 59.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.331 1.452 . . . . 0.0 112.827 -170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -153.09 137.85 17.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.441 1.097 . . . . 0.0 110.282 154.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.73 168.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.875 2.47 . . . . 0.0 113.57 165.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.1 mtm -82.71 134.5 35.14 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.135 -0.978 . . . . 0.0 113.525 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.16 31.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.892 1.277 . . . . 0.0 110.546 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -83.27 159.75 21.87 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -111.39 169.24 8.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.105 1.762 . . . . 0.0 111.863 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -26.73 64.74 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.893 0.877 . . . . 0.0 112.283 164.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -63.7 -11.8 29.02 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.765 1.626 . . . . 0.0 112.261 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.8 76.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.249 1.404 . . . . 0.0 113.843 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 p -76.16 165.64 24.61 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.672 1.989 . . . . 0.0 110.658 165.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -125.44 147.4 49.22 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.994 0.918 . . . . 0.0 110.956 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.6 t -114.43 120.98 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.377 1.071 . . . . 0.0 109.363 -171.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.53 133.5 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.06 1.744 . . . . 0.0 109.102 -173.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -103.45 115.79 31.18 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.547 1.067 . . . . 0.0 110.034 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -88.76 161.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.207 0.603 . . . . 0.0 110.108 170.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.39 142.42 47.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.201 1.801 . . . . 0.0 107.237 154.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -78.41 155.1 30.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.451 1.478 . . . . 0.0 110.653 169.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -127.02 -62.34 1.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.869 0.868 . . . . 0.0 110.337 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -29.26 -59.74 0.17 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.956 3.17 . . . . 0.0 118.353 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.37 15.69 3.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -160.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -45.71 3.0 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.743 -1.223 . . . . 0.0 114.061 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.08 8.0 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 128.045 2.538 . . . . 0.0 115.539 -170.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -66.71 161.32 42.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.041 2.494 . . . . 0.0 112.414 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.3 m -156.25 155.7 32.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 0.0 111.179 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 137.57 38.46 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 142.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 48' ' ' PRO 0.291 1.7 m -99.74 134.38 21.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.767 -169.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.8 Cg_endo -81.58 100.71 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.174 2.583 . . . . 0.0 109.256 -172.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mt -112.22 124.41 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.76 0.824 . . . . 0.0 111.08 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.73 163.1 21.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.826 1.251 . . . . 0.0 110.225 164.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.48 HG13 HD11 ' A' ' 81' ' ' LEU . 3.8 mt -118.78 126.69 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 146.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.23 163.94 12.59 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.61 1.164 . . . . 0.0 111.966 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -56.59 171.01 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 127.343 2.257 . . . . 0.0 113.803 173.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.75 -26.53 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.451 -0.78 . . . . 0.0 112.847 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -72.81 -17.25 61.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.614 1.565 . . . . 0.0 113.449 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 89' ' ' TYR . 42.8 mttp 71.73 23.62 3.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.734 2.413 . . . . 0.0 113.4 175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -119.19 -31.6 4.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.148 1.779 . . . . 0.0 114.009 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -126.0 129.16 48.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.705 1.138 . . . . 0.0 110.917 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.53 133.74 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.358 1.463 . . . . 0.0 111.576 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -133.44 -10.5 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.149 1.78 . . . . 0.0 114.252 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.63 170.92 13.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.349 0.976 . . . . 0.0 114.599 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -131.35 138.22 49.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.812 1.645 . . . . 0.0 110.439 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -93.02 128.85 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.583 0.753 . . . . 0.0 109.616 178.432 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.59 -54.52 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 112.522 -162.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -60.41 -33.39 72.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -175.75 169.27 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.54 1.936 . . . . 0.0 110.135 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 p -66.52 105.13 0.73 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.334 157.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -58.44 145.52 93.93 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.528 2.819 . . . . 0.0 115.806 -163.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -144.7 167.68 21.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.13 0.972 . . . . 0.0 112.837 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.96 128.8 29.06 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.386 2.274 . . . . 0.0 108.334 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -75.2 -16.6 60.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.59 168.43 3.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.613 2.365 . . . . 0.0 110.429 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -58.47 -44.75 89.42 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.472 0.709 . . . . 0.0 110.065 156.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -69.88 40.13 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.453 1.901 . . . . 0.0 112.678 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -156.19 148.8 23.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 119.653 -1.904 . . . . 0.0 111.964 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.61 156.34 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.766 1.626 . . . . 0.0 111.078 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -142.98 107.76 4.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.101 0.56 . . . . 0.0 110.608 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -74.18 125.51 28.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.587 0.755 . . . . 0.0 110.852 164.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 mm -128.66 120.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.5 1.52 . . . . 0.0 110.022 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -71.04 130.66 42.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.4 1.08 . . . . 0.0 111.276 162.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 51' ' ' ILE . 30.5 tp -143.94 151.55 39.93 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.308 2.243 . . . . 0.0 109.731 -168.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -125.7 94.37 42.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.901 1.68 . . . . 0.0 109.653 -165.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -76.07 172.59 15.98 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.606 3.537 . . . . 0.0 113.268 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.34 160.42 49.9 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.347 2.031 . . . . 0.0 110.692 162.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.26 72.61 2.33 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.221 -0.924 . . . . 0.0 111.097 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.33 42.42 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.318 1.913 . . . . 0.0 111.269 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.64 148.12 38.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.316 0.579 . . . . 0.0 111.045 169.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -163.97 161.3 22.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.929 0.891 . . . . 0.0 111.903 -167.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 86.5 m-85 -128.12 100.54 5.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 111.558 -169.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.57 126.56 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 127.668 2.387 . . . . 0.0 107.351 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.261 0.9 OUTLIER -119.08 120.95 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.259 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -122.04 97.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.498 1.519 . . . . 0.0 108.639 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.94 179.79 15.91 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.275 2.369 . . . . 0.0 110.493 -166.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.85 144.34 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.033 0.917 . . . . 0.0 111.169 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 38.0 -119.31 0.75 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.531 1.539 . . . . 0.0 113.858 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.44 -14.04 62.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.8 m -86.84 -10.79 52.64 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.226 1.011 . . . . 0.0 112.688 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.32 116.49 17.06 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.473 1.109 . . . . 0.0 113.467 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.7 mt -55.46 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 157.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.2 m -107.37 95.68 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.1 160.25 34.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.149 0.976 . . . . 0.0 113.38 -172.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.66 23.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.921 2.088 . . . . 0.0 114.521 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -151.64 132.01 13.74 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.157 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -103.88 109.31 21.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.003 1.321 . . . . 0.0 110.31 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.08 141.16 58.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 126.617 1.967 . . . . 0.0 114.353 -176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 127.44 32.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -154.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.0 p -100.17 -7.58 24.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.0 113.708 163.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.72 170.26 34.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.91 1.243 . . . . 0.0 114.185 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 157.22 27.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.69 1.996 . . . . 0.0 112.734 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.5 m-85 -129.77 168.46 16.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.052 2.141 . . . . 0.0 111.732 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -105.51 141.3 37.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.611 1.565 . . . . 0.0 110.682 164.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 tp -77.01 95.09 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 156.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -93.15 -12.04 31.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.053 1.341 . . . . 0.0 112.613 -166.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.9 ttpp -151.13 132.48 14.59 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.46 1.104 . . . . 0.0 109.62 149.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.7 153.61 0.57 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.694 1.998 . . . . 0.0 113.336 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -69.55 145.82 52.29 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.38 13.16 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.825 1.65 . . . . 0.0 109.519 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -78.41 156.91 29.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 113.272 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.1 p -108.53 170.24 8.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.636 1.574 . . . . 0.0 111.475 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -25.24 62.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.399 1.08 . . . . 0.0 112.248 164.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -64.57 -12.49 45.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.499 1.52 . . . . 0.0 112.023 164.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 1.63 84.28 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.421 1.486 . . . . 0.0 113.861 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -73.6 168.07 20.07 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.974 2.11 . . . . 0.0 110.847 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -125.0 148.61 48.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.262 1.025 . . . . 0.0 110.198 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 t -115.86 110.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.062 0.945 . . . . 0.0 109.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.64 124.27 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.6 1.16 . . . . 0.0 109.774 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.9 ttmt -92.46 112.57 24.56 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.438 1.017 . . . . 0.0 110.018 173.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.01 165.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.978 0.511 . . . . 0.0 110.099 169.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 154.93 45.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.092 2.157 . . . . 0.0 108.113 156.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -98.79 139.15 34.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.934 1.697 . . . . 0.0 112.802 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -119.71 -33.26 4.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.692 -1.255 . . . . 0.0 113.101 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.81 -25.68 71.9 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -157.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.05 -47.1 3.07 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 120.678 1.581 . . . . 0.0 114.679 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.51 169.21 20.55 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 127.781 2.432 . . . . 0.0 113.964 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -68.01 160.19 49.7 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.905 2.404 . . . . 0.0 115.738 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 13.0 m -151.15 154.64 37.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.527 1.931 . . . . 0.0 110.733 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 136.07 36.73 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 144.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.295 1.1 m -96.85 141.81 23.62 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 118.308 0.504 . . . . 0.0 111.765 -165.243 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -88.16 96.89 0.4 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.999 2.466 . . . . 0.0 109.324 -168.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.28 129.41 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.6 0.76 . . . . 0.0 112.189 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.22 170.01 16.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.698 1.199 . . . . 0.0 110.147 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 81' ' ' LEU . 3.9 mt -115.36 129.2 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 148.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.94 164.11 12.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.681 1.192 . . . . 0.0 111.995 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -58.62 172.0 0.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.226 2.21 . . . . 0.0 114.167 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.44 -31.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.081 -1.012 . . . . 0.0 112.464 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.46 -16.14 62.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.608 1.963 . . . . 0.0 113.255 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 mttm 67.23 20.18 10.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.498 2.719 . . . . 0.0 113.436 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.57 -40.35 7.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 112.09 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.93 1.241 . . . . 0.0 112.879 -165.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.1 137.63 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.989 1.716 . . . . 0.0 112.442 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.35 -14.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.05 169.04 14.73 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-N 119.745 1.157 . . . . 0.0 114.977 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -129.95 122.87 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.266 1.426 . . . . 0.0 112.216 -172.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.08 100.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.561 1.144 . . . . 0.0 111.398 176.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.8 mm -71.7 -44.03 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 110.642 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -62.87 -3.2 1.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m 62.92 -26.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 129.398 3.079 . . . . 0.0 118.785 155.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.2 p -128.25 69.6 78.23 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.21 1.368 . . . . 0.0 112.223 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -54.12 106.97 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.671 2.914 . . . . 0.0 113.211 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 169.6 17.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 166.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.84 116.98 13.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.418 2.687 . . . . 0.0 107.837 171.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -72.08 -16.46 62.02 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.42 173.48 3.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.144 3.378 . . . . 0.0 108.384 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.6 -45.36 77.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.333 -0.855 . . . . 0.0 111.653 166.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.17 0.63 2.57 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.8 m -96.6 112.07 23.96 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 m -80.46 152.66 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.244 1.017 . . . . 0.0 111.717 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m -144.58 110.44 5.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.283 0.633 . . . . 0.0 110.754 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.3 124.0 28.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.457 0.703 . . . . 0.0 111.741 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.05 109.46 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.997 1.319 . . . . 0.0 109.197 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -67.53 127.64 33.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.05 0.94 . . . . 0.0 111.025 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.59 HD11 HG13 ' A' ' 51' ' ' ILE . 19.7 tp -147.08 145.73 29.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.108 1.763 . . . . 0.0 110.154 -167.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -120.16 97.48 49.2 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.581 1.552 . . . . 0.0 110.496 -165.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.94 170.83 19.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.265 3.31 . . . . 0.0 113.423 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.88 161.16 47.05 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.548 2.165 . . . . 0.0 111.062 163.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -72.63 90.55 1.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.369 -0.832 . . . . 0.0 110.548 168.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.04 -171.91 37.19 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.041 1.305 . . . . 0.0 111.147 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.82 147.97 31.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.536 0.734 . . . . 0.0 111.048 170.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 90.4 p -162.57 159.94 25.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 112.325 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -128.72 96.91 4.51 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.545 1.164 . . . . 0.0 110.923 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 90' ' ' ILE . 4.1 mp -65.8 128.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 127.704 2.402 . . . . 0.0 106.918 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.23 120.76 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.5 mt -122.48 94.32 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.136 1.374 . . . . 0.0 108.064 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 177.69 15.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.669 2.08 . . . . 0.0 110.543 -166.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 m -114.1 149.85 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.804 0.842 . . . . 0.0 110.763 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 32.72 -111.71 0.06 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 126.047 1.784 . . . . 0.0 114.971 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -70.41 -12.95 61.92 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 m -98.59 -9.32 24.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.626 1.571 . . . . 0.0 112.455 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.84 123.52 20.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.785 1.234 . . . . 0.0 112.934 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.99 90.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 151.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.6 m -84.68 101.25 12.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 168.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -125.63 154.66 41.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.701 1.239 . . . . 0.0 113.552 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 138.97 32.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.054 2.541 . . . . 0.0 114.618 -170.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -144.43 129.44 18.51 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 161.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -101.15 112.43 24.91 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.523 1.129 . . . . 0.0 109.656 165.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -66.58 134.46 52.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 126.435 1.894 . . . . 0.0 112.707 -172.253 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.9 mmm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 100.38 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -138.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 p -79.15 -10.85 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.298 1.839 . . . . 0.0 114.86 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.57 171.93 14.31 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.327 1.441 . . . . 0.0 114.63 -172.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -74.0 159.04 33.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.743 1.217 . . . . 0.0 114.023 -168.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -124.02 171.57 9.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.316 2.646 . . . . 0.0 109.741 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.406 ' OG ' ' OE2' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -110.18 139.63 45.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.969 1.708 . . . . 0.0 109.696 166.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.14 100.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.64 -10.0 20.42 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.179 1.391 . . . . 0.0 112.131 -165.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -153.42 143.57 22.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.149 1.38 . . . . 0.0 110.077 150.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.47 166.68 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 113.869 166.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -89.78 136.29 33.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.74 30.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 109.843 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.55 158.53 23.08 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -110.69 170.6 7.98 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.315 1.846 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.6 68.9 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.047 -1.033 . . . . 0.0 112.737 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -67.97 -10.77 56.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.096 1.758 . . . . 0.0 112.236 167.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.95 4.64 72.63 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.427 1.489 . . . . 0.0 114.052 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -74.6 166.12 24.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.446 1.898 . . . . 0.0 110.292 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -119.21 152.88 35.85 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.48 1.112 . . . . 0.0 110.15 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -115.04 113.26 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.024 0.929 . . . . 0.0 109.871 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.24 116.55 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.566 1.546 . . . . 0.0 109.27 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.83 117.5 29.84 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.876 0.762 . . . . 0.0 110.572 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.57 160.03 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 110.234 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -141.17 150.43 42.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.636 1.974 . . . . 0.0 108.227 164.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -98.55 150.85 21.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.27 1.395 . . . . 0.0 112.982 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' OE2' ' OG ' ' A' ' 19' ' ' SER . 53.5 mt-10 -128.09 -63.87 0.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 110.971 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -7.66 -72.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 129.649 3.499 . . . . 0.0 117.106 -169.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.39 18.62 3.66 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.578 1.551 . . . . 0.0 113.446 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.46 -43.64 1.1 Allowed Glycine 0 CA--C 1.539 1.593 0 N-CA-C 116.557 1.383 . . . . 0.0 116.557 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 165.43 4.47 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.713 2.805 . . . . 0.0 114.761 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.03 157.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.647 2.231 . . . . 0.0 113.831 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.0 m -151.76 157.22 41.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.277 1.431 . . . . 0.0 112.014 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 138.05 36.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 139.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 m -97.53 123.75 51.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.873 -171.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.86 124.24 13.7 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.557 2.171 . . . . 0.0 110.072 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mt -132.8 130.99 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 109.73 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.21 167.98 16.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 166.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.7 mt -124.25 128.8 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 147.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.52 164.11 13.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.704 1.202 . . . . 0.0 112.088 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.97 175.5 0.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.466 2.306 . . . . 0.0 113.492 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.0 -32.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.45 -8.04 58.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.583 1.553 . . . . 0.0 113.177 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 66.82 32.42 6.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.188 2.195 . . . . 0.0 113.0 171.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -130.85 -20.72 2.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.409 1.484 . . . . 0.0 114.64 -175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -121.65 121.65 37.84 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.685 1.129 . . . . 0.0 110.359 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.07 133.84 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 111.624 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -137.35 -7.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.794 1.638 . . . . 0.0 114.537 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.5 170.01 13.22 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.682 1.128 . . . . 0.0 114.679 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -131.71 119.58 21.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.12 1.768 . . . . 0.0 110.947 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.516 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -72.11 122.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.857 0.863 . . . . 0.0 109.78 176.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.1 mm -97.36 -33.24 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.499 0.719 . . . . 0.0 111.707 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.7 t -62.2 20.28 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.386 2.274 . . . . 0.0 116.84 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.1 p 60.01 -169.01 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.805 2.042 . . . . 0.0 112.535 -163.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.4 p -60.87 106.38 0.77 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.246 1.818 . . . . 0.0 111.083 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.59 144.4 97.38 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.645 2.896 . . . . 0.0 113.46 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.02 167.21 22.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.87 123.7 18.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.87 2.068 . . . . 0.0 108.358 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -75.3 -26.46 58.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.933 0.893 . . . . 0.0 113.135 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.62 172.86 4.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.139 2.575 . . . . 0.0 109.916 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -39.28 63.76 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 171.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -72.8 -2.65 21.37 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -94.86 155.44 16.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 111.749 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.5 147.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.514 1.126 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.7 m -139.35 105.34 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.592 0.357 . . . . 0.0 110.644 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.79 89.56 4.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.204 1.801 . . . . 0.0 111.837 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.52 117.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.931 1.692 . . . . 0.0 111.201 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -69.13 126.88 31.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.054 0.942 . . . . 0.0 111.466 159.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.5 tp -143.04 147.01 34.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.679 1.991 . . . . 0.0 110.268 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -118.65 97.48 50.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.395 1.478 . . . . 0.0 110.528 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.05 172.08 16.67 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.752 3.635 . . . . 0.0 113.666 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.61 163.14 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.498 2.132 . . . . 0.0 111.1 164.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.83 74.01 4.39 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.322 -0.861 . . . . 0.0 111.688 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.65 -168.14 40.94 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.053 1.311 . . . . 0.0 111.632 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -67.24 144.35 56.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.476 0.655 . . . . 0.0 111.085 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.6 p -161.73 160.14 28.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.083 0.953 . . . . 0.0 111.502 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.47 98.03 4.73 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.493 0.717 . . . . 0.0 110.333 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.89 135.45 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.764 1.626 . . . . 0.0 107.305 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.87 123.45 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.2 mt -125.31 109.85 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.719 1.207 . . . . 0.0 109.488 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.49 163.63 26.28 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.963 1.744 . . . . 0.0 111.422 -162.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.88 166.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.708 -0.878 . . . . 0.0 111.872 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -30.17 -59.81 0.21 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.456 2.455 . . . . 0.0 116.885 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.99 3.24 0.87 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.848 1.659 . . . . 0.0 115.232 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -161.93 12.09 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.269 -1.519 . . . . 0.0 114.29 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.31 108.34 7.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.349 1.459 . . . . 0.0 112.286 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.08 101.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 160.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.5 m -112.31 95.2 5.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.317 1.047 . . . . 0.0 108.386 -167.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -130.44 146.45 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 137.95 45.75 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.037 2.935 . . . . 0.0 114.872 -172.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -149.22 121.02 8.12 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.943 0.897 . . . . 0.0 112.539 165.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -92.3 108.05 19.66 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.443 0.697 . . . . 0.0 109.754 164.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -64.05 131.78 48.59 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.978 0.511 . . . . 0.0 111.038 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 mttp . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.946 1.699 . . . . 0.0 112.728 -171.414 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.99 108.56 10.13 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -153.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.414 ' HA ' HG22 ' A' ' 94' ' ' VAL . 53.7 p -69.39 -4.52 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.25 1.42 . . . . 0.0 114.315 165.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.65 172.15 46.14 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.506 1.527 . . . . 0.0 114.339 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.56 163.17 27.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.59 1.556 . . . . 0.0 113.799 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.48 174.38 10.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.444 2.298 . . . . 0.0 109.76 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 p -112.13 145.46 39.76 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.259 1.024 . . . . 0.0 110.983 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.2 103.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 156.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 -14.71 14.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.905 0.882 . . . . 0.0 111.45 -159.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.516 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.7 ttpp -143.83 136.91 27.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.635 1.574 . . . . 0.0 108.615 149.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.29 156.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.917 2.087 . . . . 0.0 113.628 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 mtm -70.69 132.78 45.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.1 122.74 36.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.034 1.333 . . . . 0.0 109.996 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 152.61 34.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.581 0.705 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.7 p -101.27 167.54 10.13 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 111.105 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -24.69 64.12 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.244 -0.91 . . . . 0.0 112.27 163.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -64.94 -9.22 19.7 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.232 1.813 . . . . 0.0 112.419 165.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.89 -3.82 63.48 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.764 1.65 . . . . 0.0 114.17 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -69.58 168.35 14.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.73 2.012 . . . . 0.0 110.736 165.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 t -125.8 154.06 43.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.758 0.823 . . . . 0.0 110.481 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -118.72 118.95 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.43 1.092 . . . . 0.0 109.663 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.16 116.81 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.49 1.516 . . . . 0.0 110.125 -173.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 tmmt? -89.59 109.9 20.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.376 0.989 . . . . 0.0 109.822 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -86.75 165.66 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.205 1.002 . . . . 0.0 110.495 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 150.99 45.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.941 1.696 . . . . 0.0 108.544 153.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -94.15 129.96 40.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.289 0.95 . . . . 0.0 113.024 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -131.21 1.82 4.22 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.09 -61.82 2.76 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.102 0.858 . . . . 0.0 114.561 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.19 19.35 1.4 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -165.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.1 -43.77 2.52 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.612 -1.305 . . . . 0.0 115.553 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.18 174.33 2.95 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 127.16 2.184 . . . . 0.0 114.31 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.07 162.82 33.84 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.515 2.81 . . . . 0.0 114.22 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.2 m -145.35 151.59 38.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.684 1.994 . . . . 0.0 110.284 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 131.78 34.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 131.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.276 0.9 OUTLIER -90.43 137.91 27.22 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 118.561 0.618 . . . . 0.0 110.824 -168.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.07 97.3 0.56 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.845 2.363 . . . . 0.0 109.569 -168.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.66 124.57 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.781 0.832 . . . . 0.0 111.384 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.64 168.63 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.23 1.412 . . . . 0.0 110.242 164.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.23 133.03 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 147.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -112.17 162.87 14.98 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.533 1.133 . . . . 0.0 111.921 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -56.6 171.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.809 2.043 . . . . 0.0 113.138 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -57.49 -28.83 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 112.701 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -75.63 -12.62 60.24 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.03 2.132 . . . . 0.0 113.772 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 68.04 25.88 7.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.637 2.375 . . . . 0.0 113.452 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -120.59 -27.42 5.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.403 1.481 . . . . 0.0 114.04 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -124.07 129.05 50.23 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.676 1.125 . . . . 0.0 111.364 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.79 131.39 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.826 1.65 . . . . 0.0 111.535 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.51 -7.37 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.962 1.705 . . . . 0.0 114.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.49 166.04 15.0 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.637 1.108 . . . . 0.0 114.745 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -129.54 109.87 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.017 1.727 . . . . 0.0 109.837 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -70.14 114.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 0.0 109.645 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.5 mm -87.58 -33.9 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.887 . . . . 0.0 111.977 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.9 t -64.27 23.19 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.551 1.94 . . . . 0.0 116.062 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p 74.63 -101.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 129.997 3.319 . . . . 0.0 113.134 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.7 p -131.39 99.03 17.72 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.705 1.602 . . . . 0.0 109.072 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.46 137.71 31.82 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.86 3.04 . . . . 0.0 113.797 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -141.94 168.16 20.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 137.18 37.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.909 2.084 . . . . 0.0 108.256 168.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -91.59 -17.0 26.27 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.256 -0.903 . . . . 0.0 112.852 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.98 176.42 1.79 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 130.939 3.695 . . . . 0.0 108.167 173.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -40.88 64.52 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.816 -1.178 . . . . 0.0 112.848 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -65.31 -6.69 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.41 1.084 . . . . 0.0 113.852 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -78.49 123.82 27.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.227 0.922 . . . . 0.0 111.398 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.25 154.51 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.116 159.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.3 109.14 4.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.833 0.453 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 107.35 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.179 0.992 . . . . 0.0 112.004 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -104.27 114.08 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 125.455 1.502 . . . . 0.0 110.684 -172.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.36 129.96 41.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.868 0.842 . . . . 0.0 111.137 161.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.7 147.61 29.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.066 1.746 . . . . 0.0 110.217 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.98 94.13 43.77 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.645 1.578 . . . . 0.0 110.433 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -66.95 171.38 11.27 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.581 3.521 . . . . 0.0 112.826 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.53 155.59 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.005 1.803 . . . . 0.0 110.634 162.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -70.68 90.63 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.511 -0.743 . . . . 0.0 110.246 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.51 -170.62 32.92 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.849 1.214 . . . . 0.0 111.352 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.77 143.18 44.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.594 0.758 . . . . 0.0 111.607 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -160.68 158.06 28.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 112.36 -166.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -126.23 97.0 4.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.151 0.976 . . . . 0.0 110.972 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 132.42 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.424 2.29 . . . . 0.0 107.231 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.263 1.9 m -125.87 118.13 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mt -122.97 100.09 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.062 1.345 . . . . 0.0 108.97 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.65 -178.4 16.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.047 2.261 . . . . 0.0 110.285 -165.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 15' ' ' SER . 3.3 m -119.93 148.29 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.181 0.991 . . . . 0.0 111.06 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.92 -121.65 2.04 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.852 1.215 . . . . 0.0 113.523 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -69.69 -12.84 61.95 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.1 m -87.53 -9.86 53.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.485 1.114 . . . . 0.0 112.898 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.35 112.14 10.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.705 1.202 . . . . 0.0 113.072 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.49 95.84 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.838 0.855 . . . . 0.0 108.907 159.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -102.87 98.76 8.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.8 157.7 43.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.382 1.086 . . . . 0.0 113.766 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 143.07 28.95 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.098 2.159 . . . . 0.0 114.693 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -149.56 136.94 19.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.572 0.749 . . . . 0.0 112.86 160.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -104.28 108.07 19.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.719 1.208 . . . . 0.0 109.402 165.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -70.4 142.44 52.05 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.904 -0.498 . . . . 0.0 111.704 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 126.442 1.897 . . . . 0.0 112.217 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mmm . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -83.82 154.63 23.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -134.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HG22 ' A' ' 94' ' ' VAL . 78.9 p -125.24 1.56 7.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.918 1.687 . . . . 0.0 114.069 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.79 174.45 49.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.92 1.247 . . . . 0.0 113.452 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -74.48 161.53 29.69 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.933 1.293 . . . . 0.0 112.514 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 47' ' ' VAL . 86.0 m-85 -130.05 177.06 7.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.014 2.126 . . . . 0.0 109.373 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.8 p -107.32 151.58 25.29 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.914 0.779 . . . . 0.0 111.183 155.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 tp -83.59 100.33 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -15.17 15.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.062 1.345 . . . . 0.0 112.233 -160.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -147.57 141.8 26.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.774 2.43 . . . . 0.0 107.381 151.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.62 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.069 2.948 . . . . 0.0 115.006 167.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -86.01 129.88 34.71 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.155 -0.966 . . . . 0.0 112.563 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.78 118.17 24.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -80.31 156.1 26.95 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.1 p -112.68 171.77 7.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.578 1.551 . . . . 0.0 112.832 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.12 66.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.129 0.972 . . . . 0.0 113.316 166.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.07 -6.66 58.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.997 2.119 . . . . 0.0 111.597 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.0 6.7 60.8 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 120.832 -1.167 . . . . 0.0 113.705 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -76.36 169.67 17.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.972 2.109 . . . . 0.0 110.103 164.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -129.31 147.65 51.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.073 0.949 . . . . 0.0 111.149 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.85 102.25 13.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.519 1.128 . . . . 0.0 110.312 -171.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.45 144.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.45 1.9 . . . . 0.0 109.2 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 3.5 ttmt -111.85 125.28 53.85 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.238 1.381 . . . . 0.0 109.228 168.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 m -104.15 169.39 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.422 1.089 . . . . 0.0 110.44 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.28 155.5 44.49 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.43 1.892 . . . . 0.0 108.523 158.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -97.78 130.1 44.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.087 1.312 . . . . 0.0 112.836 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -132.19 13.98 4.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.099 -1.0 . . . . 0.0 112.679 -169.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.04 -50.04 2.53 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.227 0.918 . . . . 0.0 115.103 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.83 9.88 1.02 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -166.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.46 -41.97 1.91 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 120.112 1.324 . . . . 0.0 114.783 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.24 177.42 2.81 Favored Pre-proline 0 CA--C 1.561 1.365 0 C-N-CA 127.719 2.408 . . . . 0.0 114.188 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 166.25 24.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.241 3.294 . . . . 0.0 115.161 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.2 m -149.14 155.22 40.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.749 2.02 . . . . 0.0 110.798 172.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -83.3 134.1 34.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 118.79 -1.164 . . . . 0.0 107.925 127.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 18' ' ' PHE 0.287 1.9 m -93.87 131.06 32.77 Favored Pre-proline 0 N--CA 1.468 0.434 0 O-C-N 123.551 0.532 . . . . 0.0 110.258 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.82 105.18 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.89 2.393 . . . . 0.0 108.859 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.91 124.9 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.914 0.886 . . . . 0.0 111.092 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -136.2 169.45 17.62 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 109.768 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 ' HG ' ' A' ' 81' ' ' LEU . 3.4 mt -119.78 124.6 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -107.79 162.22 14.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 111.048 171.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -59.84 176.22 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.956 2.102 . . . . 0.0 113.967 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.06 -33.59 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.841 -1.162 . . . . 0.0 112.766 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -74.22 -11.44 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.279 1.832 . . . . 0.0 113.543 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 63.43 28.85 15.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.243 2.617 . . . . 0.0 113.606 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.21 -40.1 5.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.88 1.672 . . . . 0.0 112.563 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -124.32 138.0 54.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.874 1.215 . . . . 0.0 111.677 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.63 133.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.783 1.233 . . . . 0.0 111.38 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.27 -11.38 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.079 1.752 . . . . 0.0 114.072 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.35 168.03 14.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.541 1.067 . . . . 0.0 114.659 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -133.42 121.83 22.85 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.176 1.79 . . . . 0.0 111.274 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 122.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.963 0.802 . . . . 0.0 110.177 174.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.2 mm -95.85 -37.05 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 0.0 111.596 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 t -64.24 -7.51 9.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.7 m 117.82 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 1 C-N-CA 132.944 4.497 . . . . 0.0 108.961 -166.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 m -65.41 117.57 41.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.178 -0.915 . . . . 0.0 108.733 159.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.29 156.59 20.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.589 3.526 . . . . 0.0 115.261 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.16 169.08 18.87 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 172.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.64 139.37 31.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.457 2.303 . . . . 0.0 108.583 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -97.95 -17.6 19.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.006 0.923 . . . . 0.0 112.717 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.81 174.94 7.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.643 3.177 . . . . 0.0 108.072 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -44.65 62.54 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.309 -0.869 . . . . 0.0 112.369 173.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -65.65 -7.49 15.52 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.117 1.367 . . . . 0.0 113.917 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -71.62 106.42 4.04 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.32 0.964 . . . . 0.0 110.834 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.05 149.19 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.625 154.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 m -141.41 117.7 10.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.049 0.54 . . . . 0.0 110.134 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.25 119.66 29.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.753 0.821 . . . . 0.0 111.669 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 mm -120.82 110.87 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.877 1.671 . . . . 0.0 110.683 -167.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -69.01 123.79 21.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.536 1.134 . . . . 0.0 111.165 162.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' A' ' 51' ' ' ILE . 45.4 tp -142.35 141.66 32.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.782 2.033 . . . . 0.0 109.943 -169.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -113.78 100.58 52.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.853 1.661 . . . . 0.0 110.564 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -78.06 173.36 14.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.391 3.394 . . . . 0.0 113.77 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.74 161.92 43.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.522 2.148 . . . . 0.0 110.878 162.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -72.7 102.63 3.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.984 166.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.47 -169.82 25.78 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.87 1.224 . . . . 0.0 111.964 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.64 139.52 39.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.165 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -159.59 164.48 34.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.105 0.962 . . . . 0.0 112.261 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -129.11 104.93 7.84 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.224 1.011 . . . . 0.0 111.526 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.33 123.82 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.261 2.224 . . . . 0.0 107.102 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.68 122.63 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.33 100.38 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.994 1.317 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.19 176.28 18.59 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.714 2.102 . . . . 0.0 110.216 -161.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 15' ' ' SER . 12.6 m -107.25 139.71 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.16 0.98 . . . . 0.0 110.3 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 23.14 -100.17 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 127.902 2.667 . . . . 0.0 115.563 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -59.02 -16.37 18.01 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -110.09 -2.9 16.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.738 1.615 . . . . 0.0 112.767 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.17 111.33 16.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.103 0.961 . . . . 0.0 112.963 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.9 mt -56.22 100.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 93.03 4.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.37 156.27 34.29 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.293 1.044 . . . . 0.0 113.51 -172.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 147.0 33.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.444 1.898 . . . . 0.0 114.495 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -146.1 144.08 29.77 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.33 1.052 . . . . 0.0 110.725 157.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -114.42 116.84 29.53 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -70.03 138.68 52.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 126.035 1.734 . . . . 0.0 115.401 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 84.7 mmm . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.82 105.51 7.93 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -133.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -72.45 -3.52 24.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.09 1.756 . . . . 0.0 114.547 166.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 170.49 51.22 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.888 1.232 . . . . 0.0 113.67 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -73.66 160.66 31.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.146 1.378 . . . . 0.0 113.014 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -131.31 175.0 9.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.093 2.157 . . . . 0.0 109.901 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p -114.71 144.66 43.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 111.382 160.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.59 93.57 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 159.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.4 -16.49 21.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.264 -159.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -145.74 139.42 26.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.85 2.06 . . . . 0.0 108.105 148.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.1 162.05 0.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.779 2.432 . . . . 0.0 114.602 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.408 ' HG2' HG22 ' A' ' 34' ' ' VAL . 27.3 mtm -69.88 127.39 32.73 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 123.4 37.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.898 1.279 . . . . 0.0 110.245 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.93 155.16 27.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 p -105.21 170.82 7.66 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.252 1.821 . . . . 0.0 111.448 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -27.34 67.78 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.196 -0.94 . . . . 0.0 112.416 165.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.55 -9.73 37.99 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.555 1.942 . . . . 0.0 112.256 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.39 1.44 60.83 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.317 1.436 . . . . 0.0 114.014 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.25 166.12 22.22 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.157 1.783 . . . . 0.0 110.262 164.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -122.79 148.0 45.87 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 110.5 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.84 113.57 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 109.4 -173.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.8 t -110.41 116.08 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 109.792 -172.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -96.09 105.04 17.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.42 0.555 . . . . 0.0 109.688 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.27 166.22 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.506 1.122 . . . . 0.0 110.655 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 146.63 30.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.914 1.685 . . . . 0.0 108.716 160.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -91.09 134.96 34.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.795 0.725 . . . . 0.0 112.496 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -133.38 3.15 3.6 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.135 -0.978 . . . . 0.0 113.583 -171.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.78 -36.5 7.28 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.216 1.247 . . . . 0.0 116.216 -170.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.96 7.88 0.41 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.16 -43.07 1.96 Allowed Glycine 0 CA--C 1.535 1.322 0 CA-C-N 120.211 1.369 . . . . 0.0 114.928 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.46 167.66 6.54 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 127.696 2.399 . . . . 0.0 115.025 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.94 163.42 22.32 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.657 2.904 . . . . 0.0 113.478 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -147.29 154.5 41.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.733 1.613 . . . . 0.0 111.59 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -87.27 140.49 29.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 127.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 1.4 m -100.74 120.53 55.49 Favored Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.06 115.59 3.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.28 1.987 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mt -126.1 129.64 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 110.712 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.09 165.32 18.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.392 1.077 . . . . 0.0 110.154 162.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.94 130.74 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 146.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -112.12 164.9 12.64 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.431 1.492 . . . . 0.0 112.435 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -58.14 171.32 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.591 1.956 . . . . 0.0 113.508 172.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.9 -36.13 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.367 -0.833 . . . . 0.0 112.932 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.87 -12.33 60.64 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.876 2.07 . . . . 0.0 113.988 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 67.09 27.76 8.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 113.419 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.17 -27.96 7.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.084 2.154 . . . . 0.0 113.012 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -131.72 132.92 44.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.214 0.916 . . . . 0.0 111.041 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.98 134.22 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.204 1.402 . . . . 0.0 110.89 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.61 -8.46 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.921 1.688 . . . . 0.0 114.19 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.9 163.59 18.42 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 119.555 1.07 . . . . 0.0 114.686 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -127.21 112.87 15.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.889 1.675 . . . . 0.0 110.36 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -72.31 109.77 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.607 0.763 . . . . 0.0 109.947 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.01 -38.23 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.971 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -67.44 30.71 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.73 2.012 . . . . 0.0 114.558 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.34 -173.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.943 2.097 . . . . 0.0 113.095 -169.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -66.93 111.72 7.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.371 1.068 . . . . 0.0 109.238 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -55.82 152.99 32.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.476 3.451 . . . . 0.0 115.544 -169.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.26 167.26 22.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.6 143.71 31.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.008 1.723 . . . . 0.0 109.127 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -96.4 -18.53 19.84 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.79 174.03 5.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.844 2.858 . . . . 0.0 108.547 173.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -45.75 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.608 -0.682 . . . . 0.0 112.018 169.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -66.36 -3.39 5.88 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.3 m -87.41 119.81 28.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 111.459 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.58 156.12 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 159.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.51 119.05 10.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.069 0.548 . . . . 0.0 110.87 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.67 106.11 18.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.66 109.06 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.085 1.754 . . . . 0.0 110.526 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -67.14 126.55 29.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.385 0.612 . . . . 0.0 110.875 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.8 tp -146.65 140.73 26.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 110.235 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.94 94.14 23.8 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.011 1.324 . . . . 0.0 110.727 -172.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.83 169.95 20.82 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.641 3.561 . . . . 0.0 112.865 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 163.47 39.07 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.815 2.343 . . . . 0.0 111.664 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -75.22 72.11 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.852 0.861 . . . . 0.0 111.442 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.49 -169.34 41.42 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.233 1.397 . . . . 0.0 111.813 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.82 145.05 50.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.273 0.559 . . . . 0.0 111.11 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -161.02 154.68 22.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.574 0.749 . . . . 0.0 112.138 -166.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -127.78 101.92 6.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.157 0.98 . . . . 0.0 111.656 -171.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 90' ' ' ILE . 3.1 mp -72.89 139.53 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.966 2.106 . . . . 0.0 107.647 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.4 125.04 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 170.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 mt -125.67 103.34 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.685 1.194 . . . . 0.0 109.099 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.27 178.13 20.84 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.109 1.814 . . . . 0.0 111.117 -162.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 145.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.074 0.937 . . . . 0.0 110.786 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 22.03 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.683 2.563 . . . . 0.0 116.063 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.05 -11.28 28.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -107.98 -7.74 16.09 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.276 1.83 . . . . 0.0 112.639 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 127.41 32.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 112.171 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.54 87.12 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 157.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.8 m -79.39 98.26 6.68 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -125.05 176.62 6.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.207 1.403 . . . . 0.0 113.008 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 139.9 53.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -154.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -154.86 131.27 10.46 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -106.22 109.84 21.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.02 1.328 . . . . 0.0 109.327 165.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -63.82 148.35 49.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.649 0.78 . . . . 0.0 111.775 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 129.079 2.952 . . . . 0.0 116.214 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mmm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.3 m -79.83 107.67 12.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -138.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 p -69.36 -9.45 53.51 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 164.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 171.93 52.48 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.701 1.619 . . . . 0.0 114.337 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -77.22 160.82 28.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.447 1.499 . . . . 0.0 114.301 -169.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.7 m-85 -130.46 173.64 10.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.535 2.334 . . . . 0.0 109.954 173.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.0 p -119.75 142.93 48.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.073 0.949 . . . . 0.0 112.037 159.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 101.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 163.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -106.52 -13.19 15.39 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.809 1.243 . . . . 0.0 111.046 -164.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -149.23 140.82 23.43 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.872 2.069 . . . . 0.0 108.883 148.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.15 170.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.464 2.706 . . . . 0.0 114.477 166.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.0 mtm -80.89 133.8 35.63 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.95 114.76 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.945 1.698 . . . . 0.0 110.718 176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.49 151.45 43.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p -106.36 168.89 8.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.976 1.711 . . . . 0.0 111.72 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -26.21 66.97 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.291 -0.881 . . . . 0.0 112.559 166.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -67.21 -8.64 33.08 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.311 2.244 . . . . 0.0 112.422 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.08 0.48 65.56 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.405 1.479 . . . . 0.0 114.205 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -73.31 173.29 9.73 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.126 2.17 . . . . 0.0 110.263 164.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -133.44 146.06 50.83 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 111.133 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.37 103.95 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.855 1.262 . . . . 0.0 110.385 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.58 168.4 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.599 1.96 . . . . 0.0 110.144 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -133.86 124.97 27.38 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.472 -0.767 . . . . 0.0 111.054 159.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.75 165.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.434 1.093 . . . . 0.0 110.524 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.03 145.33 39.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.952 1.701 . . . . 0.0 108.564 156.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -84.81 143.69 28.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.797 1.181 . . . . 0.0 111.654 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -136.27 -9.37 1.98 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -36.0 62.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.162 -1.355 . . . . 0.0 116.344 -170.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.86 12.78 0.25 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -166.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 -43.89 2.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 120.9 1.682 . . . . 0.0 114.416 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.57 175.44 4.68 Favored Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 127.4 2.28 . . . . 0.0 114.743 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.18 167.89 17.16 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.352 3.368 . . . . 0.0 115.388 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -148.21 160.84 42.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.624 1.969 . . . . 0.0 110.911 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -88.1 136.29 33.04 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 129.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 48' ' ' PRO 0.332 2.0 m -96.29 135.52 22.51 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.355 0.409 . . . . 0.0 111.158 -169.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.3 Cg_endo -87.14 89.39 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.019 2.479 . . . . 0.0 107.888 -163.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.1 125.69 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.725 0.81 . . . . 0.0 111.342 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.81 162.77 24.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.32 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 88' ' ' SER . 4.1 mt -118.62 126.91 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 151.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -110.84 162.99 14.24 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.323 1.014 . . . . 0.0 112.452 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -58.39 171.94 0.53 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.136 2.174 . . . . 0.0 113.079 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.86 -31.99 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -74.69 -12.85 60.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.186 1.794 . . . . 0.0 113.515 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 mttm 67.84 26.56 7.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.122 2.169 . . . . 0.0 113.171 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.47 4.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.995 2.118 . . . . 0.0 113.165 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.3 131.07 57.05 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.347 0.976 . . . . 0.0 110.624 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.1 138.72 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.991 0.916 . . . . 0.0 111.447 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.36 -10.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.617 1.567 . . . . 0.0 115.083 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.83 169.77 13.86 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.994 1.27 . . . . 0.0 115.715 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.59 107.82 9.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.081 2.152 . . . . 0.0 110.553 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.425 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.42 108.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.296 0.638 . . . . 0.0 110.07 175.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.3 mm -78.95 -36.54 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.215 1.006 . . . . 0.0 111.408 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -67.43 26.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.85 1.66 . . . . 0.0 114.658 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t 63.43 -178.5 0.15 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.946 2.498 . . . . 0.0 113.168 -168.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.5 m -61.64 110.68 3.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.428 1.091 . . . . 0.0 108.925 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.57 159.2 11.48 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.315 3.343 . . . . 0.0 115.431 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.98 168.2 20.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.22 38.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.935 1.694 . . . . 0.0 108.286 171.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -93.84 -14.37 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.09 172.9 2.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 130.483 3.513 . . . . 0.0 108.451 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -57.74 -50.35 73.51 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 110.967 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -66.44 3.09 1.03 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 m -97.84 124.79 42.39 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.479 1.111 . . . . 0.0 111.077 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 m -86.91 162.15 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.426 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.32 107.02 4.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.689 0.795 . . . . 0.0 109.111 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -73.28 136.27 44.52 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.991 -0.443 . . . . 0.0 109.978 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -135.64 109.55 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.497 1.119 . . . . 0.0 110.094 -168.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -73.0 130.3 40.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.272 1.029 . . . . 0.0 110.746 163.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.8 tp -151.9 144.56 24.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.995 1.318 . . . . 0.0 110.986 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -117.39 96.91 50.13 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.747 1.619 . . . . 0.0 110.77 -171.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.73 171.1 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.803 3.668 . . . . 0.0 112.564 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.94 164.33 32.15 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.477 2.118 . . . . 0.0 111.483 168.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.25 87.55 1.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.77 166.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.01 -173.47 44.09 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.856 1.217 . . . . 0.0 112.051 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.97 159.15 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.755 0.822 . . . . 0.0 110.21 165.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.442 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 18.7 m -171.39 158.3 5.23 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.475 1.11 . . . . 0.0 112.784 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.97 102.94 7.49 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.663 1.22 . . . . 0.0 110.328 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.71 125.31 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 128.599 2.759 . . . . 0.0 106.746 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.19 130.53 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.1 mt -129.16 94.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.209 1.404 . . . . 0.0 108.577 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.24 -170.52 18.07 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.421 1.963 . . . . 0.0 109.767 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.61 179.11 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.231 1.015 . . . . 0.0 110.721 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.74 -20.17 17.24 Favored Glycine 0 CA--C 1.541 1.705 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 -168.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.51 0.26 49.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -154.32 -8.46 0.14 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.62 128.08 34.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.692 1.197 . . . . 0.0 113.942 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.09 98.61 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 152.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -96.41 100.94 12.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.93 165.83 18.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 112.381 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 153.11 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.115 1.766 . . . . 0.0 114.552 -167.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -150.37 147.57 27.75 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.098 0.559 . . . . 0.0 111.843 162.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -124.19 111.88 16.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -66.97 144.13 56.39 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 111.392 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 129.102 2.961 . . . . 0.0 116.928 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mmm . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -85.24 95.99 9.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -140.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.0 p -65.87 -2.5 3.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 162.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.67 176.56 53.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.255 1.407 . . . . 0.0 113.925 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 154.01 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.69 2.396 . . . . 0.0 111.797 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -135.15 174.06 11.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.199 1.8 . . . . 0.0 110.77 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 m -123.46 144.19 49.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.601 0.76 . . . . 0.0 112.172 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.4 91.48 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 107.249 159.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -94.29 -13.41 26.51 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.913 1.285 . . . . 0.0 111.857 -163.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.3 ttpp -150.25 135.83 18.22 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.415 1.886 . . . . 0.0 109.431 148.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.76 162.81 0.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.884 2.874 . . . . 0.0 115.169 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 32.3 mtm -70.41 122.41 19.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.3 119.61 36.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.597 1.159 . . . . 0.0 110.975 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.14 157.65 34.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 0.0 112.368 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -117.37 168.48 10.32 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.783 1.233 . . . . 0.0 112.802 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -25.03 67.2 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.419 -0.801 . . . . 0.0 112.835 166.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -71.9 -7.63 49.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.485 1.914 . . . . 0.0 112.275 168.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.78 71.29 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.068 1.318 . . . . 0.0 113.964 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 p -76.61 174.44 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.314 2.246 . . . . 0.0 110.667 168.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.73 154.26 44.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.851 0.86 . . . . 0.0 110.932 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.41 125.01 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.864 1.266 . . . . 0.0 109.613 -174.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.76 127.43 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.803 1.641 . . . . 0.0 109.482 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.4 ttmt -100.56 115.43 30.13 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.717 1.144 . . . . 0.0 110.081 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.2 m -98.8 159.05 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.482 0.713 . . . . 0.0 111.707 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.86 147.95 37.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.903 2.081 . . . . 0.0 109.357 169.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -100.95 137.53 39.2 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.593 1.088 . . . . 0.0 112.552 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -135.51 1.74 2.89 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.25 -46.62 15.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.033 -0.871 . . . . 0.0 115.129 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.89 11.35 0.48 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.9 -46.96 2.74 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.591 -1.318 . . . . 0.0 114.584 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.01 163.89 3.89 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 128.098 2.559 . . . . 0.0 114.703 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.06 162.82 36.5 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.293 2.662 . . . . 0.0 113.803 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.6 m -144.26 154.96 43.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.54 1.936 . . . . 0.0 111.183 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -90.69 141.07 29.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 128.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.73 123.33 44.41 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 115.52 3.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.993 1.795 . . . . 0.0 109.687 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mt -125.81 134.54 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.88 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -132.96 169.12 17.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.771 1.228 . . . . 0.0 109.579 163.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mt -120.04 129.04 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 146.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -109.65 164.62 12.37 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.542 1.137 . . . . 0.0 112.508 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -54.84 170.26 0.18 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.386 2.275 . . . . 0.0 113.428 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.4 m -58.46 -33.0 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.232 -0.918 . . . . 0.0 112.919 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -70.6 -15.61 62.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.991 2.116 . . . . 0.0 113.759 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.4 mttm 66.74 33.73 6.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.275 2.23 . . . . 0.0 113.254 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.27 -27.67 5.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.504 1.922 . . . . 0.0 113.698 -174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -133.98 135.27 43.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.811 1.187 . . . . 0.0 111.726 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.76 136.34 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.0 111.876 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.51 -10.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.872 1.669 . . . . 0.0 114.733 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.87 169.14 12.75 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.585 1.084 . . . . 0.0 114.72 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -130.52 111.79 12.6 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.145 1.778 . . . . 0.0 110.911 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -66.58 131.63 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.734 -0.603 . . . . 0.0 109.533 172.021 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.61 -32.14 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.302 0.641 . . . . 0.0 111.392 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 38.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.262 1.825 . . . . 0.0 115.27 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 t 59.26 -172.68 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.964 2.106 . . . . 0.0 113.077 -171.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -70.26 108.94 3.99 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.311 1.445 . . . . 0.0 110.661 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.01 139.41 61.26 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.644 3.562 . . . . 0.0 116.035 -171.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.76 166.3 24.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.22 1.008 . . . . 0.0 113.605 177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.88 130.36 21.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.891 1.677 . . . . 0.0 108.914 171.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -83.58 -17.55 41.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.09 172.95 3.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.919 2.888 . . . . 0.0 109.181 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -51.72 -48.63 63.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.67 -0.55 13.38 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -83.01 152.05 25.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.295 0.952 . . . . 0.0 111.023 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.84 148.45 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.151 0.98 . . . . 0.0 110.451 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -137.77 108.05 6.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.803 0.441 . . . . 0.0 109.865 -174.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.91 111.94 19.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.086 1.355 . . . . 0.0 111.2 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.5 mt -115.38 112.99 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.487 1.915 . . . . 0.0 109.88 -163.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -69.93 127.81 34.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.312 1.045 . . . . 0.0 111.543 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.9 tp -146.68 144.07 29.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.442 1.897 . . . . 0.0 110.242 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -116.69 94.03 42.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.744 1.617 . . . . 0.0 110.49 -170.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -73.93 170.38 20.22 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.759 3.64 . . . . 0.0 113.158 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.11 161.78 44.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.543 2.162 . . . . 0.0 111.271 167.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.44 74.89 3.19 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.335 -0.853 . . . . 0.0 111.25 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.76 -170.66 43.09 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.647 1.594 . . . . 0.0 111.382 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -69.62 142.21 53.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.388 0.613 . . . . 0.0 111.069 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.9 p -160.0 159.39 32.05 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.137 0.975 . . . . 0.0 111.354 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -130.73 103.65 6.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.88 137.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.42 125.18 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.41 98.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.801 1.24 . . . . 0.0 109.517 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.66 -169.22 14.1 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.735 1.635 . . . . 0.0 111.331 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.9 -174.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.896 0.879 . . . . 0.0 111.881 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.71 -14.76 5.49 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.96 4.57 23.45 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 113.822 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 p -153.29 -9.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.58 107.64 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.85 1.66 . . . . 0.0 114.062 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 mt -54.75 104.97 0.13 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 159.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -111.53 88.01 2.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -168.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -119.87 140.46 50.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.712 1.244 . . . . 0.0 113.801 -160.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 136.6 54.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.601 3.16 . . . . 0.0 115.092 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -153.11 120.42 5.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -100.72 104.87 16.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.463 1.105 . . . . 0.0 109.819 166.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -60.67 140.97 57.27 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.726 -0.609 . . . . 0.0 111.31 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 128.205 2.602 . . . . 0.0 116.545 -169.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mmm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 m -73.6 102.94 4.04 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -140.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 p -66.01 -12.12 52.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.422 1.489 . . . . 0.0 113.782 166.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.38 169.41 43.44 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.268 1.413 . . . . 0.0 114.398 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 157.08 37.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.492 1.917 . . . . 0.0 113.87 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.05 167.25 19.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.253 2.621 . . . . 0.0 109.78 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -102.7 139.6 38.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.469 1.108 . . . . 0.0 110.416 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 tp -73.97 103.93 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 155.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -106.8 -14.15 15.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.743 -165.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.6 ttpp -153.08 138.73 17.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.324 1.85 . . . . 0.0 109.615 146.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.13 165.55 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.44 2.696 . . . . 0.0 114.454 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.5 mtm -70.65 135.01 48.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.13 119.29 21.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.171 1.389 . . . . 0.0 111.349 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 160.89 30.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -116.54 168.03 10.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.667 1.587 . . . . 0.0 111.992 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -26.15 64.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.198 0.999 . . . . 0.0 112.435 165.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -65.73 -10.57 38.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.735 1.614 . . . . 0.0 112.494 165.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.99 89.18 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 124.895 1.236 . . . . 0.0 113.976 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.6 p -82.0 171.18 14.71 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.905 2.482 . . . . 0.0 110.553 168.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t -125.41 148.73 48.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.256 1.022 . . . . 0.0 111.02 169.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.21 119.68 61.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.96 1.304 . . . . 0.0 108.928 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.79 146.45 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.65 1.58 . . . . 0.0 108.469 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -115.12 115.89 27.51 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 109.686 170.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -93.87 164.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 109.903 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 149.61 49.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.24 1.816 . . . . 0.0 107.406 157.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -86.05 157.85 19.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.469 1.486 . . . . 0.0 111.055 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.59 -63.23 0.84 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.155 -0.966 . . . . 0.0 110.198 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -15.5 -75.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 129.88 3.61 . . . . 0.0 117.655 -167.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -130.75 15.16 5.35 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -162.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 -44.01 2.56 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.627 -1.296 . . . . 0.0 113.809 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.4 170.3 3.07 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 128.591 2.756 . . . . 0.0 115.208 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -66.7 163.23 33.9 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.52 2.814 . . . . 0.0 113.611 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.27 151.32 38.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.241 1.816 . . . . 0.0 110.488 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -88.72 126.33 35.27 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 134.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.6 m -86.12 129.98 51.81 Favored Pre-proline 0 N--CA 1.472 0.63 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -166.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.4 Cg_endo -72.36 111.92 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.935 1.757 . . . . 0.0 109.109 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.98 131.37 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.572 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.28 169.12 16.92 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.095 164.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 mt -122.56 123.63 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 152.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -102.62 157.39 16.97 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.979 0.8 . . . . 0.0 110.211 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -58.54 174.48 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.465 1.906 . . . . 0.0 113.37 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.93 -35.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.995 -1.066 . . . . 0.0 113.037 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -72.57 -16.71 61.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.891 2.076 . . . . 0.0 113.597 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttm 68.28 27.44 6.62 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.057 2.543 . . . . 0.0 113.512 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.89 -38.74 7.26 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.616 1.966 . . . . 0.0 111.823 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -124.17 137.37 54.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.707 1.14 . . . . 0.0 111.632 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -68.87 134.16 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.597 1.159 . . . . 0.0 110.666 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.34 -9.16 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.242 1.417 . . . . 0.0 114.618 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.94 167.98 12.72 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.438 1.017 . . . . 0.0 114.928 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -130.81 110.83 11.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.224 1.81 . . . . 0.0 110.403 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.54 115.63 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.635 0.774 . . . . 0.0 109.501 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 mm -93.53 -39.87 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.199 1.0 . . . . 0.0 111.711 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -63.64 8.73 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t 97.7 179.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.504 3.522 . . . . 0.0 110.149 -163.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.3 p -65.07 114.58 15.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.793 1.237 . . . . 0.0 109.74 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.05 136.18 44.73 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.323 2.682 . . . . 0.0 114.057 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.14 166.97 23.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -140.37 131.64 26.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.084 2.153 . . . . 0.0 108.279 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -85.29 -18.41 33.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.93 172.41 5.55 Favored 'General case' 0 CA--C 1.549 0.912 1 C-N-CA 131.769 4.027 . . . . 0.0 108.639 175.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -54.81 7.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.19 1.396 . . . . 0.0 112.216 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -66.87 -1.07 3.51 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 m -74.37 121.59 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.813 1.188 . . . . 0.0 111.057 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -90.34 146.63 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.34 0.656 . . . . 0.0 110.758 162.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 m -139.5 110.99 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.637 0.775 . . . . 0.0 109.57 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.52 134.71 37.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 110.548 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.6 mt -139.36 106.85 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.965 1.306 . . . . 0.0 109.599 -166.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -65.5 127.84 33.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.923 1.289 . . . . 0.0 111.955 161.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 tp -147.75 146.08 29.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.978 2.111 . . . . 0.0 110.111 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.18 96.6 50.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 111.524 -171.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.17 170.0 19.26 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.437 3.424 . . . . 0.0 113.108 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.27 166.55 28.92 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.456 2.104 . . . . 0.0 111.157 166.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -74.8 77.43 2.09 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.327 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.59 -169.18 42.1 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.746 1.165 . . . . 0.0 112.149 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.86 143.12 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.073 0.949 . . . . 0.0 110.481 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 m -164.57 169.26 17.29 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.997 -1.064 . . . . 0.0 112.698 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -125.97 107.55 10.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 110.736 -169.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.0 124.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 127.922 2.489 . . . . 0.0 107.055 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.69 123.23 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.5 mt -125.35 99.88 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.318 1.447 . . . . 0.0 108.719 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.6 -169.15 13.37 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 127.07 2.272 . . . . 0.0 110.242 -161.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.52 -177.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.636 1.218 . . . . 0.0 111.675 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.32 -18.29 6.79 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.95 2.91 44.05 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.18 1.49 . . . . 0.0 114.267 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 p -157.97 -11.36 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.2 117.45 6.07 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.665 1.186 . . . . 0.0 114.106 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 mt -52.54 104.73 0.1 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 156.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.4 m -110.66 94.54 5.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.97 160.35 27.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.276 1.031 . . . . 0.0 112.455 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.7 148.38 25.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.425 1.49 . . . . 0.0 114.292 -161.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -149.77 147.39 27.96 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 171.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.04 107.15 11.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.32 1.048 . . . . 0.0 108.885 164.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -63.32 140.01 58.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.257 0.623 . . . . 0.0 111.559 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 128.534 2.734 . . . . 0.0 116.228 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mmm . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.79 138.69 52.92 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -143.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -132.04 13.3 4.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.659 1.184 . . . . 0.0 113.388 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.34 175.03 15.64 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.868 1.699 . . . . 0.0 112.549 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -71.45 157.86 37.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -127.5 173.86 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.119 2.568 . . . . 0.0 110.332 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.97 139.1 47.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.066 1.746 . . . . 0.0 109.927 165.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tp -75.81 89.51 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 160.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.48 -12.84 41.83 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.789 1.235 . . . . 0.0 112.379 -164.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.1 ttpp -149.38 142.95 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.647 1.579 . . . . 0.0 109.663 149.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 167.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.777 2.431 . . . . 0.0 113.701 166.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 141.89 31.85 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 120.78 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.913 1.285 . . . . 0.0 110.654 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.44 162.01 23.47 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 p -116.9 178.65 4.27 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.792 1.637 . . . . 0.0 112.528 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -17.01 63.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.141 0.976 . . . . 0.0 113.444 166.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -75.87 -10.73 59.67 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.906 1.23 . . . . 0.0 112.118 164.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.84 8.13 32.78 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.485 -1.384 . . . . 0.0 113.306 -164.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.1 p -66.23 160.3 24.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.996 1.398 . . . . 0.0 108.879 162.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -126.67 144.04 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.893 0.877 . . . . 0.0 110.627 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -105.03 118.91 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.523 1.129 . . . . 0.0 109.172 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.19 129.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -104.13 110.03 22.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.341 0.973 . . . . 0.0 110.253 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -86.05 163.78 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.533 0.733 . . . . 0.0 110.375 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.2 155.61 43.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.581 1.952 . . . . 0.0 108.156 157.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -108.95 142.4 39.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.367 1.439 . . . . 0.0 113.177 -170.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -128.96 -24.29 2.94 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.29 73.37 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 117.406 1.722 . . . . 0.0 117.406 -163.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.61 1.51 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.95 -41.1 1.04 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 120.177 1.353 . . . . 0.0 115.193 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.04 171.5 6.42 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.288 2.635 . . . . 0.0 114.146 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.28 159.3 35.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.608 2.872 . . . . 0.0 114.39 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.52 152.73 29.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.122 1.769 . . . . 0.0 110.476 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 132.88 35.82 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 142.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -94.29 124.74 54.76 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -170.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -67.11 114.05 3.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 109.374 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.8 mt -120.43 123.34 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.256 1.022 . . . . 0.0 108.769 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.49 174.47 10.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.561 0.744 . . . . 0.0 109.931 167.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 mt -124.1 130.01 73.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 153.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -110.83 160.32 16.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.133 0.968 . . . . 0.0 111.126 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -58.63 176.07 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.852 2.461 . . . . 0.0 114.083 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.32 -29.96 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.007 -1.058 . . . . 0.0 112.945 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -71.96 -17.7 62.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.215 1.406 . . . . 0.0 112.974 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 45.7 mttp 67.66 29.9 6.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.304 2.641 . . . . 0.0 112.954 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.15 -29.99 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.763 1.625 . . . . 0.0 113.487 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -122.45 131.4 53.85 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.896 1.225 . . . . 0.0 110.894 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.79 135.68 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.346 1.458 . . . . 0.0 111.656 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.53 -7.01 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.78 168.63 12.61 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.855 1.207 . . . . 0.0 115.27 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -131.31 118.1 19.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.756 1.622 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.498 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -77.87 99.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.348 1.059 . . . . 0.0 111.101 -177.05 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.81 -49.49 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.033 0.933 . . . . 0.0 111.876 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.2 t -63.03 -4.97 2.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m 62.82 -12.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.935 2.494 . . . . 0.0 117.692 158.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.6 p -120.16 59.71 6.6 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.481 1.512 . . . . 0.0 113.663 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -58.04 84.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.832 3.022 . . . . 0.0 113.786 163.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.42 166.99 23.2 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.67 137.31 36.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.445 2.698 . . . . 0.0 108.32 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -102.77 -7.49 21.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.662 1.185 . . . . 0.0 112.962 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.25 170.77 11.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 130.17 3.388 . . . . 0.0 108.258 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -44.62 41.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.319 0.648 . . . . 0.0 111.794 167.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -66.76 -6.08 14.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.112 1.765 . . . . 0.0 114.429 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -73.58 101.56 3.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.42 1.009 . . . . 0.0 111.345 174.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 m -73.88 135.46 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.434 158.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -137.95 108.06 6.4 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.779 0.432 . . . . 0.0 110.828 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.58 121.63 25.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.283 1.433 . . . . 0.0 111.833 170.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mm -124.49 115.84 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 126.129 1.772 . . . . 0.0 110.188 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.58 127.95 34.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.405 1.082 . . . . 0.0 110.898 161.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 tp -141.4 145.19 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.359 2.263 . . . . 0.0 109.561 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -113.73 101.05 53.39 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.162 1.385 . . . . 0.0 110.901 -171.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.66 168.91 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.348 3.365 . . . . 0.0 113.135 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.31 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.261 1.974 . . . . 0.0 110.857 162.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -76.32 75.4 3.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.087 -1.008 . . . . 0.0 111.748 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.94 -166.94 39.27 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.987 1.279 . . . . 0.0 112.492 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.99 135.67 47.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.961 1.304 . . . . 0.0 110.626 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -163.38 173.5 13.14 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.075 -1.015 . . . . 0.0 112.098 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.452 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 90.5 m-85 -125.67 105.0 8.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.743 0.817 . . . . 0.0 110.765 -165.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.95 129.86 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.976 1.711 . . . . 0.0 106.841 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.69 122.66 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.79 98.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.575 1.15 . . . . 0.0 109.223 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.56 -176.99 16.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.025 2.25 . . . . 0.0 111.279 -162.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.95 177.21 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.638 1.175 . . . . 0.0 111.57 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.27 -17.18 5.42 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 117.675 1.83 . . . . 0.0 117.675 -170.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.39 6.36 44.47 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.514 1.657 . . . . 0.0 113.992 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -162.75 -1.23 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.57 114.88 3.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.512 1.525 . . . . 0.0 114.282 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.63 103.35 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 157.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 m -112.32 92.83 4.17 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -126.51 148.73 49.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.814 1.292 . . . . 0.0 113.908 -166.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 139.84 47.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.683 2.393 . . . . 0.0 114.132 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -140.03 153.57 46.86 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.417 0.687 . . . . 0.0 110.718 156.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -124.48 115.45 20.92 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 165.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -66.65 134.35 52.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.24 0.473 . . . . 0.0 111.865 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' H3 ' ' CD ' ' A' ' 2' ' ' GLU . 5.3 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -37.46 -52.59 1.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.129 2.971 . . . . 0.0 115.566 165.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -140.62 -36.21 0.48 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 128.461 2.704 . . . . 0.0 110.992 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.11 87.13 1.89 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.58 1.152 . . . . 0.0 107.922 163.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 11' ' ' TYR . 11.4 ptm180 -159.5 174.33 14.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.924 2.09 . . . . 0.0 110.972 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -71.55 82.45 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.806 0.842 . . . . 0.0 110.387 168.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -51.0 -56.59 11.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.077 2.151 . . . . 0.0 114.497 -167.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.6 -21.79 74.84 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.819 0.723 . . . . 0.0 114.144 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -89.76 -70.43 0.66 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 0.0 109.466 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.2 p -70.08 14.62 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.861 2.464 . . . . 0.0 117.164 -161.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 5' ' ' ARG . 2.2 m-85 -121.99 156.6 33.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.517 1.127 . . . . 0.0 111.537 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -149.75 93.72 2.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.097 2.559 . . . . 0.0 106.122 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.1 mmm -120.9 -92.51 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -151.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.4 m -86.98 96.65 10.34 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -143.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.6 p -67.37 -10.74 54.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.895 1.678 . . . . 0.0 114.549 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 170.4 48.2 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.75 1.167 . . . . 0.0 113.726 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.18 158.04 27.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.446 1.498 . . . . 0.0 111.616 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -132.4 167.88 19.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.573 2.349 . . . . 0.0 110.616 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -108.46 139.7 42.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.387 1.075 . . . . 0.0 110.807 165.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tp -71.09 113.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 154.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.21 -14.11 9.29 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.807 0.843 . . . . 0.0 112.51 -162.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.1 ttpp -147.82 141.19 25.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.575 1.55 . . . . 0.0 109.013 144.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' HE3' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -50.47 161.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.358 2.263 . . . . 0.0 114.287 170.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.95 131.35 37.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 130.04 46.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.549 1.54 . . . . 0.0 110.708 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -82.77 159.86 22.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.03 0.932 . . . . 0.0 113.127 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -115.54 168.27 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.175 1.39 . . . . 0.0 112.481 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.21 65.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.749 0.82 . . . . 0.0 112.581 166.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -67.21 -10.14 47.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.192 1.797 . . . . 0.0 112.152 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.92 78.15 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.19 1.376 . . . . 0.0 114.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -76.01 171.72 13.97 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.076 2.15 . . . . 0.0 110.582 167.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.54 154.33 43.99 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.107 0.963 . . . . 0.0 110.782 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.44 105.93 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.599 1.16 . . . . 0.0 109.637 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.93 164.3 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.662 1.185 . . . . 0.0 109.253 167.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.6 tmmt? -132.29 128.39 37.68 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.238 -0.914 . . . . 0.0 109.891 155.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.0 161.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 111.033 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.81 145.64 51.69 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 107.949 161.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -81.66 155.26 25.68 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.778 1.172 . . . . 0.0 110.69 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -124.86 -63.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.696 0.799 . . . . 0.0 109.567 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -8.69 -77.7 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 130.233 3.778 . . . . 0.0 118.362 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.63 15.31 3.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -157.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.8 -54.56 4.68 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.701 -1.249 . . . . 0.0 112.842 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.74 164.3 3.21 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.747 2.419 . . . . 0.0 114.969 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.18 164.0 21.26 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.397 2.732 . . . . 0.0 113.979 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 70.7 m -141.55 148.43 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.072 1.749 . . . . 0.0 111.102 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -86.22 141.02 29.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.5 -1.28 . . . . 0.0 108.035 126.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.38 129.0 25.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.535 -168.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.64 117.41 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.082 1.855 . . . . 0.0 109.617 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.39 127.22 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.228 1.011 . . . . 0.0 109.107 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.05 170.04 11.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.657 0.783 . . . . 0.0 109.144 161.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.41 131.71 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 153.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -115.62 153.58 31.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.415 1.086 . . . . 0.0 111.015 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -62.76 176.03 0.74 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.364 1.466 . . . . 0.0 112.718 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.0 -39.62 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 120.803 -1.186 . . . . 0.0 112.711 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -72.14 -18.52 61.88 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.423 1.889 . . . . 0.0 113.399 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.27 20.6 mttm 74.19 4.84 4.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.426 3.09 . . . . 0.0 114.529 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.49 -43.34 63.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.259 2.224 . . . . 0.0 113.053 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -109.21 133.39 53.08 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.048 0.84 . . . . 0.0 110.997 -165.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -74.73 134.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.857 0.863 . . . . 0.0 110.256 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.67 -8.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.68 168.68 12.86 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.617 1.099 . . . . 0.0 114.759 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -131.25 122.18 26.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.724 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.455 HD12 ' H ' ' A' ' 63' ' ' ILE . 1.2 mp -76.02 138.07 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.895 0.77 . . . . 0.0 109.848 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.85 -34.98 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 111.798 -172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 t -68.56 38.44 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.604 1.962 . . . . 0.0 114.866 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.8 t 57.12 -172.33 0.08 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.573 1.949 . . . . 0.0 112.889 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -64.23 109.54 2.85 Favored Pre-proline 0 C--O 1.246 0.889 0 C-N-CA 125.243 1.417 . . . . 0.0 110.175 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.04 136.38 60.92 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 124.465 3.444 . . . . 0.0 114.918 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.94 160.91 39.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.485 1.114 . . . . 0.0 112.806 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.64 123.5 11.98 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.52 1.528 . . . . 0.0 108.823 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -72.1 -22.49 61.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -170.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.38 169.68 10.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.871 2.468 . . . . 0.0 109.742 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -52.5 -45.64 66.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.294 1.038 . . . . 0.0 111.438 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -70.93 0.95 6.24 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 m -100.41 158.31 15.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.291 1.405 . . . . 0.0 112.376 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.74 154.23 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 125.079 1.352 . . . . 0.0 110.741 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -142.05 115.98 9.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.205 0.602 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -68.92 134.4 49.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.096 0.959 . . . . 0.0 110.341 164.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mm -132.04 104.62 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.803 1.241 . . . . 0.0 109.947 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.51 131.17 44.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.793 0.837 . . . . 0.0 111.172 161.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 tp -150.12 145.16 26.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.063 1.745 . . . . 0.0 110.649 -163.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -119.72 94.62 48.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.523 1.529 . . . . 0.0 110.77 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.21 168.3 20.5 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.967 3.778 . . . . 0.0 112.712 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.92 165.65 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.183 1.922 . . . . 0.0 111.544 169.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -75.41 74.99 2.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.854 0.862 . . . . 0.0 111.702 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.43 -167.09 38.89 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.77 1.176 . . . . 0.0 112.374 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.17 140.28 52.52 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.688 1.195 . . . . 0.0 110.543 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.0 m -163.6 171.11 16.22 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.835 -1.166 . . . . 0.0 112.361 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -128.34 101.29 6.15 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.572 1.149 . . . . 0.0 109.867 -169.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.2 136.66 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.23 122.72 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.419 0.554 . . . . 0.0 109.61 174.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.6 mt -123.82 105.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.844 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.99 172.14 20.3 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.647 2.07 . . . . 0.0 111.097 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 m -95.8 129.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.3 1.05 . . . . 0.0 110.687 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 26.28 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 127.774 2.607 . . . . 0.0 116.081 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.95 -27.77 8.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.052 1.741 . . . . 0.0 115.474 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.8 m -101.29 -3.63 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.552 1.941 . . . . 0.0 112.932 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.31 109.83 16.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.288 1.035 . . . . 0.0 113.089 -166.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 mt -53.85 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.951 162.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.8 m -103.63 89.53 3.38 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -170.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -118.66 139.29 51.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.586 1.184 . . . . 0.0 113.484 -165.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 142.48 55.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.708 2.403 . . . . 0.0 114.208 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -145.53 153.81 41.51 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.888 0.875 . . . . 0.0 111.267 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -135.5 111.62 9.63 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.568 1.147 . . . . 0.0 108.973 168.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -68.49 144.1 54.75 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.929 -0.482 . . . . 0.0 111.647 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 129.653 3.181 . . . . 0.0 115.69 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.97 50.93 4.25 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.896 1.236 . . . . 0.0 111.209 158.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.0 m -59.54 20.06 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 131.611 3.964 . . . . 0.0 118.59 -154.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 m -157.51 9.99 0.19 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.43 -1.419 . . . . 0.0 114.537 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -28.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.531 1.059 . . . . 0.0 111.249 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.13 158.4 15.39 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 156.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 23' ' ' GLU . 26.4 mmmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.182 2.193 . . . . 0.0 112.52 -170.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.04 -86.93 0.47 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.108 2.963 . . . . 0.0 108.99 -160.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -66.85 -40.97 88.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.587 1.155 . . . . 0.0 110.531 157.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 mt -81.04 69.21 7.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.217 0.462 . . . . 0.0 110.145 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -167.17 177.54 6.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.636 2.375 . . . . 0.0 111.46 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.36 77.17 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.835 1.302 . . . . 0.0 110.575 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.76 -52.32 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.045 2.538 . . . . 0.0 115.11 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.8 -34.62 61.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.133 0.873 . . . . 0.0 114.816 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -99.78 -39.37 8.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.963 0.882 . . . . 0.0 112.818 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -82.48 2.58 32.08 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -103.8 149.4 25.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.535 1.061 . . . . 0.0 111.952 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -146.73 90.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.913 2.485 . . . . 0.0 106.465 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.56 -104.69 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 -145.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.67 109.01 18.9 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -133.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -72.33 -13.33 61.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.746 1.618 . . . . 0.0 114.506 164.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.53 163.13 54.75 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.347 0.975 . . . . 0.0 113.317 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 158.93 34.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.967 0.907 . . . . 0.0 112.792 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -129.1 166.73 18.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.652 1.981 . . . . 0.0 110.239 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.39 137.2 54.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.58 1.952 . . . . 0.0 111.038 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 tp -80.15 95.47 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.941 1.296 . . . . 0.0 108.711 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.98 -11.71 28.0 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 112.633 -165.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.4 ttpp -152.71 137.77 17.28 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 109.379 151.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.62 168.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.073 2.949 . . . . 0.0 114.749 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 mtm -77.29 123.55 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.52 118.11 29.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.087 1.355 . . . . 0.0 110.256 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.11 161.79 21.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.312 1.045 . . . . 0.0 113.703 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 p -118.01 169.62 9.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 112.512 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -27.99 66.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.855 0.862 . . . . 0.0 112.387 166.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -65.06 -12.91 55.82 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.38 1.872 . . . . 0.0 112.469 168.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.32 -5.05 79.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.166 1.365 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -69.71 167.65 16.6 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 111.43 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -127.27 148.38 50.22 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.063 1.345 . . . . 0.0 110.072 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.51 116.25 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.526 1.13 . . . . 0.0 109.037 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.68 131.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.783 1.633 . . . . 0.0 108.946 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 5.9 ttmt -102.52 111.61 23.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.283 0.947 . . . . 0.0 109.606 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -87.6 157.0 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 122.585 0.354 . . . . 0.0 110.065 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -130.04 143.34 50.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.057 2.143 . . . . 0.0 107.491 160.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.85 154.74 26.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.586 1.085 . . . . 0.0 110.725 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.34 -63.13 1.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 110.712 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -18.73 -80.15 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 129.391 3.377 . . . . 0.0 117.793 -164.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.58 22.12 6.45 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.6 -49.15 3.82 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 120.917 -1.115 . . . . 0.0 114.327 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.6 178.73 1.71 Allowed Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 128.424 2.689 . . . . 0.0 114.761 -170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.75 166.28 14.18 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 124.255 3.303 . . . . 0.0 115.705 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.0 m -148.13 154.36 40.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.428 1.891 . . . . 0.0 111.286 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -92.12 138.67 31.34 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 128.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.29 125.11 44.57 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -66.14 101.19 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.305 2.003 . . . . 0.0 110.532 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.8 mt -106.84 130.94 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.099 0.96 . . . . 0.0 110.568 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.79 166.79 20.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.563 0.745 . . . . 0.0 110.461 157.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.49 130.61 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 146.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -111.83 162.67 15.03 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.615 1.166 . . . . 0.0 112.916 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -55.9 169.03 0.39 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.86 2.064 . . . . 0.0 113.351 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -58.25 -28.93 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.317 -0.864 . . . . 0.0 112.898 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -74.92 -17.07 60.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.235 1.814 . . . . 0.0 113.718 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 49.8 mttp 69.85 28.19 4.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.234 2.214 . . . . 0.0 113.205 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -115.26 -28.42 6.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.646 1.978 . . . . 0.0 113.173 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -132.6 138.19 47.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.694 1.134 . . . . 0.0 112.255 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.73 133.45 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.292 1.837 . . . . 0.0 111.213 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.51 -8.9 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 0.0 114.112 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.72 168.75 13.05 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 119.578 1.081 . . . . 0.0 115.257 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.55 114.1 14.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.068 1.747 . . . . 0.0 110.854 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -74.92 102.38 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.08 0.952 . . . . 0.0 110.186 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.4 mm -76.36 -42.34 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.421 1.089 . . . . 0.0 111.767 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -70.49 36.94 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.649 1.98 . . . . 0.0 115.78 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t 62.66 -174.92 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.708 2.003 . . . . 0.0 113.588 -175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -59.5 107.01 0.84 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 127.584 2.354 . . . . 0.0 111.859 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.21 121.1 9.3 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.356 3.37 . . . . 0.0 114.57 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.05 165.93 26.17 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.89 148.59 34.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.82 1.648 . . . . 0.0 109.953 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -99.67 -21.46 15.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 112.173 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.6 165.03 19.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.76 1.624 . . . . 0.0 111.296 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -57.98 -28.56 64.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.328 1.051 . . . . 0.0 112.759 168.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -81.48 -4.24 55.34 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 m -83.79 155.97 22.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.621 1.1 . . . . 0.0 112.244 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.69 149.61 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 124.82 1.248 . . . . 0.0 110.204 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -138.62 107.42 5.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.39 0.676 . . . . 0.0 109.492 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.72 121.09 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.01 . . . . 0.0 110.939 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.88 111.84 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.716 1.606 . . . . 0.0 109.131 -168.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -67.42 126.57 29.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 110.765 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 tp -143.3 144.72 32.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.785 2.034 . . . . 0.0 109.527 -172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -114.46 100.21 52.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.413 1.485 . . . . 0.0 110.805 -170.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.19 175.31 10.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.472 3.448 . . . . 0.0 112.893 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -76.67 167.15 25.96 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.396 2.731 . . . . 0.0 111.518 165.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -76.97 78.43 3.52 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.841 -1.162 . . . . 0.0 111.679 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.57 -166.66 39.41 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.257 0.932 . . . . 0.0 112.3 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.66 143.79 54.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.153 0.501 . . . . 0.0 110.761 165.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.0 p -160.27 157.74 28.63 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.938 0.895 . . . . 0.0 111.64 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.489 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 96.1 m-85 -129.3 102.57 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.935 0.874 . . . . 0.0 111.446 -171.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.71 137.22 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.691 1.996 . . . . 0.0 107.568 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.37 129.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -130.86 97.91 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.649 1.18 . . . . 0.0 109.343 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.44 -175.78 15.9 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 127.11 2.29 . . . . 0.0 111.245 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.2 135.17 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 118.473 1.137 . . . . 0.0 111.418 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.27 -117.48 0.91 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.253 1.406 . . . . 0.0 114.158 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -70.43 -9.7 57.13 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.1 m -86.64 -11.23 51.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.518 1.127 . . . . 0.0 112.89 165.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.05 116.84 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.843 0.857 . . . . 0.0 112.583 -172.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.8 102.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 158.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.7 m -112.95 93.31 4.36 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -168.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -131.94 157.42 44.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.746 1.26 . . . . 0.0 114.018 -162.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 135.96 33.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.331 2.652 . . . . 0.0 114.355 -165.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -143.84 118.83 10.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 165.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -91.76 105.67 17.9 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.585 1.154 . . . . 0.0 110.148 164.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 139.09 58.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 56.26 22.81 6.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.471 1.908 . . . . 0.0 114.062 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.63 -24.14 0.04 OUTLIER Glycine 0 CA--C 1.534 1.249 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t 58.78 8.04 0.87 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.598 2.199 . . . . 0.0 114.779 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.5 p -47.81 -42.96 27.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.536 2.335 . . . . 0.0 115.382 -165.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -126.87 16.8 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 126.15 1.78 . . . . 0.0 110.958 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.36 130.71 7.4 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.069 1.319 . . . . 0.0 113.074 -165.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.752 2.021 . . . . 0.0 112.048 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.69 -52.2 11.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.883 2.473 . . . . 0.0 113.983 166.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 7.9 mtmp? -127.43 -39.96 1.82 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 128.219 2.608 . . . . 0.0 111.347 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.52 89.5 1.28 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 169.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 12.2 ptm180 -161.05 173.02 15.82 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.381 2.272 . . . . 0.0 110.165 -176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -73.4 82.29 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.531 0.732 . . . . 0.0 109.322 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -55.14 -27.99 49.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.359 1.464 . . . . 0.0 113.428 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.82 -53.81 12.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 127.224 2.345 . . . . 0.0 113.852 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -128.34 -15.57 4.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -81.86 3.16 27.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.748 1.158 . . . . 0.0 114.081 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' CE1' ' HD3' ' A' ' 5' ' ' ARG . 6.5 m-30 -124.35 139.7 53.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.235 1.814 . . . . 0.0 109.117 166.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 p -140.98 92.15 2.47 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.84 2.056 . . . . 0.0 106.955 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 87.6 mmm -124.49 -109.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -148.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.38 113.02 20.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -135.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.7 p -68.67 -10.97 59.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.54 1.536 . . . . 0.0 114.564 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.3 170.68 44.58 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.279 0.942 . . . . 0.0 114.793 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 156.17 28.26 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.183 1.793 . . . . 0.0 111.484 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 82.6 m-85 -130.7 167.48 18.74 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.416 2.286 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -107.97 137.31 46.18 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.561 1.144 . . . . 0.0 111.054 167.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.8 tp -75.35 92.7 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 159.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.91 -13.2 25.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.754 1.222 . . . . 0.0 112.088 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -149.04 142.38 25.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.374 1.47 . . . . 0.0 109.535 148.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.36 162.68 0.13 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.211 2.204 . . . . 0.0 113.845 167.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.19 132.3 42.06 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 122.21 35.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.858 1.263 . . . . 0.0 110.418 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -80.82 160.89 24.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.5 p -113.65 169.56 8.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.655 1.582 . . . . 0.0 112.006 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.92 69.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.975 0.91 . . . . 0.0 112.287 165.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -68.67 -11.14 59.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.595 1.958 . . . . 0.0 112.764 171.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.42 -3.1 79.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.726 1.155 . . . . 0.0 113.818 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -72.7 165.35 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.445 1.898 . . . . 0.0 111.076 166.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -125.95 146.18 49.97 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.706 1.203 . . . . 0.0 110.405 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.98 118.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 109.164 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.39 124.96 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.607 1.563 . . . . 0.0 109.161 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -95.55 110.8 22.83 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.313 0.961 . . . . 0.0 109.233 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.88 161.53 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.151 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 152.54 49.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.272 1.829 . . . . 0.0 107.733 156.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -87.92 159.01 18.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.199 1.363 . . . . 0.0 110.966 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -130.95 -52.9 1.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.275 -0.891 . . . . 0.0 110.843 173.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.38 -11.21 46.27 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 120.252 2.861 . . . . 0.0 120.252 -151.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.31 2.64 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.61 2.705 . . . . 0.0 117.112 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.88 -56.77 4.29 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-N 120.522 1.51 . . . . 0.0 113.061 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.98 5.03 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 127.371 2.269 . . . . 0.0 114.269 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.66 164.81 22.63 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.031 3.154 . . . . 0.0 116.193 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -147.61 151.18 35.79 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.509 2.324 . . . . 0.0 111.391 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 142.61 28.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 129.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.25 1.0 OUTLIER -104.2 134.86 19.48 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.724 -169.576 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.84 106.42 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.247 1.965 . . . . 0.0 109.112 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 mt -115.14 130.69 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.548 0.739 . . . . 0.0 109.757 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -134.06 172.98 12.08 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.014 0.926 . . . . 0.0 110.048 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' HG ' ' A' ' 81' ' ' LEU . 5.0 mt -126.42 125.71 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 156.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -109.15 162.89 13.85 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.922 0.868 . . . . 0.0 111.148 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -57.74 173.67 0.29 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.622 2.369 . . . . 0.0 113.487 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 m -56.57 -34.9 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.874 -1.141 . . . . 0.0 112.71 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -71.8 -14.07 61.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.563 1.945 . . . . 0.0 113.495 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 67.99 22.98 8.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.267 2.627 . . . . 0.0 113.662 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -108.74 -32.76 7.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.49 1.916 . . . . 0.0 112.692 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -127.15 135.82 51.24 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.249 1.386 . . . . 0.0 111.954 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.76 135.38 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.495 1.518 . . . . 0.0 111.625 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.93 -11.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.559 1.544 . . . . 0.0 114.622 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.97 171.01 13.65 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -170.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtm-85 -133.1 128.89 37.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.676 1.59 . . . . 0.0 110.729 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 63' ' ' ILE . 1.9 mp -79.72 124.09 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.52 -36.99 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.568 0.747 . . . . 0.0 111.282 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.8 t -68.63 35.29 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.296 1.838 . . . . 0.0 114.617 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.76 -170.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.899 2.08 . . . . 0.0 113.641 -175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -64.0 108.6 1.96 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.929 2.092 . . . . 0.0 111.157 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -55.05 143.78 72.05 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.31 3.34 . . . . 0.0 115.495 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -147.46 166.27 27.74 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.96 121.93 11.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.458 1.903 . . . . 0.0 108.168 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.52 -17.29 59.34 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.584 -0.697 . . . . 0.0 112.677 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.53 170.26 16.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.319 2.648 . . . . 0.0 109.419 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 m -50.5 -49.9 54.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.312 1.045 . . . . 0.0 110.464 163.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -67.03 -3.54 7.49 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 m -85.24 144.18 28.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.148 1.34 . . . . 0.0 112.093 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.02 150.96 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.045 1.338 . . . . 0.0 110.637 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 m -141.77 115.59 9.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.98 122.75 32.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 111.568 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.73 111.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 124.819 1.248 . . . . 0.0 109.827 -162.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.1 124.59 23.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.141 1.376 . . . . 0.0 111.42 165.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 51' ' ' ILE . 57.4 tp -141.02 142.92 34.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.074 2.149 . . . . 0.0 110.013 -166.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -119.23 98.99 50.7 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -167.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.82 168.77 18.89 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.483 3.455 . . . . 0.0 113.573 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.49 165.13 32.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.946 2.431 . . . . 0.0 111.019 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -72.67 73.42 1.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.27 -0.894 . . . . 0.0 112.004 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -173.44 46.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.148 0.88 . . . . 0.0 113.789 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.54 129.61 41.39 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.13 0.972 . . . . 0.0 110.163 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 m -145.56 150.5 36.52 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.279 1.432 . . . . 0.0 111.011 -163.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.58 98.17 5.61 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.957 0.884 . . . . 0.0 111.317 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.82 126.44 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.391 1.876 . . . . 0.0 107.259 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.47 123.96 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.871 0.868 . . . . 0.0 109.039 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.1 mt -128.16 98.58 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.031 1.332 . . . . 0.0 109.256 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.93 -174.57 15.84 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 127.657 2.551 . . . . 0.0 110.649 -164.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.11 164.54 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.506 1.153 . . . . 0.0 110.585 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -10.14 -74.5 0.01 OUTLIER Glycine 0 CA--C 1.541 1.707 0 C-N-CA 127.55 2.5 . . . . 0.0 117.682 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.3 58.68 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.9 p -122.91 -10.29 8.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.295 1.838 . . . . 0.0 114.025 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.15 118.53 6.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.582 1.953 . . . . 0.0 112.67 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.5 mt -56.67 98.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 154.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 83.4 m -101.08 95.57 6.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.94 154.35 39.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.816 1.293 . . . . 0.0 113.735 -170.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.38 137.89 33.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.917 2.487 . . . . 0.0 114.267 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -134.64 156.48 48.67 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.201 1.0 . . . . 0.0 111.129 162.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -129.8 111.06 12.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 162.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -63.26 135.33 57.0 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm 55.46 30.9 15.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.528 1.931 . . . . 0.0 113.705 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.53 -25.71 0.03 OUTLIER Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 t 52.35 -96.2 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.83 1.815 . . . . 0.0 112.144 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.3 p 55.87 -101.34 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.197 1.799 . . . . 0.0 113.067 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.19 -21.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.368 1.867 . . . . 0.0 113.125 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.9 113.69 4.71 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.479 1.514 . . . . 0.0 112.387 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.455 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 3.2 mmpt? . . . . . 0 C--O 1.251 1.139 0 C-N-CA 126.982 2.113 . . . . 0.0 112.674 173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.73 -0.1 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.08 -54.07 0.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 130.05 3.34 . . . . 0.0 115.009 166.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -144.31 -28.15 0.5 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.8 2.04 . . . . 0.0 112.519 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.2 mt -69.31 80.11 0.37 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 108.465 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -159.4 171.48 19.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.975 2.91 . . . . 0.0 108.88 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.98 81.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.621 162.332 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -40.88 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.481 2.712 . . . . 0.0 114.199 -163.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.24 -58.22 12.61 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.243 1.402 . . . . 0.0 113.008 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -49.92 75.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.94 0.87 . . . . 0.0 113.001 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.9 p -81.95 -10.34 59.3 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -168.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -76.46 159.69 30.19 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.759 1.163 . . . . 0.0 112.484 171.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.4 p -139.42 91.17 2.47 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.367 1.867 . . . . 0.0 106.474 161.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.44 -110.03 0.33 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -145.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.62 99.56 8.2 Favored 'General case' 0 N--CA 1.458 -0.056 0 O-C-N 121.106 -0.996 . . . . 0.0 113.36 -145.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -68.64 -6.44 25.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.517 166.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.24 53.83 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.045 1.307 . . . . 0.0 114.169 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 154.71 32.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.261 1.824 . . . . 0.0 112.459 -174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.04 166.22 18.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.748 2.019 . . . . 0.0 110.794 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -101.39 137.45 39.71 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.579 1.151 . . . . 0.0 110.183 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.57 101.75 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -106.53 -14.37 15.07 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.319 1.448 . . . . 0.0 111.482 -163.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.5 ttpp -149.38 137.84 20.86 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.686 1.595 . . . . 0.0 109.359 145.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.94 168.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.06 2.944 . . . . 0.0 114.351 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 34' ' ' VAL . 24.9 mtm -79.88 136.36 36.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.39 122.57 21.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.013 1.725 . . . . 0.0 109.74 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.62 164.89 21.54 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -120.66 170.06 9.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.041 1.737 . . . . 0.0 111.778 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -27.56 66.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.117 0.967 . . . . 0.0 112.312 165.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -65.37 -9.15 22.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.338 1.855 . . . . 0.0 112.733 168.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.03 -7.4 55.96 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.477 1.513 . . . . 0.0 113.539 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -68.54 163.54 23.3 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.976 1.71 . . . . 0.0 111.067 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -126.71 148.29 49.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 109.503 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 t -114.65 115.3 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.127 0.971 . . . . 0.0 109.508 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.6 t -117.81 132.6 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 109.087 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 25.7 ttpp -107.27 120.49 42.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.775 1.17 . . . . 0.0 110.47 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -93.75 165.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.656 1.182 . . . . 0.0 109.987 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.57 159.12 42.88 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.126 1.771 . . . . 0.0 108.183 156.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -104.31 139.04 39.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.724 1.602 . . . . 0.0 112.421 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -121.71 -27.82 4.63 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.87 -1.144 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.85 -18.13 79.51 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -157.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.34 2.57 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.31 -42.7 1.7 Allowed Glycine 0 CA--C 1.537 1.419 0 CA-C-N 120.765 1.62 . . . . 0.0 114.497 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.31 170.7 5.06 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 128.33 2.652 . . . . 0.0 115.107 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -67.64 166.24 24.77 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.926 3.084 . . . . 0.0 113.172 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.35 155.31 40.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.27 136.69 33.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 129.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.274 1.7 m -95.54 129.11 35.7 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -170.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.2 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.644 2.23 . . . . 0.0 109.091 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.7 mt -119.06 129.15 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.58 0.752 . . . . 0.0 110.833 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -132.83 169.06 17.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.525 1.13 . . . . 0.0 109.437 162.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -119.09 131.25 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 149.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -110.12 163.69 13.35 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.465 1.103 . . . . 0.0 112.209 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -59.64 175.52 0.35 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.706 1.603 . . . . 0.0 113.027 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -65.3 -22.77 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -79.72 -25.56 41.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.34 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 46.9 mttp 85.91 14.02 0.16 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.939 3.295 . . . . 0.0 112.565 169.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -83.09 -51.05 7.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.489 2.716 . . . . 0.0 112.815 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -122.68 151.48 41.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.127 1.33 . . . . 0.0 112.669 -167.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.32 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.938 1.695 . . . . 0.0 112.136 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.22 -28.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.188 1.795 . . . . 0.0 114.171 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.55 161.76 17.87 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.917 1.235 . . . . 0.0 114.429 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -124.17 105.21 9.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.455 1.502 . . . . 0.0 110.354 -170.021 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.1 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.985 -1.072 . . . . 0.0 110.151 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.6 mm -108.73 -40.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.471 0.708 . . . . 0.0 111.603 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 t -66.41 10.14 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 98.13 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 130.588 3.555 . . . . 0.0 111.413 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 p -67.76 106.87 1.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.403 1.481 . . . . 0.0 109.375 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.94 147.21 64.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.635 2.89 . . . . 0.0 115.238 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 169.16 18.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.94 140.38 38.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.319 2.248 . . . . 0.0 108.914 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.12 -27.59 21.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.446 1.098 . . . . 0.0 112.283 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 177.73 7.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 130.163 3.385 . . . . 0.0 108.84 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.14 -43.71 61.26 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.085 -1.009 . . . . 0.0 112.342 170.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.37 -10.09 15.12 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 114.044 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -72.74 119.99 17.74 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 m -90.49 146.29 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.081 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -139.15 105.3 5.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -86.3 125.31 33.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 111.493 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.4 mt -131.69 115.47 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.309 1.444 . . . . 0.0 109.555 -159.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.11 126.51 29.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.103 0.961 . . . . 0.0 111.647 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.9 tp -145.5 143.13 29.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.021 1.728 . . . . 0.0 110.367 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 62' ' ' ARG . 5.2 tm-20 -118.19 92.63 43.17 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.619 1.568 . . . . 0.0 111.429 -165.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.85 170.47 19.99 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.288 3.325 . . . . 0.0 114.419 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.49 160.13 49.37 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.675 2.25 . . . . 0.0 111.17 165.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.85 92.18 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.456 0.702 . . . . 0.0 110.358 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.49 -172.38 34.24 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.218 1.389 . . . . 0.0 111.236 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.81 143.95 39.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.999 0.92 . . . . 0.0 111.512 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 162.18 24.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.064 0.946 . . . . 0.0 111.953 -171.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 91.8 m-85 -127.78 102.34 6.76 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.939 0.876 . . . . 0.0 111.747 -170.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.39 126.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 127.539 2.336 . . . . 0.0 106.968 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.32 120.36 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -124.28 98.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.075 1.35 . . . . 0.0 108.995 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.82 -174.04 15.01 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.85 2.167 . . . . 0.0 110.247 -161.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 m -114.76 161.53 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.569 1.184 . . . . 0.0 110.93 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 4.51 -85.57 0.0 OUTLIER Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.825 2.631 . . . . 0.0 117.406 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -4.43 58.67 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -119.41 -9.59 9.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.187 1.795 . . . . 0.0 113.853 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.93 8.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.716 2.006 . . . . 0.0 113.347 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.97 96.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 155.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.8 m -99.94 97.3 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -126.46 160.64 29.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.394 1.093 . . . . 0.0 113.307 -172.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 141.15 28.92 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 114.345 -162.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -146.24 129.45 16.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 166.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -105.93 108.76 20.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.548 1.539 . . . . 0.0 109.669 165.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -66.47 141.08 58.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm 51.54 33.36 10.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.203 1.801 . . . . 0.0 113.624 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.67 -29.29 0.02 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 115.621 1.009 . . . . 0.0 115.621 172.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.9 t 54.66 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.443 1.897 . . . . 0.0 113.381 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.3 p 54.07 -104.26 0.2 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.969 1.708 . . . . 0.0 112.378 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.2 tt -69.04 -27.92 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.094 1.358 . . . . 0.0 112.568 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.87 102.67 1.09 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.652 1.12 . . . . 0.0 111.082 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.485 2.714 . . . . 0.0 112.079 -176.787 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.85 -58.86 0.5 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.916 2.886 . . . . 0.0 114.66 165.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -141.52 -21.61 0.74 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.374 1.869 . . . . 0.0 113.004 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.7 tp -71.18 84.84 0.75 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.793 1.179 . . . . 0.0 108.611 159.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -161.31 176.17 11.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.511 2.725 . . . . 0.0 109.386 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -73.46 79.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.444 -0.785 . . . . 0.0 109.951 162.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -48.86 -58.54 4.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.65 2.38 . . . . 0.0 113.406 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.0 -56.09 20.57 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.584 1.088 . . . . 0.0 112.172 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.34 -58.66 6.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.039 0.936 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.0 p -82.95 6.89 17.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -160.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -102.6 165.78 10.88 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.847 1.203 . . . . 0.0 111.445 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -141.11 91.29 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.151 1.78 . . . . 0.0 107.117 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . 0.289 0.0 OUTLIER -129.1 -116.53 0.25 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -147.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.08 106.65 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -139.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.3 p -70.66 -7.35 43.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.657 1.583 . . . . 0.0 114.2 162.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.01 168.67 54.79 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.655 1.121 . . . . 0.0 113.893 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 155.18 36.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.638 1.575 . . . . 0.0 112.332 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.53 166.22 21.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.049 2.14 . . . . 0.0 110.477 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -106.53 140.25 39.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.39 1.476 . . . . 0.0 110.667 166.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -76.45 94.28 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 159.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.48 -13.05 26.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.816 1.246 . . . . 0.0 112.267 -165.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.9 ttpp -145.87 140.79 27.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.745 1.618 . . . . 0.0 108.684 146.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.61 167.66 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.48 2.312 . . . . 0.0 113.691 166.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.434 ' HG2' HG22 ' A' ' 34' ' ' VAL . 28.8 mtm -76.23 137.63 40.1 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.264 -0.897 . . . . 0.0 113.183 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.65 128.66 35.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.565 1.146 . . . . 0.0 110.137 171.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -85.15 161.3 19.69 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -111.52 168.63 9.4 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.896 1.678 . . . . 0.0 111.764 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -30.28 70.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.545 1.138 . . . . 0.0 111.965 164.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -62.12 -14.68 39.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.771 1.628 . . . . 0.0 112.645 166.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 1.98 90.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.989 1.28 . . . . 0.0 113.954 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -76.35 164.31 26.14 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.925 2.09 . . . . 0.0 110.916 166.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -119.86 146.07 46.08 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.186 0.994 . . . . 0.0 110.245 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.7 119.09 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.079 0.952 . . . . 0.0 109.044 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.5 t -117.49 130.7 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.553 1.541 . . . . 0.0 109.211 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.5 ttmt -106.77 108.3 19.74 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.113 0.869 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.5 162.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 110.156 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 145.6 41.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.201 1.8 . . . . 0.0 107.459 154.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.63 153.02 22.66 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.96 1.254 . . . . 0.0 111.115 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -124.28 -59.32 1.48 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.199 -0.938 . . . . 0.0 109.645 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -20.66 -64.65 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 130.192 3.758 . . . . 0.0 118.587 -167.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.86 11.64 2.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -158.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.74 -45.85 2.77 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 120.606 -1.309 . . . . 0.0 113.417 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 165.74 6.28 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 128.473 2.709 . . . . 0.0 115.559 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.06 167.82 20.7 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.513 3.475 . . . . 0.0 113.622 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.2 m -147.59 157.23 43.47 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.225 1.81 . . . . 0.0 111.611 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 137.73 32.07 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 128.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 1.9 m -100.29 128.15 31.26 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.381 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.03 105.71 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.599 2.199 . . . . 0.0 109.707 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.0 128.01 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 110.491 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -131.75 168.07 18.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 109.247 165.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.95 135.09 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 151.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -119.62 157.94 27.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.228 1.411 . . . . 0.0 110.929 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.1 177.67 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.03 0.932 . . . . 0.0 112.544 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -56.16 -34.82 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 120.902 -1.124 . . . . 0.0 113.354 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -82.29 -6.55 59.31 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.34 1.856 . . . . 0.0 112.592 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 66.12 -5.42 0.56 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.207 3.003 . . . . 0.0 115.272 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.06 -38.65 88.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.302 1.841 . . . . 0.0 114.658 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -118.13 140.09 50.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.424 1.465 . . . . 0.0 111.862 -168.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -73.68 139.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.291 1.436 . . . . 0.0 111.062 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.82 -7.93 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 114.955 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.99 13.09 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 119.982 1.264 . . . . 0.0 115.795 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -133.38 119.58 19.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.363 1.865 . . . . 0.0 111.513 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.96 99.72 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.029 0.932 . . . . 0.0 110.853 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.61 -38.22 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 111.424 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -67.33 18.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.928 1.291 . . . . 0.0 114.242 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.1 m 60.64 -176.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.531 2.332 . . . . 0.0 113.335 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.0 p -57.35 107.83 1.05 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.057 1.743 . . . . 0.0 110.827 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -59.29 159.81 21.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.26 3.307 . . . . 0.0 115.319 -172.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.88 167.17 22.74 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.75 143.97 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.671 1.589 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -92.56 -22.57 19.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.21 171.11 5.8 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.882 3.273 . . . . 0.0 109.399 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 m -51.68 -47.68 63.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.223 1.009 . . . . 0.0 110.989 164.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -66.48 1.36 1.71 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 m -104.28 130.42 52.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.535 1.061 . . . . 0.0 112.022 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.39 152.58 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.988 1.315 . . . . 0.0 111.579 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -142.7 111.49 6.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.726 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -76.59 130.38 37.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.614 1.166 . . . . 0.0 111.204 167.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mm -132.74 116.98 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.315 1.846 . . . . 0.0 110.023 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.8 128.24 34.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 111.303 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 tp -144.13 146.91 33.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.506 1.922 . . . . 0.0 110.695 -169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.4 100.3 41.92 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.397 1.479 . . . . 0.0 110.871 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.55 174.05 13.26 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.962 3.775 . . . . 0.0 113.314 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.71 165.53 32.04 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.631 2.22 . . . . 0.0 111.001 162.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.72 79.47 2.05 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.131 -0.981 . . . . 0.0 111.834 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.39 -168.53 41.5 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.766 1.174 . . . . 0.0 112.496 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.64 142.82 55.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.367 1.067 . . . . 0.0 110.357 170.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.7 m -164.6 168.52 18.08 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.675 -1.266 . . . . 0.0 112.531 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -126.31 100.77 6.43 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.214 1.006 . . . . 0.0 110.231 -171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.91 138.98 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 171.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.43 130.08 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.3 mt -127.12 101.93 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.255 . . . . 0.0 108.645 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.46 164.03 17.81 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.367 1.937 . . . . 0.0 111.071 -164.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.9 148.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.639 -0.918 . . . . 0.0 110.455 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 6.37 -92.1 0.01 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 128.457 2.932 . . . . 0.0 117.296 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -64.26 -13.81 51.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.7 m -108.54 -5.14 16.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.992 2.117 . . . . 0.0 112.507 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.87 127.03 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.515 1.126 . . . . 0.0 113.09 -168.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.87 82.01 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.9 m -79.01 104.95 10.0 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.756 0.822 . . . . 0.0 109.185 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.83 151.93 51.92 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 138.98 37.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.887 2.475 . . . . 0.0 114.976 -171.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -136.16 156.77 48.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.734 0.814 . . . . 0.0 111.785 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -128.87 109.47 11.29 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.843 1.257 . . . . 0.0 108.273 162.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -65.03 136.38 56.71 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.144 -0.347 . . . . 0.0 111.831 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 58.61 24.43 12.04 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.361 1.865 . . . . 0.0 114.156 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -153.72 -17.48 0.05 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.5 t 43.34 -104.3 0.06 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.502 1.921 . . . . 0.0 111.758 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m 58.18 -76.21 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.051 2.54 . . . . 0.0 114.26 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.08 -22.01 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.03 1.332 . . . . 0.0 112.289 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.4 124.57 7.5 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.968 1.747 . . . . 0.0 112.695 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 4.7 mmpt? . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.359 2.664 . . . . 0.0 112.159 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' H3 ' ' CD ' ' A' ' 2' ' ' GLU . 1.7 mpt? . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.193 0.044 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.411 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -37.02 -54.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.877 3.271 . . . . 0.0 115.075 167.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.42 -29.77 0.74 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.599 2.36 . . . . 0.0 111.851 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.25 85.96 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.911 0.884 . . . . 0.0 108.737 164.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -163.26 172.57 14.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.298 3.039 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 pt -73.21 82.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.332 -0.855 . . . . 0.0 109.852 163.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -47.3 -55.41 8.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.327 1.851 . . . . 0.0 113.318 -168.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.66 -52.91 38.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.938 1.256 . . . . 0.0 113.918 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.0 ttt -82.53 -45.19 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.466 0.633 . . . . 0.0 112.682 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.6 p -83.78 -9.18 58.98 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -167.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -85.88 146.7 26.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.249 1.386 . . . . 0.0 111.381 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 p -137.66 90.49 2.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.726 2.01 . . . . 0.0 106.842 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.1 mmm -119.12 -81.68 0.63 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -150.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 102.55 6.24 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -149.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 p -76.77 -15.36 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.55 173.37 35.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.741 1.163 . . . . 0.0 115.298 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 155.63 27.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.175 2.19 . . . . 0.0 112.792 -173.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -129.92 168.45 16.63 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.434 2.294 . . . . 0.0 112.009 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -104.1 138.46 40.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.247 1.419 . . . . 0.0 110.661 163.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 tp -75.9 82.24 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 122.783 1.278 . . . . 0.0 107.859 160.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.28 -14.56 59.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.331 1.452 . . . . 0.0 112.827 -170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -153.09 137.85 17.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.441 1.097 . . . . 0.0 110.282 154.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.73 168.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.875 2.47 . . . . 0.0 113.57 165.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.1 mtm -82.71 134.5 35.14 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.135 -0.978 . . . . 0.0 113.525 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.16 31.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.892 1.277 . . . . 0.0 110.546 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -83.27 159.75 21.87 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -111.39 169.24 8.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.105 1.762 . . . . 0.0 111.863 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -26.73 64.74 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.893 0.877 . . . . 0.0 112.283 164.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -63.7 -11.8 29.02 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.765 1.626 . . . . 0.0 112.261 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.8 76.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.249 1.404 . . . . 0.0 113.843 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 p -76.16 165.64 24.61 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.672 1.989 . . . . 0.0 110.658 165.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -125.44 147.4 49.22 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.994 0.918 . . . . 0.0 110.956 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.6 t -114.43 120.98 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.377 1.071 . . . . 0.0 109.363 -171.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.53 133.5 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.06 1.744 . . . . 0.0 109.102 -173.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -103.45 115.79 31.18 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.547 1.067 . . . . 0.0 110.034 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -88.76 161.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.207 0.603 . . . . 0.0 110.108 170.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.39 142.42 47.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.201 1.801 . . . . 0.0 107.237 154.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -78.41 155.1 30.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.451 1.478 . . . . 0.0 110.653 169.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -127.02 -62.34 1.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.869 0.868 . . . . 0.0 110.337 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -29.26 -59.74 0.17 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.956 3.17 . . . . 0.0 118.353 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.37 15.69 3.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -160.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -45.71 3.0 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.743 -1.223 . . . . 0.0 114.061 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.08 8.0 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 128.045 2.538 . . . . 0.0 115.539 -170.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -66.71 161.32 42.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.041 2.494 . . . . 0.0 112.414 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.3 m -156.25 155.7 32.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 0.0 111.179 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 137.57 38.46 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 142.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 48' ' ' PRO 0.291 1.7 m -99.74 134.38 21.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.767 -169.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.8 Cg_endo -81.58 100.71 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.174 2.583 . . . . 0.0 109.256 -172.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mt -112.22 124.41 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.76 0.824 . . . . 0.0 111.08 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.73 163.1 21.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.826 1.251 . . . . 0.0 110.225 164.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.48 HG13 HD11 ' A' ' 81' ' ' LEU . 3.8 mt -118.78 126.69 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 146.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.23 163.94 12.59 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.61 1.164 . . . . 0.0 111.966 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -56.59 171.01 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 127.343 2.257 . . . . 0.0 113.803 173.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.75 -26.53 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.451 -0.78 . . . . 0.0 112.847 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -72.81 -17.25 61.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.614 1.565 . . . . 0.0 113.449 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 89' ' ' TYR . 42.8 mttp 71.73 23.62 3.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.734 2.413 . . . . 0.0 113.4 175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -119.19 -31.6 4.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.148 1.779 . . . . 0.0 114.009 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -126.0 129.16 48.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.705 1.138 . . . . 0.0 110.917 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.53 133.74 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.358 1.463 . . . . 0.0 111.576 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -133.44 -10.5 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.149 1.78 . . . . 0.0 114.252 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.63 170.92 13.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.349 0.976 . . . . 0.0 114.599 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -131.35 138.22 49.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.812 1.645 . . . . 0.0 110.439 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -93.02 128.85 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.583 0.753 . . . . 0.0 109.616 178.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.59 -54.52 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 112.522 -162.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -60.41 -33.39 72.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -175.75 169.27 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.54 1.936 . . . . 0.0 110.135 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 p -66.52 105.13 0.73 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.334 157.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -58.44 145.52 93.93 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.528 2.819 . . . . 0.0 115.806 -163.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -144.7 167.68 21.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.13 0.972 . . . . 0.0 112.837 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.96 128.8 29.06 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.386 2.274 . . . . 0.0 108.334 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -75.2 -16.6 60.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.59 168.43 3.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.613 2.365 . . . . 0.0 110.429 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -58.47 -44.75 89.42 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.472 0.709 . . . . 0.0 110.065 156.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -69.88 40.13 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.453 1.901 . . . . 0.0 112.678 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -156.19 148.8 23.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 119.653 -1.904 . . . . 0.0 111.964 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.61 156.34 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.766 1.626 . . . . 0.0 111.078 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -142.98 107.76 4.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.101 0.56 . . . . 0.0 110.608 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -74.18 125.51 28.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.587 0.755 . . . . 0.0 110.852 164.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 mm -128.66 120.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.5 1.52 . . . . 0.0 110.022 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -71.04 130.66 42.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.4 1.08 . . . . 0.0 111.276 162.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 51' ' ' ILE . 30.5 tp -143.94 151.55 39.93 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.308 2.243 . . . . 0.0 109.731 -168.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -125.7 94.37 42.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.901 1.68 . . . . 0.0 109.653 -165.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -76.07 172.59 15.98 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.606 3.537 . . . . 0.0 113.268 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.34 160.42 49.9 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.347 2.031 . . . . 0.0 110.692 162.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.26 72.61 2.33 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.221 -0.924 . . . . 0.0 111.097 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.33 42.42 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.318 1.913 . . . . 0.0 111.269 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.64 148.12 38.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.316 0.579 . . . . 0.0 111.045 169.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -163.97 161.3 22.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.929 0.891 . . . . 0.0 111.903 -167.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 86.5 m-85 -128.12 100.54 5.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 111.558 -169.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.57 126.56 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 127.668 2.387 . . . . 0.0 107.351 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.261 0.9 OUTLIER -119.08 120.95 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.259 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -122.04 97.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.498 1.519 . . . . 0.0 108.639 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.94 179.79 15.91 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.275 2.369 . . . . 0.0 110.493 -166.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.85 144.34 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.033 0.917 . . . . 0.0 111.169 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 38.0 -119.31 0.75 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.531 1.539 . . . . 0.0 113.858 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.44 -14.04 62.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.8 m -86.84 -10.79 52.64 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.226 1.011 . . . . 0.0 112.688 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.32 116.49 17.06 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.473 1.109 . . . . 0.0 113.467 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.7 mt -55.46 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 157.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.2 m -107.37 95.68 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.1 160.25 34.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.149 0.976 . . . . 0.0 113.38 -172.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.66 23.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.921 2.088 . . . . 0.0 114.521 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -151.64 132.01 13.74 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.157 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -103.88 109.31 21.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.003 1.321 . . . . 0.0 110.31 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.08 141.16 58.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.13 26.23 11.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.617 1.967 . . . . 0.0 114.353 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.81 -16.19 0.02 OUTLIER Glycine 0 CA--C 1.535 1.308 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.8 t 39.5 -94.83 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.267 2.227 . . . . 0.0 113.755 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m 63.28 -54.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 129.153 2.981 . . . . 0.0 115.382 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.21 -17.1 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.402 1.881 . . . . 0.0 112.657 170.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.7 108.57 3.69 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.388 1.475 . . . . 0.0 114.108 -164.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.9 -0.037 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.3 -57.38 0.33 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.514 3.126 . . . . 0.0 115.057 166.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -139.34 -32.06 0.67 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.685 2.394 . . . . 0.0 111.73 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 93.26 4.18 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -155.96 164.69 38.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 110.406 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mm -76.27 82.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.711 0.804 . . . . 0.0 109.077 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -55.04 -27.98 48.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.117 1.767 . . . . 0.0 113.724 -170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.54 -37.37 75.1 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.571 1.558 . . . . 0.0 114.015 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -136.94 -20.82 1.26 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 9.62 1.24 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -143.15 139.35 30.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.183 2.193 . . . . 0.0 108.858 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -142.83 77.03 1.56 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.78 2.032 . . . . 0.0 107.597 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 tpt -115.89 -75.83 0.58 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -130.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 127.44 32.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -154.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.0 p -100.17 -7.58 24.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.0 113.708 163.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.72 170.26 34.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.91 1.243 . . . . 0.0 114.185 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 157.22 27.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.69 1.996 . . . . 0.0 112.734 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.5 m-85 -129.77 168.46 16.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.052 2.141 . . . . 0.0 111.732 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -105.51 141.3 37.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.611 1.565 . . . . 0.0 110.682 164.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 tp -77.01 95.09 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 156.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -93.15 -12.04 31.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.053 1.341 . . . . 0.0 112.613 -166.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.9 ttpp -151.13 132.48 14.59 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.46 1.104 . . . . 0.0 109.62 149.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.7 153.61 0.57 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.694 1.998 . . . . 0.0 113.336 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -69.55 145.82 52.29 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.38 13.16 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.825 1.65 . . . . 0.0 109.519 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -78.41 156.91 29.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 113.272 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.1 p -108.53 170.24 8.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.636 1.574 . . . . 0.0 111.475 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -25.24 62.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.399 1.08 . . . . 0.0 112.248 164.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -64.57 -12.49 45.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.499 1.52 . . . . 0.0 112.023 164.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 1.63 84.28 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.421 1.486 . . . . 0.0 113.861 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -73.6 168.07 20.07 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.974 2.11 . . . . 0.0 110.847 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -125.0 148.61 48.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.262 1.025 . . . . 0.0 110.198 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 t -115.86 110.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.062 0.945 . . . . 0.0 109.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.64 124.27 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.6 1.16 . . . . 0.0 109.774 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.9 ttmt -92.46 112.57 24.56 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.438 1.017 . . . . 0.0 110.018 173.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.01 165.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.978 0.511 . . . . 0.0 110.099 169.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 154.93 45.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.092 2.157 . . . . 0.0 108.113 156.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -98.79 139.15 34.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.934 1.697 . . . . 0.0 112.802 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -119.71 -33.26 4.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.692 -1.255 . . . . 0.0 113.101 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.81 -25.68 71.9 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -157.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.05 -47.1 3.07 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 120.678 1.581 . . . . 0.0 114.679 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.51 169.21 20.55 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 127.781 2.432 . . . . 0.0 113.964 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -68.01 160.19 49.7 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.905 2.404 . . . . 0.0 115.738 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 13.0 m -151.15 154.64 37.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.527 1.931 . . . . 0.0 110.733 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 136.07 36.73 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 144.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.295 1.1 m -96.85 141.81 23.62 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 118.308 0.504 . . . . 0.0 111.765 -165.243 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -88.16 96.89 0.4 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.999 2.466 . . . . 0.0 109.324 -168.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.28 129.41 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.6 0.76 . . . . 0.0 112.189 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.22 170.01 16.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.698 1.199 . . . . 0.0 110.147 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 81' ' ' LEU . 3.9 mt -115.36 129.2 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 148.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.94 164.11 12.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.681 1.192 . . . . 0.0 111.995 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -58.62 172.0 0.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.226 2.21 . . . . 0.0 114.167 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.44 -31.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.081 -1.012 . . . . 0.0 112.464 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.46 -16.14 62.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.608 1.963 . . . . 0.0 113.255 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 mttm 67.23 20.18 10.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.498 2.719 . . . . 0.0 113.436 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.57 -40.35 7.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 112.09 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.93 1.241 . . . . 0.0 112.879 -165.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.1 137.63 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.989 1.716 . . . . 0.0 112.442 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.35 -14.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.05 169.04 14.73 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-N 119.745 1.157 . . . . 0.0 114.977 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -129.95 122.87 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.266 1.426 . . . . 0.0 112.216 -172.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.08 100.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.561 1.144 . . . . 0.0 111.398 176.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.8 mm -71.7 -44.03 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 110.642 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -62.87 -3.2 1.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m 62.92 -26.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 129.398 3.079 . . . . 0.0 118.785 155.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.2 p -128.25 69.6 78.23 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.21 1.368 . . . . 0.0 112.223 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -54.12 106.97 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.671 2.914 . . . . 0.0 113.211 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 169.6 17.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 166.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.84 116.98 13.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.418 2.687 . . . . 0.0 107.837 171.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -72.08 -16.46 62.02 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.42 173.48 3.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.144 3.378 . . . . 0.0 108.384 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.6 -45.36 77.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.333 -0.855 . . . . 0.0 111.653 166.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.17 0.63 2.57 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.8 m -96.6 112.07 23.96 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 m -80.46 152.66 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.244 1.017 . . . . 0.0 111.717 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m -144.58 110.44 5.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.283 0.633 . . . . 0.0 110.754 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.3 124.0 28.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.457 0.703 . . . . 0.0 111.741 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.05 109.46 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.997 1.319 . . . . 0.0 109.197 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -67.53 127.64 33.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.05 0.94 . . . . 0.0 111.025 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.59 HD11 HG13 ' A' ' 51' ' ' ILE . 19.7 tp -147.08 145.73 29.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.108 1.763 . . . . 0.0 110.154 -167.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -120.16 97.48 49.2 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.581 1.552 . . . . 0.0 110.496 -165.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.94 170.83 19.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.265 3.31 . . . . 0.0 113.423 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.88 161.16 47.05 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.548 2.165 . . . . 0.0 111.062 163.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -72.63 90.55 1.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.369 -0.832 . . . . 0.0 110.548 168.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.04 -171.91 37.19 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.041 1.305 . . . . 0.0 111.147 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.82 147.97 31.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.536 0.734 . . . . 0.0 111.048 170.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 90.4 p -162.57 159.94 25.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 112.325 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -128.72 96.91 4.51 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.545 1.164 . . . . 0.0 110.923 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 90' ' ' ILE . 4.1 mp -65.8 128.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 127.704 2.402 . . . . 0.0 106.918 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.23 120.76 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.5 mt -122.48 94.32 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.136 1.374 . . . . 0.0 108.064 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 177.69 15.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.669 2.08 . . . . 0.0 110.543 -166.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 m -114.1 149.85 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.804 0.842 . . . . 0.0 110.763 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 32.72 -111.71 0.06 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 126.047 1.784 . . . . 0.0 114.971 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -70.41 -12.95 61.92 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 m -98.59 -9.32 24.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.626 1.571 . . . . 0.0 112.455 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.84 123.52 20.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.785 1.234 . . . . 0.0 112.934 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.99 90.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 151.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.6 m -84.68 101.25 12.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 168.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -125.63 154.66 41.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.701 1.239 . . . . 0.0 113.552 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 138.97 32.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.054 2.541 . . . . 0.0 114.618 -170.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -144.43 129.44 18.51 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 161.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -101.15 112.43 24.91 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.523 1.129 . . . . 0.0 109.656 165.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -66.58 134.46 52.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm 52.72 47.2 25.19 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.435 1.894 . . . . 0.0 112.707 -172.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.284 -1.287 . . . . 0.0 116.264 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.7 t 46.39 -110.35 0.27 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.6 1.7 . . . . 0.0 111.22 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.3 m 60.42 -77.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 114.0 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.1 tt -76.54 -22.19 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.343 1.057 . . . . 0.0 112.087 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.04 8.3 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.438 1.971 . . . . 0.0 111.201 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.366 0 C-N-CA 126.122 1.769 . . . . 0.0 111.501 -169.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 tpp . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.63 -51.03 0.64 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.414 3.486 . . . . 0.0 115.55 167.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -147.9 -28.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.126 2.17 . . . . 0.0 112.088 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.07 84.51 0.52 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 162.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -164.34 170.99 15.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 108.324 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 tp -74.98 84.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 O-C-N 121.131 -0.98 . . . . 0.0 109.385 165.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -46.05 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.524 2.329 . . . . 0.0 114.564 -161.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.12 -46.37 56.4 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.415 1.007 . . . . 0.0 112.823 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.7 ttm -64.14 -59.93 3.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.262 1.025 . . . . 0.0 111.749 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.0 p -86.82 -9.53 55.58 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.932 1.826 . . . . 0.0 115.932 -164.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -68.55 156.44 38.03 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.436 1.471 . . . . 0.0 111.064 165.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -143.81 90.2 2.12 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.896 1.679 . . . . 0.0 107.276 165.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.9 mmm -129.79 -87.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -151.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 100.38 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -138.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 p -79.15 -10.85 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.298 1.839 . . . . 0.0 114.86 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.57 171.93 14.31 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.327 1.441 . . . . 0.0 114.63 -172.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -74.0 159.04 33.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.743 1.217 . . . . 0.0 114.023 -168.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -124.02 171.57 9.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.316 2.646 . . . . 0.0 109.741 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.406 ' OG ' ' OE2' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -110.18 139.63 45.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.969 1.708 . . . . 0.0 109.696 166.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.14 100.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.64 -10.0 20.42 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.179 1.391 . . . . 0.0 112.131 -165.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -153.42 143.57 22.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.149 1.38 . . . . 0.0 110.077 150.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.47 166.68 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 113.869 166.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -89.78 136.29 33.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.74 30.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 109.843 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.55 158.53 23.08 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -110.69 170.6 7.98 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.315 1.846 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.6 68.9 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.047 -1.033 . . . . 0.0 112.737 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -67.97 -10.77 56.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.096 1.758 . . . . 0.0 112.236 167.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.95 4.64 72.63 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.427 1.489 . . . . 0.0 114.052 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -74.6 166.12 24.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.446 1.898 . . . . 0.0 110.292 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -119.21 152.88 35.85 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.48 1.112 . . . . 0.0 110.15 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -115.04 113.26 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.024 0.929 . . . . 0.0 109.871 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.24 116.55 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.566 1.546 . . . . 0.0 109.27 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.83 117.5 29.84 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.876 0.762 . . . . 0.0 110.572 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.57 160.03 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 110.234 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -141.17 150.43 42.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.636 1.974 . . . . 0.0 108.227 164.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -98.55 150.85 21.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.27 1.395 . . . . 0.0 112.982 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' OE2' ' OG ' ' A' ' 19' ' ' SER . 53.5 mt-10 -128.09 -63.87 0.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 110.971 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -7.66 -72.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 129.649 3.499 . . . . 0.0 117.106 -169.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.39 18.62 3.66 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.578 1.551 . . . . 0.0 113.446 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.46 -43.64 1.1 Allowed Glycine 0 CA--C 1.539 1.593 0 N-CA-C 116.557 1.383 . . . . 0.0 116.557 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 165.43 4.47 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.713 2.805 . . . . 0.0 114.761 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.03 157.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.647 2.231 . . . . 0.0 113.831 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.0 m -151.76 157.22 41.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.277 1.431 . . . . 0.0 112.014 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 138.05 36.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 139.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 m -97.53 123.75 51.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.873 -171.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.86 124.24 13.7 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.557 2.171 . . . . 0.0 110.072 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mt -132.8 130.99 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 109.73 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.21 167.98 16.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 166.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.7 mt -124.25 128.8 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 147.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.52 164.11 13.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.704 1.202 . . . . 0.0 112.088 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.97 175.5 0.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.466 2.306 . . . . 0.0 113.492 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.0 -32.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.45 -8.04 58.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.583 1.553 . . . . 0.0 113.177 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 66.82 32.42 6.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.188 2.195 . . . . 0.0 113.0 171.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -130.85 -20.72 2.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.409 1.484 . . . . 0.0 114.64 -175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -121.65 121.65 37.84 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.685 1.129 . . . . 0.0 110.359 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.07 133.84 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 111.624 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -137.35 -7.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.794 1.638 . . . . 0.0 114.537 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.5 170.01 13.22 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.682 1.128 . . . . 0.0 114.679 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -131.71 119.58 21.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.12 1.768 . . . . 0.0 110.947 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.516 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -72.11 122.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.857 0.863 . . . . 0.0 109.78 176.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.1 mm -97.36 -33.24 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.499 0.719 . . . . 0.0 111.707 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.7 t -62.2 20.28 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.386 2.274 . . . . 0.0 116.84 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.1 p 60.01 -169.01 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.805 2.042 . . . . 0.0 112.535 -163.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.4 p -60.87 106.38 0.77 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.246 1.818 . . . . 0.0 111.083 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.59 144.4 97.38 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.645 2.896 . . . . 0.0 113.46 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.02 167.21 22.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.87 123.7 18.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.87 2.068 . . . . 0.0 108.358 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -75.3 -26.46 58.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.933 0.893 . . . . 0.0 113.135 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.62 172.86 4.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.139 2.575 . . . . 0.0 109.916 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -39.28 63.76 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 171.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -72.8 -2.65 21.37 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -94.86 155.44 16.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 111.749 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.5 147.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.514 1.126 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.7 m -139.35 105.34 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.592 0.357 . . . . 0.0 110.644 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.79 89.56 4.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.204 1.801 . . . . 0.0 111.837 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.52 117.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.931 1.692 . . . . 0.0 111.201 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -69.13 126.88 31.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.054 0.942 . . . . 0.0 111.466 159.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.5 tp -143.04 147.01 34.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.679 1.991 . . . . 0.0 110.268 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -118.65 97.48 50.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.395 1.478 . . . . 0.0 110.528 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.05 172.08 16.67 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.752 3.635 . . . . 0.0 113.666 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.61 163.14 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.498 2.132 . . . . 0.0 111.1 164.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.83 74.01 4.39 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.322 -0.861 . . . . 0.0 111.688 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.65 -168.14 40.94 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.053 1.311 . . . . 0.0 111.632 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -67.24 144.35 56.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.476 0.655 . . . . 0.0 111.085 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.6 p -161.73 160.14 28.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.083 0.953 . . . . 0.0 111.502 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.47 98.03 4.73 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.493 0.717 . . . . 0.0 110.333 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.89 135.45 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.764 1.626 . . . . 0.0 107.305 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.87 123.45 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.2 mt -125.31 109.85 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.719 1.207 . . . . 0.0 109.488 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.49 163.63 26.28 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.963 1.744 . . . . 0.0 111.422 -162.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.88 166.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.708 -0.878 . . . . 0.0 111.872 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -30.17 -59.81 0.21 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.456 2.455 . . . . 0.0 116.885 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.99 3.24 0.87 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.848 1.659 . . . . 0.0 115.232 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -161.93 12.09 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.269 -1.519 . . . . 0.0 114.29 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.31 108.34 7.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.349 1.459 . . . . 0.0 112.286 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.08 101.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 160.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.5 m -112.31 95.2 5.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.317 1.047 . . . . 0.0 108.386 -167.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -130.44 146.45 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 137.95 45.75 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.037 2.935 . . . . 0.0 114.872 -172.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -149.22 121.02 8.12 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.943 0.897 . . . . 0.0 112.539 165.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -92.3 108.05 19.66 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.443 0.697 . . . . 0.0 109.754 164.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -64.05 131.78 48.59 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.978 0.511 . . . . 0.0 111.038 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 mttp 49.23 55.31 9.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.946 1.699 . . . . 0.0 112.728 -171.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.04 -37.52 0.04 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.528 1.061 . . . . 0.0 112.301 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m 54.7 22.77 4.3 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 149.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.0 m -122.84 -48.29 2.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.404 1.482 . . . . 0.0 111.498 -167.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.5 tt -74.07 -10.33 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.161 0.984 . . . . 0.0 112.653 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.51 141.67 10.01 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 124.444 1.021 . . . . 0.0 112.191 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt . . . . . 0 C--O 1.254 1.337 0 C-N-CA 130.015 3.326 . . . . 0.0 111.05 -173.36 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -58.41 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.583 1.953 . . . . 0.0 110.302 -163.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -106.51 -37.65 6.41 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 129.324 3.05 . . . . 0.0 109.457 163.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -76.46 81.44 3.17 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.521 1.528 . . . . 0.0 108.262 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -163.75 156.44 17.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.689 2.396 . . . . 0.0 108.642 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 tt -73.11 93.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 122.014 0.911 . . . . 0.0 110.096 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.7 -25.71 67.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.717 1.607 . . . . 0.0 114.386 -170.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.02 -23.51 77.88 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 119.546 -0.586 . . . . 0.0 114.05 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -114.75 -47.83 2.87 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.239 1.02 . . . . 0.0 111.655 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 81.0 p -75.75 7.44 3.85 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.072 1.749 . . . . 0.0 115.206 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -132.35 150.67 52.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.172 1.389 . . . . 0.0 110.715 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -148.01 85.34 1.54 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.984 2.114 . . . . 0.0 107.534 166.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 tpt -115.65 -102.81 0.42 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -128.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.99 108.56 10.13 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -153.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.414 ' HA ' HG22 ' A' ' 94' ' ' VAL . 53.7 p -69.39 -4.52 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.25 1.42 . . . . 0.0 114.315 165.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.65 172.15 46.14 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.506 1.527 . . . . 0.0 114.339 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.56 163.17 27.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.59 1.556 . . . . 0.0 113.799 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.48 174.38 10.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.444 2.298 . . . . 0.0 109.76 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 p -112.13 145.46 39.76 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.259 1.024 . . . . 0.0 110.983 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.2 103.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 156.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 -14.71 14.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.905 0.882 . . . . 0.0 111.45 -159.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.516 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.7 ttpp -143.83 136.91 27.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.635 1.574 . . . . 0.0 108.615 149.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.29 156.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.917 2.087 . . . . 0.0 113.628 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 mtm -70.69 132.78 45.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.1 122.74 36.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.034 1.333 . . . . 0.0 109.996 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 152.61 34.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.581 0.705 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.7 p -101.27 167.54 10.13 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 111.105 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -24.69 64.12 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.244 -0.91 . . . . 0.0 112.27 163.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -64.94 -9.22 19.7 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.232 1.813 . . . . 0.0 112.419 165.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.89 -3.82 63.48 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.764 1.65 . . . . 0.0 114.17 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -69.58 168.35 14.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.73 2.012 . . . . 0.0 110.736 165.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 t -125.8 154.06 43.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.758 0.823 . . . . 0.0 110.481 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -118.72 118.95 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.43 1.092 . . . . 0.0 109.663 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.16 116.81 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.49 1.516 . . . . 0.0 110.125 -173.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 tmmt? -89.59 109.9 20.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.376 0.989 . . . . 0.0 109.822 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -86.75 165.66 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.205 1.002 . . . . 0.0 110.495 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 150.99 45.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.941 1.696 . . . . 0.0 108.544 153.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -94.15 129.96 40.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.289 0.95 . . . . 0.0 113.024 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -131.21 1.82 4.22 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.09 -61.82 2.76 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.102 0.858 . . . . 0.0 114.561 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.19 19.35 1.4 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -165.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.1 -43.77 2.52 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.612 -1.305 . . . . 0.0 115.553 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.18 174.33 2.95 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 127.16 2.184 . . . . 0.0 114.31 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.07 162.82 33.84 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.515 2.81 . . . . 0.0 114.22 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.2 m -145.35 151.59 38.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.684 1.994 . . . . 0.0 110.284 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 131.78 34.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 131.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.276 0.9 OUTLIER -90.43 137.91 27.22 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 118.561 0.618 . . . . 0.0 110.824 -168.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.07 97.3 0.56 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.845 2.363 . . . . 0.0 109.569 -168.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.66 124.57 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.781 0.832 . . . . 0.0 111.384 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.64 168.63 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.23 1.412 . . . . 0.0 110.242 164.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.23 133.03 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 147.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -112.17 162.87 14.98 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.533 1.133 . . . . 0.0 111.921 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -56.6 171.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.809 2.043 . . . . 0.0 113.138 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -57.49 -28.83 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 112.701 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -75.63 -12.62 60.24 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.03 2.132 . . . . 0.0 113.772 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 68.04 25.88 7.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.637 2.375 . . . . 0.0 113.452 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -120.59 -27.42 5.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.403 1.481 . . . . 0.0 114.04 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -124.07 129.05 50.23 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.676 1.125 . . . . 0.0 111.364 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.79 131.39 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.826 1.65 . . . . 0.0 111.535 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.51 -7.37 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.962 1.705 . . . . 0.0 114.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.49 166.04 15.0 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.637 1.108 . . . . 0.0 114.745 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -129.54 109.87 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.017 1.727 . . . . 0.0 109.837 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -70.14 114.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 0.0 109.645 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.5 mm -87.58 -33.9 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.887 . . . . 0.0 111.977 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.9 t -64.27 23.19 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.551 1.94 . . . . 0.0 116.062 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p 74.63 -101.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 129.997 3.319 . . . . 0.0 113.134 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.7 p -131.39 99.03 17.72 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.705 1.602 . . . . 0.0 109.072 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.46 137.71 31.82 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.86 3.04 . . . . 0.0 113.797 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -141.94 168.16 20.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 137.18 37.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.909 2.084 . . . . 0.0 108.256 168.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -91.59 -17.0 26.27 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.256 -0.903 . . . . 0.0 112.852 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.98 176.42 1.79 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 130.939 3.695 . . . . 0.0 108.167 173.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -40.88 64.52 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.816 -1.178 . . . . 0.0 112.848 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -65.31 -6.69 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.41 1.084 . . . . 0.0 113.852 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -78.49 123.82 27.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.227 0.922 . . . . 0.0 111.398 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.25 154.51 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.116 159.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.3 109.14 4.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.833 0.453 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 107.35 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.179 0.992 . . . . 0.0 112.004 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -104.27 114.08 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 125.455 1.502 . . . . 0.0 110.684 -172.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.36 129.96 41.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.868 0.842 . . . . 0.0 111.137 161.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.7 147.61 29.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.066 1.746 . . . . 0.0 110.217 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.98 94.13 43.77 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.645 1.578 . . . . 0.0 110.433 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -66.95 171.38 11.27 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.581 3.521 . . . . 0.0 112.826 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.53 155.59 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.005 1.803 . . . . 0.0 110.634 162.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -70.68 90.63 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.511 -0.743 . . . . 0.0 110.246 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.51 -170.62 32.92 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.849 1.214 . . . . 0.0 111.352 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.77 143.18 44.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.594 0.758 . . . . 0.0 111.607 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -160.68 158.06 28.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 112.36 -166.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -126.23 97.0 4.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.151 0.976 . . . . 0.0 110.972 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 132.42 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.424 2.29 . . . . 0.0 107.231 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.263 1.9 m -125.87 118.13 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mt -122.97 100.09 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.062 1.345 . . . . 0.0 108.97 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.65 -178.4 16.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.047 2.261 . . . . 0.0 110.285 -165.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 15' ' ' SER . 3.3 m -119.93 148.29 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.181 0.991 . . . . 0.0 111.06 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.92 -121.65 2.04 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.852 1.215 . . . . 0.0 113.523 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -69.69 -12.84 61.95 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.1 m -87.53 -9.86 53.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.485 1.114 . . . . 0.0 112.898 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.35 112.14 10.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.705 1.202 . . . . 0.0 113.072 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.49 95.84 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.838 0.855 . . . . 0.0 108.907 159.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -102.87 98.76 8.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.8 157.7 43.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.382 1.086 . . . . 0.0 113.766 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 143.07 28.95 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.098 2.159 . . . . 0.0 114.693 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -149.56 136.94 19.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.572 0.749 . . . . 0.0 112.86 160.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -104.28 108.07 19.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.719 1.208 . . . . 0.0 109.402 165.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -70.4 142.44 52.05 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.904 -0.498 . . . . 0.0 111.704 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.99 46.53 25.36 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.442 1.897 . . . . 0.0 112.217 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.19 -33.07 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.124 1.345 . . . . 0.0 111.705 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m 63.66 19.22 11.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.201 1.401 . . . . 0.0 114.108 147.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.7 m -126.56 -54.53 1.44 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.31 1.844 . . . . 0.0 112.984 -162.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.1 tt -70.86 -11.51 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.199 0.999 . . . . 0.0 113.263 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.12 154.75 22.45 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.257 1.408 . . . . 0.0 110.298 165.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 129.097 2.959 . . . . 0.0 111.142 -173.414 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.53 -55.55 0.84 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.654 3.182 . . . . 0.0 114.802 166.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -133.05 -34.24 1.11 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 128.285 2.634 . . . . 0.0 111.714 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.53 81.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.455 1.102 . . . . 0.0 108.264 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -159.63 167.71 27.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.074 2.55 . . . . 0.0 108.867 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.06 79.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.863 0.839 . . . . 0.0 109.706 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -67.91 0.24 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.531 1.932 . . . . 0.0 114.796 -161.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.54 -37.48 67.4 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.568 0.604 . . . . 0.0 112.925 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.09 -5.62 54.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -144.68 -7.5 0.67 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -167.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -82.65 167.1 18.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 121.004 1.729 . . . . 0.0 112.455 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 p -147.53 107.08 3.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.565 2.746 . . . . 0.0 107.133 162.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mmm -135.16 -107.27 0.22 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -161.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -83.82 154.63 23.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -134.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HG22 ' A' ' 94' ' ' VAL . 78.9 p -125.24 1.56 7.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.918 1.687 . . . . 0.0 114.069 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.79 174.45 49.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.92 1.247 . . . . 0.0 113.452 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -74.48 161.53 29.69 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.933 1.293 . . . . 0.0 112.514 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 47' ' ' VAL . 86.0 m-85 -130.05 177.06 7.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.014 2.126 . . . . 0.0 109.373 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.8 p -107.32 151.58 25.29 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.914 0.779 . . . . 0.0 111.183 155.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 tp -83.59 100.33 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -15.17 15.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.062 1.345 . . . . 0.0 112.233 -160.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -147.57 141.8 26.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.774 2.43 . . . . 0.0 107.381 151.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.62 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.069 2.948 . . . . 0.0 115.006 167.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -86.01 129.88 34.71 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.155 -0.966 . . . . 0.0 112.563 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.78 118.17 24.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -80.31 156.1 26.95 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.1 p -112.68 171.77 7.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.578 1.551 . . . . 0.0 112.832 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.12 66.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.129 0.972 . . . . 0.0 113.316 166.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.07 -6.66 58.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.997 2.119 . . . . 0.0 111.597 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.0 6.7 60.8 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 120.832 -1.167 . . . . 0.0 113.705 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -76.36 169.67 17.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.972 2.109 . . . . 0.0 110.103 164.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -129.31 147.65 51.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.073 0.949 . . . . 0.0 111.149 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.85 102.25 13.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.519 1.128 . . . . 0.0 110.312 -171.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.45 144.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.45 1.9 . . . . 0.0 109.2 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 3.5 ttmt -111.85 125.28 53.85 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.238 1.381 . . . . 0.0 109.228 168.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 m -104.15 169.39 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.422 1.089 . . . . 0.0 110.44 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.28 155.5 44.49 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.43 1.892 . . . . 0.0 108.523 158.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -97.78 130.1 44.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.087 1.312 . . . . 0.0 112.836 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -132.19 13.98 4.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.099 -1.0 . . . . 0.0 112.679 -169.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.04 -50.04 2.53 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.227 0.918 . . . . 0.0 115.103 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.83 9.88 1.02 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -166.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.46 -41.97 1.91 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 120.112 1.324 . . . . 0.0 114.783 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.24 177.42 2.81 Favored Pre-proline 0 CA--C 1.561 1.365 0 C-N-CA 127.719 2.408 . . . . 0.0 114.188 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 166.25 24.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.241 3.294 . . . . 0.0 115.161 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.2 m -149.14 155.22 40.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.749 2.02 . . . . 0.0 110.798 172.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -83.3 134.1 34.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 118.79 -1.164 . . . . 0.0 107.925 127.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 18' ' ' PHE 0.287 1.9 m -93.87 131.06 32.77 Favored Pre-proline 0 N--CA 1.468 0.434 0 O-C-N 123.551 0.532 . . . . 0.0 110.258 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.82 105.18 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.89 2.393 . . . . 0.0 108.859 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.91 124.9 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.914 0.886 . . . . 0.0 111.092 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -136.2 169.45 17.62 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 109.768 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 ' HG ' ' A' ' 81' ' ' LEU . 3.4 mt -119.78 124.6 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -107.79 162.22 14.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 111.048 171.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -59.84 176.22 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.956 2.102 . . . . 0.0 113.967 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.06 -33.59 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.841 -1.162 . . . . 0.0 112.766 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -74.22 -11.44 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.279 1.832 . . . . 0.0 113.543 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 63.43 28.85 15.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.243 2.617 . . . . 0.0 113.606 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.21 -40.1 5.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.88 1.672 . . . . 0.0 112.563 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -124.32 138.0 54.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.874 1.215 . . . . 0.0 111.677 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.63 133.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.783 1.233 . . . . 0.0 111.38 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.27 -11.38 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.079 1.752 . . . . 0.0 114.072 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.35 168.03 14.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.541 1.067 . . . . 0.0 114.659 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -133.42 121.83 22.85 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.176 1.79 . . . . 0.0 111.274 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 122.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.963 0.802 . . . . 0.0 110.177 174.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.2 mm -95.85 -37.05 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 0.0 111.596 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 t -64.24 -7.51 9.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.7 m 117.82 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 1 C-N-CA 132.944 4.497 . . . . 0.0 108.961 -166.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 m -65.41 117.57 41.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.178 -0.915 . . . . 0.0 108.733 159.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.29 156.59 20.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.589 3.526 . . . . 0.0 115.261 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.16 169.08 18.87 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 172.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.64 139.37 31.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.457 2.303 . . . . 0.0 108.583 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -97.95 -17.6 19.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.006 0.923 . . . . 0.0 112.717 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.81 174.94 7.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.643 3.177 . . . . 0.0 108.072 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -44.65 62.54 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.309 -0.869 . . . . 0.0 112.369 173.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -65.65 -7.49 15.52 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.117 1.367 . . . . 0.0 113.917 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -71.62 106.42 4.04 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.32 0.964 . . . . 0.0 110.834 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.05 149.19 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.625 154.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 m -141.41 117.7 10.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.049 0.54 . . . . 0.0 110.134 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.25 119.66 29.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.753 0.821 . . . . 0.0 111.669 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 mm -120.82 110.87 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.877 1.671 . . . . 0.0 110.683 -167.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -69.01 123.79 21.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.536 1.134 . . . . 0.0 111.165 162.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' A' ' 51' ' ' ILE . 45.4 tp -142.35 141.66 32.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.782 2.033 . . . . 0.0 109.943 -169.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -113.78 100.58 52.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.853 1.661 . . . . 0.0 110.564 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -78.06 173.36 14.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.391 3.394 . . . . 0.0 113.77 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.74 161.92 43.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.522 2.148 . . . . 0.0 110.878 162.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -72.7 102.63 3.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.984 166.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.47 -169.82 25.78 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.87 1.224 . . . . 0.0 111.964 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.64 139.52 39.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.165 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -159.59 164.48 34.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.105 0.962 . . . . 0.0 112.261 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -129.11 104.93 7.84 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.224 1.011 . . . . 0.0 111.526 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.33 123.82 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.261 2.224 . . . . 0.0 107.102 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.68 122.63 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.33 100.38 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.994 1.317 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.19 176.28 18.59 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.714 2.102 . . . . 0.0 110.216 -161.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 15' ' ' SER . 12.6 m -107.25 139.71 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.16 0.98 . . . . 0.0 110.3 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 23.14 -100.17 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 127.902 2.667 . . . . 0.0 115.563 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -59.02 -16.37 18.01 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -110.09 -2.9 16.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.738 1.615 . . . . 0.0 112.767 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.17 111.33 16.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.103 0.961 . . . . 0.0 112.963 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.9 mt -56.22 100.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 93.03 4.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.37 156.27 34.29 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.293 1.044 . . . . 0.0 113.51 -172.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 147.0 33.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.444 1.898 . . . . 0.0 114.495 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -146.1 144.08 29.77 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.33 1.052 . . . . 0.0 110.725 157.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -114.42 116.84 29.53 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -70.03 138.68 52.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.31 17.48 4.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.035 1.734 . . . . 0.0 115.401 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.02 42.56 0.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.809 1.195 . . . . 0.0 113.042 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.5 m -68.35 34.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.845 2.858 . . . . 0.0 117.238 -157.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.3 t -72.75 -1.27 15.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.591 1.556 . . . . 0.0 114.877 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.3 tt -131.96 -1.48 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.04 1.336 . . . . 0.0 113.467 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.97 143.8 9.81 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 121.305 -0.872 . . . . 0.0 112.281 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 C--O 1.252 1.215 0 C-N-CA 128.154 2.582 . . . . 0.0 112.615 -170.042 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.9 mmm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.13 -59.54 2.01 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 130.834 3.653 . . . . 0.0 115.257 164.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -135.63 -33.3 0.87 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.37 3.068 . . . . 0.0 111.018 -167.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.9 84.91 0.96 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.861 1.264 . . . . 0.0 108.378 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.41 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 11.3 ptm180 -166.52 165.34 16.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.593 2.757 . . . . 0.0 109.668 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.99 84.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.903 0.859 . . . . 0.0 110.0 167.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -64.0 -34.18 77.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.582 1.553 . . . . 0.0 113.675 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.49 -34.1 63.28 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.157 0.884 . . . . 0.0 112.963 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -92.58 -66.16 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.17 0.985 . . . . 0.0 110.366 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -73.2 8.34 1.72 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -159.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.41 ' CE1' ' HD3' ' A' ' 5' ' ' ARG . 8.1 m-30 -109.66 156.5 20.16 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.663 1.12 . . . . 0.0 110.418 165.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -145.16 91.34 2.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.482 1.913 . . . . 0.0 106.997 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 84.7 mmm -128.59 -115.01 0.26 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -152.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.82 105.51 7.93 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -133.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -72.45 -3.52 24.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.09 1.756 . . . . 0.0 114.547 166.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 170.49 51.22 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.888 1.232 . . . . 0.0 113.67 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -73.66 160.66 31.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.146 1.378 . . . . 0.0 113.014 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -131.31 175.0 9.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.093 2.157 . . . . 0.0 109.901 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p -114.71 144.66 43.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 111.382 160.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.59 93.57 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 159.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.4 -16.49 21.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.264 -159.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -145.74 139.42 26.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.85 2.06 . . . . 0.0 108.105 148.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.1 162.05 0.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.779 2.432 . . . . 0.0 114.602 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.408 ' HG2' HG22 ' A' ' 34' ' ' VAL . 27.3 mtm -69.88 127.39 32.73 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 123.4 37.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.898 1.279 . . . . 0.0 110.245 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.93 155.16 27.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 p -105.21 170.82 7.66 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.252 1.821 . . . . 0.0 111.448 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -27.34 67.78 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.196 -0.94 . . . . 0.0 112.416 165.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.55 -9.73 37.99 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.555 1.942 . . . . 0.0 112.256 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.39 1.44 60.83 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.317 1.436 . . . . 0.0 114.014 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.25 166.12 22.22 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.157 1.783 . . . . 0.0 110.262 164.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -122.79 148.0 45.87 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 110.5 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.84 113.57 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 109.4 -173.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.8 t -110.41 116.08 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 109.792 -172.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -96.09 105.04 17.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.42 0.555 . . . . 0.0 109.688 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.27 166.22 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.506 1.122 . . . . 0.0 110.655 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 146.63 30.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.914 1.685 . . . . 0.0 108.716 160.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -91.09 134.96 34.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.795 0.725 . . . . 0.0 112.496 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -133.38 3.15 3.6 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.135 -0.978 . . . . 0.0 113.583 -171.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.78 -36.5 7.28 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.216 1.247 . . . . 0.0 116.216 -170.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.96 7.88 0.41 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.16 -43.07 1.96 Allowed Glycine 0 CA--C 1.535 1.322 0 CA-C-N 120.211 1.369 . . . . 0.0 114.928 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.46 167.66 6.54 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 127.696 2.399 . . . . 0.0 115.025 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.94 163.42 22.32 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.657 2.904 . . . . 0.0 113.478 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -147.29 154.5 41.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.733 1.613 . . . . 0.0 111.59 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -87.27 140.49 29.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 127.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 1.4 m -100.74 120.53 55.49 Favored Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.06 115.59 3.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.28 1.987 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mt -126.1 129.64 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 110.712 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.09 165.32 18.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.392 1.077 . . . . 0.0 110.154 162.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.94 130.74 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 146.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -112.12 164.9 12.64 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.431 1.492 . . . . 0.0 112.435 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -58.14 171.32 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.591 1.956 . . . . 0.0 113.508 172.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.9 -36.13 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.367 -0.833 . . . . 0.0 112.932 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.87 -12.33 60.64 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.876 2.07 . . . . 0.0 113.988 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 67.09 27.76 8.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 113.419 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.17 -27.96 7.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.084 2.154 . . . . 0.0 113.012 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -131.72 132.92 44.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.214 0.916 . . . . 0.0 111.041 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.98 134.22 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.204 1.402 . . . . 0.0 110.89 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.61 -8.46 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.921 1.688 . . . . 0.0 114.19 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.9 163.59 18.42 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 119.555 1.07 . . . . 0.0 114.686 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -127.21 112.87 15.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.889 1.675 . . . . 0.0 110.36 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -72.31 109.77 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.607 0.763 . . . . 0.0 109.947 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.01 -38.23 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.971 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -67.44 30.71 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.73 2.012 . . . . 0.0 114.558 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.34 -173.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.943 2.097 . . . . 0.0 113.095 -169.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -66.93 111.72 7.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.371 1.068 . . . . 0.0 109.238 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -55.82 152.99 32.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.476 3.451 . . . . 0.0 115.544 -169.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.26 167.26 22.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.6 143.71 31.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.008 1.723 . . . . 0.0 109.127 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -96.4 -18.53 19.84 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.79 174.03 5.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.844 2.858 . . . . 0.0 108.547 173.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -45.75 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.608 -0.682 . . . . 0.0 112.018 169.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -66.36 -3.39 5.88 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.3 m -87.41 119.81 28.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 111.459 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.58 156.12 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 159.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.51 119.05 10.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.069 0.548 . . . . 0.0 110.87 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.67 106.11 18.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.66 109.06 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.085 1.754 . . . . 0.0 110.526 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -67.14 126.55 29.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.385 0.612 . . . . 0.0 110.875 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.8 tp -146.65 140.73 26.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 110.235 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.94 94.14 23.8 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.011 1.324 . . . . 0.0 110.727 -172.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.83 169.95 20.82 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.641 3.561 . . . . 0.0 112.865 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 163.47 39.07 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.815 2.343 . . . . 0.0 111.664 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -75.22 72.11 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.852 0.861 . . . . 0.0 111.442 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.49 -169.34 41.42 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.233 1.397 . . . . 0.0 111.813 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.82 145.05 50.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.273 0.559 . . . . 0.0 111.11 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -161.02 154.68 22.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.574 0.749 . . . . 0.0 112.138 -166.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -127.78 101.92 6.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.157 0.98 . . . . 0.0 111.656 -171.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 90' ' ' ILE . 3.1 mp -72.89 139.53 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.966 2.106 . . . . 0.0 107.647 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.4 125.04 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 170.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 mt -125.67 103.34 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.685 1.194 . . . . 0.0 109.099 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.27 178.13 20.84 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.109 1.814 . . . . 0.0 111.117 -162.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 145.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.074 0.937 . . . . 0.0 110.786 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 22.03 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.683 2.563 . . . . 0.0 116.063 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.05 -11.28 28.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -107.98 -7.74 16.09 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.276 1.83 . . . . 0.0 112.639 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 127.41 32.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 112.171 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.54 87.12 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 157.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.8 m -79.39 98.26 6.68 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -125.05 176.62 6.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.207 1.403 . . . . 0.0 113.008 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 139.9 53.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -154.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -154.86 131.27 10.46 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -106.22 109.84 21.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.02 1.328 . . . . 0.0 109.327 165.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -63.82 148.35 49.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.649 0.78 . . . . 0.0 111.775 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -25.83 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 129.079 2.952 . . . . 0.0 116.214 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.98 43.47 3.24 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.298 1.428 . . . . 0.0 111.7 160.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.1 m -63.33 29.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 131.494 3.918 . . . . 0.0 118.194 -151.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 m -156.26 1.85 0.15 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.9 tt -68.63 -19.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.278 1.399 . . . . 0.0 112.5 170.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -121.23 160.8 15.47 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.971 1.748 . . . . 0.0 109.276 156.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 5.2 mmpt? . . . . . 0 C--O 1.256 1.441 0 C-N-CA 125.934 1.694 . . . . 0.0 112.413 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -111.48 -88.24 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 130.399 3.48 . . . . 0.0 111.32 -163.423 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -77.25 -40.51 44.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.066 2.146 . . . . 0.0 109.719 162.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.54 76.77 1.07 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.291 1.036 . . . . 0.0 111.156 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -164.7 162.35 21.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 127.501 2.321 . . . . 0.0 110.268 167.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -70.98 96.96 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.758 0.79 . . . . 0.0 109.337 168.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -60.32 -55.62 31.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.411 1.885 . . . . 0.0 112.847 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.2 -28.27 54.05 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.342 0.972 . . . . 0.0 114.001 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -85.52 -68.58 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.395 1.097 . . . . 0.0 110.263 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.6 p -79.08 -4.91 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -161.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.82 165.7 12.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.585 1.538 . . . . 0.0 112.827 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 p -148.51 104.67 3.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.724 2.81 . . . . 0.0 106.44 158.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mmm -129.95 -110.39 0.26 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -152.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.3 m -79.83 107.67 12.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -138.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 p -69.36 -9.45 53.51 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 164.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 171.93 52.48 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.701 1.619 . . . . 0.0 114.337 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -77.22 160.82 28.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.447 1.499 . . . . 0.0 114.301 -169.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.7 m-85 -130.46 173.64 10.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.535 2.334 . . . . 0.0 109.954 173.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.0 p -119.75 142.93 48.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.073 0.949 . . . . 0.0 112.037 159.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 101.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 163.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -106.52 -13.19 15.39 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.809 1.243 . . . . 0.0 111.046 -164.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -149.23 140.82 23.43 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.872 2.069 . . . . 0.0 108.883 148.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.15 170.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.464 2.706 . . . . 0.0 114.477 166.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.0 mtm -80.89 133.8 35.63 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.95 114.76 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.945 1.698 . . . . 0.0 110.718 176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.49 151.45 43.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p -106.36 168.89 8.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.976 1.711 . . . . 0.0 111.72 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -26.21 66.97 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.291 -0.881 . . . . 0.0 112.559 166.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -67.21 -8.64 33.08 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.311 2.244 . . . . 0.0 112.422 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.08 0.48 65.56 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.405 1.479 . . . . 0.0 114.205 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -73.31 173.29 9.73 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.126 2.17 . . . . 0.0 110.263 164.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -133.44 146.06 50.83 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 111.133 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.37 103.95 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.855 1.262 . . . . 0.0 110.385 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.58 168.4 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.599 1.96 . . . . 0.0 110.144 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -133.86 124.97 27.38 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.472 -0.767 . . . . 0.0 111.054 159.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.75 165.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.434 1.093 . . . . 0.0 110.524 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.03 145.33 39.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.952 1.701 . . . . 0.0 108.564 156.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -84.81 143.69 28.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.797 1.181 . . . . 0.0 111.654 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -136.27 -9.37 1.98 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -36.0 62.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.162 -1.355 . . . . 0.0 116.344 -170.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.86 12.78 0.25 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -166.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 -43.89 2.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 120.9 1.682 . . . . 0.0 114.416 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.57 175.44 4.68 Favored Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 127.4 2.28 . . . . 0.0 114.743 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.18 167.89 17.16 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.352 3.368 . . . . 0.0 115.388 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -148.21 160.84 42.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.624 1.969 . . . . 0.0 110.911 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -88.1 136.29 33.04 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 129.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 48' ' ' PRO 0.332 2.0 m -96.29 135.52 22.51 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.355 0.409 . . . . 0.0 111.158 -169.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.3 Cg_endo -87.14 89.39 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.019 2.479 . . . . 0.0 107.888 -163.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.1 125.69 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.725 0.81 . . . . 0.0 111.342 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.81 162.77 24.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.32 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 88' ' ' SER . 4.1 mt -118.62 126.91 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 151.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -110.84 162.99 14.24 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.323 1.014 . . . . 0.0 112.452 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -58.39 171.94 0.53 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.136 2.174 . . . . 0.0 113.079 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.86 -31.99 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -74.69 -12.85 60.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.186 1.794 . . . . 0.0 113.515 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 mttm 67.84 26.56 7.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.122 2.169 . . . . 0.0 113.171 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.47 4.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.995 2.118 . . . . 0.0 113.165 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.3 131.07 57.05 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.347 0.976 . . . . 0.0 110.624 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.1 138.72 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.991 0.916 . . . . 0.0 111.447 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.36 -10.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.617 1.567 . . . . 0.0 115.083 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.83 169.77 13.86 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.994 1.27 . . . . 0.0 115.715 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.59 107.82 9.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.081 2.152 . . . . 0.0 110.553 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.425 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.42 108.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.296 0.638 . . . . 0.0 110.07 175.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.3 mm -78.95 -36.54 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.215 1.006 . . . . 0.0 111.408 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -67.43 26.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.85 1.66 . . . . 0.0 114.658 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t 63.43 -178.5 0.15 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.946 2.498 . . . . 0.0 113.168 -168.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.5 m -61.64 110.68 3.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.428 1.091 . . . . 0.0 108.925 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.57 159.2 11.48 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.315 3.343 . . . . 0.0 115.431 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.98 168.2 20.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.22 38.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.935 1.694 . . . . 0.0 108.286 171.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -93.84 -14.37 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.09 172.9 2.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 130.483 3.513 . . . . 0.0 108.451 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -57.74 -50.35 73.51 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 110.967 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -66.44 3.09 1.03 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 m -97.84 124.79 42.39 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.479 1.111 . . . . 0.0 111.077 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 m -86.91 162.15 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.426 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.32 107.02 4.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.689 0.795 . . . . 0.0 109.111 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -73.28 136.27 44.52 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.991 -0.443 . . . . 0.0 109.978 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -135.64 109.55 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.497 1.119 . . . . 0.0 110.094 -168.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -73.0 130.3 40.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.272 1.029 . . . . 0.0 110.746 163.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.8 tp -151.9 144.56 24.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.995 1.318 . . . . 0.0 110.986 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -117.39 96.91 50.13 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.747 1.619 . . . . 0.0 110.77 -171.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.73 171.1 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.803 3.668 . . . . 0.0 112.564 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.94 164.33 32.15 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.477 2.118 . . . . 0.0 111.483 168.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.25 87.55 1.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.77 166.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.01 -173.47 44.09 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.856 1.217 . . . . 0.0 112.051 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.97 159.15 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.755 0.822 . . . . 0.0 110.21 165.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.442 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 18.7 m -171.39 158.3 5.23 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.475 1.11 . . . . 0.0 112.784 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.97 102.94 7.49 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.663 1.22 . . . . 0.0 110.328 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.71 125.31 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 128.599 2.759 . . . . 0.0 106.746 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.19 130.53 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.1 mt -129.16 94.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.209 1.404 . . . . 0.0 108.577 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.24 -170.52 18.07 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.421 1.963 . . . . 0.0 109.767 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.61 179.11 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.231 1.015 . . . . 0.0 110.721 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.74 -20.17 17.24 Favored Glycine 0 CA--C 1.541 1.705 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 -168.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.51 0.26 49.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -154.32 -8.46 0.14 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.62 128.08 34.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.692 1.197 . . . . 0.0 113.942 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.09 98.61 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 152.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -96.41 100.94 12.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.93 165.83 18.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 112.381 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 153.11 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.115 1.766 . . . . 0.0 114.552 -167.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -150.37 147.57 27.75 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.098 0.559 . . . . 0.0 111.843 162.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -124.19 111.88 16.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -66.97 144.13 56.39 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 111.392 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER 62.5 -24.28 0.05 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.102 2.961 . . . . 0.0 116.928 -175.388 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.24 52.19 1.86 Allowed Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.842 1.201 . . . . 0.0 110.521 161.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -64.6 28.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 131.408 3.883 . . . . 0.0 117.508 -153.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 m -154.16 9.77 0.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.317 -1.489 . . . . 0.0 114.27 165.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.489 1.041 . . . . 0.0 110.965 163.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.39 165.82 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.481 1.515 . . . . 0.0 110.187 162.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 5.5 mmpt? . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.812 2.045 . . . . 0.0 112.015 -174.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -30.95 -58.49 0.22 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.044 2.537 . . . . 0.0 114.977 165.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -132.98 -31.96 1.25 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.174 2.989 . . . . 0.0 110.813 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.58 87.62 2.69 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.31 0.959 . . . . 0.0 108.563 166.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.402 ' HD3' ' CZ ' ' A' ' 11' ' ' TYR . 10.4 ptm180 -161.65 165.87 27.63 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.574 1.949 . . . . 0.0 111.765 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 tp -72.61 83.92 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.506 1.122 . . . . 0.0 110.278 164.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -59.96 -35.98 76.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.51 1.124 . . . . 0.0 113.319 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.36 62.17 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.941 0.781 . . . . 0.0 113.407 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ttt -102.59 -69.45 0.79 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 110.209 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.0 p -65.73 9.78 0.12 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.739 2.816 . . . . 0.0 117.401 -162.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CZ ' ' HD3' ' A' ' 5' ' ' ARG . 2.6 m-30 -121.53 152.7 38.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.873 1.269 . . . . 0.0 110.4 174.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.1 p -145.13 86.41 1.77 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 163.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mmm -117.67 -92.92 0.52 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -147.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -85.24 95.99 9.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -140.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.0 p -65.87 -2.5 3.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 162.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.67 176.56 53.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.255 1.407 . . . . 0.0 113.925 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 154.01 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.69 2.396 . . . . 0.0 111.797 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -135.15 174.06 11.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.199 1.8 . . . . 0.0 110.77 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 m -123.46 144.19 49.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.601 0.76 . . . . 0.0 112.172 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.4 91.48 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 107.249 159.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -94.29 -13.41 26.51 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.913 1.285 . . . . 0.0 111.857 -163.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.3 ttpp -150.25 135.83 18.22 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.415 1.886 . . . . 0.0 109.431 148.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.76 162.81 0.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.884 2.874 . . . . 0.0 115.169 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 32.3 mtm -70.41 122.41 19.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.3 119.61 36.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.597 1.159 . . . . 0.0 110.975 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.14 157.65 34.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 0.0 112.368 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -117.37 168.48 10.32 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.783 1.233 . . . . 0.0 112.802 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -25.03 67.2 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.419 -0.801 . . . . 0.0 112.835 166.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -71.9 -7.63 49.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.485 1.914 . . . . 0.0 112.275 168.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.78 71.29 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.068 1.318 . . . . 0.0 113.964 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 p -76.61 174.44 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.314 2.246 . . . . 0.0 110.667 168.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.73 154.26 44.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.851 0.86 . . . . 0.0 110.932 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.41 125.01 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.864 1.266 . . . . 0.0 109.613 -174.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.76 127.43 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.803 1.641 . . . . 0.0 109.482 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.4 ttmt -100.56 115.43 30.13 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.717 1.144 . . . . 0.0 110.081 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.2 m -98.8 159.05 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.482 0.713 . . . . 0.0 111.707 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.86 147.95 37.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.903 2.081 . . . . 0.0 109.357 169.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -100.95 137.53 39.2 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.593 1.088 . . . . 0.0 112.552 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -135.51 1.74 2.89 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.25 -46.62 15.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.033 -0.871 . . . . 0.0 115.129 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.89 11.35 0.48 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.9 -46.96 2.74 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.591 -1.318 . . . . 0.0 114.584 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.01 163.89 3.89 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 128.098 2.559 . . . . 0.0 114.703 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.06 162.82 36.5 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.293 2.662 . . . . 0.0 113.803 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.6 m -144.26 154.96 43.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.54 1.936 . . . . 0.0 111.183 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -90.69 141.07 29.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 128.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.73 123.33 44.41 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 115.52 3.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.993 1.795 . . . . 0.0 109.687 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mt -125.81 134.54 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.88 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -132.96 169.12 17.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.771 1.228 . . . . 0.0 109.579 163.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mt -120.04 129.04 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 146.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -109.65 164.62 12.37 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.542 1.137 . . . . 0.0 112.508 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -54.84 170.26 0.18 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.386 2.275 . . . . 0.0 113.428 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.4 m -58.46 -33.0 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.232 -0.918 . . . . 0.0 112.919 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -70.6 -15.61 62.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.991 2.116 . . . . 0.0 113.759 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.4 mttm 66.74 33.73 6.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.275 2.23 . . . . 0.0 113.254 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.27 -27.67 5.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.504 1.922 . . . . 0.0 113.698 -174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -133.98 135.27 43.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.811 1.187 . . . . 0.0 111.726 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.76 136.34 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.0 111.876 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.51 -10.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.872 1.669 . . . . 0.0 114.733 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.87 169.14 12.75 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.585 1.084 . . . . 0.0 114.72 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -130.52 111.79 12.6 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.145 1.778 . . . . 0.0 110.911 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -66.58 131.63 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.734 -0.603 . . . . 0.0 109.533 172.021 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.61 -32.14 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.302 0.641 . . . . 0.0 111.392 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 38.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.262 1.825 . . . . 0.0 115.27 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 t 59.26 -172.68 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.964 2.106 . . . . 0.0 113.077 -171.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -70.26 108.94 3.99 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.311 1.445 . . . . 0.0 110.661 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.01 139.41 61.26 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.644 3.562 . . . . 0.0 116.035 -171.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.76 166.3 24.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.22 1.008 . . . . 0.0 113.605 177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.88 130.36 21.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.891 1.677 . . . . 0.0 108.914 171.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -83.58 -17.55 41.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.09 172.95 3.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.919 2.888 . . . . 0.0 109.181 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -51.72 -48.63 63.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.67 -0.55 13.38 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -83.01 152.05 25.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.295 0.952 . . . . 0.0 111.023 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.84 148.45 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.151 0.98 . . . . 0.0 110.451 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -137.77 108.05 6.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.803 0.441 . . . . 0.0 109.865 -174.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.91 111.94 19.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.086 1.355 . . . . 0.0 111.2 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.5 mt -115.38 112.99 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.487 1.915 . . . . 0.0 109.88 -163.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -69.93 127.81 34.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.312 1.045 . . . . 0.0 111.543 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.9 tp -146.68 144.07 29.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.442 1.897 . . . . 0.0 110.242 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -116.69 94.03 42.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.744 1.617 . . . . 0.0 110.49 -170.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -73.93 170.38 20.22 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.759 3.64 . . . . 0.0 113.158 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.11 161.78 44.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.543 2.162 . . . . 0.0 111.271 167.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.44 74.89 3.19 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.335 -0.853 . . . . 0.0 111.25 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.76 -170.66 43.09 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.647 1.594 . . . . 0.0 111.382 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -69.62 142.21 53.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.388 0.613 . . . . 0.0 111.069 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.9 p -160.0 159.39 32.05 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.137 0.975 . . . . 0.0 111.354 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -130.73 103.65 6.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.88 137.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.42 125.18 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.41 98.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.801 1.24 . . . . 0.0 109.517 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.66 -169.22 14.1 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.735 1.635 . . . . 0.0 111.331 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.9 -174.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.896 0.879 . . . . 0.0 111.881 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.71 -14.76 5.49 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.96 4.57 23.45 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 113.822 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 p -153.29 -9.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.58 107.64 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.85 1.66 . . . . 0.0 114.062 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 mt -54.75 104.97 0.13 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 159.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -111.53 88.01 2.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -168.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -119.87 140.46 50.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.712 1.244 . . . . 0.0 113.801 -160.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 136.6 54.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.601 3.16 . . . . 0.0 115.092 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -153.11 120.42 5.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -100.72 104.87 16.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.463 1.105 . . . . 0.0 109.819 166.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -60.67 140.97 57.27 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.726 -0.609 . . . . 0.0 111.31 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER 61.22 -19.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.205 2.602 . . . . 0.0 116.545 -169.016 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.44 47.64 3.89 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.134 1.35 . . . . 0.0 110.786 158.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -60.02 17.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 130.856 3.663 . . . . 0.0 118.253 -152.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.0 m -154.96 7.7 0.28 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.188 -1.57 . . . . 0.0 114.657 164.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.78 -26.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.76 1.164 . . . . 0.0 111.358 170.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -116.02 160.59 13.28 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 156.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 5.3 mmpt? . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.475 1.91 . . . . 0.0 111.628 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 mmt . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -28.5 -50.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.656 3.182 . . . . 0.0 115.575 167.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -137.76 -21.36 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.288 1.835 . . . . 0.0 113.322 161.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.77 80.58 1.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.572 1.078 . . . . 0.0 109.84 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -165.46 -170.62 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 130.399 3.48 . . . . 0.0 108.731 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -68.35 78.83 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 O-C-N 121.072 -1.017 . . . . 0.0 112.209 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.65 -69.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.181 2.192 . . . . 0.0 114.016 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.14 -30.35 63.87 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.16 -12.47 40.88 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.636 1.174 . . . . 0.0 113.731 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.8 p -128.03 16.09 6.78 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.11 151.06 41.33 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.849 1.66 . . . . 0.0 110.057 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.6 p -144.78 89.54 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.272 2.229 . . . . 0.0 105.882 163.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mmm -114.44 -111.95 0.34 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -149.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 m -73.6 102.94 4.04 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -140.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 p -66.01 -12.12 52.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.422 1.489 . . . . 0.0 113.782 166.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.38 169.41 43.44 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.268 1.413 . . . . 0.0 114.398 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 157.08 37.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.492 1.917 . . . . 0.0 113.87 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.05 167.25 19.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.253 2.621 . . . . 0.0 109.78 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -102.7 139.6 38.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.469 1.108 . . . . 0.0 110.416 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 tp -73.97 103.93 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 155.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -106.8 -14.15 15.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.743 -165.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.6 ttpp -153.08 138.73 17.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.324 1.85 . . . . 0.0 109.615 146.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.13 165.55 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.44 2.696 . . . . 0.0 114.454 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.5 mtm -70.65 135.01 48.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.13 119.29 21.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.171 1.389 . . . . 0.0 111.349 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 160.89 30.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -116.54 168.03 10.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.667 1.587 . . . . 0.0 111.992 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -26.15 64.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.198 0.999 . . . . 0.0 112.435 165.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -65.73 -10.57 38.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.735 1.614 . . . . 0.0 112.494 165.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.99 89.18 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 124.895 1.236 . . . . 0.0 113.976 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.6 p -82.0 171.18 14.71 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.905 2.482 . . . . 0.0 110.553 168.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t -125.41 148.73 48.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.256 1.022 . . . . 0.0 111.02 169.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.21 119.68 61.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.96 1.304 . . . . 0.0 108.928 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.79 146.45 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.65 1.58 . . . . 0.0 108.469 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -115.12 115.89 27.51 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 109.686 170.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -93.87 164.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 109.903 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 149.61 49.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.24 1.816 . . . . 0.0 107.406 157.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -86.05 157.85 19.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.469 1.486 . . . . 0.0 111.055 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.59 -63.23 0.84 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.155 -0.966 . . . . 0.0 110.198 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -15.5 -75.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 129.88 3.61 . . . . 0.0 117.655 -167.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -130.75 15.16 5.35 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -162.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 -44.01 2.56 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.627 -1.296 . . . . 0.0 113.809 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.4 170.3 3.07 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 128.591 2.756 . . . . 0.0 115.208 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -66.7 163.23 33.9 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.52 2.814 . . . . 0.0 113.611 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.27 151.32 38.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.241 1.816 . . . . 0.0 110.488 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -88.72 126.33 35.27 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 134.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.6 m -86.12 129.98 51.81 Favored Pre-proline 0 N--CA 1.472 0.63 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -166.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.4 Cg_endo -72.36 111.92 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.935 1.757 . . . . 0.0 109.109 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.98 131.37 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.572 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.28 169.12 16.92 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.095 164.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 mt -122.56 123.63 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 152.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -102.62 157.39 16.97 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.979 0.8 . . . . 0.0 110.211 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -58.54 174.48 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.465 1.906 . . . . 0.0 113.37 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.93 -35.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.995 -1.066 . . . . 0.0 113.037 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -72.57 -16.71 61.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.891 2.076 . . . . 0.0 113.597 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttm 68.28 27.44 6.62 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.057 2.543 . . . . 0.0 113.512 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.89 -38.74 7.26 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.616 1.966 . . . . 0.0 111.823 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -124.17 137.37 54.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.707 1.14 . . . . 0.0 111.632 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -68.87 134.16 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.597 1.159 . . . . 0.0 110.666 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.34 -9.16 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.242 1.417 . . . . 0.0 114.618 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.94 167.98 12.72 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.438 1.017 . . . . 0.0 114.928 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -130.81 110.83 11.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.224 1.81 . . . . 0.0 110.403 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.54 115.63 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.635 0.774 . . . . 0.0 109.501 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 mm -93.53 -39.87 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.199 1.0 . . . . 0.0 111.711 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -63.64 8.73 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t 97.7 179.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.504 3.522 . . . . 0.0 110.149 -163.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.3 p -65.07 114.58 15.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.793 1.237 . . . . 0.0 109.74 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.05 136.18 44.73 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.323 2.682 . . . . 0.0 114.057 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.14 166.97 23.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -140.37 131.64 26.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.084 2.153 . . . . 0.0 108.279 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -85.29 -18.41 33.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.93 172.41 5.55 Favored 'General case' 0 CA--C 1.549 0.912 1 C-N-CA 131.769 4.027 . . . . 0.0 108.639 175.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -54.81 7.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.19 1.396 . . . . 0.0 112.216 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -66.87 -1.07 3.51 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 m -74.37 121.59 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.813 1.188 . . . . 0.0 111.057 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -90.34 146.63 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.34 0.656 . . . . 0.0 110.758 162.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 m -139.5 110.99 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.637 0.775 . . . . 0.0 109.57 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.52 134.71 37.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 110.548 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.6 mt -139.36 106.85 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.965 1.306 . . . . 0.0 109.599 -166.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -65.5 127.84 33.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.923 1.289 . . . . 0.0 111.955 161.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 tp -147.75 146.08 29.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.978 2.111 . . . . 0.0 110.111 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.18 96.6 50.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 111.524 -171.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.17 170.0 19.26 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.437 3.424 . . . . 0.0 113.108 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.27 166.55 28.92 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.456 2.104 . . . . 0.0 111.157 166.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -74.8 77.43 2.09 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.327 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.59 -169.18 42.1 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.746 1.165 . . . . 0.0 112.149 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.86 143.12 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.073 0.949 . . . . 0.0 110.481 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 m -164.57 169.26 17.29 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.997 -1.064 . . . . 0.0 112.698 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -125.97 107.55 10.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 110.736 -169.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.0 124.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 127.922 2.489 . . . . 0.0 107.055 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.69 123.23 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.5 mt -125.35 99.88 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.318 1.447 . . . . 0.0 108.719 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.6 -169.15 13.37 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 127.07 2.272 . . . . 0.0 110.242 -161.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.52 -177.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.636 1.218 . . . . 0.0 111.675 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.32 -18.29 6.79 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.95 2.91 44.05 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.18 1.49 . . . . 0.0 114.267 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 p -157.97 -11.36 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.2 117.45 6.07 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.665 1.186 . . . . 0.0 114.106 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 mt -52.54 104.73 0.1 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 156.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.4 m -110.66 94.54 5.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.97 160.35 27.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.276 1.031 . . . . 0.0 112.455 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.416 ' CE1' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -101.7 148.38 25.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.425 1.49 . . . . 0.0 114.292 -161.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -149.77 147.39 27.96 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 171.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.04 107.15 11.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.32 1.048 . . . . 0.0 108.885 164.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -63.32 140.01 58.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.257 0.623 . . . . 0.0 111.559 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.49 -4.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.534 2.734 . . . . 0.0 116.228 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.5 50.09 0.81 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.219 1.866 . . . . 0.0 109.924 162.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.4 m -61.68 22.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.651 1 C-N-CA 132.582 4.353 . . . . 0.0 117.726 -157.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.6 t -140.41 1.99 1.81 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 114.313 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -25.2 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 120.097 1.317 . . . . 0.0 111.826 167.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.28 171.18 21.57 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.664 1.602 . . . . 0.0 110.534 166.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 6.5 mmpt? . . . . . 0 C--O 1.258 1.518 0 C-N-CA 127.805 2.442 . . . . 0.0 111.456 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' H3 ' ' CD ' ' A' ' 2' ' ' GLU . 4.4 mpp? . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -23.62 -58.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.991 3.316 . . . . 0.0 115.627 167.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -128.79 -28.9 2.4 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.894 2.478 . . . . 0.0 111.222 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.68 84.63 7.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.518 1.053 . . . . 0.0 110.477 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -164.94 174.0 11.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.42 1.888 . . . . 0.0 111.83 168.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 tp -71.51 77.75 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 125.53 1.532 . . . . 0.0 112.02 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -67.84 -13.0 61.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.037 1.735 . . . . 0.0 114.583 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.28 93.79 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.406 0.548 . . . . 0.0 112.006 169.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.32 -56.27 2.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.163 1.385 . . . . 0.0 110.757 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.9 p -74.68 36.37 0.11 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 115.08 -172.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.71 146.53 24.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.497 1.919 . . . . 0.0 109.336 162.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.1 p -139.22 93.6 2.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.623 1.969 . . . . 0.0 106.599 163.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mmm -120.15 -87.23 0.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -155.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.79 138.69 52.92 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -143.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -132.04 13.3 4.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.659 1.184 . . . . 0.0 113.388 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.34 175.03 15.64 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.868 1.699 . . . . 0.0 112.549 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -71.45 157.86 37.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -127.5 173.86 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.119 2.568 . . . . 0.0 110.332 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.97 139.1 47.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.066 1.746 . . . . 0.0 109.927 165.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tp -75.81 89.51 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 160.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.48 -12.84 41.83 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.789 1.235 . . . . 0.0 112.379 -164.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.1 ttpp -149.38 142.95 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.647 1.579 . . . . 0.0 109.663 149.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 167.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.777 2.431 . . . . 0.0 113.701 166.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 141.89 31.85 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 120.78 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.913 1.285 . . . . 0.0 110.654 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.44 162.01 23.47 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 p -116.9 178.65 4.27 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.792 1.637 . . . . 0.0 112.528 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -17.01 63.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.141 0.976 . . . . 0.0 113.444 166.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -75.87 -10.73 59.67 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.906 1.23 . . . . 0.0 112.118 164.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.84 8.13 32.78 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.485 -1.384 . . . . 0.0 113.306 -164.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.1 p -66.23 160.3 24.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.996 1.398 . . . . 0.0 108.879 162.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -126.67 144.04 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.893 0.877 . . . . 0.0 110.627 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -105.03 118.91 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.523 1.129 . . . . 0.0 109.172 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.19 129.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -104.13 110.03 22.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.341 0.973 . . . . 0.0 110.253 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -86.05 163.78 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.533 0.733 . . . . 0.0 110.375 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.2 155.61 43.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.581 1.952 . . . . 0.0 108.156 157.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -108.95 142.4 39.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.367 1.439 . . . . 0.0 113.177 -170.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -128.96 -24.29 2.94 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.29 73.37 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 117.406 1.722 . . . . 0.0 117.406 -163.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.61 1.51 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.95 -41.1 1.04 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 120.177 1.353 . . . . 0.0 115.193 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.04 171.5 6.42 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.288 2.635 . . . . 0.0 114.146 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.28 159.3 35.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.608 2.872 . . . . 0.0 114.39 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.52 152.73 29.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.122 1.769 . . . . 0.0 110.476 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 132.88 35.82 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 142.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -94.29 124.74 54.76 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -170.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -67.11 114.05 3.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 109.374 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.8 mt -120.43 123.34 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.256 1.022 . . . . 0.0 108.769 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.49 174.47 10.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.561 0.744 . . . . 0.0 109.931 167.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 mt -124.1 130.01 73.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 153.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -110.83 160.32 16.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.133 0.968 . . . . 0.0 111.126 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -58.63 176.07 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.852 2.461 . . . . 0.0 114.083 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.32 -29.96 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.007 -1.058 . . . . 0.0 112.945 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -71.96 -17.7 62.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.215 1.406 . . . . 0.0 112.974 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 45.7 mttp 67.66 29.9 6.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.304 2.641 . . . . 0.0 112.954 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.15 -29.99 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.763 1.625 . . . . 0.0 113.487 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -122.45 131.4 53.85 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.896 1.225 . . . . 0.0 110.894 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.79 135.68 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.346 1.458 . . . . 0.0 111.656 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.53 -7.01 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.78 168.63 12.61 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.855 1.207 . . . . 0.0 115.27 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -131.31 118.1 19.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.756 1.622 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.498 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -77.87 99.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.348 1.059 . . . . 0.0 111.101 -177.05 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.81 -49.49 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.033 0.933 . . . . 0.0 111.876 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.2 t -63.03 -4.97 2.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m 62.82 -12.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.935 2.494 . . . . 0.0 117.692 158.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.6 p -120.16 59.71 6.6 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.481 1.512 . . . . 0.0 113.663 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -58.04 84.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.832 3.022 . . . . 0.0 113.786 163.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.42 166.99 23.2 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.67 137.31 36.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.445 2.698 . . . . 0.0 108.32 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -102.77 -7.49 21.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.662 1.185 . . . . 0.0 112.962 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.25 170.77 11.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 130.17 3.388 . . . . 0.0 108.258 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -44.62 41.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.319 0.648 . . . . 0.0 111.794 167.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -66.76 -6.08 14.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.112 1.765 . . . . 0.0 114.429 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -73.58 101.56 3.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.42 1.009 . . . . 0.0 111.345 174.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 m -73.88 135.46 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.434 158.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -137.95 108.06 6.4 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.779 0.432 . . . . 0.0 110.828 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.58 121.63 25.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.283 1.433 . . . . 0.0 111.833 170.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mm -124.49 115.84 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 126.129 1.772 . . . . 0.0 110.188 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.58 127.95 34.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.405 1.082 . . . . 0.0 110.898 161.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 tp -141.4 145.19 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.359 2.263 . . . . 0.0 109.561 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -113.73 101.05 53.39 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.162 1.385 . . . . 0.0 110.901 -171.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.66 168.91 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.348 3.365 . . . . 0.0 113.135 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.31 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.261 1.974 . . . . 0.0 110.857 162.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -76.32 75.4 3.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.087 -1.008 . . . . 0.0 111.748 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.94 -166.94 39.27 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.987 1.279 . . . . 0.0 112.492 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.99 135.67 47.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.961 1.304 . . . . 0.0 110.626 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -163.38 173.5 13.14 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.075 -1.015 . . . . 0.0 112.098 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.452 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 90.5 m-85 -125.67 105.0 8.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.743 0.817 . . . . 0.0 110.765 -165.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.95 129.86 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.976 1.711 . . . . 0.0 106.841 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.69 122.66 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.79 98.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.575 1.15 . . . . 0.0 109.223 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.56 -176.99 16.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.025 2.25 . . . . 0.0 111.279 -162.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.95 177.21 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.638 1.175 . . . . 0.0 111.57 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.27 -17.18 5.42 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 117.675 1.83 . . . . 0.0 117.675 -170.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.39 6.36 44.47 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.514 1.657 . . . . 0.0 113.992 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -162.75 -1.23 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.57 114.88 3.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.512 1.525 . . . . 0.0 114.282 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.63 103.35 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 157.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 m -112.32 92.83 4.17 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -126.51 148.73 49.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.814 1.292 . . . . 0.0 113.908 -166.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 139.84 47.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.683 2.393 . . . . 0.0 114.132 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -140.03 153.57 46.86 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.417 0.687 . . . . 0.0 110.718 156.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -124.48 115.45 20.92 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 165.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -66.65 134.35 52.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.24 0.473 . . . . 0.0 111.865 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.26 -29.94 0.05 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.56 30.18 10.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.747 2.118 . . . . 0.0 113.39 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -57.26 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 128.413 2.685 . . . . 0.0 113.42 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 p -143.42 -67.49 0.35 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.889 1.676 . . . . 0.0 110.472 -165.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.7 tp -67.56 -9.88 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.522 1.529 . . . . 0.0 113.576 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.02 144.46 16.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.734 1.159 . . . . 0.0 112.591 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 127.955 2.502 . . . . 0.0 111.346 -171.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.1 mmm . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.4 m -86.98 96.65 10.34 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -143.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.6 p -67.37 -10.74 54.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.895 1.678 . . . . 0.0 114.549 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 170.4 48.2 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.75 1.167 . . . . 0.0 113.726 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.18 158.04 27.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.446 1.498 . . . . 0.0 111.616 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -132.4 167.88 19.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.573 2.349 . . . . 0.0 110.616 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -108.46 139.7 42.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.387 1.075 . . . . 0.0 110.807 165.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tp -71.09 113.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 154.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.21 -14.11 9.29 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.807 0.843 . . . . 0.0 112.51 -162.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.1 ttpp -147.82 141.19 25.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.575 1.55 . . . . 0.0 109.013 144.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.47 161.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.358 2.263 . . . . 0.0 114.287 170.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.95 131.35 37.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 130.04 46.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.549 1.54 . . . . 0.0 110.708 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -82.77 159.86 22.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.03 0.932 . . . . 0.0 113.127 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -115.54 168.27 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.175 1.39 . . . . 0.0 112.481 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.21 65.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.749 0.82 . . . . 0.0 112.581 166.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -67.21 -10.14 47.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.192 1.797 . . . . 0.0 112.152 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.92 78.15 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.19 1.376 . . . . 0.0 114.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -76.01 171.72 13.97 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.076 2.15 . . . . 0.0 110.582 167.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.54 154.33 43.99 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.107 0.963 . . . . 0.0 110.782 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.44 105.93 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.599 1.16 . . . . 0.0 109.637 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.93 164.3 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.662 1.185 . . . . 0.0 109.253 167.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.6 tmmt? -132.29 128.39 37.68 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.238 -0.914 . . . . 0.0 109.891 155.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.0 161.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 111.033 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.81 145.64 51.69 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 107.949 161.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -81.66 155.26 25.68 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.778 1.172 . . . . 0.0 110.69 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -124.86 -63.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.696 0.799 . . . . 0.0 109.567 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -8.69 -77.7 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 130.233 3.778 . . . . 0.0 118.362 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.63 15.31 3.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -157.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.8 -54.56 4.68 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.701 -1.249 . . . . 0.0 112.842 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.74 164.3 3.21 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.747 2.419 . . . . 0.0 114.969 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.18 164.0 21.26 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.397 2.732 . . . . 0.0 113.979 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 70.7 m -141.55 148.43 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.072 1.749 . . . . 0.0 111.102 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -86.22 141.02 29.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.5 -1.28 . . . . 0.0 108.035 126.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.38 129.0 25.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.535 -168.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.64 117.41 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.082 1.855 . . . . 0.0 109.617 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.39 127.22 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.228 1.011 . . . . 0.0 109.107 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.05 170.04 11.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.657 0.783 . . . . 0.0 109.144 161.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.41 131.71 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 153.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -115.62 153.58 31.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.415 1.086 . . . . 0.0 111.015 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -62.76 176.03 0.74 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.364 1.466 . . . . 0.0 112.718 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.0 -39.62 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 120.803 -1.186 . . . . 0.0 112.711 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -72.14 -18.52 61.88 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.423 1.889 . . . . 0.0 113.399 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.27 20.6 mttm 74.19 4.84 4.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.426 3.09 . . . . 0.0 114.529 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.49 -43.34 63.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.259 2.224 . . . . 0.0 113.053 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -109.21 133.39 53.08 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.048 0.84 . . . . 0.0 110.997 -165.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -74.73 134.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.857 0.863 . . . . 0.0 110.256 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.67 -8.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.68 168.68 12.86 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.617 1.099 . . . . 0.0 114.759 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -131.25 122.18 26.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.724 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.455 HD12 ' H ' ' A' ' 63' ' ' ILE . 1.2 mp -76.02 138.07 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.895 0.77 . . . . 0.0 109.848 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.85 -34.98 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 111.798 -172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 t -68.56 38.44 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.604 1.962 . . . . 0.0 114.866 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.8 t 57.12 -172.33 0.08 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.573 1.949 . . . . 0.0 112.889 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -64.23 109.54 2.85 Favored Pre-proline 0 C--O 1.246 0.889 0 C-N-CA 125.243 1.417 . . . . 0.0 110.175 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.04 136.38 60.92 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 124.465 3.444 . . . . 0.0 114.918 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.94 160.91 39.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.485 1.114 . . . . 0.0 112.806 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.64 123.5 11.98 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.52 1.528 . . . . 0.0 108.823 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -72.1 -22.49 61.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -170.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.38 169.68 10.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.871 2.468 . . . . 0.0 109.742 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -52.5 -45.64 66.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.294 1.038 . . . . 0.0 111.438 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -70.93 0.95 6.24 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 m -100.41 158.31 15.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.291 1.405 . . . . 0.0 112.376 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.74 154.23 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 125.079 1.352 . . . . 0.0 110.741 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -142.05 115.98 9.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.205 0.602 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -68.92 134.4 49.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.096 0.959 . . . . 0.0 110.341 164.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mm -132.04 104.62 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.803 1.241 . . . . 0.0 109.947 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.51 131.17 44.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.793 0.837 . . . . 0.0 111.172 161.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 tp -150.12 145.16 26.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.063 1.745 . . . . 0.0 110.649 -163.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -119.72 94.62 48.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.523 1.529 . . . . 0.0 110.77 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.21 168.3 20.5 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.967 3.778 . . . . 0.0 112.712 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.92 165.65 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.183 1.922 . . . . 0.0 111.544 169.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -75.41 74.99 2.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.854 0.862 . . . . 0.0 111.702 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.43 -167.09 38.89 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.77 1.176 . . . . 0.0 112.374 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.17 140.28 52.52 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.688 1.195 . . . . 0.0 110.543 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.0 m -163.6 171.11 16.22 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.835 -1.166 . . . . 0.0 112.361 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -128.34 101.29 6.15 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.572 1.149 . . . . 0.0 109.867 -169.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.2 136.66 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.23 122.72 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.419 0.554 . . . . 0.0 109.61 174.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.6 mt -123.82 105.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.844 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.99 172.14 20.3 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.647 2.07 . . . . 0.0 111.097 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 m -95.8 129.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.3 1.05 . . . . 0.0 110.687 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 26.28 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 127.774 2.607 . . . . 0.0 116.081 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.95 -27.77 8.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.052 1.741 . . . . 0.0 115.474 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.8 m -101.29 -3.63 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.552 1.941 . . . . 0.0 112.932 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.31 109.83 16.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.288 1.035 . . . . 0.0 113.089 -166.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 mt -53.85 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.951 162.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.8 m -103.63 89.53 3.38 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -170.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -118.66 139.29 51.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.586 1.184 . . . . 0.0 113.484 -165.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 142.48 55.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.708 2.403 . . . . 0.0 114.208 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -145.53 153.81 41.51 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.888 0.875 . . . . 0.0 111.267 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -135.5 111.62 9.63 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.568 1.147 . . . . 0.0 108.973 168.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -68.49 144.1 54.75 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.929 -0.482 . . . . 0.0 111.647 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 129.653 3.181 . . . . 0.0 115.69 -172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.67 109.01 18.9 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -133.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -72.33 -13.33 61.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.746 1.618 . . . . 0.0 114.506 164.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.53 163.13 54.75 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.347 0.975 . . . . 0.0 113.317 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 158.93 34.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.967 0.907 . . . . 0.0 112.792 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -129.1 166.73 18.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.652 1.981 . . . . 0.0 110.239 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.39 137.2 54.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.58 1.952 . . . . 0.0 111.038 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 tp -80.15 95.47 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.941 1.296 . . . . 0.0 108.711 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.98 -11.71 28.0 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 112.633 -165.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.4 ttpp -152.71 137.77 17.28 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 109.379 151.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.62 168.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.073 2.949 . . . . 0.0 114.749 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 mtm -77.29 123.55 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.52 118.11 29.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.087 1.355 . . . . 0.0 110.256 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.11 161.79 21.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.312 1.045 . . . . 0.0 113.703 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 p -118.01 169.62 9.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 112.512 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -27.99 66.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.855 0.862 . . . . 0.0 112.387 166.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -65.06 -12.91 55.82 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.38 1.872 . . . . 0.0 112.469 168.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.32 -5.05 79.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.166 1.365 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -69.71 167.65 16.6 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 111.43 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -127.27 148.38 50.22 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.063 1.345 . . . . 0.0 110.072 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.51 116.25 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.526 1.13 . . . . 0.0 109.037 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.68 131.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.783 1.633 . . . . 0.0 108.946 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 5.9 ttmt -102.52 111.61 23.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.283 0.947 . . . . 0.0 109.606 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -87.6 157.0 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 122.585 0.354 . . . . 0.0 110.065 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -130.04 143.34 50.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.057 2.143 . . . . 0.0 107.491 160.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.85 154.74 26.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.586 1.085 . . . . 0.0 110.725 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.34 -63.13 1.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 110.712 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -18.73 -80.15 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 129.391 3.377 . . . . 0.0 117.793 -164.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.58 22.12 6.45 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.6 -49.15 3.82 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 120.917 -1.115 . . . . 0.0 114.327 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.6 178.73 1.71 Allowed Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 128.424 2.689 . . . . 0.0 114.761 -170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.75 166.28 14.18 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 124.255 3.303 . . . . 0.0 115.705 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.0 m -148.13 154.36 40.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.428 1.891 . . . . 0.0 111.286 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -92.12 138.67 31.34 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 128.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.29 125.11 44.57 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -66.14 101.19 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.305 2.003 . . . . 0.0 110.532 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.8 mt -106.84 130.94 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.099 0.96 . . . . 0.0 110.568 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.79 166.79 20.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.563 0.745 . . . . 0.0 110.461 157.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.49 130.61 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 146.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -111.83 162.67 15.03 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.615 1.166 . . . . 0.0 112.916 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -55.9 169.03 0.39 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.86 2.064 . . . . 0.0 113.351 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -58.25 -28.93 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.317 -0.864 . . . . 0.0 112.898 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -74.92 -17.07 60.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.235 1.814 . . . . 0.0 113.718 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 49.8 mttp 69.85 28.19 4.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.234 2.214 . . . . 0.0 113.205 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -115.26 -28.42 6.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.646 1.978 . . . . 0.0 113.173 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -132.6 138.19 47.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.694 1.134 . . . . 0.0 112.255 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.73 133.45 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.292 1.837 . . . . 0.0 111.213 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.51 -8.9 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 0.0 114.112 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.72 168.75 13.05 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 119.578 1.081 . . . . 0.0 115.257 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.55 114.1 14.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.068 1.747 . . . . 0.0 110.854 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -74.92 102.38 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.08 0.952 . . . . 0.0 110.186 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.4 mm -76.36 -42.34 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.421 1.089 . . . . 0.0 111.767 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -70.49 36.94 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.649 1.98 . . . . 0.0 115.78 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t 62.66 -174.92 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.708 2.003 . . . . 0.0 113.588 -175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -59.5 107.01 0.84 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 127.584 2.354 . . . . 0.0 111.859 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.21 121.1 9.3 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.356 3.37 . . . . 0.0 114.57 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.05 165.93 26.17 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.89 148.59 34.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.82 1.648 . . . . 0.0 109.953 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -99.67 -21.46 15.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 112.173 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.6 165.03 19.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.76 1.624 . . . . 0.0 111.296 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -57.98 -28.56 64.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.328 1.051 . . . . 0.0 112.759 168.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -81.48 -4.24 55.34 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 m -83.79 155.97 22.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.621 1.1 . . . . 0.0 112.244 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.69 149.61 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 124.82 1.248 . . . . 0.0 110.204 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -138.62 107.42 5.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.39 0.676 . . . . 0.0 109.492 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.72 121.09 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.01 . . . . 0.0 110.939 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.88 111.84 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.716 1.606 . . . . 0.0 109.131 -168.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -67.42 126.57 29.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 110.765 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 tp -143.3 144.72 32.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.785 2.034 . . . . 0.0 109.527 -172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -114.46 100.21 52.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.413 1.485 . . . . 0.0 110.805 -170.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.19 175.31 10.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.472 3.448 . . . . 0.0 112.893 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -76.67 167.15 25.96 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.396 2.731 . . . . 0.0 111.518 165.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -76.97 78.43 3.52 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.841 -1.162 . . . . 0.0 111.679 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.57 -166.66 39.41 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.257 0.932 . . . . 0.0 112.3 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.66 143.79 54.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.153 0.501 . . . . 0.0 110.761 165.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.0 p -160.27 157.74 28.63 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.938 0.895 . . . . 0.0 111.64 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.489 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 96.1 m-85 -129.3 102.57 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.935 0.874 . . . . 0.0 111.446 -171.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.71 137.22 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.691 1.996 . . . . 0.0 107.568 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.37 129.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -130.86 97.91 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.649 1.18 . . . . 0.0 109.343 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.44 -175.78 15.9 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 127.11 2.29 . . . . 0.0 111.245 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.2 135.17 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 118.473 1.137 . . . . 0.0 111.418 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.27 -117.48 0.91 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.253 1.406 . . . . 0.0 114.158 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -70.43 -9.7 57.13 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.1 m -86.64 -11.23 51.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.518 1.127 . . . . 0.0 112.89 165.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.05 116.84 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.843 0.857 . . . . 0.0 112.583 -172.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.8 102.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 158.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.7 m -112.95 93.31 4.36 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -168.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -131.94 157.42 44.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.746 1.26 . . . . 0.0 114.018 -162.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 135.96 33.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.331 2.652 . . . . 0.0 114.355 -165.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -143.84 118.83 10.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 165.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -91.76 105.67 17.9 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.585 1.154 . . . . 0.0 110.148 164.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 139.09 58.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm . . . . . 0 N--CA 1.473 0.712 0 C-N-CA 126.471 1.908 . . . . 0.0 114.062 -179.617 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.38 113.02 20.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -135.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.7 p -68.67 -10.97 59.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.54 1.536 . . . . 0.0 114.564 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.3 170.68 44.58 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.279 0.942 . . . . 0.0 114.793 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 156.17 28.26 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.183 1.793 . . . . 0.0 111.484 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 82.6 m-85 -130.7 167.48 18.74 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.416 2.286 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -107.97 137.31 46.18 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.561 1.144 . . . . 0.0 111.054 167.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.8 tp -75.35 92.7 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 159.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.91 -13.2 25.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.754 1.222 . . . . 0.0 112.088 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -149.04 142.38 25.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.374 1.47 . . . . 0.0 109.535 148.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.36 162.68 0.13 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.211 2.204 . . . . 0.0 113.845 167.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.19 132.3 42.06 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 122.21 35.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.858 1.263 . . . . 0.0 110.418 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -80.82 160.89 24.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.5 p -113.65 169.56 8.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.655 1.582 . . . . 0.0 112.006 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.92 69.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.975 0.91 . . . . 0.0 112.287 165.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -68.67 -11.14 59.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.595 1.958 . . . . 0.0 112.764 171.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.42 -3.1 79.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.726 1.155 . . . . 0.0 113.818 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -72.7 165.35 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.445 1.898 . . . . 0.0 111.076 166.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -125.95 146.18 49.97 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.706 1.203 . . . . 0.0 110.405 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.98 118.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 109.164 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.39 124.96 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.607 1.563 . . . . 0.0 109.161 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -95.55 110.8 22.83 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.313 0.961 . . . . 0.0 109.233 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.88 161.53 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.151 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 152.54 49.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.272 1.829 . . . . 0.0 107.733 156.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -87.92 159.01 18.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.199 1.363 . . . . 0.0 110.966 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -130.95 -52.9 1.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.275 -0.891 . . . . 0.0 110.843 173.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.38 -11.21 46.27 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 120.252 2.861 . . . . 0.0 120.252 -151.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.31 2.64 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.61 2.705 . . . . 0.0 117.112 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.88 -56.77 4.29 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-N 120.522 1.51 . . . . 0.0 113.061 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.98 5.03 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 127.371 2.269 . . . . 0.0 114.269 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.66 164.81 22.63 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.031 3.154 . . . . 0.0 116.193 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -147.61 151.18 35.79 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.509 2.324 . . . . 0.0 111.391 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 142.61 28.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 129.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.25 1.0 OUTLIER -104.2 134.86 19.48 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.724 -169.576 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.84 106.42 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.247 1.965 . . . . 0.0 109.112 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 mt -115.14 130.69 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.548 0.739 . . . . 0.0 109.757 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -134.06 172.98 12.08 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.014 0.926 . . . . 0.0 110.048 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' HG ' ' A' ' 81' ' ' LEU . 5.0 mt -126.42 125.71 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 156.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -109.15 162.89 13.85 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.922 0.868 . . . . 0.0 111.148 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -57.74 173.67 0.29 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.622 2.369 . . . . 0.0 113.487 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 m -56.57 -34.9 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.874 -1.141 . . . . 0.0 112.71 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -71.8 -14.07 61.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.563 1.945 . . . . 0.0 113.495 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 67.99 22.98 8.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.267 2.627 . . . . 0.0 113.662 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -108.74 -32.76 7.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.49 1.916 . . . . 0.0 112.692 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -127.15 135.82 51.24 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.249 1.386 . . . . 0.0 111.954 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.76 135.38 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.495 1.518 . . . . 0.0 111.625 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.93 -11.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.559 1.544 . . . . 0.0 114.622 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.97 171.01 13.65 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -170.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtm-85 -133.1 128.89 37.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.676 1.59 . . . . 0.0 110.729 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 63' ' ' ILE . 1.9 mp -79.72 124.09 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.52 -36.99 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.568 0.747 . . . . 0.0 111.282 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.8 t -68.63 35.29 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.296 1.838 . . . . 0.0 114.617 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.76 -170.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.899 2.08 . . . . 0.0 113.641 -175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -64.0 108.6 1.96 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.929 2.092 . . . . 0.0 111.157 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -55.05 143.78 72.05 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.31 3.34 . . . . 0.0 115.495 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -147.46 166.27 27.74 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.96 121.93 11.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.458 1.903 . . . . 0.0 108.168 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.52 -17.29 59.34 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.584 -0.697 . . . . 0.0 112.677 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.53 170.26 16.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.319 2.648 . . . . 0.0 109.419 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 m -50.5 -49.9 54.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.312 1.045 . . . . 0.0 110.464 163.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -67.03 -3.54 7.49 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 m -85.24 144.18 28.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.148 1.34 . . . . 0.0 112.093 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.02 150.96 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.045 1.338 . . . . 0.0 110.637 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 m -141.77 115.59 9.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.98 122.75 32.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 111.568 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.73 111.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 124.819 1.248 . . . . 0.0 109.827 -162.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.1 124.59 23.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.141 1.376 . . . . 0.0 111.42 165.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 51' ' ' ILE . 57.4 tp -141.02 142.92 34.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.074 2.149 . . . . 0.0 110.013 -166.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -119.23 98.99 50.7 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -167.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.82 168.77 18.89 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.483 3.455 . . . . 0.0 113.573 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.49 165.13 32.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.946 2.431 . . . . 0.0 111.019 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -72.67 73.42 1.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.27 -0.894 . . . . 0.0 112.004 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -173.44 46.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.148 0.88 . . . . 0.0 113.789 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.54 129.61 41.39 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.13 0.972 . . . . 0.0 110.163 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 m -145.56 150.5 36.52 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.279 1.432 . . . . 0.0 111.011 -163.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.58 98.17 5.61 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.957 0.884 . . . . 0.0 111.317 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.82 126.44 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.391 1.876 . . . . 0.0 107.259 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.47 123.96 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.871 0.868 . . . . 0.0 109.039 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.1 mt -128.16 98.58 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.031 1.332 . . . . 0.0 109.256 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.93 -174.57 15.84 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 127.657 2.551 . . . . 0.0 110.649 -164.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.11 164.54 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.506 1.153 . . . . 0.0 110.585 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -10.14 -74.5 0.01 OUTLIER Glycine 0 CA--C 1.541 1.707 0 C-N-CA 127.55 2.5 . . . . 0.0 117.682 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.3 58.68 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.9 p -122.91 -10.29 8.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.295 1.838 . . . . 0.0 114.025 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.15 118.53 6.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.582 1.953 . . . . 0.0 112.67 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.5 mt -56.67 98.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 154.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 83.4 m -101.08 95.57 6.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.94 154.35 39.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.816 1.293 . . . . 0.0 113.735 -170.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.38 137.89 33.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.917 2.487 . . . . 0.0 114.267 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -134.64 156.48 48.67 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.201 1.0 . . . . 0.0 111.129 162.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -129.8 111.06 12.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 162.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -63.26 135.33 57.0 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 126.528 1.931 . . . . 0.0 113.705 -175.052 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.62 99.56 8.2 Favored 'General case' 0 N--CA 1.458 -0.056 0 O-C-N 121.106 -0.996 . . . . 0.0 113.36 -145.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -68.64 -6.44 25.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.517 166.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.24 53.83 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.045 1.307 . . . . 0.0 114.169 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 154.71 32.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.261 1.824 . . . . 0.0 112.459 -174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.04 166.22 18.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.748 2.019 . . . . 0.0 110.794 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -101.39 137.45 39.71 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.579 1.151 . . . . 0.0 110.183 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.57 101.75 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -106.53 -14.37 15.07 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.319 1.448 . . . . 0.0 111.482 -163.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.5 ttpp -149.38 137.84 20.86 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.686 1.595 . . . . 0.0 109.359 145.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.94 168.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.06 2.944 . . . . 0.0 114.351 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 34' ' ' VAL . 24.9 mtm -79.88 136.36 36.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.39 122.57 21.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.013 1.725 . . . . 0.0 109.74 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.62 164.89 21.54 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -120.66 170.06 9.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.041 1.737 . . . . 0.0 111.778 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -27.56 66.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.117 0.967 . . . . 0.0 112.312 165.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -65.37 -9.15 22.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.338 1.855 . . . . 0.0 112.733 168.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.03 -7.4 55.96 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.477 1.513 . . . . 0.0 113.539 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -68.54 163.54 23.3 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.976 1.71 . . . . 0.0 111.067 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -126.71 148.29 49.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 109.503 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 t -114.65 115.3 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.127 0.971 . . . . 0.0 109.508 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.6 t -117.81 132.6 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 109.087 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 25.7 ttpp -107.27 120.49 42.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.775 1.17 . . . . 0.0 110.47 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -93.75 165.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.656 1.182 . . . . 0.0 109.987 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.57 159.12 42.88 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.126 1.771 . . . . 0.0 108.183 156.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -104.31 139.04 39.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.724 1.602 . . . . 0.0 112.421 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -121.71 -27.82 4.63 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.87 -1.144 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.85 -18.13 79.51 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -157.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.34 2.57 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.31 -42.7 1.7 Allowed Glycine 0 CA--C 1.537 1.419 0 CA-C-N 120.765 1.62 . . . . 0.0 114.497 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.31 170.7 5.06 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 128.33 2.652 . . . . 0.0 115.107 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -67.64 166.24 24.77 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.926 3.084 . . . . 0.0 113.172 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.35 155.31 40.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.27 136.69 33.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 129.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.274 1.7 m -95.54 129.11 35.7 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -170.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.2 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.644 2.23 . . . . 0.0 109.091 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.7 mt -119.06 129.15 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.58 0.752 . . . . 0.0 110.833 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -132.83 169.06 17.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.525 1.13 . . . . 0.0 109.437 162.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -119.09 131.25 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 149.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -110.12 163.69 13.35 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.465 1.103 . . . . 0.0 112.209 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -59.64 175.52 0.35 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.706 1.603 . . . . 0.0 113.027 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -65.3 -22.77 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -79.72 -25.56 41.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.34 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 46.9 mttp 85.91 14.02 0.16 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.939 3.295 . . . . 0.0 112.565 169.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -83.09 -51.05 7.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.489 2.716 . . . . 0.0 112.815 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -122.68 151.48 41.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.127 1.33 . . . . 0.0 112.669 -167.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.32 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.938 1.695 . . . . 0.0 112.136 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.22 -28.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.188 1.795 . . . . 0.0 114.171 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.55 161.76 17.87 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.917 1.235 . . . . 0.0 114.429 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -124.17 105.21 9.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.455 1.502 . . . . 0.0 110.354 -170.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.1 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.985 -1.072 . . . . 0.0 110.151 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.6 mm -108.73 -40.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.471 0.708 . . . . 0.0 111.603 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 t -66.41 10.14 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 98.13 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 130.588 3.555 . . . . 0.0 111.413 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 p -67.76 106.87 1.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.403 1.481 . . . . 0.0 109.375 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.94 147.21 64.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.635 2.89 . . . . 0.0 115.238 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 169.16 18.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.94 140.38 38.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.319 2.248 . . . . 0.0 108.914 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.12 -27.59 21.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.446 1.098 . . . . 0.0 112.283 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 177.73 7.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 130.163 3.385 . . . . 0.0 108.84 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.14 -43.71 61.26 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.085 -1.009 . . . . 0.0 112.342 170.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.37 -10.09 15.12 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 114.044 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -72.74 119.99 17.74 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 m -90.49 146.29 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.081 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -139.15 105.3 5.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -86.3 125.31 33.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 111.493 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.4 mt -131.69 115.47 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.309 1.444 . . . . 0.0 109.555 -159.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.11 126.51 29.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.103 0.961 . . . . 0.0 111.647 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.9 tp -145.5 143.13 29.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.021 1.728 . . . . 0.0 110.367 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 62' ' ' ARG . 5.2 tm-20 -118.19 92.63 43.17 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.619 1.568 . . . . 0.0 111.429 -165.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.85 170.47 19.99 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.288 3.325 . . . . 0.0 114.419 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.49 160.13 49.37 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.675 2.25 . . . . 0.0 111.17 165.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.85 92.18 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.456 0.702 . . . . 0.0 110.358 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.49 -172.38 34.24 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.218 1.389 . . . . 0.0 111.236 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.81 143.95 39.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.999 0.92 . . . . 0.0 111.512 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 162.18 24.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.064 0.946 . . . . 0.0 111.953 -171.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 91.8 m-85 -127.78 102.34 6.76 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.939 0.876 . . . . 0.0 111.747 -170.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.39 126.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 127.539 2.336 . . . . 0.0 106.968 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.32 120.36 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -124.28 98.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.075 1.35 . . . . 0.0 108.995 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.82 -174.04 15.01 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.85 2.167 . . . . 0.0 110.247 -161.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 m -114.76 161.53 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.569 1.184 . . . . 0.0 110.93 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 4.51 -85.57 0.0 OUTLIER Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.825 2.631 . . . . 0.0 117.406 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -4.43 58.67 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -119.41 -9.59 9.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.187 1.795 . . . . 0.0 113.853 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.93 8.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.716 2.006 . . . . 0.0 113.347 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.97 96.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 155.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.8 m -99.94 97.3 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -126.46 160.64 29.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.394 1.093 . . . . 0.0 113.307 -172.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 141.15 28.92 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 114.345 -162.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -146.24 129.45 16.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 166.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -105.93 108.76 20.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.548 1.539 . . . . 0.0 109.669 165.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -66.47 141.08 58.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 126.203 1.801 . . . . 0.0 113.624 -176.591 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . 0.289 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.08 106.65 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -139.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.3 p -70.66 -7.35 43.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.657 1.583 . . . . 0.0 114.2 162.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.01 168.67 54.79 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.655 1.121 . . . . 0.0 113.893 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 155.18 36.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.638 1.575 . . . . 0.0 112.332 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.53 166.22 21.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.049 2.14 . . . . 0.0 110.477 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -106.53 140.25 39.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.39 1.476 . . . . 0.0 110.667 166.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -76.45 94.28 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 159.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.48 -13.05 26.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.816 1.246 . . . . 0.0 112.267 -165.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.9 ttpp -145.87 140.79 27.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.745 1.618 . . . . 0.0 108.684 146.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.61 167.66 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.48 2.312 . . . . 0.0 113.691 166.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.434 ' HG2' HG22 ' A' ' 34' ' ' VAL . 28.8 mtm -76.23 137.63 40.1 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.264 -0.897 . . . . 0.0 113.183 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.65 128.66 35.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.565 1.146 . . . . 0.0 110.137 171.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -85.15 161.3 19.69 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -111.52 168.63 9.4 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.896 1.678 . . . . 0.0 111.764 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -30.28 70.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.545 1.138 . . . . 0.0 111.965 164.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -62.12 -14.68 39.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.771 1.628 . . . . 0.0 112.645 166.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 1.98 90.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.989 1.28 . . . . 0.0 113.954 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -76.35 164.31 26.14 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.925 2.09 . . . . 0.0 110.916 166.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -119.86 146.07 46.08 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.186 0.994 . . . . 0.0 110.245 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.7 119.09 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.079 0.952 . . . . 0.0 109.044 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.5 t -117.49 130.7 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.553 1.541 . . . . 0.0 109.211 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.5 ttmt -106.77 108.3 19.74 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.113 0.869 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.5 162.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 110.156 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 145.6 41.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.201 1.8 . . . . 0.0 107.459 154.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.63 153.02 22.66 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.96 1.254 . . . . 0.0 111.115 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -124.28 -59.32 1.48 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.199 -0.938 . . . . 0.0 109.645 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -20.66 -64.65 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 130.192 3.758 . . . . 0.0 118.587 -167.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.86 11.64 2.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -158.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.74 -45.85 2.77 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 120.606 -1.309 . . . . 0.0 113.417 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 165.74 6.28 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 128.473 2.709 . . . . 0.0 115.559 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.06 167.82 20.7 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.513 3.475 . . . . 0.0 113.622 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.2 m -147.59 157.23 43.47 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.225 1.81 . . . . 0.0 111.611 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 137.73 32.07 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 128.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 1.9 m -100.29 128.15 31.26 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.381 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.03 105.71 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.599 2.199 . . . . 0.0 109.707 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.0 128.01 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 110.491 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -131.75 168.07 18.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 109.247 165.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.95 135.09 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 151.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -119.62 157.94 27.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.228 1.411 . . . . 0.0 110.929 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.1 177.67 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.03 0.932 . . . . 0.0 112.544 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -56.16 -34.82 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 120.902 -1.124 . . . . 0.0 113.354 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -82.29 -6.55 59.31 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.34 1.856 . . . . 0.0 112.592 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 66.12 -5.42 0.56 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.207 3.003 . . . . 0.0 115.272 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.06 -38.65 88.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.302 1.841 . . . . 0.0 114.658 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -118.13 140.09 50.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.424 1.465 . . . . 0.0 111.862 -168.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -73.68 139.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.291 1.436 . . . . 0.0 111.062 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.82 -7.93 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 114.955 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.99 13.09 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 119.982 1.264 . . . . 0.0 115.795 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -133.38 119.58 19.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.363 1.865 . . . . 0.0 111.513 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.96 99.72 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.029 0.932 . . . . 0.0 110.853 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.61 -38.22 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 111.424 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -67.33 18.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.928 1.291 . . . . 0.0 114.242 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.1 m 60.64 -176.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.531 2.332 . . . . 0.0 113.335 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.0 p -57.35 107.83 1.05 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.057 1.743 . . . . 0.0 110.827 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -59.29 159.81 21.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.26 3.307 . . . . 0.0 115.319 -172.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.88 167.17 22.74 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.75 143.97 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.671 1.589 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -92.56 -22.57 19.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.21 171.11 5.8 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.882 3.273 . . . . 0.0 109.399 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 m -51.68 -47.68 63.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.223 1.009 . . . . 0.0 110.989 164.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -66.48 1.36 1.71 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 m -104.28 130.42 52.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.535 1.061 . . . . 0.0 112.022 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.39 152.58 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.988 1.315 . . . . 0.0 111.579 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -142.7 111.49 6.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.726 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -76.59 130.38 37.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.614 1.166 . . . . 0.0 111.204 167.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mm -132.74 116.98 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.315 1.846 . . . . 0.0 110.023 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.8 128.24 34.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 111.303 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 tp -144.13 146.91 33.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.506 1.922 . . . . 0.0 110.695 -169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.4 100.3 41.92 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.397 1.479 . . . . 0.0 110.871 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.55 174.05 13.26 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.962 3.775 . . . . 0.0 113.314 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.71 165.53 32.04 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.631 2.22 . . . . 0.0 111.001 162.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.72 79.47 2.05 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.131 -0.981 . . . . 0.0 111.834 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.39 -168.53 41.5 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.766 1.174 . . . . 0.0 112.496 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.64 142.82 55.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.367 1.067 . . . . 0.0 110.357 170.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.7 m -164.6 168.52 18.08 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.675 -1.266 . . . . 0.0 112.531 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -126.31 100.77 6.43 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.214 1.006 . . . . 0.0 110.231 -171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.91 138.98 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 171.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.43 130.08 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.3 mt -127.12 101.93 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.255 . . . . 0.0 108.645 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.46 164.03 17.81 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.367 1.937 . . . . 0.0 111.071 -164.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.9 148.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.639 -0.918 . . . . 0.0 110.455 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 6.37 -92.1 0.01 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 128.457 2.932 . . . . 0.0 117.296 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -64.26 -13.81 51.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.7 m -108.54 -5.14 16.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.992 2.117 . . . . 0.0 112.507 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.87 127.03 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.515 1.126 . . . . 0.0 113.09 -168.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.87 82.01 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.9 m -79.01 104.95 10.0 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.756 0.822 . . . . 0.0 109.185 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.83 151.93 51.92 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 138.98 37.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.887 2.475 . . . . 0.0 114.976 -171.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -136.16 156.77 48.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.734 0.814 . . . . 0.0 111.785 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -128.87 109.47 11.29 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.843 1.257 . . . . 0.0 108.273 162.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -65.03 136.38 56.71 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.144 -0.347 . . . . 0.0 111.831 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 126.361 1.865 . . . . 0.0 114.156 -175.457 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.1 mmm . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 102.55 6.24 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -149.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 p -76.77 -15.36 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.55 173.37 35.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.741 1.163 . . . . 0.0 115.298 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 155.63 27.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.175 2.19 . . . . 0.0 112.792 -173.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -129.92 168.45 16.63 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.434 2.294 . . . . 0.0 112.009 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -104.1 138.46 40.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.247 1.419 . . . . 0.0 110.661 163.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 tp -75.9 82.24 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 122.783 1.278 . . . . 0.0 107.859 160.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.28 -14.56 59.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.331 1.452 . . . . 0.0 112.827 -170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -153.09 137.85 17.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.441 1.097 . . . . 0.0 110.282 154.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.73 168.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.875 2.47 . . . . 0.0 113.57 165.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.1 mtm -82.71 134.5 35.14 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.135 -0.978 . . . . 0.0 113.525 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.16 31.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.892 1.277 . . . . 0.0 110.546 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -83.27 159.75 21.87 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -111.39 169.24 8.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.105 1.762 . . . . 0.0 111.863 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -26.73 64.74 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.893 0.877 . . . . 0.0 112.283 164.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -63.7 -11.8 29.02 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.765 1.626 . . . . 0.0 112.261 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.8 76.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.249 1.404 . . . . 0.0 113.843 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 p -76.16 165.64 24.61 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.672 1.989 . . . . 0.0 110.658 165.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -125.44 147.4 49.22 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.994 0.918 . . . . 0.0 110.956 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.6 t -114.43 120.98 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.377 1.071 . . . . 0.0 109.363 -171.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.53 133.5 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.06 1.744 . . . . 0.0 109.102 -173.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -103.45 115.79 31.18 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.547 1.067 . . . . 0.0 110.034 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -88.76 161.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.207 0.603 . . . . 0.0 110.108 170.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.39 142.42 47.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.201 1.801 . . . . 0.0 107.237 154.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -78.41 155.1 30.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.451 1.478 . . . . 0.0 110.653 169.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -127.02 -62.34 1.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.869 0.868 . . . . 0.0 110.337 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -29.26 -59.74 0.17 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.956 3.17 . . . . 0.0 118.353 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.37 15.69 3.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -160.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -45.71 3.0 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.743 -1.223 . . . . 0.0 114.061 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.08 8.0 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 128.045 2.538 . . . . 0.0 115.539 -170.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -66.71 161.32 42.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.041 2.494 . . . . 0.0 112.414 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.3 m -156.25 155.7 32.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 0.0 111.179 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 137.57 38.46 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 142.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 48' ' ' PRO 0.291 1.7 m -99.74 134.38 21.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.767 -169.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.8 Cg_endo -81.58 100.71 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.174 2.583 . . . . 0.0 109.256 -172.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mt -112.22 124.41 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.76 0.824 . . . . 0.0 111.08 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.73 163.1 21.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.826 1.251 . . . . 0.0 110.225 164.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.48 HG13 HD11 ' A' ' 81' ' ' LEU . 3.8 mt -118.78 126.69 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 146.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.23 163.94 12.59 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.61 1.164 . . . . 0.0 111.966 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -56.59 171.01 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 127.343 2.257 . . . . 0.0 113.803 173.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.75 -26.53 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.451 -0.78 . . . . 0.0 112.847 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -72.81 -17.25 61.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.614 1.565 . . . . 0.0 113.449 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 89' ' ' TYR . 42.8 mttp 71.73 23.62 3.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.734 2.413 . . . . 0.0 113.4 175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -119.19 -31.6 4.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.148 1.779 . . . . 0.0 114.009 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -126.0 129.16 48.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.705 1.138 . . . . 0.0 110.917 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.53 133.74 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.358 1.463 . . . . 0.0 111.576 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -133.44 -10.5 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.149 1.78 . . . . 0.0 114.252 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.63 170.92 13.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.349 0.976 . . . . 0.0 114.599 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -131.35 138.22 49.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.812 1.645 . . . . 0.0 110.439 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -93.02 128.85 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.583 0.753 . . . . 0.0 109.616 178.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.59 -54.52 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 112.522 -162.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -60.41 -33.39 72.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -175.75 169.27 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.54 1.936 . . . . 0.0 110.135 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 p -66.52 105.13 0.73 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.334 157.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -58.44 145.52 93.93 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.528 2.819 . . . . 0.0 115.806 -163.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -144.7 167.68 21.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.13 0.972 . . . . 0.0 112.837 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.96 128.8 29.06 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.386 2.274 . . . . 0.0 108.334 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -75.2 -16.6 60.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.59 168.43 3.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.613 2.365 . . . . 0.0 110.429 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -58.47 -44.75 89.42 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.472 0.709 . . . . 0.0 110.065 156.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -69.88 40.13 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.453 1.901 . . . . 0.0 112.678 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -156.19 148.8 23.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 119.653 -1.904 . . . . 0.0 111.964 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.61 156.34 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.766 1.626 . . . . 0.0 111.078 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -142.98 107.76 4.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.101 0.56 . . . . 0.0 110.608 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -74.18 125.51 28.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.587 0.755 . . . . 0.0 110.852 164.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 mm -128.66 120.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.5 1.52 . . . . 0.0 110.022 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -71.04 130.66 42.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.4 1.08 . . . . 0.0 111.276 162.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 51' ' ' ILE . 30.5 tp -143.94 151.55 39.93 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.308 2.243 . . . . 0.0 109.731 -168.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -125.7 94.37 42.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.901 1.68 . . . . 0.0 109.653 -165.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -76.07 172.59 15.98 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.606 3.537 . . . . 0.0 113.268 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.34 160.42 49.9 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.347 2.031 . . . . 0.0 110.692 162.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.26 72.61 2.33 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.221 -0.924 . . . . 0.0 111.097 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.33 42.42 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.318 1.913 . . . . 0.0 111.269 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.64 148.12 38.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.316 0.579 . . . . 0.0 111.045 169.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -163.97 161.3 22.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.929 0.891 . . . . 0.0 111.903 -167.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 86.5 m-85 -128.12 100.54 5.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 111.558 -169.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.57 126.56 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 127.668 2.387 . . . . 0.0 107.351 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.261 0.9 OUTLIER -119.08 120.95 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -122.04 97.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.498 1.519 . . . . 0.0 108.639 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.94 179.79 15.91 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.275 2.369 . . . . 0.0 110.493 -166.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.85 144.34 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.033 0.917 . . . . 0.0 111.169 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 38.0 -119.31 0.75 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.531 1.539 . . . . 0.0 113.858 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.44 -14.04 62.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.8 m -86.84 -10.79 52.64 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.226 1.011 . . . . 0.0 112.688 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.32 116.49 17.06 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.473 1.109 . . . . 0.0 113.467 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.7 mt -55.46 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 157.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.2 m -107.37 95.68 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.1 160.25 34.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.149 0.976 . . . . 0.0 113.38 -172.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.66 23.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.921 2.088 . . . . 0.0 114.521 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -151.64 132.01 13.74 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.157 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -103.88 109.31 21.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.003 1.321 . . . . 0.0 110.31 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.08 141.16 58.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 126.617 1.967 . . . . 0.0 114.353 -176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 127.44 32.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -154.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.0 p -100.17 -7.58 24.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.0 113.708 163.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.72 170.26 34.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.91 1.243 . . . . 0.0 114.185 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 157.22 27.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.69 1.996 . . . . 0.0 112.734 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.5 m-85 -129.77 168.46 16.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.052 2.141 . . . . 0.0 111.732 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -105.51 141.3 37.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.611 1.565 . . . . 0.0 110.682 164.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 tp -77.01 95.09 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 156.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -93.15 -12.04 31.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.053 1.341 . . . . 0.0 112.613 -166.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.9 ttpp -151.13 132.48 14.59 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.46 1.104 . . . . 0.0 109.62 149.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.7 153.61 0.57 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.694 1.998 . . . . 0.0 113.336 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -69.55 145.82 52.29 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.38 13.16 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.825 1.65 . . . . 0.0 109.519 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -78.41 156.91 29.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 113.272 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.1 p -108.53 170.24 8.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.636 1.574 . . . . 0.0 111.475 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -25.24 62.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.399 1.08 . . . . 0.0 112.248 164.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -64.57 -12.49 45.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.499 1.52 . . . . 0.0 112.023 164.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 1.63 84.28 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.421 1.486 . . . . 0.0 113.861 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -73.6 168.07 20.07 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.974 2.11 . . . . 0.0 110.847 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -125.0 148.61 48.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.262 1.025 . . . . 0.0 110.198 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 t -115.86 110.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.062 0.945 . . . . 0.0 109.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.64 124.27 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.6 1.16 . . . . 0.0 109.774 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.9 ttmt -92.46 112.57 24.56 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.438 1.017 . . . . 0.0 110.018 173.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.01 165.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.978 0.511 . . . . 0.0 110.099 169.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 154.93 45.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.092 2.157 . . . . 0.0 108.113 156.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -98.79 139.15 34.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.934 1.697 . . . . 0.0 112.802 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -119.71 -33.26 4.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.692 -1.255 . . . . 0.0 113.101 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.81 -25.68 71.9 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -157.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.05 -47.1 3.07 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 120.678 1.581 . . . . 0.0 114.679 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.51 169.21 20.55 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 127.781 2.432 . . . . 0.0 113.964 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -68.01 160.19 49.7 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.905 2.404 . . . . 0.0 115.738 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 13.0 m -151.15 154.64 37.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.527 1.931 . . . . 0.0 110.733 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 136.07 36.73 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 144.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.295 1.1 m -96.85 141.81 23.62 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 118.308 0.504 . . . . 0.0 111.765 -165.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -88.16 96.89 0.4 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.999 2.466 . . . . 0.0 109.324 -168.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.28 129.41 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.6 0.76 . . . . 0.0 112.189 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.22 170.01 16.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.698 1.199 . . . . 0.0 110.147 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 81' ' ' LEU . 3.9 mt -115.36 129.2 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 148.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.94 164.11 12.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.681 1.192 . . . . 0.0 111.995 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -58.62 172.0 0.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.226 2.21 . . . . 0.0 114.167 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.44 -31.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.081 -1.012 . . . . 0.0 112.464 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.46 -16.14 62.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.608 1.963 . . . . 0.0 113.255 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 mttm 67.23 20.18 10.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.498 2.719 . . . . 0.0 113.436 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.57 -40.35 7.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 112.09 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.93 1.241 . . . . 0.0 112.879 -165.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.1 137.63 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.989 1.716 . . . . 0.0 112.442 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.35 -14.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.05 169.04 14.73 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-N 119.745 1.157 . . . . 0.0 114.977 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -129.95 122.87 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.266 1.426 . . . . 0.0 112.216 -172.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.08 100.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.561 1.144 . . . . 0.0 111.398 176.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.8 mm -71.7 -44.03 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 110.642 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -62.87 -3.2 1.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m 62.92 -26.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 129.398 3.079 . . . . 0.0 118.785 155.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.2 p -128.25 69.6 78.23 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.21 1.368 . . . . 0.0 112.223 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -54.12 106.97 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.671 2.914 . . . . 0.0 113.211 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 169.6 17.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 166.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.84 116.98 13.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.418 2.687 . . . . 0.0 107.837 171.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -72.08 -16.46 62.02 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.42 173.48 3.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.144 3.378 . . . . 0.0 108.384 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.6 -45.36 77.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.333 -0.855 . . . . 0.0 111.653 166.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.17 0.63 2.57 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.8 m -96.6 112.07 23.96 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 m -80.46 152.66 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.244 1.017 . . . . 0.0 111.717 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m -144.58 110.44 5.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.283 0.633 . . . . 0.0 110.754 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.3 124.0 28.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.457 0.703 . . . . 0.0 111.741 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.05 109.46 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.997 1.319 . . . . 0.0 109.197 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -67.53 127.64 33.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.05 0.94 . . . . 0.0 111.025 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.59 HD11 HG13 ' A' ' 51' ' ' ILE . 19.7 tp -147.08 145.73 29.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.108 1.763 . . . . 0.0 110.154 -167.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -120.16 97.48 49.2 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.581 1.552 . . . . 0.0 110.496 -165.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.94 170.83 19.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.265 3.31 . . . . 0.0 113.423 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.88 161.16 47.05 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.548 2.165 . . . . 0.0 111.062 163.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -72.63 90.55 1.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.369 -0.832 . . . . 0.0 110.548 168.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.04 -171.91 37.19 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.041 1.305 . . . . 0.0 111.147 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.82 147.97 31.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.536 0.734 . . . . 0.0 111.048 170.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 90.4 p -162.57 159.94 25.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 112.325 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -128.72 96.91 4.51 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.545 1.164 . . . . 0.0 110.923 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 90' ' ' ILE . 4.1 mp -65.8 128.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 127.704 2.402 . . . . 0.0 106.918 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.23 120.76 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.5 mt -122.48 94.32 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.136 1.374 . . . . 0.0 108.064 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 177.69 15.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.669 2.08 . . . . 0.0 110.543 -166.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 m -114.1 149.85 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.804 0.842 . . . . 0.0 110.763 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 32.72 -111.71 0.06 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 126.047 1.784 . . . . 0.0 114.971 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -70.41 -12.95 61.92 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 m -98.59 -9.32 24.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.626 1.571 . . . . 0.0 112.455 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.84 123.52 20.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.785 1.234 . . . . 0.0 112.934 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.99 90.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 151.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.6 m -84.68 101.25 12.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 168.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -125.63 154.66 41.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.701 1.239 . . . . 0.0 113.552 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 138.97 32.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.054 2.541 . . . . 0.0 114.618 -170.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -144.43 129.44 18.51 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 161.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -101.15 112.43 24.91 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.523 1.129 . . . . 0.0 109.656 165.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -66.58 134.46 52.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 126.435 1.894 . . . . 0.0 112.707 -172.253 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.9 mmm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 100.38 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -138.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 p -79.15 -10.85 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.298 1.839 . . . . 0.0 114.86 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.57 171.93 14.31 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.327 1.441 . . . . 0.0 114.63 -172.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -74.0 159.04 33.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.743 1.217 . . . . 0.0 114.023 -168.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -124.02 171.57 9.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.316 2.646 . . . . 0.0 109.741 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.406 ' OG ' ' OE2' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -110.18 139.63 45.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.969 1.708 . . . . 0.0 109.696 166.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.14 100.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.64 -10.0 20.42 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.179 1.391 . . . . 0.0 112.131 -165.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -153.42 143.57 22.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.149 1.38 . . . . 0.0 110.077 150.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.47 166.68 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 113.869 166.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -89.78 136.29 33.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.74 30.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 109.843 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.55 158.53 23.08 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -110.69 170.6 7.98 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.315 1.846 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.6 68.9 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.047 -1.033 . . . . 0.0 112.737 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -67.97 -10.77 56.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.096 1.758 . . . . 0.0 112.236 167.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.95 4.64 72.63 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.427 1.489 . . . . 0.0 114.052 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -74.6 166.12 24.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.446 1.898 . . . . 0.0 110.292 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -119.21 152.88 35.85 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.48 1.112 . . . . 0.0 110.15 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -115.04 113.26 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.024 0.929 . . . . 0.0 109.871 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.24 116.55 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.566 1.546 . . . . 0.0 109.27 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.83 117.5 29.84 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.876 0.762 . . . . 0.0 110.572 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.57 160.03 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 110.234 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -141.17 150.43 42.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.636 1.974 . . . . 0.0 108.227 164.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -98.55 150.85 21.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.27 1.395 . . . . 0.0 112.982 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' OE2' ' OG ' ' A' ' 19' ' ' SER . 53.5 mt-10 -128.09 -63.87 0.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 110.971 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -7.66 -72.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 129.649 3.499 . . . . 0.0 117.106 -169.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.39 18.62 3.66 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.578 1.551 . . . . 0.0 113.446 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.46 -43.64 1.1 Allowed Glycine 0 CA--C 1.539 1.593 0 N-CA-C 116.557 1.383 . . . . 0.0 116.557 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 165.43 4.47 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.713 2.805 . . . . 0.0 114.761 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.03 157.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.647 2.231 . . . . 0.0 113.831 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.0 m -151.76 157.22 41.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.277 1.431 . . . . 0.0 112.014 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 138.05 36.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 139.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 m -97.53 123.75 51.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.873 -171.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.86 124.24 13.7 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.557 2.171 . . . . 0.0 110.072 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mt -132.8 130.99 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 109.73 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.21 167.98 16.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 166.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.7 mt -124.25 128.8 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 147.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.52 164.11 13.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.704 1.202 . . . . 0.0 112.088 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.97 175.5 0.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.466 2.306 . . . . 0.0 113.492 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.0 -32.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.45 -8.04 58.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.583 1.553 . . . . 0.0 113.177 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 66.82 32.42 6.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.188 2.195 . . . . 0.0 113.0 171.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -130.85 -20.72 2.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.409 1.484 . . . . 0.0 114.64 -175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -121.65 121.65 37.84 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.685 1.129 . . . . 0.0 110.359 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.07 133.84 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 111.624 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -137.35 -7.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.794 1.638 . . . . 0.0 114.537 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.5 170.01 13.22 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.682 1.128 . . . . 0.0 114.679 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -131.71 119.58 21.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.12 1.768 . . . . 0.0 110.947 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.516 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -72.11 122.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.857 0.863 . . . . 0.0 109.78 176.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.1 mm -97.36 -33.24 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.499 0.719 . . . . 0.0 111.707 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.7 t -62.2 20.28 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.386 2.274 . . . . 0.0 116.84 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.1 p 60.01 -169.01 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.805 2.042 . . . . 0.0 112.535 -163.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.4 p -60.87 106.38 0.77 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.246 1.818 . . . . 0.0 111.083 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.59 144.4 97.38 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.645 2.896 . . . . 0.0 113.46 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.02 167.21 22.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.87 123.7 18.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.87 2.068 . . . . 0.0 108.358 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -75.3 -26.46 58.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.933 0.893 . . . . 0.0 113.135 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.62 172.86 4.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.139 2.575 . . . . 0.0 109.916 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -39.28 63.76 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 171.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -72.8 -2.65 21.37 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -94.86 155.44 16.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 111.749 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.5 147.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.514 1.126 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.7 m -139.35 105.34 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.592 0.357 . . . . 0.0 110.644 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.79 89.56 4.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.204 1.801 . . . . 0.0 111.837 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.52 117.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.931 1.692 . . . . 0.0 111.201 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -69.13 126.88 31.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.054 0.942 . . . . 0.0 111.466 159.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.5 tp -143.04 147.01 34.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.679 1.991 . . . . 0.0 110.268 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -118.65 97.48 50.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.395 1.478 . . . . 0.0 110.528 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.05 172.08 16.67 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.752 3.635 . . . . 0.0 113.666 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.61 163.14 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.498 2.132 . . . . 0.0 111.1 164.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.83 74.01 4.39 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.322 -0.861 . . . . 0.0 111.688 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.65 -168.14 40.94 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.053 1.311 . . . . 0.0 111.632 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -67.24 144.35 56.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.476 0.655 . . . . 0.0 111.085 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.6 p -161.73 160.14 28.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.083 0.953 . . . . 0.0 111.502 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.47 98.03 4.73 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.493 0.717 . . . . 0.0 110.333 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.89 135.45 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.764 1.626 . . . . 0.0 107.305 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.87 123.45 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.2 mt -125.31 109.85 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.719 1.207 . . . . 0.0 109.488 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.49 163.63 26.28 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.963 1.744 . . . . 0.0 111.422 -162.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.88 166.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.708 -0.878 . . . . 0.0 111.872 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -30.17 -59.81 0.21 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.456 2.455 . . . . 0.0 116.885 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.99 3.24 0.87 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.848 1.659 . . . . 0.0 115.232 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -161.93 12.09 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.269 -1.519 . . . . 0.0 114.29 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.31 108.34 7.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.349 1.459 . . . . 0.0 112.286 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.08 101.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 160.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.5 m -112.31 95.2 5.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.317 1.047 . . . . 0.0 108.386 -167.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -130.44 146.45 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 137.95 45.75 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.037 2.935 . . . . 0.0 114.872 -172.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -149.22 121.02 8.12 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.943 0.897 . . . . 0.0 112.539 165.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -92.3 108.05 19.66 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.443 0.697 . . . . 0.0 109.754 164.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -64.05 131.78 48.59 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.978 0.511 . . . . 0.0 111.038 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 mttp . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.946 1.699 . . . . 0.0 112.728 -171.414 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.99 108.56 10.13 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -153.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.414 ' HA ' HG22 ' A' ' 94' ' ' VAL . 53.7 p -69.39 -4.52 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.25 1.42 . . . . 0.0 114.315 165.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.65 172.15 46.14 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.506 1.527 . . . . 0.0 114.339 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.56 163.17 27.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.59 1.556 . . . . 0.0 113.799 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.48 174.38 10.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.444 2.298 . . . . 0.0 109.76 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 p -112.13 145.46 39.76 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.259 1.024 . . . . 0.0 110.983 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.2 103.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 156.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 -14.71 14.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.905 0.882 . . . . 0.0 111.45 -159.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.516 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.7 ttpp -143.83 136.91 27.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.635 1.574 . . . . 0.0 108.615 149.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.29 156.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.917 2.087 . . . . 0.0 113.628 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 mtm -70.69 132.78 45.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.1 122.74 36.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.034 1.333 . . . . 0.0 109.996 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 152.61 34.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.581 0.705 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.7 p -101.27 167.54 10.13 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 111.105 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -24.69 64.12 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.244 -0.91 . . . . 0.0 112.27 163.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -64.94 -9.22 19.7 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.232 1.813 . . . . 0.0 112.419 165.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.89 -3.82 63.48 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.764 1.65 . . . . 0.0 114.17 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -69.58 168.35 14.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.73 2.012 . . . . 0.0 110.736 165.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 t -125.8 154.06 43.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.758 0.823 . . . . 0.0 110.481 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -118.72 118.95 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.43 1.092 . . . . 0.0 109.663 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.16 116.81 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.49 1.516 . . . . 0.0 110.125 -173.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 tmmt? -89.59 109.9 20.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.376 0.989 . . . . 0.0 109.822 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -86.75 165.66 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.205 1.002 . . . . 0.0 110.495 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 150.99 45.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.941 1.696 . . . . 0.0 108.544 153.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -94.15 129.96 40.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.289 0.95 . . . . 0.0 113.024 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -131.21 1.82 4.22 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.09 -61.82 2.76 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.102 0.858 . . . . 0.0 114.561 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.19 19.35 1.4 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -165.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.1 -43.77 2.52 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.612 -1.305 . . . . 0.0 115.553 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.18 174.33 2.95 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 127.16 2.184 . . . . 0.0 114.31 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.07 162.82 33.84 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.515 2.81 . . . . 0.0 114.22 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.2 m -145.35 151.59 38.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.684 1.994 . . . . 0.0 110.284 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 131.78 34.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 131.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.276 0.9 OUTLIER -90.43 137.91 27.22 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 118.561 0.618 . . . . 0.0 110.824 -168.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.07 97.3 0.56 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.845 2.363 . . . . 0.0 109.569 -168.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.66 124.57 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.781 0.832 . . . . 0.0 111.384 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.64 168.63 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.23 1.412 . . . . 0.0 110.242 164.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.23 133.03 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 147.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -112.17 162.87 14.98 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.533 1.133 . . . . 0.0 111.921 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -56.6 171.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.809 2.043 . . . . 0.0 113.138 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -57.49 -28.83 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 112.701 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -75.63 -12.62 60.24 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.03 2.132 . . . . 0.0 113.772 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 68.04 25.88 7.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.637 2.375 . . . . 0.0 113.452 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -120.59 -27.42 5.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.403 1.481 . . . . 0.0 114.04 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -124.07 129.05 50.23 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.676 1.125 . . . . 0.0 111.364 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.79 131.39 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.826 1.65 . . . . 0.0 111.535 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.51 -7.37 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.962 1.705 . . . . 0.0 114.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.49 166.04 15.0 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.637 1.108 . . . . 0.0 114.745 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -129.54 109.87 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.017 1.727 . . . . 0.0 109.837 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -70.14 114.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 0.0 109.645 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.5 mm -87.58 -33.9 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.887 . . . . 0.0 111.977 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.9 t -64.27 23.19 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.551 1.94 . . . . 0.0 116.062 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p 74.63 -101.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 129.997 3.319 . . . . 0.0 113.134 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.7 p -131.39 99.03 17.72 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.705 1.602 . . . . 0.0 109.072 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.46 137.71 31.82 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.86 3.04 . . . . 0.0 113.797 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -141.94 168.16 20.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 137.18 37.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.909 2.084 . . . . 0.0 108.256 168.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -91.59 -17.0 26.27 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.256 -0.903 . . . . 0.0 112.852 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.98 176.42 1.79 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 130.939 3.695 . . . . 0.0 108.167 173.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -40.88 64.52 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.816 -1.178 . . . . 0.0 112.848 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -65.31 -6.69 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.41 1.084 . . . . 0.0 113.852 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -78.49 123.82 27.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.227 0.922 . . . . 0.0 111.398 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.25 154.51 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.116 159.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.3 109.14 4.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.833 0.453 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 107.35 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.179 0.992 . . . . 0.0 112.004 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -104.27 114.08 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 125.455 1.502 . . . . 0.0 110.684 -172.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.36 129.96 41.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.868 0.842 . . . . 0.0 111.137 161.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.7 147.61 29.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.066 1.746 . . . . 0.0 110.217 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.98 94.13 43.77 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.645 1.578 . . . . 0.0 110.433 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -66.95 171.38 11.27 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.581 3.521 . . . . 0.0 112.826 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.53 155.59 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.005 1.803 . . . . 0.0 110.634 162.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -70.68 90.63 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.511 -0.743 . . . . 0.0 110.246 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.51 -170.62 32.92 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.849 1.214 . . . . 0.0 111.352 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.77 143.18 44.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.594 0.758 . . . . 0.0 111.607 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -160.68 158.06 28.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 112.36 -166.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -126.23 97.0 4.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.151 0.976 . . . . 0.0 110.972 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 132.42 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.424 2.29 . . . . 0.0 107.231 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.263 1.9 m -125.87 118.13 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mt -122.97 100.09 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.062 1.345 . . . . 0.0 108.97 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.65 -178.4 16.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.047 2.261 . . . . 0.0 110.285 -165.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 15' ' ' SER . 3.3 m -119.93 148.29 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.181 0.991 . . . . 0.0 111.06 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.92 -121.65 2.04 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.852 1.215 . . . . 0.0 113.523 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -69.69 -12.84 61.95 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.1 m -87.53 -9.86 53.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.485 1.114 . . . . 0.0 112.898 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.35 112.14 10.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.705 1.202 . . . . 0.0 113.072 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.49 95.84 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.838 0.855 . . . . 0.0 108.907 159.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -102.87 98.76 8.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.8 157.7 43.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.382 1.086 . . . . 0.0 113.766 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 143.07 28.95 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.098 2.159 . . . . 0.0 114.693 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -149.56 136.94 19.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.572 0.749 . . . . 0.0 112.86 160.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -104.28 108.07 19.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.719 1.208 . . . . 0.0 109.402 165.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -70.4 142.44 52.05 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.904 -0.498 . . . . 0.0 111.704 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 126.442 1.897 . . . . 0.0 112.217 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mmm . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -83.82 154.63 23.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -134.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HG22 ' A' ' 94' ' ' VAL . 78.9 p -125.24 1.56 7.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.918 1.687 . . . . 0.0 114.069 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.79 174.45 49.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.92 1.247 . . . . 0.0 113.452 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -74.48 161.53 29.69 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.933 1.293 . . . . 0.0 112.514 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 47' ' ' VAL . 86.0 m-85 -130.05 177.06 7.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.014 2.126 . . . . 0.0 109.373 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.8 p -107.32 151.58 25.29 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.914 0.779 . . . . 0.0 111.183 155.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 tp -83.59 100.33 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -15.17 15.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.062 1.345 . . . . 0.0 112.233 -160.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -147.57 141.8 26.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.774 2.43 . . . . 0.0 107.381 151.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.62 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.069 2.948 . . . . 0.0 115.006 167.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -86.01 129.88 34.71 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.155 -0.966 . . . . 0.0 112.563 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.78 118.17 24.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -80.31 156.1 26.95 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.1 p -112.68 171.77 7.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.578 1.551 . . . . 0.0 112.832 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.12 66.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.129 0.972 . . . . 0.0 113.316 166.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.07 -6.66 58.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.997 2.119 . . . . 0.0 111.597 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.0 6.7 60.8 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 120.832 -1.167 . . . . 0.0 113.705 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -76.36 169.67 17.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.972 2.109 . . . . 0.0 110.103 164.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -129.31 147.65 51.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.073 0.949 . . . . 0.0 111.149 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.85 102.25 13.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.519 1.128 . . . . 0.0 110.312 -171.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.45 144.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.45 1.9 . . . . 0.0 109.2 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 3.5 ttmt -111.85 125.28 53.85 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.238 1.381 . . . . 0.0 109.228 168.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 m -104.15 169.39 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.422 1.089 . . . . 0.0 110.44 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.28 155.5 44.49 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.43 1.892 . . . . 0.0 108.523 158.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -97.78 130.1 44.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.087 1.312 . . . . 0.0 112.836 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -132.19 13.98 4.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.099 -1.0 . . . . 0.0 112.679 -169.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.04 -50.04 2.53 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.227 0.918 . . . . 0.0 115.103 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.83 9.88 1.02 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -166.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.46 -41.97 1.91 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 120.112 1.324 . . . . 0.0 114.783 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.24 177.42 2.81 Favored Pre-proline 0 CA--C 1.561 1.365 0 C-N-CA 127.719 2.408 . . . . 0.0 114.188 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 166.25 24.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.241 3.294 . . . . 0.0 115.161 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.2 m -149.14 155.22 40.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.749 2.02 . . . . 0.0 110.798 172.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -83.3 134.1 34.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 118.79 -1.164 . . . . 0.0 107.925 127.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 18' ' ' PHE 0.287 1.9 m -93.87 131.06 32.77 Favored Pre-proline 0 N--CA 1.468 0.434 0 O-C-N 123.551 0.532 . . . . 0.0 110.258 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.82 105.18 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.89 2.393 . . . . 0.0 108.859 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.91 124.9 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.914 0.886 . . . . 0.0 111.092 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -136.2 169.45 17.62 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 109.768 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 ' HG ' ' A' ' 81' ' ' LEU . 3.4 mt -119.78 124.6 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -107.79 162.22 14.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 111.048 171.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -59.84 176.22 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.956 2.102 . . . . 0.0 113.967 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.06 -33.59 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.841 -1.162 . . . . 0.0 112.766 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -74.22 -11.44 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.279 1.832 . . . . 0.0 113.543 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 63.43 28.85 15.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.243 2.617 . . . . 0.0 113.606 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.21 -40.1 5.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.88 1.672 . . . . 0.0 112.563 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -124.32 138.0 54.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.874 1.215 . . . . 0.0 111.677 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.63 133.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.783 1.233 . . . . 0.0 111.38 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.27 -11.38 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.079 1.752 . . . . 0.0 114.072 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.35 168.03 14.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.541 1.067 . . . . 0.0 114.659 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -133.42 121.83 22.85 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.176 1.79 . . . . 0.0 111.274 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 122.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.963 0.802 . . . . 0.0 110.177 174.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.2 mm -95.85 -37.05 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 0.0 111.596 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 t -64.24 -7.51 9.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.7 m 117.82 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 1 C-N-CA 132.944 4.497 . . . . 0.0 108.961 -166.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 m -65.41 117.57 41.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.178 -0.915 . . . . 0.0 108.733 159.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.29 156.59 20.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.589 3.526 . . . . 0.0 115.261 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.16 169.08 18.87 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 172.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.64 139.37 31.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.457 2.303 . . . . 0.0 108.583 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -97.95 -17.6 19.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.006 0.923 . . . . 0.0 112.717 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.81 174.94 7.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.643 3.177 . . . . 0.0 108.072 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -44.65 62.54 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.309 -0.869 . . . . 0.0 112.369 173.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -65.65 -7.49 15.52 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.117 1.367 . . . . 0.0 113.917 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -71.62 106.42 4.04 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.32 0.964 . . . . 0.0 110.834 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.05 149.19 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.625 154.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 m -141.41 117.7 10.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.049 0.54 . . . . 0.0 110.134 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.25 119.66 29.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.753 0.821 . . . . 0.0 111.669 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 mm -120.82 110.87 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.877 1.671 . . . . 0.0 110.683 -167.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -69.01 123.79 21.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.536 1.134 . . . . 0.0 111.165 162.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' A' ' 51' ' ' ILE . 45.4 tp -142.35 141.66 32.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.782 2.033 . . . . 0.0 109.943 -169.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -113.78 100.58 52.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.853 1.661 . . . . 0.0 110.564 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -78.06 173.36 14.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.391 3.394 . . . . 0.0 113.77 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.74 161.92 43.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.522 2.148 . . . . 0.0 110.878 162.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -72.7 102.63 3.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.984 166.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.47 -169.82 25.78 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.87 1.224 . . . . 0.0 111.964 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.64 139.52 39.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.165 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -159.59 164.48 34.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.105 0.962 . . . . 0.0 112.261 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -129.11 104.93 7.84 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.224 1.011 . . . . 0.0 111.526 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.33 123.82 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.261 2.224 . . . . 0.0 107.102 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.68 122.63 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.33 100.38 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.994 1.317 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.19 176.28 18.59 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.714 2.102 . . . . 0.0 110.216 -161.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 15' ' ' SER . 12.6 m -107.25 139.71 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.16 0.98 . . . . 0.0 110.3 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 23.14 -100.17 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 127.902 2.667 . . . . 0.0 115.563 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -59.02 -16.37 18.01 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -110.09 -2.9 16.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.738 1.615 . . . . 0.0 112.767 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.17 111.33 16.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.103 0.961 . . . . 0.0 112.963 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.9 mt -56.22 100.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 93.03 4.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.37 156.27 34.29 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.293 1.044 . . . . 0.0 113.51 -172.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 147.0 33.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.444 1.898 . . . . 0.0 114.495 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -146.1 144.08 29.77 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.33 1.052 . . . . 0.0 110.725 157.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -114.42 116.84 29.53 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -70.03 138.68 52.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 126.035 1.734 . . . . 0.0 115.401 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 84.7 mmm . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.82 105.51 7.93 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -133.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -72.45 -3.52 24.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.09 1.756 . . . . 0.0 114.547 166.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 170.49 51.22 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.888 1.232 . . . . 0.0 113.67 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -73.66 160.66 31.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.146 1.378 . . . . 0.0 113.014 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -131.31 175.0 9.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.093 2.157 . . . . 0.0 109.901 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p -114.71 144.66 43.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 111.382 160.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.59 93.57 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 159.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.4 -16.49 21.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.264 -159.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -145.74 139.42 26.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.85 2.06 . . . . 0.0 108.105 148.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.1 162.05 0.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.779 2.432 . . . . 0.0 114.602 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.408 ' HG2' HG22 ' A' ' 34' ' ' VAL . 27.3 mtm -69.88 127.39 32.73 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 123.4 37.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.898 1.279 . . . . 0.0 110.245 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.93 155.16 27.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 p -105.21 170.82 7.66 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.252 1.821 . . . . 0.0 111.448 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -27.34 67.78 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.196 -0.94 . . . . 0.0 112.416 165.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.55 -9.73 37.99 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.555 1.942 . . . . 0.0 112.256 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.39 1.44 60.83 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.317 1.436 . . . . 0.0 114.014 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.25 166.12 22.22 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.157 1.783 . . . . 0.0 110.262 164.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -122.79 148.0 45.87 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 110.5 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.84 113.57 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 109.4 -173.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.8 t -110.41 116.08 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 109.792 -172.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -96.09 105.04 17.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.42 0.555 . . . . 0.0 109.688 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.27 166.22 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.506 1.122 . . . . 0.0 110.655 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 146.63 30.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.914 1.685 . . . . 0.0 108.716 160.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -91.09 134.96 34.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.795 0.725 . . . . 0.0 112.496 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -133.38 3.15 3.6 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.135 -0.978 . . . . 0.0 113.583 -171.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.78 -36.5 7.28 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.216 1.247 . . . . 0.0 116.216 -170.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.96 7.88 0.41 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.16 -43.07 1.96 Allowed Glycine 0 CA--C 1.535 1.322 0 CA-C-N 120.211 1.369 . . . . 0.0 114.928 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.46 167.66 6.54 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 127.696 2.399 . . . . 0.0 115.025 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.94 163.42 22.32 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.657 2.904 . . . . 0.0 113.478 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -147.29 154.5 41.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.733 1.613 . . . . 0.0 111.59 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -87.27 140.49 29.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 127.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 1.4 m -100.74 120.53 55.49 Favored Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.06 115.59 3.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.28 1.987 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mt -126.1 129.64 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 110.712 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.09 165.32 18.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.392 1.077 . . . . 0.0 110.154 162.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.94 130.74 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 146.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -112.12 164.9 12.64 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.431 1.492 . . . . 0.0 112.435 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -58.14 171.32 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.591 1.956 . . . . 0.0 113.508 172.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.9 -36.13 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.367 -0.833 . . . . 0.0 112.932 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.87 -12.33 60.64 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.876 2.07 . . . . 0.0 113.988 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 67.09 27.76 8.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 113.419 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.17 -27.96 7.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.084 2.154 . . . . 0.0 113.012 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -131.72 132.92 44.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.214 0.916 . . . . 0.0 111.041 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.98 134.22 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.204 1.402 . . . . 0.0 110.89 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.61 -8.46 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.921 1.688 . . . . 0.0 114.19 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.9 163.59 18.42 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 119.555 1.07 . . . . 0.0 114.686 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -127.21 112.87 15.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.889 1.675 . . . . 0.0 110.36 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -72.31 109.77 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.607 0.763 . . . . 0.0 109.947 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.01 -38.23 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.971 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -67.44 30.71 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.73 2.012 . . . . 0.0 114.558 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.34 -173.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.943 2.097 . . . . 0.0 113.095 -169.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -66.93 111.72 7.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.371 1.068 . . . . 0.0 109.238 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -55.82 152.99 32.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.476 3.451 . . . . 0.0 115.544 -169.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.26 167.26 22.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.6 143.71 31.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.008 1.723 . . . . 0.0 109.127 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -96.4 -18.53 19.84 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.79 174.03 5.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.844 2.858 . . . . 0.0 108.547 173.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -45.75 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.608 -0.682 . . . . 0.0 112.018 169.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -66.36 -3.39 5.88 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.3 m -87.41 119.81 28.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 111.459 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.58 156.12 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 159.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.51 119.05 10.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.069 0.548 . . . . 0.0 110.87 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.67 106.11 18.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.66 109.06 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.085 1.754 . . . . 0.0 110.526 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -67.14 126.55 29.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.385 0.612 . . . . 0.0 110.875 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.8 tp -146.65 140.73 26.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 110.235 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.94 94.14 23.8 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.011 1.324 . . . . 0.0 110.727 -172.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.83 169.95 20.82 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.641 3.561 . . . . 0.0 112.865 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 163.47 39.07 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.815 2.343 . . . . 0.0 111.664 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -75.22 72.11 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.852 0.861 . . . . 0.0 111.442 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.49 -169.34 41.42 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.233 1.397 . . . . 0.0 111.813 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.82 145.05 50.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.273 0.559 . . . . 0.0 111.11 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -161.02 154.68 22.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.574 0.749 . . . . 0.0 112.138 -166.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -127.78 101.92 6.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.157 0.98 . . . . 0.0 111.656 -171.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 90' ' ' ILE . 3.1 mp -72.89 139.53 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.966 2.106 . . . . 0.0 107.647 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.4 125.04 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 170.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 mt -125.67 103.34 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.685 1.194 . . . . 0.0 109.099 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.27 178.13 20.84 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.109 1.814 . . . . 0.0 111.117 -162.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 145.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.074 0.937 . . . . 0.0 110.786 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 22.03 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.683 2.563 . . . . 0.0 116.063 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.05 -11.28 28.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -107.98 -7.74 16.09 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.276 1.83 . . . . 0.0 112.639 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 127.41 32.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 112.171 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.54 87.12 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 157.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.8 m -79.39 98.26 6.68 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -125.05 176.62 6.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.207 1.403 . . . . 0.0 113.008 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 139.9 53.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -154.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -154.86 131.27 10.46 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -106.22 109.84 21.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.02 1.328 . . . . 0.0 109.327 165.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -63.82 148.35 49.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.649 0.78 . . . . 0.0 111.775 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 129.079 2.952 . . . . 0.0 116.214 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mmm . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.3 m -79.83 107.67 12.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -138.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 p -69.36 -9.45 53.51 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 164.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 171.93 52.48 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.701 1.619 . . . . 0.0 114.337 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -77.22 160.82 28.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.447 1.499 . . . . 0.0 114.301 -169.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.7 m-85 -130.46 173.64 10.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.535 2.334 . . . . 0.0 109.954 173.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.0 p -119.75 142.93 48.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.073 0.949 . . . . 0.0 112.037 159.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 101.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 163.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -106.52 -13.19 15.39 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.809 1.243 . . . . 0.0 111.046 -164.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -149.23 140.82 23.43 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.872 2.069 . . . . 0.0 108.883 148.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.15 170.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.464 2.706 . . . . 0.0 114.477 166.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.0 mtm -80.89 133.8 35.63 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.95 114.76 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.945 1.698 . . . . 0.0 110.718 176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.49 151.45 43.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p -106.36 168.89 8.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.976 1.711 . . . . 0.0 111.72 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -26.21 66.97 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.291 -0.881 . . . . 0.0 112.559 166.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -67.21 -8.64 33.08 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.311 2.244 . . . . 0.0 112.422 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.08 0.48 65.56 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.405 1.479 . . . . 0.0 114.205 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -73.31 173.29 9.73 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.126 2.17 . . . . 0.0 110.263 164.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -133.44 146.06 50.83 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 111.133 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.37 103.95 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.855 1.262 . . . . 0.0 110.385 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.58 168.4 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.599 1.96 . . . . 0.0 110.144 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -133.86 124.97 27.38 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.472 -0.767 . . . . 0.0 111.054 159.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.75 165.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.434 1.093 . . . . 0.0 110.524 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.03 145.33 39.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.952 1.701 . . . . 0.0 108.564 156.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -84.81 143.69 28.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.797 1.181 . . . . 0.0 111.654 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -136.27 -9.37 1.98 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -36.0 62.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.162 -1.355 . . . . 0.0 116.344 -170.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.86 12.78 0.25 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -166.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 -43.89 2.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 120.9 1.682 . . . . 0.0 114.416 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.57 175.44 4.68 Favored Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 127.4 2.28 . . . . 0.0 114.743 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.18 167.89 17.16 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.352 3.368 . . . . 0.0 115.388 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -148.21 160.84 42.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.624 1.969 . . . . 0.0 110.911 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -88.1 136.29 33.04 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 129.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 48' ' ' PRO 0.332 2.0 m -96.29 135.52 22.51 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.355 0.409 . . . . 0.0 111.158 -169.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.3 Cg_endo -87.14 89.39 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.019 2.479 . . . . 0.0 107.888 -163.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.1 125.69 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.725 0.81 . . . . 0.0 111.342 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.81 162.77 24.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.32 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 88' ' ' SER . 4.1 mt -118.62 126.91 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 151.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -110.84 162.99 14.24 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.323 1.014 . . . . 0.0 112.452 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -58.39 171.94 0.53 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.136 2.174 . . . . 0.0 113.079 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.86 -31.99 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -74.69 -12.85 60.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.186 1.794 . . . . 0.0 113.515 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 mttm 67.84 26.56 7.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.122 2.169 . . . . 0.0 113.171 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.47 4.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.995 2.118 . . . . 0.0 113.165 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.3 131.07 57.05 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.347 0.976 . . . . 0.0 110.624 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.1 138.72 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.991 0.916 . . . . 0.0 111.447 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.36 -10.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.617 1.567 . . . . 0.0 115.083 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.83 169.77 13.86 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.994 1.27 . . . . 0.0 115.715 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.59 107.82 9.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.081 2.152 . . . . 0.0 110.553 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.425 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.42 108.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.296 0.638 . . . . 0.0 110.07 175.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.3 mm -78.95 -36.54 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.215 1.006 . . . . 0.0 111.408 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -67.43 26.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.85 1.66 . . . . 0.0 114.658 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t 63.43 -178.5 0.15 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.946 2.498 . . . . 0.0 113.168 -168.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.5 m -61.64 110.68 3.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.428 1.091 . . . . 0.0 108.925 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.57 159.2 11.48 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.315 3.343 . . . . 0.0 115.431 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.98 168.2 20.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.22 38.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.935 1.694 . . . . 0.0 108.286 171.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -93.84 -14.37 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.09 172.9 2.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 130.483 3.513 . . . . 0.0 108.451 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -57.74 -50.35 73.51 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 110.967 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -66.44 3.09 1.03 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 m -97.84 124.79 42.39 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.479 1.111 . . . . 0.0 111.077 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 m -86.91 162.15 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.426 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.32 107.02 4.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.689 0.795 . . . . 0.0 109.111 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -73.28 136.27 44.52 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.991 -0.443 . . . . 0.0 109.978 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -135.64 109.55 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.497 1.119 . . . . 0.0 110.094 -168.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -73.0 130.3 40.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.272 1.029 . . . . 0.0 110.746 163.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.8 tp -151.9 144.56 24.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.995 1.318 . . . . 0.0 110.986 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -117.39 96.91 50.13 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.747 1.619 . . . . 0.0 110.77 -171.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.73 171.1 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.803 3.668 . . . . 0.0 112.564 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.94 164.33 32.15 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.477 2.118 . . . . 0.0 111.483 168.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.25 87.55 1.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.77 166.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.01 -173.47 44.09 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.856 1.217 . . . . 0.0 112.051 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.97 159.15 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.755 0.822 . . . . 0.0 110.21 165.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.442 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 18.7 m -171.39 158.3 5.23 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.475 1.11 . . . . 0.0 112.784 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.97 102.94 7.49 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.663 1.22 . . . . 0.0 110.328 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.71 125.31 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 128.599 2.759 . . . . 0.0 106.746 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.19 130.53 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.1 mt -129.16 94.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.209 1.404 . . . . 0.0 108.577 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.24 -170.52 18.07 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.421 1.963 . . . . 0.0 109.767 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.61 179.11 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.231 1.015 . . . . 0.0 110.721 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.74 -20.17 17.24 Favored Glycine 0 CA--C 1.541 1.705 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 -168.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.51 0.26 49.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -154.32 -8.46 0.14 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.62 128.08 34.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.692 1.197 . . . . 0.0 113.942 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.09 98.61 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 152.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -96.41 100.94 12.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.93 165.83 18.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 112.381 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 153.11 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.115 1.766 . . . . 0.0 114.552 -167.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -150.37 147.57 27.75 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.098 0.559 . . . . 0.0 111.843 162.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -124.19 111.88 16.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -66.97 144.13 56.39 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 111.392 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 129.102 2.961 . . . . 0.0 116.928 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mmm . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -85.24 95.99 9.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -140.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.0 p -65.87 -2.5 3.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 162.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.67 176.56 53.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.255 1.407 . . . . 0.0 113.925 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 154.01 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.69 2.396 . . . . 0.0 111.797 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -135.15 174.06 11.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.199 1.8 . . . . 0.0 110.77 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 m -123.46 144.19 49.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.601 0.76 . . . . 0.0 112.172 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.4 91.48 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 107.249 159.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -94.29 -13.41 26.51 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.913 1.285 . . . . 0.0 111.857 -163.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.3 ttpp -150.25 135.83 18.22 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.415 1.886 . . . . 0.0 109.431 148.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.76 162.81 0.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.884 2.874 . . . . 0.0 115.169 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 32.3 mtm -70.41 122.41 19.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.3 119.61 36.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.597 1.159 . . . . 0.0 110.975 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.14 157.65 34.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 0.0 112.368 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -117.37 168.48 10.32 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.783 1.233 . . . . 0.0 112.802 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -25.03 67.2 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.419 -0.801 . . . . 0.0 112.835 166.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -71.9 -7.63 49.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.485 1.914 . . . . 0.0 112.275 168.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.78 71.29 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.068 1.318 . . . . 0.0 113.964 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 p -76.61 174.44 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.314 2.246 . . . . 0.0 110.667 168.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.73 154.26 44.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.851 0.86 . . . . 0.0 110.932 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.41 125.01 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.864 1.266 . . . . 0.0 109.613 -174.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.76 127.43 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.803 1.641 . . . . 0.0 109.482 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.4 ttmt -100.56 115.43 30.13 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.717 1.144 . . . . 0.0 110.081 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.2 m -98.8 159.05 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.482 0.713 . . . . 0.0 111.707 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.86 147.95 37.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.903 2.081 . . . . 0.0 109.357 169.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -100.95 137.53 39.2 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.593 1.088 . . . . 0.0 112.552 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -135.51 1.74 2.89 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.25 -46.62 15.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.033 -0.871 . . . . 0.0 115.129 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.89 11.35 0.48 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.9 -46.96 2.74 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.591 -1.318 . . . . 0.0 114.584 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.01 163.89 3.89 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 128.098 2.559 . . . . 0.0 114.703 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.06 162.82 36.5 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.293 2.662 . . . . 0.0 113.803 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.6 m -144.26 154.96 43.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.54 1.936 . . . . 0.0 111.183 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -90.69 141.07 29.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 128.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.73 123.33 44.41 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 115.52 3.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.993 1.795 . . . . 0.0 109.687 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mt -125.81 134.54 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.88 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -132.96 169.12 17.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.771 1.228 . . . . 0.0 109.579 163.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mt -120.04 129.04 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 146.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -109.65 164.62 12.37 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.542 1.137 . . . . 0.0 112.508 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -54.84 170.26 0.18 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.386 2.275 . . . . 0.0 113.428 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.4 m -58.46 -33.0 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.232 -0.918 . . . . 0.0 112.919 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -70.6 -15.61 62.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.991 2.116 . . . . 0.0 113.759 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.4 mttm 66.74 33.73 6.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.275 2.23 . . . . 0.0 113.254 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.27 -27.67 5.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.504 1.922 . . . . 0.0 113.698 -174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -133.98 135.27 43.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.811 1.187 . . . . 0.0 111.726 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.76 136.34 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.0 111.876 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.51 -10.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.872 1.669 . . . . 0.0 114.733 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.87 169.14 12.75 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.585 1.084 . . . . 0.0 114.72 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -130.52 111.79 12.6 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.145 1.778 . . . . 0.0 110.911 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -66.58 131.63 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.734 -0.603 . . . . 0.0 109.533 172.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.61 -32.14 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.302 0.641 . . . . 0.0 111.392 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 38.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.262 1.825 . . . . 0.0 115.27 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 t 59.26 -172.68 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.964 2.106 . . . . 0.0 113.077 -171.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -70.26 108.94 3.99 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.311 1.445 . . . . 0.0 110.661 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.01 139.41 61.26 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.644 3.562 . . . . 0.0 116.035 -171.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.76 166.3 24.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.22 1.008 . . . . 0.0 113.605 177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.88 130.36 21.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.891 1.677 . . . . 0.0 108.914 171.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -83.58 -17.55 41.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.09 172.95 3.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.919 2.888 . . . . 0.0 109.181 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -51.72 -48.63 63.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.67 -0.55 13.38 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -83.01 152.05 25.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.295 0.952 . . . . 0.0 111.023 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.84 148.45 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.151 0.98 . . . . 0.0 110.451 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -137.77 108.05 6.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.803 0.441 . . . . 0.0 109.865 -174.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.91 111.94 19.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.086 1.355 . . . . 0.0 111.2 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.5 mt -115.38 112.99 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.487 1.915 . . . . 0.0 109.88 -163.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -69.93 127.81 34.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.312 1.045 . . . . 0.0 111.543 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.9 tp -146.68 144.07 29.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.442 1.897 . . . . 0.0 110.242 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -116.69 94.03 42.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.744 1.617 . . . . 0.0 110.49 -170.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -73.93 170.38 20.22 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.759 3.64 . . . . 0.0 113.158 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.11 161.78 44.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.543 2.162 . . . . 0.0 111.271 167.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.44 74.89 3.19 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.335 -0.853 . . . . 0.0 111.25 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.76 -170.66 43.09 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.647 1.594 . . . . 0.0 111.382 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -69.62 142.21 53.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.388 0.613 . . . . 0.0 111.069 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.9 p -160.0 159.39 32.05 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.137 0.975 . . . . 0.0 111.354 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -130.73 103.65 6.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.88 137.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.42 125.18 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.41 98.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.801 1.24 . . . . 0.0 109.517 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.66 -169.22 14.1 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.735 1.635 . . . . 0.0 111.331 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.9 -174.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.896 0.879 . . . . 0.0 111.881 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.71 -14.76 5.49 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.96 4.57 23.45 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 113.822 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 p -153.29 -9.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.58 107.64 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.85 1.66 . . . . 0.0 114.062 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 mt -54.75 104.97 0.13 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 159.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -111.53 88.01 2.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -168.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -119.87 140.46 50.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.712 1.244 . . . . 0.0 113.801 -160.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 136.6 54.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.601 3.16 . . . . 0.0 115.092 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -153.11 120.42 5.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -100.72 104.87 16.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.463 1.105 . . . . 0.0 109.819 166.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -60.67 140.97 57.27 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.726 -0.609 . . . . 0.0 111.31 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 128.205 2.602 . . . . 0.0 116.545 -169.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mmm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 m -73.6 102.94 4.04 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -140.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 p -66.01 -12.12 52.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.422 1.489 . . . . 0.0 113.782 166.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.38 169.41 43.44 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.268 1.413 . . . . 0.0 114.398 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 157.08 37.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.492 1.917 . . . . 0.0 113.87 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.05 167.25 19.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.253 2.621 . . . . 0.0 109.78 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -102.7 139.6 38.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.469 1.108 . . . . 0.0 110.416 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 tp -73.97 103.93 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 155.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -106.8 -14.15 15.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.743 -165.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.6 ttpp -153.08 138.73 17.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.324 1.85 . . . . 0.0 109.615 146.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.13 165.55 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.44 2.696 . . . . 0.0 114.454 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.5 mtm -70.65 135.01 48.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.13 119.29 21.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.171 1.389 . . . . 0.0 111.349 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 160.89 30.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -116.54 168.03 10.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.667 1.587 . . . . 0.0 111.992 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -26.15 64.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.198 0.999 . . . . 0.0 112.435 165.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -65.73 -10.57 38.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.735 1.614 . . . . 0.0 112.494 165.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.99 89.18 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 124.895 1.236 . . . . 0.0 113.976 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.6 p -82.0 171.18 14.71 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.905 2.482 . . . . 0.0 110.553 168.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t -125.41 148.73 48.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.256 1.022 . . . . 0.0 111.02 169.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.21 119.68 61.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.96 1.304 . . . . 0.0 108.928 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.79 146.45 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.65 1.58 . . . . 0.0 108.469 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -115.12 115.89 27.51 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 109.686 170.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -93.87 164.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 109.903 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 149.61 49.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.24 1.816 . . . . 0.0 107.406 157.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -86.05 157.85 19.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.469 1.486 . . . . 0.0 111.055 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.59 -63.23 0.84 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.155 -0.966 . . . . 0.0 110.198 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -15.5 -75.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 129.88 3.61 . . . . 0.0 117.655 -167.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -130.75 15.16 5.35 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -162.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 -44.01 2.56 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.627 -1.296 . . . . 0.0 113.809 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.4 170.3 3.07 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 128.591 2.756 . . . . 0.0 115.208 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -66.7 163.23 33.9 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.52 2.814 . . . . 0.0 113.611 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.27 151.32 38.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.241 1.816 . . . . 0.0 110.488 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -88.72 126.33 35.27 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 134.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.6 m -86.12 129.98 51.81 Favored Pre-proline 0 N--CA 1.472 0.63 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -166.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.4 Cg_endo -72.36 111.92 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.935 1.757 . . . . 0.0 109.109 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.98 131.37 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.572 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.28 169.12 16.92 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.095 164.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 mt -122.56 123.63 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 152.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -102.62 157.39 16.97 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.979 0.8 . . . . 0.0 110.211 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -58.54 174.48 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.465 1.906 . . . . 0.0 113.37 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.93 -35.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.995 -1.066 . . . . 0.0 113.037 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -72.57 -16.71 61.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.891 2.076 . . . . 0.0 113.597 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttm 68.28 27.44 6.62 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.057 2.543 . . . . 0.0 113.512 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.89 -38.74 7.26 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.616 1.966 . . . . 0.0 111.823 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -124.17 137.37 54.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.707 1.14 . . . . 0.0 111.632 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -68.87 134.16 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.597 1.159 . . . . 0.0 110.666 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.34 -9.16 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.242 1.417 . . . . 0.0 114.618 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.94 167.98 12.72 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.438 1.017 . . . . 0.0 114.928 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -130.81 110.83 11.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.224 1.81 . . . . 0.0 110.403 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.54 115.63 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.635 0.774 . . . . 0.0 109.501 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 mm -93.53 -39.87 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.199 1.0 . . . . 0.0 111.711 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -63.64 8.73 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t 97.7 179.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.504 3.522 . . . . 0.0 110.149 -163.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.3 p -65.07 114.58 15.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.793 1.237 . . . . 0.0 109.74 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.05 136.18 44.73 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.323 2.682 . . . . 0.0 114.057 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.14 166.97 23.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -140.37 131.64 26.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.084 2.153 . . . . 0.0 108.279 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -85.29 -18.41 33.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.93 172.41 5.55 Favored 'General case' 0 CA--C 1.549 0.912 1 C-N-CA 131.769 4.027 . . . . 0.0 108.639 175.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -54.81 7.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.19 1.396 . . . . 0.0 112.216 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -66.87 -1.07 3.51 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 m -74.37 121.59 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.813 1.188 . . . . 0.0 111.057 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -90.34 146.63 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.34 0.656 . . . . 0.0 110.758 162.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 m -139.5 110.99 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.637 0.775 . . . . 0.0 109.57 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.52 134.71 37.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 110.548 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.6 mt -139.36 106.85 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.965 1.306 . . . . 0.0 109.599 -166.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -65.5 127.84 33.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.923 1.289 . . . . 0.0 111.955 161.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 tp -147.75 146.08 29.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.978 2.111 . . . . 0.0 110.111 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.18 96.6 50.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 111.524 -171.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.17 170.0 19.26 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.437 3.424 . . . . 0.0 113.108 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.27 166.55 28.92 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.456 2.104 . . . . 0.0 111.157 166.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -74.8 77.43 2.09 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.327 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.59 -169.18 42.1 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.746 1.165 . . . . 0.0 112.149 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.86 143.12 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.073 0.949 . . . . 0.0 110.481 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 m -164.57 169.26 17.29 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.997 -1.064 . . . . 0.0 112.698 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -125.97 107.55 10.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 110.736 -169.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.0 124.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 127.922 2.489 . . . . 0.0 107.055 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.69 123.23 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.5 mt -125.35 99.88 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.318 1.447 . . . . 0.0 108.719 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.6 -169.15 13.37 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 127.07 2.272 . . . . 0.0 110.242 -161.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.52 -177.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.636 1.218 . . . . 0.0 111.675 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.32 -18.29 6.79 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.95 2.91 44.05 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.18 1.49 . . . . 0.0 114.267 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 p -157.97 -11.36 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.2 117.45 6.07 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.665 1.186 . . . . 0.0 114.106 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 mt -52.54 104.73 0.1 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 156.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.4 m -110.66 94.54 5.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.97 160.35 27.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.276 1.031 . . . . 0.0 112.455 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.7 148.38 25.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.425 1.49 . . . . 0.0 114.292 -161.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -149.77 147.39 27.96 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 171.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.04 107.15 11.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.32 1.048 . . . . 0.0 108.885 164.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -63.32 140.01 58.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.257 0.623 . . . . 0.0 111.559 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 128.534 2.734 . . . . 0.0 116.228 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mmm . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.79 138.69 52.92 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -143.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -132.04 13.3 4.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.659 1.184 . . . . 0.0 113.388 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.34 175.03 15.64 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.868 1.699 . . . . 0.0 112.549 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -71.45 157.86 37.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -127.5 173.86 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.119 2.568 . . . . 0.0 110.332 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.97 139.1 47.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.066 1.746 . . . . 0.0 109.927 165.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tp -75.81 89.51 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 160.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.48 -12.84 41.83 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.789 1.235 . . . . 0.0 112.379 -164.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.1 ttpp -149.38 142.95 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.647 1.579 . . . . 0.0 109.663 149.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 167.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.777 2.431 . . . . 0.0 113.701 166.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 141.89 31.85 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 120.78 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.913 1.285 . . . . 0.0 110.654 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.44 162.01 23.47 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 p -116.9 178.65 4.27 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.792 1.637 . . . . 0.0 112.528 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -17.01 63.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.141 0.976 . . . . 0.0 113.444 166.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -75.87 -10.73 59.67 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.906 1.23 . . . . 0.0 112.118 164.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.84 8.13 32.78 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.485 -1.384 . . . . 0.0 113.306 -164.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.1 p -66.23 160.3 24.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.996 1.398 . . . . 0.0 108.879 162.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -126.67 144.04 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.893 0.877 . . . . 0.0 110.627 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -105.03 118.91 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.523 1.129 . . . . 0.0 109.172 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.19 129.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -104.13 110.03 22.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.341 0.973 . . . . 0.0 110.253 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -86.05 163.78 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.533 0.733 . . . . 0.0 110.375 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.2 155.61 43.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.581 1.952 . . . . 0.0 108.156 157.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -108.95 142.4 39.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.367 1.439 . . . . 0.0 113.177 -170.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -128.96 -24.29 2.94 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.29 73.37 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 117.406 1.722 . . . . 0.0 117.406 -163.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.61 1.51 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.95 -41.1 1.04 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 120.177 1.353 . . . . 0.0 115.193 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.04 171.5 6.42 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.288 2.635 . . . . 0.0 114.146 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.28 159.3 35.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.608 2.872 . . . . 0.0 114.39 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.52 152.73 29.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.122 1.769 . . . . 0.0 110.476 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 132.88 35.82 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 142.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -94.29 124.74 54.76 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -170.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -67.11 114.05 3.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 109.374 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.8 mt -120.43 123.34 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.256 1.022 . . . . 0.0 108.769 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.49 174.47 10.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.561 0.744 . . . . 0.0 109.931 167.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 mt -124.1 130.01 73.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 153.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -110.83 160.32 16.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.133 0.968 . . . . 0.0 111.126 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -58.63 176.07 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.852 2.461 . . . . 0.0 114.083 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.32 -29.96 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.007 -1.058 . . . . 0.0 112.945 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -71.96 -17.7 62.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.215 1.406 . . . . 0.0 112.974 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 45.7 mttp 67.66 29.9 6.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.304 2.641 . . . . 0.0 112.954 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.15 -29.99 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.763 1.625 . . . . 0.0 113.487 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -122.45 131.4 53.85 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.896 1.225 . . . . 0.0 110.894 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.79 135.68 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.346 1.458 . . . . 0.0 111.656 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.53 -7.01 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.78 168.63 12.61 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.855 1.207 . . . . 0.0 115.27 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -131.31 118.1 19.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.756 1.622 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.498 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -77.87 99.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.348 1.059 . . . . 0.0 111.101 -177.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.81 -49.49 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.033 0.933 . . . . 0.0 111.876 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.2 t -63.03 -4.97 2.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m 62.82 -12.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.935 2.494 . . . . 0.0 117.692 158.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.6 p -120.16 59.71 6.6 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.481 1.512 . . . . 0.0 113.663 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -58.04 84.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.832 3.022 . . . . 0.0 113.786 163.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.42 166.99 23.2 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.67 137.31 36.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.445 2.698 . . . . 0.0 108.32 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -102.77 -7.49 21.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.662 1.185 . . . . 0.0 112.962 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.25 170.77 11.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 130.17 3.388 . . . . 0.0 108.258 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -44.62 41.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.319 0.648 . . . . 0.0 111.794 167.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -66.76 -6.08 14.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.112 1.765 . . . . 0.0 114.429 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -73.58 101.56 3.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.42 1.009 . . . . 0.0 111.345 174.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 m -73.88 135.46 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.434 158.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -137.95 108.06 6.4 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.779 0.432 . . . . 0.0 110.828 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.58 121.63 25.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.283 1.433 . . . . 0.0 111.833 170.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mm -124.49 115.84 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 126.129 1.772 . . . . 0.0 110.188 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.58 127.95 34.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.405 1.082 . . . . 0.0 110.898 161.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 tp -141.4 145.19 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.359 2.263 . . . . 0.0 109.561 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -113.73 101.05 53.39 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.162 1.385 . . . . 0.0 110.901 -171.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.66 168.91 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.348 3.365 . . . . 0.0 113.135 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.31 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.261 1.974 . . . . 0.0 110.857 162.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -76.32 75.4 3.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.087 -1.008 . . . . 0.0 111.748 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.94 -166.94 39.27 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.987 1.279 . . . . 0.0 112.492 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.99 135.67 47.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.961 1.304 . . . . 0.0 110.626 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -163.38 173.5 13.14 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.075 -1.015 . . . . 0.0 112.098 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.452 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 90.5 m-85 -125.67 105.0 8.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.743 0.817 . . . . 0.0 110.765 -165.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.95 129.86 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.976 1.711 . . . . 0.0 106.841 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.69 122.66 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.79 98.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.575 1.15 . . . . 0.0 109.223 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.56 -176.99 16.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.025 2.25 . . . . 0.0 111.279 -162.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.95 177.21 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.638 1.175 . . . . 0.0 111.57 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.27 -17.18 5.42 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 117.675 1.83 . . . . 0.0 117.675 -170.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.39 6.36 44.47 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.514 1.657 . . . . 0.0 113.992 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -162.75 -1.23 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.57 114.88 3.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.512 1.525 . . . . 0.0 114.282 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.63 103.35 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 157.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 m -112.32 92.83 4.17 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -126.51 148.73 49.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.814 1.292 . . . . 0.0 113.908 -166.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 139.84 47.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.683 2.393 . . . . 0.0 114.132 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -140.03 153.57 46.86 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.417 0.687 . . . . 0.0 110.718 156.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -124.48 115.45 20.92 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 165.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -66.65 134.35 52.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.24 0.473 . . . . 0.0 111.865 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' H3 ' ' CD ' ' A' ' 2' ' ' GLU . 5.3 mpp? . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 111.268 0.099 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.431 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -37.46 -52.59 1.15 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.129 2.971 . . . . 0.0 115.566 165.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -140.62 -36.21 0.48 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 128.461 2.704 . . . . 0.0 110.992 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.11 87.13 1.89 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.58 1.152 . . . . 0.0 107.922 163.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.407 ' HD3' ' CZ ' ' A' ' 11' ' ' TYR . 11.4 ptm180 -159.5 174.33 14.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.924 2.09 . . . . 0.0 110.972 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -71.55 82.45 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.806 0.842 . . . . 0.0 110.387 168.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -51.0 -56.59 11.74 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.077 2.151 . . . . 0.0 114.497 -167.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.6 -21.79 74.84 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.819 0.723 . . . . 0.0 114.144 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -89.76 -70.43 0.66 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.428 1.091 . . . . 0.0 109.466 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 93.2 p -70.08 14.62 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.861 2.464 . . . . 0.0 117.164 -161.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 5' ' ' ARG . 2.2 m-85 -121.99 156.6 33.11 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.517 1.127 . . . . 0.0 111.537 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -149.75 93.72 2.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.097 2.559 . . . . 0.0 106.122 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.1 mmm -120.9 -92.51 0.54 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -151.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.4 m -86.98 96.65 10.34 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -143.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.6 p -67.37 -10.74 54.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.895 1.678 . . . . 0.0 114.549 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.39 170.4 48.2 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.75 1.167 . . . . 0.0 113.726 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.18 158.04 27.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.446 1.498 . . . . 0.0 111.616 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -132.4 167.88 19.13 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.573 2.349 . . . . 0.0 110.616 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -108.46 139.7 42.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.387 1.075 . . . . 0.0 110.807 165.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tp -71.09 113.43 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 154.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.21 -14.11 9.29 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.807 0.843 . . . . 0.0 112.51 -162.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.1 ttpp -147.82 141.19 25.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.575 1.55 . . . . 0.0 109.013 144.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' HE3' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -50.47 161.95 0.27 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.358 2.263 . . . . 0.0 114.287 170.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 57.5 mtm -77.95 131.35 37.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.77 130.04 46.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.549 1.54 . . . . 0.0 110.708 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -82.77 159.86 22.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.03 0.932 . . . . 0.0 113.127 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -115.54 168.27 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.175 1.39 . . . . 0.0 112.481 -173.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.21 65.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.749 0.82 . . . . 0.0 112.581 166.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -67.21 -10.14 47.48 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.192 1.797 . . . . 0.0 112.152 167.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.92 78.15 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.19 1.376 . . . . 0.0 114.013 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -76.01 171.72 13.97 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 127.076 2.15 . . . . 0.0 110.582 167.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.54 154.33 43.99 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.107 0.963 . . . . 0.0 110.782 169.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.44 105.93 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.599 1.16 . . . . 0.0 109.637 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.93 164.3 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.662 1.185 . . . . 0.0 109.253 167.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.6 tmmt? -132.29 128.39 37.68 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.238 -0.914 . . . . 0.0 109.891 155.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.0 161.57 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.531 1.132 . . . . 0.0 111.033 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.81 145.64 51.69 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.514 1.926 . . . . 0.0 107.949 161.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -81.66 155.26 25.68 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.778 1.172 . . . . 0.0 110.69 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -124.86 -63.08 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.696 0.799 . . . . 0.0 109.567 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -8.69 -77.7 0.01 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 130.233 3.778 . . . . 0.0 118.362 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.63 15.31 3.15 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -157.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.8 -54.56 4.68 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.701 -1.249 . . . . 0.0 112.842 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.74 164.3 3.21 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.747 2.419 . . . . 0.0 114.969 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.18 164.0 21.26 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.397 2.732 . . . . 0.0 113.979 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 70.7 m -141.55 148.43 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.072 1.749 . . . . 0.0 111.102 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -86.22 141.02 29.61 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.5 -1.28 . . . . 0.0 108.035 126.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.38 129.0 25.85 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.535 -168.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.64 117.41 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.082 1.855 . . . . 0.0 109.617 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.39 127.22 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.228 1.011 . . . . 0.0 109.107 168.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.05 170.04 11.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.657 0.783 . . . . 0.0 109.144 161.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.4 mt -121.41 131.71 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 153.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mtt-85 -115.62 153.58 31.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.415 1.086 . . . . 0.0 111.015 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -62.76 176.03 0.74 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.364 1.466 . . . . 0.0 112.718 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.0 -39.62 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 120.803 -1.186 . . . . 0.0 112.711 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -72.14 -18.52 61.88 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.423 1.889 . . . . 0.0 113.399 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.27 20.6 mttm 74.19 4.84 4.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 129.426 3.09 . . . . 0.0 114.529 175.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.49 -43.34 63.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.259 2.224 . . . . 0.0 113.053 173.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -109.21 133.39 53.08 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.048 0.84 . . . . 0.0 110.997 -165.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -74.73 134.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.857 0.863 . . . . 0.0 110.256 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -134.67 -8.11 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.68 168.68 12.86 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.617 1.099 . . . . 0.0 114.759 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -131.25 122.18 26.06 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.148 1.779 . . . . 0.0 109.724 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.455 HD12 ' H ' ' A' ' 63' ' ' ILE . 1.2 mp -76.02 138.07 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.895 0.77 . . . . 0.0 109.848 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -110.85 -34.98 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.065 0.946 . . . . 0.0 111.798 -172.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.4 t -68.56 38.44 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.604 1.962 . . . . 0.0 114.866 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.8 t 57.12 -172.33 0.08 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.573 1.949 . . . . 0.0 112.889 -168.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -64.23 109.54 2.85 Favored Pre-proline 0 C--O 1.246 0.889 0 C-N-CA 125.243 1.417 . . . . 0.0 110.175 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.04 136.38 60.92 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 124.465 3.444 . . . . 0.0 114.918 -172.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.94 160.91 39.45 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.485 1.114 . . . . 0.0 112.806 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.64 123.5 11.98 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.52 1.528 . . . . 0.0 108.823 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -72.1 -22.49 61.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -170.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.38 169.68 10.44 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.871 2.468 . . . . 0.0 109.742 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -52.5 -45.64 66.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.294 1.038 . . . . 0.0 111.438 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -70.93 0.95 6.24 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.0 m -100.41 158.31 15.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.291 1.405 . . . . 0.0 112.376 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.74 154.23 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 125.079 1.352 . . . . 0.0 110.741 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 m -142.05 115.98 9.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.205 0.602 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -68.92 134.4 49.52 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.096 0.959 . . . . 0.0 110.341 164.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 mm -132.04 104.62 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.803 1.241 . . . . 0.0 109.947 -173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -68.51 131.17 44.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.793 0.837 . . . . 0.0 111.172 161.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 tp -150.12 145.16 26.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.063 1.745 . . . . 0.0 110.649 -163.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -119.72 94.62 48.66 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.523 1.529 . . . . 0.0 110.77 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.21 168.3 20.5 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.967 3.778 . . . . 0.0 112.712 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.92 165.65 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.183 1.922 . . . . 0.0 111.544 169.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -75.41 74.99 2.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.854 0.862 . . . . 0.0 111.702 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.43 -167.09 38.89 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.77 1.176 . . . . 0.0 112.374 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.17 140.28 52.52 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.688 1.195 . . . . 0.0 110.543 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.0 m -163.6 171.11 16.22 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.835 -1.166 . . . . 0.0 112.361 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -128.34 101.29 6.15 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.572 1.149 . . . . 0.0 109.867 -169.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.2 136.66 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.23 122.72 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 118.419 0.554 . . . . 0.0 109.61 174.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.6 mt -123.82 105.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.765 1.226 . . . . 0.0 109.844 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.99 172.14 20.3 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.647 2.07 . . . . 0.0 111.097 -162.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 m -95.8 129.23 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.3 1.05 . . . . 0.0 110.687 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 26.28 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.413 0 C-N-CA 127.774 2.607 . . . . 0.0 116.081 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.95 -27.77 8.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.052 1.741 . . . . 0.0 115.474 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.8 m -101.29 -3.63 28.56 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.552 1.941 . . . . 0.0 112.932 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.31 109.83 16.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.288 1.035 . . . . 0.0 113.089 -166.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 mt -53.85 98.98 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.951 162.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.8 m -103.63 89.53 3.38 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -170.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -118.66 139.29 51.76 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.586 1.184 . . . . 0.0 113.484 -165.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.99 142.48 55.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.708 2.403 . . . . 0.0 114.208 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -145.53 153.81 41.51 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 123.888 0.875 . . . . 0.0 111.267 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -135.5 111.62 9.63 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.568 1.147 . . . . 0.0 108.973 168.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -68.49 144.1 54.75 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.929 -0.482 . . . . 0.0 111.647 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.17 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 129.653 3.181 . . . . 0.0 115.69 -172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.97 50.93 4.25 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.896 1.236 . . . . 0.0 111.209 158.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.0 m -59.54 20.06 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 131.611 3.964 . . . . 0.0 118.59 -154.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 m -157.51 9.99 0.19 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.43 -1.419 . . . . 0.0 114.537 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.65 -28.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.531 1.059 . . . . 0.0 111.249 173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.13 158.4 15.39 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 156.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 23' ' ' GLU . 26.4 mmmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 127.182 2.193 . . . . 0.0 112.52 -170.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.04 -86.93 0.47 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 129.108 2.963 . . . . 0.0 108.99 -160.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -66.85 -40.97 88.08 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.587 1.155 . . . . 0.0 110.531 157.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.8 mt -81.04 69.21 7.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.217 0.462 . . . . 0.0 110.145 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -167.17 177.54 6.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.636 2.375 . . . . 0.0 111.46 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.36 77.17 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-O 122.835 1.302 . . . . 0.0 110.575 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.76 -52.32 24.35 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.045 2.538 . . . . 0.0 115.11 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.8 -34.62 61.34 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.133 0.873 . . . . 0.0 114.816 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -99.78 -39.37 8.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 117.963 0.882 . . . . 0.0 112.818 177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.4 p -82.48 2.58 32.08 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -103.8 149.4 25.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.535 1.061 . . . . 0.0 111.952 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -146.73 90.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.913 2.485 . . . . 0.0 106.465 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.56 -104.69 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 -145.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.67 109.01 18.9 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -133.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -72.33 -13.33 61.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.746 1.618 . . . . 0.0 114.506 164.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.53 163.13 54.75 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.347 0.975 . . . . 0.0 113.317 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 158.93 34.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.967 0.907 . . . . 0.0 112.792 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -129.1 166.73 18.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.652 1.981 . . . . 0.0 110.239 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.39 137.2 54.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.58 1.952 . . . . 0.0 111.038 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 tp -80.15 95.47 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.941 1.296 . . . . 0.0 108.711 172.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -94.98 -11.71 28.0 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 112.633 -165.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.4 ttpp -152.71 137.77 17.28 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.123 1.769 . . . . 0.0 109.379 151.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.62 168.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 129.073 2.949 . . . . 0.0 114.749 168.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 mtm -77.29 123.55 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.52 118.11 29.39 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.087 1.355 . . . . 0.0 110.256 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -83.11 161.79 21.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.312 1.045 . . . . 0.0 113.703 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 p -118.01 169.62 9.51 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.426 1.49 . . . . 0.0 112.512 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -27.99 66.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.855 0.862 . . . . 0.0 112.387 166.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -65.06 -12.91 55.82 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.38 1.872 . . . . 0.0 112.469 168.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.32 -5.05 79.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.166 1.365 . . . . 0.0 113.6 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -69.71 167.65 16.6 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 111.43 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 t -127.27 148.38 50.22 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.063 1.345 . . . . 0.0 110.072 169.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.51 116.25 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.526 1.13 . . . . 0.0 109.037 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.68 131.39 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.783 1.633 . . . . 0.0 108.946 -173.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 5.9 ttmt -102.52 111.61 23.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.283 0.947 . . . . 0.0 109.606 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -87.6 157.0 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 122.585 0.354 . . . . 0.0 110.065 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -130.04 143.34 50.74 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.057 2.143 . . . . 0.0 107.491 160.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.85 154.74 26.94 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.586 1.085 . . . . 0.0 110.725 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -124.34 -63.13 1.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.54 0.736 . . . . 0.0 110.712 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -18.73 -80.15 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 129.391 3.377 . . . . 0.0 117.793 -164.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.58 22.12 6.45 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -161.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.6 -49.15 3.82 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 120.917 -1.115 . . . . 0.0 114.327 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.6 178.73 1.71 Allowed Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 128.424 2.689 . . . . 0.0 114.761 -170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.75 166.28 14.18 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 124.255 3.303 . . . . 0.0 115.705 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.0 m -148.13 154.36 40.07 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.428 1.891 . . . . 0.0 111.286 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -92.12 138.67 31.34 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 128.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.29 125.11 44.57 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -66.14 101.19 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.305 2.003 . . . . 0.0 110.532 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.8 mt -106.84 130.94 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.099 0.96 . . . . 0.0 110.568 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.79 166.79 20.06 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.563 0.745 . . . . 0.0 110.461 157.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.49 130.61 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 146.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -111.83 162.67 15.03 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.615 1.166 . . . . 0.0 112.916 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -55.9 169.03 0.39 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.86 2.064 . . . . 0.0 113.351 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.3 m -58.25 -28.93 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.317 -0.864 . . . . 0.0 112.898 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -74.92 -17.07 60.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.235 1.814 . . . . 0.0 113.718 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 49.8 mttp 69.85 28.19 4.35 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 127.234 2.214 . . . . 0.0 113.205 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -115.26 -28.42 6.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.646 1.978 . . . . 0.0 113.173 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -132.6 138.19 47.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.694 1.134 . . . . 0.0 112.255 -170.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.73 133.45 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.292 1.837 . . . . 0.0 111.213 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.51 -8.9 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 0.0 114.112 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.72 168.75 13.05 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 119.578 1.081 . . . . 0.0 115.257 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.55 114.1 14.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.068 1.747 . . . . 0.0 110.854 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -74.92 102.38 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.08 0.952 . . . . 0.0 110.186 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.4 mm -76.36 -42.34 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.421 1.089 . . . . 0.0 111.767 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.5 t -70.49 36.94 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.649 1.98 . . . . 0.0 115.78 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 t 62.66 -174.92 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.708 2.003 . . . . 0.0 113.588 -175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.2 p -59.5 107.01 0.84 Allowed Pre-proline 0 N--CA 1.473 0.697 0 C-N-CA 127.584 2.354 . . . . 0.0 111.859 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -55.21 121.1 9.3 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.356 3.37 . . . . 0.0 114.57 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.05 165.93 26.17 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.89 148.59 34.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.82 1.648 . . . . 0.0 109.953 169.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -99.67 -21.46 15.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 112.173 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.6 165.03 19.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.76 1.624 . . . . 0.0 111.296 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.8 m -57.98 -28.56 64.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.328 1.051 . . . . 0.0 112.759 168.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -81.48 -4.24 55.34 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 m -83.79 155.97 22.74 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.621 1.1 . . . . 0.0 112.244 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.7 m -131.69 149.61 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 124.82 1.248 . . . . 0.0 110.204 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -138.62 107.42 5.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.39 0.676 . . . . 0.0 109.492 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.72 121.09 23.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.226 1.01 . . . . 0.0 110.939 169.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -126.88 111.84 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.716 1.606 . . . . 0.0 109.131 -168.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -67.42 126.57 29.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 110.765 161.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 tp -143.3 144.72 32.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.785 2.034 . . . . 0.0 109.527 -172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -114.46 100.21 52.61 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.413 1.485 . . . . 0.0 110.805 -170.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.19 175.31 10.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.472 3.448 . . . . 0.0 112.893 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -76.67 167.15 25.96 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.396 2.731 . . . . 0.0 111.518 165.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -76.97 78.43 3.52 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.841 -1.162 . . . . 0.0 111.679 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.57 -166.66 39.41 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.257 0.932 . . . . 0.0 112.3 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.66 143.79 54.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.153 0.501 . . . . 0.0 110.761 165.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.0 p -160.27 157.74 28.63 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.938 0.895 . . . . 0.0 111.64 -170.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.489 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 96.1 m-85 -129.3 102.57 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.935 0.874 . . . . 0.0 111.446 -171.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.71 137.22 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.691 1.996 . . . . 0.0 107.568 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.37 129.4 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 168.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -130.86 97.91 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.649 1.18 . . . . 0.0 109.343 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.44 -175.78 15.9 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 127.11 2.29 . . . . 0.0 111.245 -167.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.2 135.17 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 118.473 1.137 . . . . 0.0 111.418 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.27 -117.48 0.91 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.253 1.406 . . . . 0.0 114.158 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -70.43 -9.7 57.13 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.1 m -86.64 -11.23 51.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.518 1.127 . . . . 0.0 112.89 165.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.05 116.84 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.843 0.857 . . . . 0.0 112.583 -172.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 mt -54.8 102.47 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 158.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.7 m -112.95 93.31 4.36 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -168.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -131.94 157.42 44.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.746 1.26 . . . . 0.0 114.018 -162.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 135.96 33.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.331 2.652 . . . . 0.0 114.355 -165.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.5 t-105 -143.84 118.83 10.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 165.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -91.76 105.67 17.9 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.585 1.154 . . . . 0.0 110.148 164.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 139.09 58.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm 56.26 22.81 6.53 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.471 1.908 . . . . 0.0 114.062 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -154.63 -24.14 0.04 OUTLIER Glycine 0 CA--C 1.534 1.249 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 t 58.78 8.04 0.87 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.598 2.199 . . . . 0.0 114.779 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.5 p -47.81 -42.96 27.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.536 2.335 . . . . 0.0 115.382 -165.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.2 tp -126.87 16.8 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 126.15 1.78 . . . . 0.0 110.958 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -125.36 130.71 7.4 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 125.069 1.319 . . . . 0.0 113.074 -165.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--O 1.255 1.384 0 C-N-CA 126.752 2.021 . . . . 0.0 112.048 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.69 -52.2 11.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.883 2.473 . . . . 0.0 113.983 166.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 7.9 mtmp? -127.43 -39.96 1.82 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 128.219 2.608 . . . . 0.0 111.347 -174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.52 89.5 1.28 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 169.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 12.2 ptm180 -161.05 173.02 15.82 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.381 2.272 . . . . 0.0 110.165 -176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mm -73.4 82.29 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 123.531 0.732 . . . . 0.0 109.322 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -55.14 -27.99 49.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.359 1.464 . . . . 0.0 113.428 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.82 -53.81 12.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 127.224 2.345 . . . . 0.0 113.852 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -128.34 -15.57 4.59 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.7 p -81.86 3.16 27.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.748 1.158 . . . . 0.0 114.081 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' CE1' ' HD3' ' A' ' 5' ' ' ARG . 6.5 m-30 -124.35 139.7 53.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.235 1.814 . . . . 0.0 109.117 166.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 p -140.98 92.15 2.47 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.84 2.056 . . . . 0.0 106.955 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 87.6 mmm -124.49 -109.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 -148.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.38 113.02 20.86 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -135.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.7 p -68.67 -10.97 59.42 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.54 1.536 . . . . 0.0 114.564 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.3 170.68 44.58 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.279 0.942 . . . . 0.0 114.793 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 156.17 28.26 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.183 1.793 . . . . 0.0 111.484 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 82.6 m-85 -130.7 167.48 18.74 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.416 2.286 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -107.97 137.31 46.18 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.561 1.144 . . . . 0.0 111.054 167.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.8 tp -75.35 92.7 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 159.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.91 -13.2 25.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.754 1.222 . . . . 0.0 112.088 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -149.04 142.38 25.16 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.374 1.47 . . . . 0.0 109.535 148.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.36 162.68 0.13 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.211 2.204 . . . . 0.0 113.845 167.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.4 mtm -74.19 132.3 42.06 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.08 122.21 35.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.858 1.263 . . . . 0.0 110.418 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -80.82 160.89 24.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.5 p -113.65 169.56 8.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.655 1.582 . . . . 0.0 112.006 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.92 69.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.975 0.91 . . . . 0.0 112.287 165.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -68.67 -11.14 59.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.595 1.958 . . . . 0.0 112.764 171.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.42 -3.1 79.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.726 1.155 . . . . 0.0 113.818 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -72.7 165.35 24.95 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.445 1.898 . . . . 0.0 111.076 166.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 t -125.95 146.18 49.97 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.706 1.203 . . . . 0.0 110.405 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.98 118.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 109.164 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.39 124.96 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.607 1.563 . . . . 0.0 109.161 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -95.55 110.8 22.83 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.313 0.961 . . . . 0.0 109.233 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.88 161.53 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.151 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 152.54 49.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.272 1.829 . . . . 0.0 107.733 156.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -87.92 159.01 18.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.199 1.363 . . . . 0.0 110.966 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -130.95 -52.9 1.05 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.275 -0.891 . . . . 0.0 110.843 173.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.38 -11.21 46.27 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 120.252 2.861 . . . . 0.0 120.252 -151.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.31 2.64 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 121.61 2.705 . . . . 0.0 117.112 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.88 -56.77 4.29 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-N 120.522 1.51 . . . . 0.0 113.061 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.65 173.98 5.03 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 127.371 2.269 . . . . 0.0 114.269 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.66 164.81 22.63 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.031 3.154 . . . . 0.0 116.193 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.2 m -147.61 151.18 35.79 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.509 2.324 . . . . 0.0 111.391 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 142.61 28.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 129.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.25 1.0 OUTLIER -104.2 134.86 19.48 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.724 -169.576 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -72.84 106.42 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.247 1.965 . . . . 0.0 109.112 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 mt -115.14 130.69 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.548 0.739 . . . . 0.0 109.757 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -134.06 172.98 12.08 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.014 0.926 . . . . 0.0 110.048 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 ' HG ' ' A' ' 81' ' ' LEU . 5.0 mt -126.42 125.71 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 156.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -109.15 162.89 13.85 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.922 0.868 . . . . 0.0 111.148 172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -57.74 173.67 0.29 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.622 2.369 . . . . 0.0 113.487 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.1 m -56.57 -34.9 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 120.874 -1.141 . . . . 0.0 112.71 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -71.8 -14.07 61.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.563 1.945 . . . . 0.0 113.495 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mttm 67.99 22.98 8.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.267 2.627 . . . . 0.0 113.662 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -108.74 -32.76 7.2 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.49 1.916 . . . . 0.0 112.692 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -127.15 135.82 51.24 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.249 1.386 . . . . 0.0 111.954 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.76 135.38 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.495 1.518 . . . . 0.0 111.625 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.93 -11.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.559 1.544 . . . . 0.0 114.622 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.97 171.01 13.65 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -170.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 mtm-85 -133.1 128.89 37.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.676 1.59 . . . . 0.0 110.729 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 63' ' ' ILE . 1.9 mp -79.72 124.09 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.1 mm -96.52 -36.99 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.568 0.747 . . . . 0.0 111.282 -175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.8 t -68.63 35.29 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 126.296 1.838 . . . . 0.0 114.617 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.76 -170.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.899 2.08 . . . . 0.0 113.641 -175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -64.0 108.6 1.96 Allowed Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.929 2.092 . . . . 0.0 111.157 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -55.05 143.78 72.05 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.31 3.34 . . . . 0.0 115.495 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -147.46 166.27 27.74 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.96 121.93 11.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.458 1.903 . . . . 0.0 108.168 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.52 -17.29 59.34 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.584 -0.697 . . . . 0.0 112.677 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.53 170.26 16.08 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.319 2.648 . . . . 0.0 109.419 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 m -50.5 -49.9 54.31 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.312 1.045 . . . . 0.0 110.464 163.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -67.03 -3.54 7.49 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.8 m -85.24 144.18 28.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 120.148 1.34 . . . . 0.0 112.093 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.02 150.96 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.045 1.338 . . . . 0.0 110.637 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 m -141.77 115.59 9.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.98 122.75 32.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 111.568 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.5 mt -128.73 111.51 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 124.819 1.248 . . . . 0.0 109.827 -162.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.1 124.59 23.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.141 1.376 . . . . 0.0 111.42 165.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 51' ' ' ILE . 57.4 tp -141.02 142.92 34.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.074 2.149 . . . . 0.0 110.013 -166.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -119.23 98.99 50.7 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 111.407 -167.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -79.82 168.77 18.89 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.483 3.455 . . . . 0.0 113.573 173.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.49 165.13 32.81 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.946 2.431 . . . . 0.0 111.019 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -72.67 73.42 1.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.27 -0.894 . . . . 0.0 112.004 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -173.44 46.14 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.148 0.88 . . . . 0.0 113.789 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -62.54 129.61 41.39 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.13 0.972 . . . . 0.0 110.163 174.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 m -145.56 150.5 36.52 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.279 1.432 . . . . 0.0 111.011 -163.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.58 98.17 5.61 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.957 0.884 . . . . 0.0 111.317 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.82 126.44 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.391 1.876 . . . . 0.0 107.259 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.47 123.96 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.871 0.868 . . . . 0.0 109.039 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.1 mt -128.16 98.58 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.031 1.332 . . . . 0.0 109.256 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.93 -174.57 15.84 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 127.657 2.551 . . . . 0.0 110.649 -164.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.3 m -106.11 164.54 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.506 1.153 . . . . 0.0 110.585 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -10.14 -74.5 0.01 OUTLIER Glycine 0 CA--C 1.541 1.707 0 C-N-CA 127.55 2.5 . . . . 0.0 117.682 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -4.3 58.68 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -174.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.9 p -122.91 -10.29 8.23 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.295 1.838 . . . . 0.0 114.025 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.15 118.53 6.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.582 1.953 . . . . 0.0 112.67 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.5 mt -56.67 98.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 154.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 83.4 m -101.08 95.57 6.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.94 154.35 39.9 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.816 1.293 . . . . 0.0 113.735 -170.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.38 137.89 33.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.917 2.487 . . . . 0.0 114.267 -169.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -134.64 156.48 48.67 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.201 1.0 . . . . 0.0 111.129 162.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -129.8 111.06 12.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 162.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -63.26 135.33 57.0 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm 55.46 30.9 15.9 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.528 1.931 . . . . 0.0 113.705 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -156.53 -25.71 0.03 OUTLIER Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.781 1.472 . . . . 0.0 116.781 169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.5 t 52.35 -96.2 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.83 1.815 . . . . 0.0 112.144 -174.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.3 p 55.87 -101.34 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.197 1.799 . . . . 0.0 113.067 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.19 -21.13 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.368 1.867 . . . . 0.0 113.125 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.9 113.69 4.71 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.479 1.514 . . . . 0.0 112.387 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.455 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 3.2 mmpt? . . . . . 0 C--O 1.251 1.139 0 C-N-CA 126.982 2.113 . . . . 0.0 112.674 173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.73 -0.1 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.08 -54.07 0.99 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 130.05 3.34 . . . . 0.0 115.009 166.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -144.31 -28.15 0.5 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.8 2.04 . . . . 0.0 112.519 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.2 mt -69.31 80.11 0.37 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.67 1.188 . . . . 0.0 108.465 164.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -159.4 171.48 19.68 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.975 2.91 . . . . 0.0 108.88 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.98 81.95 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 O-C-N 121.542 -0.724 . . . . 0.0 109.621 162.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -40.88 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.481 2.712 . . . . 0.0 114.199 -163.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.24 -58.22 12.61 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.243 1.402 . . . . 0.0 113.008 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -49.92 75.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.94 0.87 . . . . 0.0 113.001 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.9 p -81.95 -10.34 59.3 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -168.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -76.46 159.69 30.19 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.759 1.163 . . . . 0.0 112.484 171.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.4 p -139.42 91.17 2.47 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.367 1.867 . . . . 0.0 106.474 161.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.44 -110.03 0.33 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -145.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.62 99.56 8.2 Favored 'General case' 0 N--CA 1.458 -0.056 0 O-C-N 121.106 -0.996 . . . . 0.0 113.36 -145.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.5 m -68.64 -6.44 25.92 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.517 166.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.46 172.24 53.83 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.045 1.307 . . . . 0.0 114.169 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 154.71 32.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.261 1.824 . . . . 0.0 112.459 -174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.04 166.22 18.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.748 2.019 . . . . 0.0 110.794 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -101.39 137.45 39.71 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.579 1.151 . . . . 0.0 110.183 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.4 tp -74.57 101.75 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 156.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -106.53 -14.37 15.07 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.319 1.448 . . . . 0.0 111.482 -163.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.5 ttpp -149.38 137.84 20.86 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.686 1.595 . . . . 0.0 109.359 145.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.94 168.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 129.06 2.944 . . . . 0.0 114.351 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.476 ' HG2' HG22 ' A' ' 34' ' ' VAL . 24.9 mtm -79.88 136.36 36.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.39 122.57 21.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.013 1.725 . . . . 0.0 109.74 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.62 164.89 21.54 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -120.66 170.06 9.79 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.041 1.737 . . . . 0.0 111.778 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -27.56 66.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.117 0.967 . . . . 0.0 112.312 165.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -65.37 -9.15 22.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.338 1.855 . . . . 0.0 112.733 168.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.03 -7.4 55.96 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.477 1.513 . . . . 0.0 113.539 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -68.54 163.54 23.3 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.976 1.71 . . . . 0.0 111.067 169.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -126.71 148.29 49.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 109.503 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 t -114.65 115.3 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.127 0.971 . . . . 0.0 109.508 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.6 t -117.81 132.6 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.698 1.599 . . . . 0.0 109.087 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 25.7 ttpp -107.27 120.49 42.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.775 1.17 . . . . 0.0 110.47 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -93.75 165.58 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.656 1.182 . . . . 0.0 109.987 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.57 159.12 42.88 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.126 1.771 . . . . 0.0 108.183 156.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -104.31 139.04 39.87 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.724 1.602 . . . . 0.0 112.421 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -121.71 -27.82 4.63 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.87 -1.144 . . . . 0.0 113.284 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.85 -18.13 79.51 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 117.886 1.914 . . . . 0.0 117.886 -157.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.34 2.57 0.15 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 -175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.31 -42.7 1.7 Allowed Glycine 0 CA--C 1.537 1.419 0 CA-C-N 120.765 1.62 . . . . 0.0 114.497 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.31 170.7 5.06 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 128.33 2.652 . . . . 0.0 115.107 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -67.64 166.24 24.77 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.926 3.084 . . . . 0.0 113.172 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.1 m -149.35 155.31 40.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.195 1.398 . . . . 0.0 111.522 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.27 136.69 33.07 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 129.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.274 1.7 m -95.54 129.11 35.7 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -170.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.2 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.644 2.23 . . . . 0.0 109.091 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.7 mt -119.06 129.15 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.58 0.752 . . . . 0.0 110.833 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -132.83 169.06 17.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.525 1.13 . . . . 0.0 109.437 162.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mt -119.09 131.25 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 149.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -110.12 163.69 13.35 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.465 1.103 . . . . 0.0 112.209 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -59.64 175.52 0.35 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.706 1.603 . . . . 0.0 113.027 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -65.3 -22.77 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -79.72 -25.56 41.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.978 0.911 . . . . 0.0 111.34 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 46.9 mttp 85.91 14.02 0.16 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 129.939 3.295 . . . . 0.0 112.565 169.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -83.09 -51.05 7.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.489 2.716 . . . . 0.0 112.815 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -122.68 151.48 41.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.127 1.33 . . . . 0.0 112.669 -167.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.32 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.938 1.695 . . . . 0.0 112.136 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.22 -28.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.188 1.795 . . . . 0.0 114.171 171.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.55 161.76 17.87 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-N 119.917 1.235 . . . . 0.0 114.429 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -124.17 105.21 9.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.455 1.502 . . . . 0.0 110.354 -170.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.1 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 120.985 -1.072 . . . . 0.0 110.151 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.6 mm -108.73 -40.78 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.471 0.708 . . . . 0.0 111.603 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 t -66.41 10.14 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 98.13 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 130.588 3.555 . . . . 0.0 111.413 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 66.0 p -67.76 106.87 1.43 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.403 1.481 . . . . 0.0 109.375 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -55.94 147.21 64.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.635 2.89 . . . . 0.0 115.238 -170.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 169.16 18.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.94 140.38 38.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.319 2.248 . . . . 0.0 108.914 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.12 -27.59 21.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.446 1.098 . . . . 0.0 112.283 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 177.73 7.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 130.163 3.385 . . . . 0.0 108.84 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.14 -43.71 61.26 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.085 -1.009 . . . . 0.0 112.342 170.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.37 -10.09 15.12 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.23 1.412 . . . . 0.0 114.044 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -72.74 119.99 17.74 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 m -90.49 146.29 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.081 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -139.15 105.3 5.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -86.3 125.31 33.51 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.779 1.232 . . . . 0.0 111.493 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.4 mt -131.69 115.47 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.309 1.444 . . . . 0.0 109.555 -159.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.11 126.51 29.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.103 0.961 . . . . 0.0 111.647 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.9 tp -145.5 143.13 29.8 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.021 1.728 . . . . 0.0 110.367 -171.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 62' ' ' ARG . 5.2 tm-20 -118.19 92.63 43.17 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 125.619 1.568 . . . . 0.0 111.429 -165.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.85 170.47 19.99 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.288 3.325 . . . . 0.0 114.419 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.49 160.13 49.37 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.675 2.25 . . . . 0.0 111.17 165.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -72.85 92.18 1.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.456 0.702 . . . . 0.0 110.358 168.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.49 -172.38 34.24 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.218 1.389 . . . . 0.0 111.236 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.81 143.95 39.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.999 0.92 . . . . 0.0 111.512 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 162.18 24.15 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.064 0.946 . . . . 0.0 111.953 -171.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 91.8 m-85 -127.78 102.34 6.76 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.939 0.876 . . . . 0.0 111.747 -170.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.3 mp -70.39 126.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 127.539 2.336 . . . . 0.0 106.968 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.32 120.36 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -124.28 98.98 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.075 1.35 . . . . 0.0 108.995 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.82 -174.04 15.01 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.85 2.167 . . . . 0.0 110.247 -161.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.5 m -114.76 161.53 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 118.569 1.184 . . . . 0.0 110.93 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 4.51 -85.57 0.0 OUTLIER Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.825 2.631 . . . . 0.0 117.406 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -4.43 58.67 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.4 p -119.41 -9.59 9.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.187 1.795 . . . . 0.0 113.853 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.43 118.93 8.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.716 2.006 . . . . 0.0 113.347 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.97 96.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 155.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.8 m -99.94 97.3 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -126.46 160.64 29.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.394 1.093 . . . . 0.0 113.307 -172.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 141.15 28.92 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 114.345 -162.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -146.24 129.45 16.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 166.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -105.93 108.76 20.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.548 1.539 . . . . 0.0 109.669 165.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -66.47 141.08 58.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm 51.54 33.36 10.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.203 1.801 . . . . 0.0 113.624 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.67 -29.29 0.02 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 115.621 1.009 . . . . 0.0 115.621 172.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.9 t 54.66 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.443 1.897 . . . . 0.0 113.381 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.3 p 54.07 -104.26 0.2 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.969 1.708 . . . . 0.0 112.378 -169.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 19.2 tt -69.04 -27.92 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.094 1.358 . . . . 0.0 112.568 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.87 102.67 1.09 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.652 1.12 . . . . 0.0 111.082 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.485 2.714 . . . . 0.0 112.079 -176.787 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.85 -58.86 0.5 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.916 2.886 . . . . 0.0 114.66 165.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -141.52 -21.61 0.74 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.374 1.869 . . . . 0.0 113.004 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 54.7 tp -71.18 84.84 0.75 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.793 1.179 . . . . 0.0 108.611 159.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -161.31 176.17 11.49 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.511 2.725 . . . . 0.0 109.386 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -73.46 79.24 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 O-C-N 121.444 -0.785 . . . . 0.0 109.951 162.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -48.86 -58.54 4.67 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.65 2.38 . . . . 0.0 113.406 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.0 -56.09 20.57 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.584 1.088 . . . . 0.0 112.172 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 mmt -62.34 -58.66 6.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.039 0.936 . . . . 0.0 111.676 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 96.0 p -82.95 6.89 17.14 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -160.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -102.6 165.78 10.88 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.847 1.203 . . . . 0.0 111.445 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -141.11 91.29 2.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.151 1.78 . . . . 0.0 107.117 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . 0.289 0.0 OUTLIER -129.1 -116.53 0.25 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 -147.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.08 106.65 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -139.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 56.3 p -70.66 -7.35 43.83 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.657 1.583 . . . . 0.0 114.2 162.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.01 168.67 54.79 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.655 1.121 . . . . 0.0 113.893 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.49 155.18 36.44 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.638 1.575 . . . . 0.0 112.332 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.53 166.22 21.04 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.049 2.14 . . . . 0.0 110.477 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 m -106.53 140.25 39.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.39 1.476 . . . . 0.0 110.667 166.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tp -76.45 94.28 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 159.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -94.48 -13.05 26.55 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.816 1.246 . . . . 0.0 112.267 -165.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.9 ttpp -145.87 140.79 27.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.745 1.618 . . . . 0.0 108.684 146.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.61 167.66 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.48 2.312 . . . . 0.0 113.691 166.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.434 ' HG2' HG22 ' A' ' 34' ' ' VAL . 28.8 mtm -76.23 137.63 40.1 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.264 -0.897 . . . . 0.0 113.183 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.65 128.66 35.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.565 1.146 . . . . 0.0 110.137 171.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -85.15 161.3 19.69 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -111.52 168.63 9.4 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.896 1.678 . . . . 0.0 111.764 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -30.28 70.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.545 1.138 . . . . 0.0 111.965 164.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -62.12 -14.68 39.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.771 1.628 . . . . 0.0 112.645 166.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 1.98 90.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.989 1.28 . . . . 0.0 113.954 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -76.35 164.31 26.14 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.925 2.09 . . . . 0.0 110.916 166.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.8 t -119.86 146.07 46.08 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.186 0.994 . . . . 0.0 110.245 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -112.7 119.09 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.079 0.952 . . . . 0.0 109.044 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.5 t -117.49 130.7 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.553 1.541 . . . . 0.0 109.211 -171.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.5 ttmt -106.77 108.3 19.74 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.113 0.869 . . . . 0.0 110.229 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.5 162.69 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.161 0.584 . . . . 0.0 110.156 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.24 145.6 41.55 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.201 1.8 . . . . 0.0 107.459 154.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -85.63 153.02 22.66 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.96 1.254 . . . . 0.0 111.115 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -124.28 -59.32 1.48 Allowed 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.199 -0.938 . . . . 0.0 109.645 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -20.66 -64.65 0.01 OUTLIER Glycine 0 CA--C 1.53 1.024 0 C-N-CA 130.192 3.758 . . . . 0.0 118.587 -167.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.86 11.64 2.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -158.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.74 -45.85 2.77 Favored Glycine 0 CA--C 1.533 1.172 0 O-C-N 120.606 -1.309 . . . . 0.0 113.417 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 165.74 6.28 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 128.473 2.709 . . . . 0.0 115.559 -174.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.06 167.82 20.7 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.513 3.475 . . . . 0.0 113.622 167.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.2 m -147.59 157.23 43.47 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.225 1.81 . . . . 0.0 111.611 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 137.73 32.07 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 128.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 1.9 m -100.29 128.15 31.26 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.381 -169.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.03 105.71 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.599 2.199 . . . . 0.0 109.707 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.0 mt -118.0 128.01 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.988 0.915 . . . . 0.0 110.491 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -131.75 168.07 18.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 109.247 165.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -117.95 135.09 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 151.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mtt-85 -119.62 157.94 27.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.228 1.411 . . . . 0.0 110.929 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.1 177.67 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.03 0.932 . . . . 0.0 112.544 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -56.16 -34.82 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 120.902 -1.124 . . . . 0.0 113.354 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -82.29 -6.55 59.31 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.34 1.856 . . . . 0.0 112.592 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.2 mttm 66.12 -5.42 0.56 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.207 3.003 . . . . 0.0 115.272 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -66.06 -38.65 88.88 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.302 1.841 . . . . 0.0 114.658 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -118.13 140.09 50.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.424 1.465 . . . . 0.0 111.862 -168.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -73.68 139.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.291 1.436 . . . . 0.0 111.062 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.82 -7.93 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 114.955 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.66 169.99 13.09 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 119.982 1.264 . . . . 0.0 115.795 -173.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -133.38 119.58 19.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.363 1.865 . . . . 0.0 111.513 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.96 99.72 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.029 0.932 . . . . 0.0 110.853 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.61 -38.22 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.735 1.214 . . . . 0.0 111.424 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 t -67.33 18.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.928 1.291 . . . . 0.0 114.242 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.1 m 60.64 -176.58 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.531 2.332 . . . . 0.0 113.335 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.0 p -57.35 107.83 1.05 Allowed Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.057 1.743 . . . . 0.0 110.827 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -59.29 159.81 21.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.26 3.307 . . . . 0.0 115.319 -172.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.88 167.17 22.74 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 173.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.75 143.97 39.24 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.671 1.589 . . . . 0.0 109.037 168.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -92.56 -22.57 19.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.21 171.11 5.8 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.882 3.273 . . . . 0.0 109.399 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 m -51.68 -47.68 63.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.223 1.009 . . . . 0.0 110.989 164.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -66.48 1.36 1.71 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.9 m -104.28 130.42 52.09 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.535 1.061 . . . . 0.0 112.022 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.39 152.58 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.988 1.315 . . . . 0.0 111.579 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -142.7 111.49 6.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.585 0.754 . . . . 0.0 110.726 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -76.59 130.38 37.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.614 1.166 . . . . 0.0 111.204 167.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.7 mm -132.74 116.98 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.315 1.846 . . . . 0.0 110.023 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.8 128.24 34.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.593 1.157 . . . . 0.0 111.303 165.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 tp -144.13 146.91 33.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.506 1.922 . . . . 0.0 110.695 -169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.4 100.3 41.92 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.397 1.479 . . . . 0.0 110.871 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.55 174.05 13.26 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.962 3.775 . . . . 0.0 113.314 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.71 165.53 32.04 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.631 2.22 . . . . 0.0 111.001 162.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -74.72 79.47 2.05 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.131 -0.981 . . . . 0.0 111.834 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.39 -168.53 41.5 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.766 1.174 . . . . 0.0 112.496 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.64 142.82 55.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.367 1.067 . . . . 0.0 110.357 170.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.7 m -164.6 168.52 18.08 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.675 -1.266 . . . . 0.0 112.531 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -126.31 100.77 6.43 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.214 1.006 . . . . 0.0 110.231 -171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.91 138.98 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 171.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.43 130.08 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.3 mt -127.12 101.93 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.836 1.255 . . . . 0.0 108.645 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.46 164.03 17.81 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.367 1.937 . . . . 0.0 111.071 -164.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.9 148.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.639 -0.918 . . . . 0.0 110.455 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 6.37 -92.1 0.01 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 128.457 2.932 . . . . 0.0 117.296 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -64.26 -13.81 51.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.7 m -108.54 -5.14 16.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.992 2.117 . . . . 0.0 112.507 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.87 127.03 32.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.515 1.126 . . . . 0.0 113.09 -168.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.87 82.01 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.9 m -79.01 104.95 10.0 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.756 0.822 . . . . 0.0 109.185 171.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.83 151.93 51.92 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.11 138.98 37.04 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.887 2.475 . . . . 0.0 114.976 -171.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -136.16 156.77 48.2 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.734 0.814 . . . . 0.0 111.785 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -128.87 109.47 11.29 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.843 1.257 . . . . 0.0 108.273 162.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -65.03 136.38 56.71 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.144 -0.347 . . . . 0.0 111.831 -173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm 58.61 24.43 12.04 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.361 1.865 . . . . 0.0 114.156 -175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -153.72 -17.48 0.05 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 169.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.5 t 43.34 -104.3 0.06 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.502 1.921 . . . . 0.0 111.758 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m 58.18 -76.21 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.051 2.54 . . . . 0.0 114.26 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.08 -22.01 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.03 1.332 . . . . 0.0 112.289 167.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.4 124.57 7.5 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.968 1.747 . . . . 0.0 112.695 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 4.7 mmpt? . . . . . 0 C--O 1.253 1.281 0 C-N-CA 128.359 2.664 . . . . 0.0 112.159 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' H3 ' ' CD ' ' A' ' 2' ' ' GLU . 1.7 mpt? . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.193 0.044 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.411 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -37.02 -54.93 0.95 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.877 3.271 . . . . 0.0 115.075 167.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -139.42 -29.77 0.74 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.599 2.36 . . . . 0.0 111.851 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.25 85.96 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.911 0.884 . . . . 0.0 108.737 164.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -163.26 172.57 14.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.298 3.039 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.8 pt -73.21 82.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.332 -0.855 . . . . 0.0 109.852 163.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -47.3 -55.41 8.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.327 1.851 . . . . 0.0 113.318 -168.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.66 -52.91 38.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.938 1.256 . . . . 0.0 113.918 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.0 ttt -82.53 -45.19 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.466 0.633 . . . . 0.0 112.682 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.6 p -83.78 -9.18 58.98 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -167.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -85.88 146.7 26.61 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.249 1.386 . . . . 0.0 111.381 168.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.3 p -137.66 90.49 2.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.726 2.01 . . . . 0.0 106.842 161.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.1 mmm -119.12 -81.68 0.63 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -150.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 102.55 6.24 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -149.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 p -76.77 -15.36 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.55 173.37 35.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.741 1.163 . . . . 0.0 115.298 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 155.63 27.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.175 2.19 . . . . 0.0 112.792 -173.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -129.92 168.45 16.63 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.434 2.294 . . . . 0.0 112.009 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 m -104.1 138.46 40.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.247 1.419 . . . . 0.0 110.661 163.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 tp -75.9 82.24 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 122.783 1.278 . . . . 0.0 107.859 160.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.28 -14.56 59.73 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.331 1.452 . . . . 0.0 112.827 -170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -153.09 137.85 17.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.441 1.097 . . . . 0.0 110.282 154.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.73 168.46 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.875 2.47 . . . . 0.0 113.57 165.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.1 mtm -82.71 134.5 35.14 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.135 -0.978 . . . . 0.0 113.525 -175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.16 31.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.892 1.277 . . . . 0.0 110.546 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -83.27 159.75 21.87 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -111.39 169.24 8.93 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.105 1.762 . . . . 0.0 111.863 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -26.73 64.74 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.893 0.877 . . . . 0.0 112.283 164.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -63.7 -11.8 29.02 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.765 1.626 . . . . 0.0 112.261 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.55 2.8 76.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.249 1.404 . . . . 0.0 113.843 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 p -76.16 165.64 24.61 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.672 1.989 . . . . 0.0 110.658 165.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.1 t -125.44 147.4 49.22 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.994 0.918 . . . . 0.0 110.956 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.6 t -114.43 120.98 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.377 1.071 . . . . 0.0 109.363 -171.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -117.53 133.5 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.06 1.744 . . . . 0.0 109.102 -173.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -103.45 115.79 31.18 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.547 1.067 . . . . 0.0 110.034 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -88.76 161.57 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.207 0.603 . . . . 0.0 110.108 170.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.39 142.42 47.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.201 1.801 . . . . 0.0 107.237 154.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -78.41 155.1 30.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.451 1.478 . . . . 0.0 110.653 169.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -127.02 -62.34 1.12 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.869 0.868 . . . . 0.0 110.337 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -29.26 -59.74 0.17 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.956 3.17 . . . . 0.0 118.353 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.37 15.69 3.2 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -160.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -45.71 3.0 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 120.743 -1.223 . . . . 0.0 114.061 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.08 8.0 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 128.045 2.538 . . . . 0.0 115.539 -170.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -66.71 161.32 42.28 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.041 2.494 . . . . 0.0 112.414 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.3 m -156.25 155.7 32.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 0.0 111.179 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 137.57 38.46 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 142.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 48' ' ' PRO 0.291 1.7 m -99.74 134.38 21.08 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.767 -169.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.8 Cg_endo -81.58 100.71 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.174 2.583 . . . . 0.0 109.256 -172.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mt -112.22 124.41 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.76 0.824 . . . . 0.0 111.08 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -123.73 163.1 21.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.826 1.251 . . . . 0.0 110.225 164.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.48 HG13 HD11 ' A' ' 81' ' ' LEU . 3.8 mt -118.78 126.69 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 146.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -107.23 163.94 12.59 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.61 1.164 . . . . 0.0 111.966 172.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -56.59 171.01 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 127.343 2.257 . . . . 0.0 113.803 173.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.75 -26.53 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.451 -0.78 . . . . 0.0 112.847 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -72.81 -17.25 61.58 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.614 1.565 . . . . 0.0 113.449 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 89' ' ' TYR . 42.8 mttp 71.73 23.62 3.65 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.734 2.413 . . . . 0.0 113.4 175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -119.19 -31.6 4.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.148 1.779 . . . . 0.0 114.009 -173.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -126.0 129.16 48.67 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.705 1.138 . . . . 0.0 110.917 -168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.2 t -62.53 133.74 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.358 1.463 . . . . 0.0 111.576 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.9 m -133.44 -10.5 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.149 1.78 . . . . 0.0 114.252 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.63 170.92 13.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.349 0.976 . . . . 0.0 114.599 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.3 mtm-85 -131.35 138.22 49.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.812 1.645 . . . . 0.0 110.439 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -93.02 128.85 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.583 0.753 . . . . 0.0 109.616 178.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.59 -54.52 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.355 0.662 . . . . 0.0 112.522 -162.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -60.41 -33.39 72.44 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -175.75 169.27 3.02 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.54 1.936 . . . . 0.0 110.135 173.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 p -66.52 105.13 0.73 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.334 157.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -58.44 145.52 93.93 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.528 2.819 . . . . 0.0 115.806 -163.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -144.7 167.68 21.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.13 0.972 . . . . 0.0 112.837 170.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.96 128.8 29.06 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.386 2.274 . . . . 0.0 108.334 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -75.2 -16.6 60.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.59 168.43 3.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.613 2.365 . . . . 0.0 110.429 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -58.47 -44.75 89.42 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.472 0.709 . . . . 0.0 110.065 156.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -69.88 40.13 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.453 1.901 . . . . 0.0 112.678 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -156.19 148.8 23.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 119.653 -1.904 . . . . 0.0 111.964 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.61 156.34 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.766 1.626 . . . . 0.0 111.078 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 m -142.98 107.76 4.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.101 0.56 . . . . 0.0 110.608 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -74.18 125.51 28.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.587 0.755 . . . . 0.0 110.852 164.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.2 mm -128.66 120.63 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.5 1.52 . . . . 0.0 110.022 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -71.04 130.66 42.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.4 1.08 . . . . 0.0 111.276 162.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.48 HD11 HG13 ' A' ' 51' ' ' ILE . 30.5 tp -143.94 151.55 39.93 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.308 2.243 . . . . 0.0 109.731 -168.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -125.7 94.37 42.48 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.901 1.68 . . . . 0.0 109.653 -165.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -76.07 172.59 15.98 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.606 3.537 . . . . 0.0 113.268 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.34 160.42 49.9 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.347 2.031 . . . . 0.0 110.692 162.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -75.26 72.61 2.33 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.221 -0.924 . . . . 0.0 111.097 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.22 -170.33 42.42 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.318 1.913 . . . . 0.0 111.269 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -75.64 148.12 38.97 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.316 0.579 . . . . 0.0 111.045 169.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.5 p -163.97 161.3 22.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.929 0.891 . . . . 0.0 111.903 -167.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' CD2' ' HE3' ' A' ' 56' ' ' LYS . 86.5 m-85 -128.12 100.54 5.9 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 111.558 -169.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.2 mp -71.57 126.56 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 127.668 2.387 . . . . 0.0 107.351 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.261 0.9 OUTLIER -119.08 120.95 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.9 mt -122.04 97.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.498 1.519 . . . . 0.0 108.639 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.94 179.79 15.91 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.275 2.369 . . . . 0.0 110.493 -166.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.85 144.34 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.033 0.917 . . . . 0.0 111.169 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 38.0 -119.31 0.75 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.531 1.539 . . . . 0.0 113.858 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -67.44 -14.04 62.57 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.8 m -86.84 -10.79 52.64 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.226 1.011 . . . . 0.0 112.688 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.32 116.49 17.06 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.473 1.109 . . . . 0.0 113.467 -172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.7 mt -55.46 100.63 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 157.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.2 m -107.37 95.68 5.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.1 160.25 34.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.149 0.976 . . . . 0.0 113.38 -172.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.53 150.66 23.58 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.921 2.088 . . . . 0.0 114.521 -170.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -151.64 132.01 13.74 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.027 0.931 . . . . 0.0 113.157 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -103.88 109.31 21.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.003 1.321 . . . . 0.0 110.31 167.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.08 141.16 58.23 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.13 26.23 11.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.617 1.967 . . . . 0.0 114.353 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -165.81 -16.19 0.02 OUTLIER Glycine 0 CA--C 1.535 1.308 0 N-CA-C 117.657 1.823 . . . . 0.0 117.657 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.8 t 39.5 -94.83 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.267 2.227 . . . . 0.0 113.755 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 m 63.28 -54.86 0.19 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 129.153 2.981 . . . . 0.0 115.382 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.21 -17.1 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 126.402 1.881 . . . . 0.0 112.657 170.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.7 108.57 3.69 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.177 0 C-N-CA 125.388 1.475 . . . . 0.0 114.108 -164.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 110.9 -0.037 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -32.3 -57.38 0.33 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 129.514 3.126 . . . . 0.0 115.057 166.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -139.34 -32.06 0.67 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.685 2.394 . . . . 0.0 111.73 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.61 93.26 4.18 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 165.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -155.96 164.69 38.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 110.406 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.3 mm -76.27 82.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.711 0.804 . . . . 0.0 109.077 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -55.04 -27.98 48.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.117 1.767 . . . . 0.0 113.724 -170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.54 -37.37 75.1 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.571 1.558 . . . . 0.0 114.015 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -136.94 -20.82 1.26 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 9.62 1.24 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -143.15 139.35 30.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.183 2.193 . . . . 0.0 108.858 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -142.83 77.03 1.56 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.78 2.032 . . . . 0.0 107.597 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.5 tpt -115.89 -75.83 0.58 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 -130.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 127.44 32.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -154.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.0 p -100.17 -7.58 24.6 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.0 113.708 163.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.72 170.26 34.85 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.91 1.243 . . . . 0.0 114.185 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.2 157.22 27.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.69 1.996 . . . . 0.0 112.734 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.5 m-85 -129.77 168.46 16.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.052 2.141 . . . . 0.0 111.732 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 m -105.51 141.3 37.24 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.611 1.565 . . . . 0.0 110.682 164.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 tp -77.01 95.09 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 156.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -93.15 -12.04 31.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.053 1.341 . . . . 0.0 112.613 -166.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.9 ttpp -151.13 132.48 14.59 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.46 1.104 . . . . 0.0 109.62 149.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.7 153.61 0.57 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.694 1.998 . . . . 0.0 113.336 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -69.55 145.82 52.29 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.52 116.38 13.16 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.825 1.65 . . . . 0.0 109.519 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -78.41 156.91 29.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 113.272 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.1 p -108.53 170.24 8.15 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.636 1.574 . . . . 0.0 111.475 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -25.24 62.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.399 1.08 . . . . 0.0 112.248 164.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -64.57 -12.49 45.65 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.499 1.52 . . . . 0.0 112.023 164.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 1.63 84.28 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.421 1.486 . . . . 0.0 113.861 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -73.6 168.07 20.07 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.974 2.11 . . . . 0.0 110.847 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -125.0 148.61 48.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.262 1.025 . . . . 0.0 110.198 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.9 t -115.86 110.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.062 0.945 . . . . 0.0 109.198 -170.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.64 124.27 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.6 1.16 . . . . 0.0 109.774 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.9 ttmt -92.46 112.57 24.56 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.438 1.017 . . . . 0.0 110.018 173.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.01 165.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.978 0.511 . . . . 0.0 110.099 169.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.46 154.93 45.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 127.092 2.157 . . . . 0.0 108.113 156.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -98.79 139.15 34.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.934 1.697 . . . . 0.0 112.802 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -119.71 -33.26 4.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.692 -1.255 . . . . 0.0 113.101 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.81 -25.68 71.9 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.595 1.798 . . . . 0.0 117.595 -157.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.5 10.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -171.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.05 -47.1 3.07 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 120.678 1.581 . . . . 0.0 114.679 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.51 169.21 20.55 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 127.781 2.432 . . . . 0.0 113.964 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -68.01 160.19 49.7 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.905 2.404 . . . . 0.0 115.738 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 13.0 m -151.15 154.64 37.3 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.527 1.931 . . . . 0.0 110.733 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 136.07 36.73 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 144.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 18' ' ' PHE 0.295 1.1 m -96.85 141.81 23.62 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 118.308 0.504 . . . . 0.0 111.765 -165.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -88.16 96.89 0.4 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.999 2.466 . . . . 0.0 109.324 -168.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.28 129.41 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.6 0.76 . . . . 0.0 112.189 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.22 170.01 16.72 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.698 1.199 . . . . 0.0 110.147 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 81' ' ' LEU . 3.9 mt -115.36 129.2 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 148.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -107.94 164.11 12.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.681 1.192 . . . . 0.0 111.995 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.1 p30 -58.62 172.0 0.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.226 2.21 . . . . 0.0 114.167 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.44 -31.28 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.081 -1.012 . . . . 0.0 112.464 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.46 -16.14 62.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.608 1.963 . . . . 0.0 113.255 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 mttm 67.23 20.18 10.18 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 128.498 2.719 . . . . 0.0 113.436 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.57 -40.35 7.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 112.09 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.93 1.241 . . . . 0.0 112.879 -165.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.1 137.63 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.989 1.716 . . . . 0.0 112.442 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.35 -14.36 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.05 169.04 14.73 Favored Glycine 0 N--CA 1.475 1.264 0 CA-C-N 119.745 1.157 . . . . 0.0 114.977 -175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -129.95 122.87 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.266 1.426 . . . . 0.0 112.216 -172.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -75.08 100.94 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.561 1.144 . . . . 0.0 111.398 176.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.8 mm -71.7 -44.03 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 110.642 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -62.87 -3.2 1.46 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m 62.92 -26.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 129.398 3.079 . . . . 0.0 118.785 155.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.2 p -128.25 69.6 78.23 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.21 1.368 . . . . 0.0 112.223 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -54.12 106.97 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.671 2.914 . . . . 0.0 113.211 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 169.6 17.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 166.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.84 116.98 13.41 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.418 2.687 . . . . 0.0 107.837 171.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -72.08 -16.46 62.02 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.42 173.48 3.48 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 130.144 3.378 . . . . 0.0 108.384 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.6 -45.36 77.47 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.333 -0.855 . . . . 0.0 111.653 166.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.17 0.63 2.57 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.8 m -96.6 112.07 23.96 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.453 1.101 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.5 m -80.46 152.66 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.244 1.017 . . . . 0.0 111.717 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m -144.58 110.44 5.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.283 0.633 . . . . 0.0 110.754 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.3 124.0 28.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.457 0.703 . . . . 0.0 111.741 170.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.9 mt -127.05 109.46 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.997 1.319 . . . . 0.0 109.197 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -67.53 127.64 33.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.05 0.94 . . . . 0.0 111.025 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.59 HD11 HG13 ' A' ' 51' ' ' ILE . 19.7 tp -147.08 145.73 29.74 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.108 1.763 . . . . 0.0 110.154 -167.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -120.16 97.48 49.2 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.581 1.552 . . . . 0.0 110.496 -165.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -75.94 170.83 19.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.265 3.31 . . . . 0.0 113.423 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.88 161.16 47.05 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.548 2.165 . . . . 0.0 111.062 163.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -72.63 90.55 1.38 Allowed 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.369 -0.832 . . . . 0.0 110.548 168.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.04 -171.91 37.19 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.041 1.305 . . . . 0.0 111.147 -173.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -79.82 147.97 31.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.536 0.734 . . . . 0.0 111.048 170.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 90.4 p -162.57 159.94 25.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.673 0.789 . . . . 0.0 112.325 -168.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -128.72 96.91 4.51 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.545 1.164 . . . . 0.0 110.923 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 90' ' ' ILE . 4.1 mp -65.8 128.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 127.704 2.402 . . . . 0.0 106.918 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.23 120.76 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.5 mt -122.48 94.32 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.136 1.374 . . . . 0.0 108.064 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.52 177.69 15.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.669 2.08 . . . . 0.0 110.543 -166.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.5 m -114.1 149.85 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.804 0.842 . . . . 0.0 110.763 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 32.72 -111.71 0.06 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 126.047 1.784 . . . . 0.0 114.971 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -70.41 -12.95 61.92 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.9 m -98.59 -9.32 24.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.626 1.571 . . . . 0.0 112.455 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.84 123.52 20.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.785 1.234 . . . . 0.0 112.934 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.9 mt -65.99 90.05 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 151.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 94.6 m -84.68 101.25 12.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 168.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -125.63 154.66 41.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.701 1.239 . . . . 0.0 113.552 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.93 138.97 32.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.054 2.541 . . . . 0.0 114.618 -170.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -144.43 129.44 18.51 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 161.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -101.15 112.43 24.91 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.523 1.129 . . . . 0.0 109.656 165.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -66.58 134.46 52.39 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm 52.72 47.2 25.19 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.435 1.894 . . . . 0.0 112.707 -172.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.21 -18.18 0.02 OUTLIER Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.284 -1.287 . . . . 0.0 116.264 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.7 t 46.39 -110.35 0.27 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.6 1.7 . . . . 0.0 111.22 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.3 m 60.42 -77.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 114.0 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.1 tt -76.54 -22.19 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.343 1.057 . . . . 0.0 112.087 167.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.04 8.3 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.438 1.971 . . . . 0.0 111.201 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HA ' ' CE ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.366 0 C-N-CA 126.122 1.769 . . . . 0.0 111.501 -169.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 tpp . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.63 -51.03 0.64 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 130.414 3.486 . . . . 0.0 115.55 167.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -147.9 -28.55 0.33 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.126 2.17 . . . . 0.0 112.088 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.07 84.51 0.52 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 162.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -164.34 170.99 15.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 108.324 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 tp -74.98 84.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 O-C-N 121.131 -0.98 . . . . 0.0 109.385 165.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -46.05 -75.44 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.524 2.329 . . . . 0.0 114.564 -161.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.12 -46.37 56.4 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.415 1.007 . . . . 0.0 112.823 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.7 ttm -64.14 -59.93 3.84 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.262 1.025 . . . . 0.0 111.749 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.0 p -86.82 -9.53 55.58 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.932 1.826 . . . . 0.0 115.932 -164.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -68.55 156.44 38.03 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.436 1.471 . . . . 0.0 111.064 165.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -143.81 90.2 2.12 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.896 1.679 . . . . 0.0 107.276 165.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.9 mmm -129.79 -87.07 0.52 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -151.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 100.38 2.56 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -138.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 p -79.15 -10.85 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.298 1.839 . . . . 0.0 114.86 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.57 171.93 14.31 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.327 1.441 . . . . 0.0 114.63 -172.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -74.0 159.04 33.27 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.743 1.217 . . . . 0.0 114.023 -168.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -124.02 171.57 9.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.316 2.646 . . . . 0.0 109.741 175.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.406 ' OG ' ' OE2' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -110.18 139.63 45.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.969 1.708 . . . . 0.0 109.696 166.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.14 100.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 164.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.64 -10.0 20.42 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.179 1.391 . . . . 0.0 112.131 -165.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -153.42 143.57 22.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.149 1.38 . . . . 0.0 110.077 150.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.47 166.68 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 113.869 166.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 71.8 mtm -89.78 136.29 33.13 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.13 131.74 30.93 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.648 1.579 . . . . 0.0 109.843 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.55 158.53 23.08 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -110.69 170.6 7.98 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.315 1.846 . . . . 0.0 111.868 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.6 68.9 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.047 -1.033 . . . . 0.0 112.737 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -67.97 -10.77 56.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.096 1.758 . . . . 0.0 112.236 167.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.95 4.64 72.63 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.427 1.489 . . . . 0.0 114.052 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p -74.6 166.12 24.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.446 1.898 . . . . 0.0 110.292 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -119.21 152.88 35.85 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.48 1.112 . . . . 0.0 110.15 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.2 t -115.04 113.26 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.024 0.929 . . . . 0.0 109.871 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.24 116.55 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.566 1.546 . . . . 0.0 109.27 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -91.83 117.5 29.84 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.876 0.762 . . . . 0.0 110.572 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.57 160.03 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.743 1.217 . . . . 0.0 110.234 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -141.17 150.43 42.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.636 1.974 . . . . 0.0 108.227 164.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -98.55 150.85 21.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.27 1.395 . . . . 0.0 112.982 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' OE2' ' OG ' ' A' ' 19' ' ' SER . 53.5 mt-10 -128.09 -63.87 0.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 110.971 176.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -7.66 -72.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 129.649 3.499 . . . . 0.0 117.106 -169.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.39 18.62 3.66 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.578 1.551 . . . . 0.0 113.446 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.46 -43.64 1.1 Allowed Glycine 0 CA--C 1.539 1.593 0 N-CA-C 116.557 1.383 . . . . 0.0 116.557 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 165.43 4.47 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.713 2.805 . . . . 0.0 114.761 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.03 157.26 62.56 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.647 2.231 . . . . 0.0 113.831 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 20.0 m -151.76 157.22 41.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.277 1.431 . . . . 0.0 112.014 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.2 138.05 36.78 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 139.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 m -97.53 123.75 51.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.873 -171.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.86 124.24 13.7 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.557 2.171 . . . . 0.0 110.072 172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.5 mt -132.8 130.99 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 109.73 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -129.21 167.98 16.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.037 1.335 . . . . 0.0 110.206 166.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.7 mt -124.25 128.8 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 147.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.52 164.11 13.03 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.704 1.202 . . . . 0.0 112.088 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.97 175.5 0.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.466 2.306 . . . . 0.0 113.492 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.0 -32.94 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -79.45 -8.04 58.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.583 1.553 . . . . 0.0 113.177 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 mttm 66.82 32.42 6.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.188 2.195 . . . . 0.0 113.0 171.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -130.85 -20.72 2.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.409 1.484 . . . . 0.0 114.64 -175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -121.65 121.65 37.84 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.685 1.129 . . . . 0.0 110.359 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -64.07 133.84 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 111.624 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -137.35 -7.59 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.794 1.638 . . . . 0.0 114.537 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.5 170.01 13.22 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.682 1.128 . . . . 0.0 114.679 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -131.71 119.58 21.56 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.12 1.768 . . . . 0.0 110.947 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.516 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.9 OUTLIER -72.11 122.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.857 0.863 . . . . 0.0 109.78 176.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.1 mm -97.36 -33.24 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.499 0.719 . . . . 0.0 111.707 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.7 t -62.2 20.28 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.386 2.274 . . . . 0.0 116.84 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.1 p 60.01 -169.01 0.15 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.805 2.042 . . . . 0.0 112.535 -163.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.4 p -60.87 106.38 0.77 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.246 1.818 . . . . 0.0 111.083 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.59 144.4 97.38 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.645 2.896 . . . . 0.0 113.46 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.02 167.21 22.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.87 123.7 18.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.87 2.068 . . . . 0.0 108.358 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -75.3 -26.46 58.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.933 0.893 . . . . 0.0 113.135 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.62 172.86 4.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.139 2.575 . . . . 0.0 109.916 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -39.28 63.76 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 171.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -72.8 -2.65 21.37 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -94.86 155.44 16.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 111.749 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.5 147.91 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.514 1.126 . . . . 0.0 110.192 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.7 m -139.35 105.34 5.2 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.592 0.357 . . . . 0.0 110.644 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.79 89.56 4.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.204 1.801 . . . . 0.0 111.837 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.52 117.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.931 1.692 . . . . 0.0 111.201 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -69.13 126.88 31.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.054 0.942 . . . . 0.0 111.466 159.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.5 tp -143.04 147.01 34.38 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.679 1.991 . . . . 0.0 110.268 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -118.65 97.48 50.77 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.395 1.478 . . . . 0.0 110.528 -171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.05 172.08 16.67 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 124.752 3.635 . . . . 0.0 113.666 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.61 163.14 39.37 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.498 2.132 . . . . 0.0 111.1 164.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -77.83 74.01 4.39 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.322 -0.861 . . . . 0.0 111.688 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.65 -168.14 40.94 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.053 1.311 . . . . 0.0 111.632 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -67.24 144.35 56.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.476 0.655 . . . . 0.0 111.085 167.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.6 p -161.73 160.14 28.1 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.083 0.953 . . . . 0.0 111.502 -169.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.47 98.03 4.73 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.493 0.717 . . . . 0.0 110.333 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.89 135.45 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.764 1.626 . . . . 0.0 107.305 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 m -125.87 123.45 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.2 mt -125.31 109.85 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.719 1.207 . . . . 0.0 109.488 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.49 163.63 26.28 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.963 1.744 . . . . 0.0 111.422 -162.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.88 166.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.708 -0.878 . . . . 0.0 111.872 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -30.17 -59.81 0.21 Allowed Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.456 2.455 . . . . 0.0 116.885 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.99 3.24 0.87 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.848 1.659 . . . . 0.0 115.232 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.1 m -161.93 12.09 0.08 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.269 -1.519 . . . . 0.0 114.29 -170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.31 108.34 7.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.349 1.459 . . . . 0.0 112.286 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.08 101.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 160.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.5 m -112.31 95.2 5.32 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.317 1.047 . . . . 0.0 108.386 -167.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -130.44 146.45 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -165.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 137.95 45.75 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 129.037 2.935 . . . . 0.0 114.872 -172.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -149.22 121.02 8.12 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.943 0.897 . . . . 0.0 112.539 165.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -92.3 108.05 19.66 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.443 0.697 . . . . 0.0 109.754 164.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -64.05 131.78 48.59 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.978 0.511 . . . . 0.0 111.038 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.0 mttp 49.23 55.31 9.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.946 1.699 . . . . 0.0 112.728 -171.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.04 -37.52 0.04 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.528 1.061 . . . . 0.0 112.301 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m 54.7 22.77 4.3 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 149.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.0 m -122.84 -48.29 2.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.404 1.482 . . . . 0.0 111.498 -167.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 15.5 tt -74.07 -10.33 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.161 0.984 . . . . 0.0 112.653 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.51 141.67 10.01 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 124.444 1.021 . . . . 0.0 112.191 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt . . . . . 0 C--O 1.254 1.337 0 C-N-CA 130.015 3.326 . . . . 0.0 111.05 -173.36 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -58.41 0.55 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.583 1.953 . . . . 0.0 110.302 -163.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -106.51 -37.65 6.41 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 129.324 3.05 . . . . 0.0 109.457 163.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 tt -76.46 81.44 3.17 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.521 1.528 . . . . 0.0 108.262 165.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -163.75 156.44 17.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.689 2.396 . . . . 0.0 108.642 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 tt -73.11 93.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 122.014 0.911 . . . . 0.0 110.096 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.7 -25.71 67.58 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.717 1.607 . . . . 0.0 114.386 -170.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.02 -23.51 77.88 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 119.546 -0.586 . . . . 0.0 114.05 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.6 mmm -114.75 -47.83 2.87 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.239 1.02 . . . . 0.0 111.655 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 81.0 p -75.75 7.44 3.85 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.072 1.749 . . . . 0.0 115.206 -174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -132.35 150.67 52.11 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.172 1.389 . . . . 0.0 110.715 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -148.01 85.34 1.54 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.984 2.114 . . . . 0.0 107.534 166.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.4 tpt -115.65 -102.81 0.42 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -128.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.99 108.56 10.13 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -153.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.414 ' HA ' HG22 ' A' ' 94' ' ' VAL . 53.7 p -69.39 -4.52 18.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.25 1.42 . . . . 0.0 114.315 165.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.65 172.15 46.14 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.506 1.527 . . . . 0.0 114.339 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.56 163.17 27.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.59 1.556 . . . . 0.0 113.799 -172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -133.48 174.38 10.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.444 2.298 . . . . 0.0 109.76 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 p -112.13 145.46 39.76 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.259 1.024 . . . . 0.0 110.983 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.2 103.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 156.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.54 -14.71 14.03 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.905 0.882 . . . . 0.0 111.45 -159.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.516 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.7 ttpp -143.83 136.91 27.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.635 1.574 . . . . 0.0 108.615 149.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.29 156.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.917 2.087 . . . . 0.0 113.628 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 mtm -70.69 132.78 45.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.1 122.74 36.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.034 1.333 . . . . 0.0 109.996 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 152.61 34.46 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.581 0.705 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.7 p -101.27 167.54 10.13 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.582 1.553 . . . . 0.0 111.105 176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -24.69 64.12 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.244 -0.91 . . . . 0.0 112.27 163.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -64.94 -9.22 19.7 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.232 1.813 . . . . 0.0 112.419 165.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.89 -3.82 63.48 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.764 1.65 . . . . 0.0 114.17 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.8 p -69.58 168.35 14.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.73 2.012 . . . . 0.0 110.736 165.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 t -125.8 154.06 43.14 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.758 0.823 . . . . 0.0 110.481 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -118.72 118.95 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.43 1.092 . . . . 0.0 109.663 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.5 t -114.16 116.81 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.49 1.516 . . . . 0.0 110.125 -173.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 1.4 tmmt? -89.59 109.9 20.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.376 0.989 . . . . 0.0 109.822 175.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -86.75 165.66 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.205 1.002 . . . . 0.0 110.495 172.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 150.99 45.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.941 1.696 . . . . 0.0 108.544 153.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -94.15 129.96 40.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.289 0.95 . . . . 0.0 113.024 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -131.21 1.82 4.22 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.09 -61.82 2.76 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.102 0.858 . . . . 0.0 114.561 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.19 19.35 1.4 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -165.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.1 -43.77 2.52 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 120.612 -1.305 . . . . 0.0 115.553 170.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.18 174.33 2.95 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 127.16 2.184 . . . . 0.0 114.31 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.07 162.82 33.84 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.515 2.81 . . . . 0.0 114.22 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.2 m -145.35 151.59 38.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.684 1.994 . . . . 0.0 110.284 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 131.78 34.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 131.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.276 0.9 OUTLIER -90.43 137.91 27.22 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 118.561 0.618 . . . . 0.0 110.824 -168.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -86.07 97.3 0.56 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.845 2.363 . . . . 0.0 109.569 -168.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.66 124.57 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.781 0.832 . . . . 0.0 111.384 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.64 168.63 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.23 1.412 . . . . 0.0 110.242 164.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -124.23 133.03 70.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 147.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -112.17 162.87 14.98 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.533 1.133 . . . . 0.0 111.921 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -56.6 171.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.809 2.043 . . . . 0.0 113.138 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.0 m -57.49 -28.83 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 112.701 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -75.63 -12.62 60.24 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.03 2.132 . . . . 0.0 113.772 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.5 mttm 68.04 25.88 7.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.637 2.375 . . . . 0.0 113.452 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -120.59 -27.42 5.13 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.403 1.481 . . . . 0.0 114.04 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -124.07 129.05 50.23 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.676 1.125 . . . . 0.0 111.364 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.79 131.39 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.826 1.65 . . . . 0.0 111.535 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.51 -7.37 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.962 1.705 . . . . 0.0 114.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.49 166.04 15.0 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.637 1.108 . . . . 0.0 114.745 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -129.54 109.87 11.38 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.017 1.727 . . . . 0.0 109.837 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -70.14 114.54 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 0.0 109.645 178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.5 mm -87.58 -33.9 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.887 . . . . 0.0 111.977 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.9 t -64.27 23.19 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.551 1.94 . . . . 0.0 116.062 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p 74.63 -101.31 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 129.997 3.319 . . . . 0.0 113.134 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.7 p -131.39 99.03 17.72 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.705 1.602 . . . . 0.0 109.072 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.46 137.71 31.82 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.86 3.04 . . . . 0.0 113.797 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -141.94 168.16 20.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.95 137.18 37.71 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.909 2.084 . . . . 0.0 108.256 168.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -91.59 -17.0 26.27 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.256 -0.903 . . . . 0.0 112.852 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.98 176.42 1.79 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 130.939 3.695 . . . . 0.0 108.167 173.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -40.88 64.52 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.816 -1.178 . . . . 0.0 112.848 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -65.31 -6.69 10.53 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.41 1.084 . . . . 0.0 113.852 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -78.49 123.82 27.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.227 0.922 . . . . 0.0 111.398 174.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.25 154.51 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.116 159.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.3 109.14 4.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.833 0.453 . . . . 0.0 110.97 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 107.35 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.179 0.992 . . . . 0.0 112.004 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -104.27 114.08 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 125.455 1.502 . . . . 0.0 110.684 -172.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.36 129.96 41.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.868 0.842 . . . . 0.0 111.137 161.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.6 tp -148.7 147.61 29.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.066 1.746 . . . . 0.0 110.217 -168.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -116.98 94.13 43.77 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.645 1.578 . . . . 0.0 110.433 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -66.95 171.38 11.27 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 124.581 3.521 . . . . 0.0 112.826 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.53 155.59 69.6 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.005 1.803 . . . . 0.0 110.634 162.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -70.68 90.63 0.77 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.511 -0.743 . . . . 0.0 110.246 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.51 -170.62 32.92 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.849 1.214 . . . . 0.0 111.352 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.77 143.18 44.16 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.594 0.758 . . . . 0.0 111.607 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 94.0 p -160.68 158.06 28.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.787 0.835 . . . . 0.0 112.36 -166.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -126.23 97.0 4.9 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.151 0.976 . . . . 0.0 110.972 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.49 132.42 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 127.424 2.29 . . . . 0.0 107.231 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . 0.263 1.9 m -125.87 118.13 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.5 mt -122.97 100.09 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.062 1.345 . . . . 0.0 108.97 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.65 -178.4 16.54 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.047 2.261 . . . . 0.0 110.285 -165.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 15' ' ' SER . 3.3 m -119.93 148.29 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.181 0.991 . . . . 0.0 111.06 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 40.92 -121.65 2.04 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.852 1.215 . . . . 0.0 113.523 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -69.69 -12.84 61.95 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.1 m -87.53 -9.86 53.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.485 1.114 . . . . 0.0 112.898 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.35 112.14 10.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.705 1.202 . . . . 0.0 113.072 -174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.4 mt -55.49 95.84 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.838 0.855 . . . . 0.0 108.907 159.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -102.87 98.76 8.7 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.8 157.7 43.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.382 1.086 . . . . 0.0 113.766 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.26 143.07 28.95 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.098 2.159 . . . . 0.0 114.693 -169.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -149.56 136.94 19.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.572 0.749 . . . . 0.0 112.86 160.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -104.28 108.07 19.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.719 1.208 . . . . 0.0 109.402 165.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -70.4 142.44 52.05 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.904 -0.498 . . . . 0.0 111.704 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.99 46.53 25.36 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.442 1.897 . . . . 0.0 112.217 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.19 -33.07 0.03 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.124 1.345 . . . . 0.0 111.705 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 m 63.66 19.22 11.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.201 1.401 . . . . 0.0 114.108 147.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.7 m -126.56 -54.53 1.44 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.31 1.844 . . . . 0.0 112.984 -162.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.1 tt -70.86 -11.51 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.199 0.999 . . . . 0.0 113.263 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -137.12 154.75 22.45 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.257 1.408 . . . . 0.0 110.298 165.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 129.097 2.959 . . . . 0.0 111.142 -173.414 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.53 -55.55 0.84 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.654 3.182 . . . . 0.0 114.802 166.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -133.05 -34.24 1.11 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 128.285 2.634 . . . . 0.0 111.714 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.53 81.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.455 1.102 . . . . 0.0 108.264 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.3 ptm85 -159.63 167.71 27.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.074 2.55 . . . . 0.0 108.867 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -77.06 79.45 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-O 121.863 0.839 . . . . 0.0 109.706 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -67.91 0.24 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.531 1.932 . . . . 0.0 114.796 -161.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.54 -37.48 67.4 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.568 0.604 . . . . 0.0 112.925 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 19.4 mmt -79.09 -5.62 54.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.5 p -144.68 -7.5 0.67 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 -167.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -82.65 167.1 18.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 121.004 1.729 . . . . 0.0 112.455 167.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 p -147.53 107.08 3.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.565 2.746 . . . . 0.0 107.133 162.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mmm -135.16 -107.27 0.22 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 -161.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 m -83.82 154.63 23.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -134.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HG22 ' A' ' 94' ' ' VAL . 78.9 p -125.24 1.56 7.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.918 1.687 . . . . 0.0 114.069 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.79 174.45 49.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.92 1.247 . . . . 0.0 113.452 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -74.48 161.53 29.69 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.933 1.293 . . . . 0.0 112.514 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.405 ' CE2' ' HB ' ' A' ' 47' ' ' VAL . 86.0 m-85 -130.05 177.06 7.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.014 2.126 . . . . 0.0 109.373 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.8 p -107.32 151.58 25.29 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.914 0.779 . . . . 0.0 111.183 155.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 tp -83.59 100.33 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -15.17 15.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.062 1.345 . . . . 0.0 112.233 -160.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -147.57 141.8 26.18 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.774 2.43 . . . . 0.0 107.381 151.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.62 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.069 2.948 . . . . 0.0 115.006 167.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 mtm -86.01 129.88 34.71 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.155 -0.966 . . . . 0.0 112.563 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.78 118.17 24.14 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.083 1.753 . . . . 0.0 109.824 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -80.31 156.1 26.95 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.1 p -112.68 171.77 7.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.578 1.551 . . . . 0.0 112.832 -171.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.12 66.95 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.129 0.972 . . . . 0.0 113.316 166.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -80.07 -6.66 58.04 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.997 2.119 . . . . 0.0 111.597 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.0 6.7 60.8 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 120.832 -1.167 . . . . 0.0 113.705 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -76.36 169.67 17.79 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.972 2.109 . . . . 0.0 110.103 164.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 t -129.31 147.65 51.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.073 0.949 . . . . 0.0 111.149 174.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.85 102.25 13.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.519 1.128 . . . . 0.0 110.312 -171.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.45 144.45 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.45 1.9 . . . . 0.0 109.2 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 3.5 ttmt -111.85 125.28 53.85 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 120.238 1.381 . . . . 0.0 109.228 168.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 m -104.15 169.39 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.422 1.089 . . . . 0.0 110.44 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.28 155.5 44.49 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.43 1.892 . . . . 0.0 108.523 158.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -97.78 130.1 44.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.087 1.312 . . . . 0.0 112.836 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -132.19 13.98 4.66 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.099 -1.0 . . . . 0.0 112.679 -169.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.04 -50.04 2.53 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.227 0.918 . . . . 0.0 115.103 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.83 9.88 1.02 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -166.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.46 -41.97 1.91 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 120.112 1.324 . . . . 0.0 114.783 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.24 177.42 2.81 Favored Pre-proline 0 CA--C 1.561 1.365 0 C-N-CA 127.719 2.408 . . . . 0.0 114.188 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 166.25 24.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.241 3.294 . . . . 0.0 115.161 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.2 m -149.14 155.22 40.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.749 2.02 . . . . 0.0 110.798 172.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -83.3 134.1 34.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 118.79 -1.164 . . . . 0.0 107.925 127.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.405 ' HB ' ' CE2' ' A' ' 18' ' ' PHE 0.287 1.9 m -93.87 131.06 32.77 Favored Pre-proline 0 N--CA 1.468 0.434 0 O-C-N 123.551 0.532 . . . . 0.0 110.258 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.82 105.18 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.89 2.393 . . . . 0.0 108.859 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.91 124.9 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.914 0.886 . . . . 0.0 111.092 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -136.2 169.45 17.62 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 109.768 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 ' HG ' ' A' ' 81' ' ' LEU . 3.4 mt -119.78 124.6 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 156.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -107.79 162.22 14.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 111.048 171.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -59.84 176.22 0.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.956 2.102 . . . . 0.0 113.967 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -57.06 -33.59 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 120.841 -1.162 . . . . 0.0 112.766 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -74.22 -11.44 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.279 1.832 . . . . 0.0 113.543 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 63.43 28.85 15.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 128.243 2.617 . . . . 0.0 113.606 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -109.21 -40.1 5.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.88 1.672 . . . . 0.0 112.563 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -124.32 138.0 54.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.874 1.215 . . . . 0.0 111.677 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.63 133.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.783 1.233 . . . . 0.0 111.38 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.27 -11.38 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.079 1.752 . . . . 0.0 114.072 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.35 168.03 14.85 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.541 1.067 . . . . 0.0 114.659 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -133.42 121.83 22.85 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.176 1.79 . . . . 0.0 111.274 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 122.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.963 0.802 . . . . 0.0 110.177 174.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.2 mm -95.85 -37.05 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 0.0 111.596 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 t -64.24 -7.51 9.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.7 m 117.82 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 1 C-N-CA 132.944 4.497 . . . . 0.0 108.961 -166.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 m -65.41 117.57 41.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.178 -0.915 . . . . 0.0 108.733 159.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.29 156.59 20.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.589 3.526 . . . . 0.0 115.261 -172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.16 169.08 18.87 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 172.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.64 139.37 31.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.457 2.303 . . . . 0.0 108.583 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -97.95 -17.6 19.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.006 0.923 . . . . 0.0 112.717 -177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.81 174.94 7.18 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.643 3.177 . . . . 0.0 108.072 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -44.65 62.54 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.309 -0.869 . . . . 0.0 112.369 173.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -65.65 -7.49 15.52 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.117 1.367 . . . . 0.0 113.917 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -71.62 106.42 4.04 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 119.32 0.964 . . . . 0.0 110.834 172.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.05 149.19 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.625 154.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 m -141.41 117.7 10.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.049 0.54 . . . . 0.0 110.134 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -89.25 119.66 29.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.753 0.821 . . . . 0.0 111.669 173.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 mm -120.82 110.87 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.877 1.671 . . . . 0.0 110.683 -167.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -69.01 123.79 21.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.536 1.134 . . . . 0.0 111.165 162.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' A' ' 51' ' ' ILE . 45.4 tp -142.35 141.66 32.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.782 2.033 . . . . 0.0 109.943 -169.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -113.78 100.58 52.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.853 1.661 . . . . 0.0 110.564 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -78.06 173.36 14.07 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.391 3.394 . . . . 0.0 113.77 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.74 161.92 43.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.522 2.148 . . . . 0.0 110.878 162.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -72.7 102.63 3.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.182 -0.949 . . . . 0.0 109.984 166.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.47 -169.82 25.78 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.87 1.224 . . . . 0.0 111.964 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.64 139.52 39.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.669 1.188 . . . . 0.0 111.165 173.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -159.59 164.48 34.16 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.105 0.962 . . . . 0.0 112.261 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -129.11 104.93 7.84 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.224 1.011 . . . . 0.0 111.526 -167.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.33 123.82 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.261 2.224 . . . . 0.0 107.102 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.68 122.63 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.33 100.38 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.994 1.317 . . . . 0.0 109.115 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.19 176.28 18.59 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.714 2.102 . . . . 0.0 110.216 -161.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 15' ' ' SER . 12.6 m -107.25 139.71 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.16 0.98 . . . . 0.0 110.3 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 23.14 -100.17 0.01 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 127.902 2.667 . . . . 0.0 115.563 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -59.02 -16.37 18.01 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -110.09 -2.9 16.73 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.738 1.615 . . . . 0.0 112.767 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.17 111.33 16.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.103 0.961 . . . . 0.0 112.963 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.9 mt -56.22 100.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 93.03 4.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.37 156.27 34.29 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.293 1.044 . . . . 0.0 113.51 -172.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.82 147.0 33.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.444 1.898 . . . . 0.0 114.495 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -146.1 144.08 29.77 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.33 1.052 . . . . 0.0 110.725 157.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -114.42 116.84 29.53 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 163.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -70.03 138.68 52.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.31 17.48 4.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.035 1.734 . . . . 0.0 115.401 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.02 42.56 0.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.809 1.195 . . . . 0.0 113.042 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.5 m -68.35 34.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.845 2.858 . . . . 0.0 117.238 -157.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.3 t -72.75 -1.27 15.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.591 1.556 . . . . 0.0 114.877 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.3 tt -131.96 -1.48 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.04 1.336 . . . . 0.0 113.467 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.97 143.8 9.81 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 121.305 -0.872 . . . . 0.0 112.281 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 C--O 1.252 1.215 0 C-N-CA 128.154 2.582 . . . . 0.0 112.615 -170.042 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.9 mmm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.13 -59.54 2.01 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 130.834 3.653 . . . . 0.0 115.257 164.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -135.63 -33.3 0.87 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.37 3.068 . . . . 0.0 111.018 -167.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 87.6 mt -71.9 84.91 0.96 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.861 1.264 . . . . 0.0 108.378 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.41 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 11.3 ptm180 -166.52 165.34 16.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.593 2.757 . . . . 0.0 109.668 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.99 84.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.903 0.859 . . . . 0.0 110.0 167.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -64.0 -34.18 77.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.582 1.553 . . . . 0.0 113.675 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.49 -34.1 63.28 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.157 0.884 . . . . 0.0 112.963 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -92.58 -66.16 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.17 0.985 . . . . 0.0 110.366 169.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -73.2 8.34 1.72 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -159.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.41 ' CE1' ' HD3' ' A' ' 5' ' ' ARG . 8.1 m-30 -109.66 156.5 20.16 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.663 1.12 . . . . 0.0 110.418 165.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -145.16 91.34 2.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.482 1.913 . . . . 0.0 106.997 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 84.7 mmm -128.59 -115.01 0.26 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -152.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.3 m -76.82 105.51 7.93 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -133.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -72.45 -3.52 24.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.09 1.756 . . . . 0.0 114.547 166.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 170.49 51.22 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.888 1.232 . . . . 0.0 113.67 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -73.66 160.66 31.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.146 1.378 . . . . 0.0 113.014 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -131.31 175.0 9.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.093 2.157 . . . . 0.0 109.901 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.9 p -114.71 144.66 43.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 111.382 160.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 tp -75.59 93.57 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 159.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.4 -16.49 21.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.264 -159.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -145.74 139.42 26.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.85 2.06 . . . . 0.0 108.105 148.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.1 162.05 0.13 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.779 2.432 . . . . 0.0 114.602 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.408 ' HG2' HG22 ' A' ' 34' ' ' VAL . 27.3 mtm -69.88 127.39 32.73 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 123.4 37.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.898 1.279 . . . . 0.0 110.245 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.93 155.16 27.84 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.5 p -105.21 170.82 7.66 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.252 1.821 . . . . 0.0 111.448 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -27.34 67.78 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.196 -0.94 . . . . 0.0 112.416 165.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -66.55 -9.73 37.99 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.555 1.942 . . . . 0.0 112.256 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.39 1.44 60.83 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.317 1.436 . . . . 0.0 114.014 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.25 166.12 22.22 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.157 1.783 . . . . 0.0 110.262 164.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -122.79 148.0 45.87 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.946 0.898 . . . . 0.0 110.5 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.84 113.57 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.407 1.083 . . . . 0.0 109.4 -173.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' A' ' 24' ' ' MET . 1.8 t -110.41 116.08 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 109.792 -172.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -96.09 105.04 17.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.42 0.555 . . . . 0.0 109.688 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.27 166.22 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.506 1.122 . . . . 0.0 110.655 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 146.63 30.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.914 1.685 . . . . 0.0 108.716 160.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -91.09 134.96 34.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.795 0.725 . . . . 0.0 112.496 -174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -133.38 3.15 3.6 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.135 -0.978 . . . . 0.0 113.583 -171.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.78 -36.5 7.28 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 116.216 1.247 . . . . 0.0 116.216 -170.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.96 7.88 0.41 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.16 -43.07 1.96 Allowed Glycine 0 CA--C 1.535 1.322 0 CA-C-N 120.211 1.369 . . . . 0.0 114.928 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.46 167.66 6.54 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 127.696 2.399 . . . . 0.0 115.025 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.94 163.42 22.32 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.657 2.904 . . . . 0.0 113.478 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 81.7 m -147.29 154.5 41.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.733 1.613 . . . . 0.0 111.59 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -87.27 140.49 29.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 127.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.254 1.4 m -100.74 120.53 55.49 Favored Pre-proline 0 N--CA 1.469 0.488 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -171.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.06 115.59 3.54 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.28 1.987 . . . . 0.0 109.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.1 mt -126.1 129.64 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 110.712 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.09 165.32 18.41 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.392 1.077 . . . . 0.0 110.154 162.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.94 130.74 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 146.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -112.12 164.9 12.64 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.431 1.492 . . . . 0.0 112.435 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -58.14 171.32 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.591 1.956 . . . . 0.0 113.508 172.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.5 m -55.9 -36.13 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.367 -0.833 . . . . 0.0 112.932 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -73.87 -12.33 60.64 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.876 2.07 . . . . 0.0 113.988 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mttm 67.09 27.76 8.53 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 113.419 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.17 -27.96 7.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.084 2.154 . . . . 0.0 113.012 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -131.72 132.92 44.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.214 0.916 . . . . 0.0 111.041 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.98 134.22 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.204 1.402 . . . . 0.0 110.89 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.61 -8.46 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.921 1.688 . . . . 0.0 114.19 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.9 163.59 18.42 Favored Glycine 0 CA--C 1.536 1.363 0 CA-C-N 119.555 1.07 . . . . 0.0 114.686 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 -127.21 112.87 15.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.889 1.675 . . . . 0.0 110.36 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -72.31 109.77 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.607 0.763 . . . . 0.0 109.947 178.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -84.01 -38.23 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.017 0.927 . . . . 0.0 110.971 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.6 t -67.44 30.71 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.73 2.012 . . . . 0.0 114.558 174.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 t 57.34 -173.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.943 2.097 . . . . 0.0 113.095 -169.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 m -66.93 111.72 7.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.371 1.068 . . . . 0.0 109.238 172.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -55.82 152.99 32.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.476 3.451 . . . . 0.0 115.544 -169.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.26 167.26 22.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.6 143.71 31.61 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.008 1.723 . . . . 0.0 109.127 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -96.4 -18.53 19.84 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.79 174.03 5.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.844 2.858 . . . . 0.0 108.547 173.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -45.75 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.608 -0.682 . . . . 0.0 112.018 169.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -66.36 -3.39 5.88 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.3 m -87.41 119.81 28.06 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.129 0.972 . . . . 0.0 111.459 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.58 156.12 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.024 159.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.51 119.05 10.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.069 0.548 . . . . 0.0 110.87 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.67 106.11 18.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.029 1.332 . . . . 0.0 111.958 176.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.66 109.06 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.085 1.754 . . . . 0.0 110.526 -172.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -67.14 126.55 29.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.385 0.612 . . . . 0.0 110.875 161.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.8 tp -146.65 140.73 26.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 110.235 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.94 94.14 23.8 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.011 1.324 . . . . 0.0 110.727 -172.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -72.83 169.95 20.82 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.641 3.561 . . . . 0.0 112.865 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 163.47 39.07 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.815 2.343 . . . . 0.0 111.664 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -75.22 72.11 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.852 0.861 . . . . 0.0 111.442 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.49 -169.34 41.42 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.233 1.397 . . . . 0.0 111.813 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -70.82 145.05 50.57 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.273 0.559 . . . . 0.0 111.11 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 95.5 p -161.02 154.68 22.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.574 0.749 . . . . 0.0 112.138 -166.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -127.78 101.92 6.57 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.157 0.98 . . . . 0.0 111.656 -171.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 90' ' ' ILE . 3.1 mp -72.89 139.53 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.966 2.106 . . . . 0.0 107.647 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.4 125.04 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 170.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 mt -125.67 103.34 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.685 1.194 . . . . 0.0 109.099 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.27 178.13 20.84 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 126.109 1.814 . . . . 0.0 111.117 -162.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 m -106.1 145.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.074 0.937 . . . . 0.0 110.786 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 22.03 -104.22 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.683 2.563 . . . . 0.0 116.063 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -64.05 -11.28 28.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -107.98 -7.74 16.09 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.276 1.83 . . . . 0.0 112.639 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.24 127.41 32.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 112.171 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.7 mt -67.54 87.12 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 157.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.8 m -79.39 98.26 6.68 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -125.05 176.62 6.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.207 1.403 . . . . 0.0 113.008 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 139.9 53.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -154.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -154.86 131.27 10.46 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -106.22 109.84 21.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.02 1.328 . . . . 0.0 109.327 165.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -63.82 148.35 49.52 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.649 0.78 . . . . 0.0 111.775 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -25.83 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 129.079 2.952 . . . . 0.0 116.214 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.98 43.47 3.24 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.298 1.428 . . . . 0.0 111.7 160.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.1 m -63.33 29.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 131.494 3.918 . . . . 0.0 118.194 -151.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 m -156.26 1.85 0.15 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 166.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 14.9 tt -68.63 -19.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.278 1.399 . . . . 0.0 112.5 170.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -121.23 160.8 15.47 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.971 1.748 . . . . 0.0 109.276 156.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 5.2 mmpt? . . . . . 0 C--O 1.256 1.441 0 C-N-CA 125.934 1.694 . . . . 0.0 112.413 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -111.48 -88.24 0.52 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 130.399 3.48 . . . . 0.0 111.32 -163.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -77.25 -40.51 44.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.066 2.146 . . . . 0.0 109.719 162.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.54 76.77 1.07 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.291 1.036 . . . . 0.0 111.156 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -164.7 162.35 21.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 127.501 2.321 . . . . 0.0 110.268 167.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 tp -70.98 96.96 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.758 0.79 . . . . 0.0 109.337 168.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -60.32 -55.62 31.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.411 1.885 . . . . 0.0 112.847 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.2 -28.27 54.05 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.342 0.972 . . . . 0.0 114.001 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -85.52 -68.58 0.72 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.395 1.097 . . . . 0.0 110.263 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 82.6 p -79.08 -4.91 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -161.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -94.82 165.7 12.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.585 1.538 . . . . 0.0 112.827 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 p -148.51 104.67 3.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.724 2.81 . . . . 0.0 106.44 158.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mmm -129.95 -110.39 0.26 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -152.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.3 m -79.83 107.67 12.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -138.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 p -69.36 -9.45 53.51 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 164.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.05 171.93 52.48 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.701 1.619 . . . . 0.0 114.337 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -77.22 160.82 28.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.447 1.499 . . . . 0.0 114.301 -169.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 47' ' ' VAL . 87.7 m-85 -130.46 173.64 10.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.535 2.334 . . . . 0.0 109.954 173.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.0 p -119.75 142.93 48.1 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.073 0.949 . . . . 0.0 112.037 159.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 tp -71.44 101.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 163.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -106.52 -13.19 15.39 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.809 1.243 . . . . 0.0 111.046 -164.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -149.23 140.82 23.43 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.872 2.069 . . . . 0.0 108.883 148.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.15 170.2 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.464 2.706 . . . . 0.0 114.477 166.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.0 mtm -80.89 133.8 35.63 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.95 114.76 16.85 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.945 1.698 . . . . 0.0 110.718 176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.49 151.45 43.92 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.1 p -106.36 168.89 8.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.976 1.711 . . . . 0.0 111.72 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -26.21 66.97 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.291 -0.881 . . . . 0.0 112.559 166.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -67.21 -8.64 33.08 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.311 2.244 . . . . 0.0 112.422 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.08 0.48 65.56 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.405 1.479 . . . . 0.0 114.205 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -73.31 173.29 9.73 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.126 2.17 . . . . 0.0 110.263 164.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.7 t -133.44 146.06 50.83 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.173 0.989 . . . . 0.0 111.133 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 t -115.37 103.95 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.855 1.262 . . . . 0.0 110.385 -169.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.58 168.4 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.599 1.96 . . . . 0.0 110.144 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -133.86 124.97 27.38 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.472 -0.767 . . . . 0.0 111.054 159.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 m -96.75 165.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.434 1.093 . . . . 0.0 110.524 174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.03 145.33 39.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.952 1.701 . . . . 0.0 108.564 156.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -84.81 143.69 28.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.797 1.181 . . . . 0.0 111.654 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -136.27 -9.37 1.98 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -36.0 62.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.162 -1.355 . . . . 0.0 116.344 -170.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.86 12.78 0.25 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -166.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 -43.89 2.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 120.9 1.682 . . . . 0.0 114.416 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.57 175.44 4.68 Favored Pre-proline 0 CA--C 1.558 1.283 0 C-N-CA 127.4 2.28 . . . . 0.0 114.743 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -66.18 167.89 17.16 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.352 3.368 . . . . 0.0 115.388 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -148.21 160.84 42.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.624 1.969 . . . . 0.0 110.911 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -88.1 136.29 33.04 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 129.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 48' ' ' PRO 0.332 2.0 m -96.29 135.52 22.51 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.355 0.409 . . . . 0.0 111.158 -169.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.3 Cg_endo -87.14 89.39 0.61 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.019 2.479 . . . . 0.0 107.888 -163.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.5 mt -106.1 125.69 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.725 0.81 . . . . 0.0 111.342 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -125.81 162.77 24.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.32 164.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 88' ' ' SER . 4.1 mt -118.62 126.91 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 151.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -110.84 162.99 14.24 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.323 1.014 . . . . 0.0 112.452 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -58.39 171.94 0.53 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.136 2.174 . . . . 0.0 113.079 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.5 m -57.86 -31.99 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -74.69 -12.85 60.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.186 1.794 . . . . 0.0 113.515 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 mttm 67.84 26.56 7.6 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.122 2.169 . . . . 0.0 113.171 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -34.47 4.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.995 2.118 . . . . 0.0 113.165 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.3 131.07 57.05 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.347 0.976 . . . . 0.0 110.624 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.1 138.72 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.991 0.916 . . . . 0.0 111.447 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.7 m -134.36 -10.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.617 1.567 . . . . 0.0 115.083 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -109.83 169.77 13.86 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.994 1.27 . . . . 0.0 115.715 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -131.59 107.82 9.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.081 2.152 . . . . 0.0 110.553 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.425 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -68.42 108.94 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.296 0.638 . . . . 0.0 110.07 175.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.3 mm -78.95 -36.54 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.215 1.006 . . . . 0.0 111.408 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -67.43 26.67 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.85 1.66 . . . . 0.0 114.658 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t 63.43 -178.5 0.15 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.946 2.498 . . . . 0.0 113.168 -168.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.5 m -61.64 110.68 3.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.428 1.091 . . . . 0.0 108.925 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.57 159.2 11.48 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.315 3.343 . . . . 0.0 115.431 -170.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.98 168.2 20.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 173.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.22 38.34 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.935 1.694 . . . . 0.0 108.286 171.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -93.84 -14.37 26.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.09 172.9 2.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 130.483 3.513 . . . . 0.0 108.451 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -57.74 -50.35 73.51 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 110.967 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -66.44 3.09 1.03 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 m -97.84 124.79 42.39 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.479 1.111 . . . . 0.0 111.077 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 m -86.91 162.15 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.426 166.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 m -142.32 107.02 4.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.689 0.795 . . . . 0.0 109.111 172.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -73.28 136.27 44.52 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.991 -0.443 . . . . 0.0 109.978 166.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -135.64 109.55 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.497 1.119 . . . . 0.0 110.094 -168.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -73.0 130.3 40.03 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.272 1.029 . . . . 0.0 110.746 163.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.8 tp -151.9 144.56 24.27 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.995 1.318 . . . . 0.0 110.986 -167.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -117.39 96.91 50.13 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.747 1.619 . . . . 0.0 110.77 -171.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.73 171.1 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.803 3.668 . . . . 0.0 112.564 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -67.94 164.33 32.15 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.477 2.118 . . . . 0.0 111.483 168.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -73.25 87.55 1.47 Allowed 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.549 -0.719 . . . . 0.0 109.77 166.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.01 -173.47 44.09 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.856 1.217 . . . . 0.0 112.051 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.97 159.15 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.755 0.822 . . . . 0.0 110.21 165.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.442 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 18.7 m -171.39 158.3 5.23 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.475 1.11 . . . . 0.0 112.784 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -125.97 102.94 7.49 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.663 1.22 . . . . 0.0 110.328 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.71 125.31 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 128.599 2.759 . . . . 0.0 106.746 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.19 130.53 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.1 mt -129.16 94.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.209 1.404 . . . . 0.0 108.577 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.24 -170.52 18.07 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.421 1.963 . . . . 0.0 109.767 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.61 179.11 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.231 1.015 . . . . 0.0 110.721 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.74 -20.17 17.24 Favored Glycine 0 CA--C 1.541 1.705 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 -168.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -96.51 0.26 49.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.178 1.391 . . . . 0.0 114.549 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 77.8 p -154.32 -8.46 0.14 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.62 128.08 34.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.692 1.197 . . . . 0.0 113.942 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.09 98.61 0.11 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 152.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -96.41 100.94 12.51 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.93 165.83 18.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 112.381 -176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.17 153.11 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.115 1.766 . . . . 0.0 114.552 -167.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -150.37 147.57 27.75 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.098 0.559 . . . . 0.0 111.843 162.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -124.19 111.88 16.41 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 164.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -66.97 144.13 56.39 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.456 0.646 . . . . 0.0 111.392 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER 62.5 -24.28 0.05 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.102 2.961 . . . . 0.0 116.928 -175.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.24 52.19 1.86 Allowed Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.842 1.201 . . . . 0.0 110.521 161.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.0 m -64.6 28.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 131.408 3.883 . . . . 0.0 117.508 -153.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 m -154.16 9.77 0.37 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.317 -1.489 . . . . 0.0 114.27 165.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.5 mt -61.68 -28.83 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.489 1.041 . . . . 0.0 110.965 163.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.39 165.82 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.481 1.515 . . . . 0.0 110.187 162.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 5.5 mmpt? . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.812 2.045 . . . . 0.0 112.015 -174.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 119.5 -0.286 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -30.95 -58.49 0.22 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.044 2.537 . . . . 0.0 114.977 165.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -132.98 -31.96 1.25 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.174 2.989 . . . . 0.0 110.813 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.58 87.62 2.69 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.31 0.959 . . . . 0.0 108.563 166.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.402 ' HD3' ' CZ ' ' A' ' 11' ' ' TYR . 10.4 ptm180 -161.65 165.87 27.63 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.574 1.949 . . . . 0.0 111.765 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 tp -72.61 83.92 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 124.506 1.122 . . . . 0.0 110.278 164.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -59.96 -35.98 76.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.51 1.124 . . . . 0.0 113.319 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.02 -29.36 62.17 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 123.941 0.781 . . . . 0.0 113.407 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ttt -102.59 -69.45 0.79 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 110.209 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.0 p -65.73 9.78 0.12 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 128.739 2.816 . . . . 0.0 117.401 -162.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' CZ ' ' HD3' ' A' ' 5' ' ' ARG . 2.6 m-30 -121.53 152.7 38.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.873 1.269 . . . . 0.0 110.4 174.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.1 p -145.13 86.41 1.77 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 163.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mmm -117.67 -92.92 0.52 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -147.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -85.24 95.99 9.36 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -140.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.0 p -65.87 -2.5 3.9 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 162.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.67 176.56 53.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.255 1.407 . . . . 0.0 113.925 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 154.01 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.69 2.396 . . . . 0.0 111.797 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -135.15 174.06 11.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.199 1.8 . . . . 0.0 110.77 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 m -123.46 144.19 49.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.601 0.76 . . . . 0.0 112.172 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.4 91.48 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 107.249 159.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -94.29 -13.41 26.51 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.913 1.285 . . . . 0.0 111.857 -163.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.455 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 18.3 ttpp -150.25 135.83 18.22 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.415 1.886 . . . . 0.0 109.431 148.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.76 162.81 0.06 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.884 2.874 . . . . 0.0 115.169 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 32.3 mtm -70.41 122.41 19.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.3 119.61 36.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.597 1.159 . . . . 0.0 110.975 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.14 157.65 34.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.75 0.82 . . . . 0.0 112.368 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -117.37 168.48 10.32 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.783 1.233 . . . . 0.0 112.802 -170.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -25.03 67.2 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.419 -0.801 . . . . 0.0 112.835 166.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -71.9 -7.63 49.65 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.485 1.914 . . . . 0.0 112.275 168.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.78 71.29 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.068 1.318 . . . . 0.0 113.964 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.7 p -76.61 174.44 10.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.314 2.246 . . . . 0.0 110.667 168.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.5 t -126.73 154.26 44.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.851 0.86 . . . . 0.0 110.932 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.41 125.01 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.864 1.266 . . . . 0.0 109.613 -174.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.76 127.43 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.803 1.641 . . . . 0.0 109.482 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.4 ttmt -100.56 115.43 30.13 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.717 1.144 . . . . 0.0 110.081 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.2 m -98.8 159.05 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.482 0.713 . . . . 0.0 111.707 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.86 147.95 37.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.903 2.081 . . . . 0.0 109.357 169.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -100.95 137.53 39.2 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.593 1.088 . . . . 0.0 112.552 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -135.51 1.74 2.89 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -173.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.25 -46.62 15.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.033 -0.871 . . . . 0.0 115.129 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.89 11.35 0.48 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.9 -46.96 2.74 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.591 -1.318 . . . . 0.0 114.584 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.01 163.89 3.89 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 128.098 2.559 . . . . 0.0 114.703 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.06 162.82 36.5 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.293 2.662 . . . . 0.0 113.803 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 83.6 m -144.26 154.96 43.62 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.54 1.936 . . . . 0.0 111.183 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -90.69 141.07 29.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 128.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.73 123.33 44.41 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.37 115.52 3.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.993 1.795 . . . . 0.0 109.687 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mt -125.81 134.54 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.88 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -132.96 169.12 17.27 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.771 1.228 . . . . 0.0 109.579 163.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 mt -120.04 129.04 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 146.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -109.65 164.62 12.37 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.542 1.137 . . . . 0.0 112.508 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.1 p-10 -54.84 170.26 0.18 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.386 2.275 . . . . 0.0 113.428 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.4 m -58.46 -33.0 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.232 -0.918 . . . . 0.0 112.919 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -70.6 -15.61 62.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.991 2.116 . . . . 0.0 113.759 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.4 mttm 66.74 33.73 6.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.275 2.23 . . . . 0.0 113.254 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.27 -27.67 5.2 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.504 1.922 . . . . 0.0 113.698 -174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -133.98 135.27 43.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.811 1.187 . . . . 0.0 111.726 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.76 136.34 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.0 111.876 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.51 -10.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.872 1.669 . . . . 0.0 114.733 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.87 169.14 12.75 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.585 1.084 . . . . 0.0 114.72 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -130.52 111.79 12.6 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.145 1.778 . . . . 0.0 110.911 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -66.58 131.63 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.734 -0.603 . . . . 0.0 109.533 172.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.61 -32.14 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.302 0.641 . . . . 0.0 111.392 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.8 t -68.2 38.23 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.262 1.825 . . . . 0.0 115.27 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 t 59.26 -172.68 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.964 2.106 . . . . 0.0 113.077 -171.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -70.26 108.94 3.99 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.311 1.445 . . . . 0.0 110.661 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.01 139.41 61.26 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.644 3.562 . . . . 0.0 116.035 -171.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.76 166.3 24.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.22 1.008 . . . . 0.0 113.605 177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.88 130.36 21.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.891 1.677 . . . . 0.0 108.914 171.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -83.58 -17.55 41.32 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.09 172.95 3.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 128.919 2.888 . . . . 0.0 109.181 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -51.72 -48.63 63.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 171.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -72.67 -0.55 13.38 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -83.01 152.05 25.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.295 0.952 . . . . 0.0 111.023 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.84 148.45 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.151 0.98 . . . . 0.0 110.451 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m -137.77 108.05 6.46 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.803 0.441 . . . . 0.0 109.865 -174.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.91 111.94 19.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.086 1.355 . . . . 0.0 111.2 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.5 mt -115.38 112.99 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.487 1.915 . . . . 0.0 109.88 -163.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -69.93 127.81 34.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.312 1.045 . . . . 0.0 111.543 165.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.9 tp -146.68 144.07 29.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.442 1.897 . . . . 0.0 110.242 -169.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -116.69 94.03 42.54 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.744 1.617 . . . . 0.0 110.49 -170.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -73.93 170.38 20.22 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.759 3.64 . . . . 0.0 113.158 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.11 161.78 44.8 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.543 2.162 . . . . 0.0 111.271 167.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.44 74.89 3.19 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.335 -0.853 . . . . 0.0 111.25 171.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.76 -170.66 43.09 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.647 1.594 . . . . 0.0 111.382 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -69.62 142.21 53.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.388 0.613 . . . . 0.0 111.069 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.9 p -160.0 159.39 32.05 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.137 0.975 . . . . 0.0 111.354 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -130.73 103.65 6.72 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.247 0.546 . . . . 0.0 110.79 -173.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.88 137.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.42 125.18 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.41 98.72 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.801 1.24 . . . . 0.0 109.517 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.66 -169.22 14.1 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.735 1.635 . . . . 0.0 111.331 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.9 -174.84 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.896 0.879 . . . . 0.0 111.881 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -54.71 -14.76 5.49 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.96 4.57 23.45 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.596 1.558 . . . . 0.0 113.822 173.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 p -153.29 -9.14 0.16 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -172.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.58 107.64 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.85 1.66 . . . . 0.0 114.062 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 mt -54.75 104.97 0.13 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 159.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.8 m -111.53 88.01 2.69 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -168.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -119.87 140.46 50.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.712 1.244 . . . . 0.0 113.801 -160.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 136.6 54.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.601 3.16 . . . . 0.0 115.092 -173.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -153.11 120.42 5.88 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 169.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -100.72 104.87 16.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.463 1.105 . . . . 0.0 109.819 166.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -60.67 140.97 57.27 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.726 -0.609 . . . . 0.0 111.31 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . 0.254 0.0 OUTLIER 61.22 -19.01 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.205 2.602 . . . . 0.0 116.545 -169.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.44 47.64 3.89 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.134 1.35 . . . . 0.0 110.786 158.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -60.02 17.53 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 130.856 3.663 . . . . 0.0 118.253 -152.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.0 m -154.96 7.7 0.28 Allowed 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.188 -1.57 . . . . 0.0 114.657 164.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 47.5 mm -66.78 -26.55 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.76 1.164 . . . . 0.0 111.358 170.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -116.02 160.59 13.28 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 156.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 5.3 mmpt? . . . . . 0 C--O 1.255 1.351 0 C-N-CA 126.475 1.91 . . . . 0.0 111.628 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 mmt . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -28.5 -50.25 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.656 3.182 . . . . 0.0 115.575 167.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -137.76 -21.36 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.288 1.835 . . . . 0.0 113.322 161.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.0 mt -72.77 80.58 1.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.572 1.078 . . . . 0.0 109.84 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.7 ptt-85 -165.46 -170.62 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 130.399 3.48 . . . . 0.0 108.731 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -68.35 78.83 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 O-C-N 121.072 -1.017 . . . . 0.0 112.209 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.65 -69.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.181 2.192 . . . . 0.0 114.016 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.14 -30.35 63.87 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.4 mmm -89.16 -12.47 40.88 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.636 1.174 . . . . 0.0 113.731 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 86.8 p -128.03 16.09 6.78 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -122.11 151.06 41.33 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.849 1.66 . . . . 0.0 110.057 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.6 p -144.78 89.54 1.99 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.272 2.229 . . . . 0.0 105.882 163.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.5 mmm -114.44 -111.95 0.34 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -149.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 m -73.6 102.94 4.04 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -140.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.2 p -66.01 -12.12 52.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.422 1.489 . . . . 0.0 113.782 166.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.38 169.41 43.44 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.268 1.413 . . . . 0.0 114.398 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 157.08 37.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.492 1.917 . . . . 0.0 113.87 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.05 167.25 19.4 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.253 2.621 . . . . 0.0 109.78 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -102.7 139.6 38.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.469 1.108 . . . . 0.0 110.416 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 tp -73.97 103.93 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 155.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -106.8 -14.15 15.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.743 -165.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 16.6 ttpp -153.08 138.73 17.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.324 1.85 . . . . 0.0 109.615 146.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.13 165.55 0.12 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.44 2.696 . . . . 0.0 114.454 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.5 mtm -70.65 135.01 48.06 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.13 119.29 21.71 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.171 1.389 . . . . 0.0 111.349 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.51 160.89 30.32 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -116.54 168.03 10.53 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.667 1.587 . . . . 0.0 111.992 -176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -26.15 64.61 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.198 0.999 . . . . 0.0 112.435 165.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -65.73 -10.57 38.02 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.735 1.614 . . . . 0.0 112.494 165.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.99 89.18 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 124.895 1.236 . . . . 0.0 113.976 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.6 p -82.0 171.18 14.71 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.905 2.482 . . . . 0.0 110.553 168.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t -125.41 148.73 48.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.256 1.022 . . . . 0.0 111.02 169.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.8 t -114.21 119.68 61.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.96 1.304 . . . . 0.0 108.928 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.79 146.45 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.65 1.58 . . . . 0.0 108.469 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -115.12 115.89 27.51 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 109.686 170.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -93.87 164.31 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.346 0.658 . . . . 0.0 109.903 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.21 149.61 49.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.24 1.816 . . . . 0.0 107.406 157.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -86.05 157.85 19.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.469 1.486 . . . . 0.0 111.055 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -131.59 -63.23 0.84 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.155 -0.966 . . . . 0.0 110.198 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -15.5 -75.69 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 129.88 3.61 . . . . 0.0 117.655 -167.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -130.75 15.16 5.35 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -162.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 -44.01 2.56 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.627 -1.296 . . . . 0.0 113.809 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.4 170.3 3.07 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 128.591 2.756 . . . . 0.0 115.208 -172.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -66.7 163.23 33.9 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.52 2.814 . . . . 0.0 113.611 172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 58.0 m -145.27 151.32 38.18 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.241 1.816 . . . . 0.0 110.488 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -88.72 126.33 35.27 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 134.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.6 m -86.12 129.98 51.81 Favored Pre-proline 0 N--CA 1.472 0.63 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -166.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 47' ' ' VAL . 1.4 Cg_endo -72.36 111.92 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.935 1.757 . . . . 0.0 109.109 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.98 131.37 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.572 173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.28 169.12 16.92 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.095 164.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.6 mt -122.56 123.63 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 152.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -102.62 157.39 16.97 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.979 0.8 . . . . 0.0 110.211 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -58.54 174.48 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.465 1.906 . . . . 0.0 113.37 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.93 -35.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 120.995 -1.066 . . . . 0.0 113.037 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -72.57 -16.71 61.75 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.891 2.076 . . . . 0.0 113.597 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttm 68.28 27.44 6.62 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.057 2.543 . . . . 0.0 113.512 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.89 -38.74 7.26 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.616 1.966 . . . . 0.0 111.823 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -124.17 137.37 54.55 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.707 1.14 . . . . 0.0 111.632 -168.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -68.87 134.16 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.597 1.159 . . . . 0.0 110.666 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.34 -9.16 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.242 1.417 . . . . 0.0 114.618 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.94 167.98 12.72 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.438 1.017 . . . . 0.0 114.928 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -130.81 110.83 11.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.224 1.81 . . . . 0.0 110.403 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.54 115.63 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.635 0.774 . . . . 0.0 109.501 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.4 mm -93.53 -39.87 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.199 1.0 . . . . 0.0 111.711 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -63.64 8.73 0.07 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 -167.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t 97.7 179.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.504 3.522 . . . . 0.0 110.149 -163.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.3 p -65.07 114.58 15.63 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.793 1.237 . . . . 0.0 109.74 170.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.05 136.18 44.73 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.323 2.682 . . . . 0.0 114.057 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.14 166.97 23.22 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -140.37 131.64 26.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.084 2.153 . . . . 0.0 108.279 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -85.29 -18.41 33.97 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.93 172.41 5.55 Favored 'General case' 0 CA--C 1.549 0.912 1 C-N-CA 131.769 4.027 . . . . 0.0 108.639 175.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -54.81 7.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.19 1.396 . . . . 0.0 112.216 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -66.87 -1.07 3.51 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 m -74.37 121.59 21.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.813 1.188 . . . . 0.0 111.057 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -90.34 146.63 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.34 0.656 . . . . 0.0 110.758 162.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.3 m -139.5 110.99 7.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.637 0.775 . . . . 0.0 109.57 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.52 134.71 37.26 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.59 0.756 . . . . 0.0 110.548 166.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.6 mt -139.36 106.85 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 124.965 1.306 . . . . 0.0 109.599 -166.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -65.5 127.84 33.46 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.923 1.289 . . . . 0.0 111.955 161.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 tp -147.75 146.08 29.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.978 2.111 . . . . 0.0 110.111 -169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -119.18 96.6 50.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 111.524 -171.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -71.17 170.0 19.26 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.437 3.424 . . . . 0.0 113.108 169.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.27 166.55 28.92 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.456 2.104 . . . . 0.0 111.157 166.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -74.8 77.43 2.09 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.327 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.59 -169.18 42.1 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.746 1.165 . . . . 0.0 112.149 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.86 143.12 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.073 0.949 . . . . 0.0 110.481 168.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 m -164.57 169.26 17.29 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.997 -1.064 . . . . 0.0 112.698 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -125.97 107.55 10.55 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 110.736 -169.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.0 124.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 127.922 2.489 . . . . 0.0 107.055 -177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -115.69 123.23 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.5 mt -125.35 99.88 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.318 1.447 . . . . 0.0 108.719 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.6 -169.15 13.37 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 127.07 2.272 . . . . 0.0 110.242 -161.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.6 m -118.52 -177.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.636 1.218 . . . . 0.0 111.675 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.32 -18.29 6.79 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 116.813 1.485 . . . . 0.0 116.813 -173.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.95 2.91 44.05 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.18 1.49 . . . . 0.0 114.267 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 p -157.97 -11.36 0.08 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -168.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.2 117.45 6.07 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.665 1.186 . . . . 0.0 114.106 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.6 mt -52.54 104.73 0.1 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 156.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 62.4 m -110.66 94.54 5.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.97 160.35 27.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.276 1.031 . . . . 0.0 112.455 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.416 ' CE1' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -101.7 148.38 25.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.425 1.49 . . . . 0.0 114.292 -161.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -149.77 147.39 27.96 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 171.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.04 107.15 11.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.32 1.048 . . . . 0.0 108.885 164.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -63.32 140.01 58.83 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.257 0.623 . . . . 0.0 111.559 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.49 -4.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.534 2.734 . . . . 0.0 116.228 -174.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.5 50.09 0.81 Allowed Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.219 1.866 . . . . 0.0 109.924 162.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.4 m -61.68 22.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.651 1 C-N-CA 132.582 4.353 . . . . 0.0 117.726 -157.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.6 t -140.41 1.99 1.81 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 114.313 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -25.2 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 120.097 1.317 . . . . 0.0 111.826 167.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.28 171.18 21.57 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.664 1.602 . . . . 0.0 110.534 166.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 6.5 mmpt? . . . . . 0 C--O 1.258 1.518 0 C-N-CA 127.805 2.442 . . . . 0.0 111.456 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' H3 ' ' CD ' ' A' ' 2' ' ' GLU . 4.4 mpp? . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 119.005 -0.522 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -23.62 -58.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 129.991 3.316 . . . . 0.0 115.627 167.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -128.79 -28.9 2.4 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.894 2.478 . . . . 0.0 111.222 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.68 84.63 7.48 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.518 1.053 . . . . 0.0 110.477 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -164.94 174.0 11.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.42 1.888 . . . . 0.0 111.83 168.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 tp -71.51 77.75 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 125.53 1.532 . . . . 0.0 112.02 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -67.84 -13.0 61.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.037 1.735 . . . . 0.0 114.583 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.28 93.79 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.406 0.548 . . . . 0.0 112.006 169.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.32 -56.27 2.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.163 1.385 . . . . 0.0 110.757 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.9 p -74.68 36.37 0.11 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 115.08 -172.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.71 146.53 24.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.497 1.919 . . . . 0.0 109.336 162.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.1 p -139.22 93.6 2.7 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.623 1.969 . . . . 0.0 106.599 163.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.9 mmm -120.15 -87.23 0.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -155.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.79 138.69 52.92 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -143.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.6 m -132.04 13.3 4.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.659 1.184 . . . . 0.0 113.388 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.34 175.03 15.64 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.868 1.699 . . . . 0.0 112.549 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -71.45 157.86 37.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -127.5 173.86 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.119 2.568 . . . . 0.0 110.332 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.97 139.1 47.75 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.066 1.746 . . . . 0.0 109.927 165.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tp -75.81 89.51 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 160.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.48 -12.84 41.83 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.789 1.235 . . . . 0.0 112.379 -164.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.481 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 20.1 ttpp -149.38 142.95 25.43 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.647 1.579 . . . . 0.0 109.663 149.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.65 167.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.777 2.431 . . . . 0.0 113.701 166.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 mtm -82.91 141.89 31.85 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 120.78 23.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.913 1.285 . . . . 0.0 110.654 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.44 162.01 23.47 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.3 p -116.9 178.65 4.27 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.792 1.637 . . . . 0.0 112.528 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -17.01 63.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.141 0.976 . . . . 0.0 113.444 166.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -75.87 -10.73 59.67 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.906 1.23 . . . . 0.0 112.118 164.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.84 8.13 32.78 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.485 -1.384 . . . . 0.0 113.306 -164.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.1 p -66.23 160.3 24.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.996 1.398 . . . . 0.0 108.879 162.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 t -126.67 144.04 51.04 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.893 0.877 . . . . 0.0 110.627 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 t -105.03 118.91 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 124.523 1.129 . . . . 0.0 109.172 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t -113.19 129.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.662 1.585 . . . . 0.0 109.152 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 22' ' ' LYS . 4.2 ttmt -104.13 110.03 22.06 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.341 0.973 . . . . 0.0 110.253 177.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 m -86.05 163.78 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.533 0.733 . . . . 0.0 110.375 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.2 155.61 43.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.581 1.952 . . . . 0.0 108.156 157.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -108.95 142.4 39.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.367 1.439 . . . . 0.0 113.177 -170.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -128.96 -24.29 2.94 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.07 -25.29 73.37 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 117.406 1.722 . . . . 0.0 117.406 -163.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.61 1.51 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.95 -41.1 1.04 Allowed Glycine 0 CA--C 1.539 1.551 0 CA-C-N 120.177 1.353 . . . . 0.0 115.193 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.04 171.5 6.42 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 128.288 2.635 . . . . 0.0 114.146 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -62.28 159.3 35.92 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.608 2.872 . . . . 0.0 114.39 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 m -155.52 152.73 29.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.122 1.769 . . . . 0.0 110.476 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 132.88 35.82 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 142.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 m -94.29 124.74 54.76 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -170.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -67.11 114.05 3.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.387 2.058 . . . . 0.0 109.374 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.8 mt -120.43 123.34 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.256 1.022 . . . . 0.0 108.769 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.49 174.47 10.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.561 0.744 . . . . 0.0 109.931 167.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.0 mt -124.1 130.01 73.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 153.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -110.83 160.32 16.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 122.133 0.968 . . . . 0.0 111.126 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -58.63 176.07 0.21 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.852 2.461 . . . . 0.0 114.083 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.32 -29.96 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.007 -1.058 . . . . 0.0 112.945 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -71.96 -17.7 62.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.215 1.406 . . . . 0.0 112.974 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HE3' ' CG ' ' A' ' 89' ' ' TYR . 45.7 mttp 67.66 29.9 6.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.304 2.641 . . . . 0.0 112.954 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -121.15 -29.99 4.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.763 1.625 . . . . 0.0 113.487 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -122.45 131.4 53.85 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.896 1.225 . . . . 0.0 110.894 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.79 135.68 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.346 1.458 . . . . 0.0 111.656 -174.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.53 -7.01 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -114.78 168.63 12.61 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 119.855 1.207 . . . . 0.0 115.27 -175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -131.31 118.1 19.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.756 1.622 . . . . 0.0 111.311 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.498 HD12 ' H ' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -77.87 99.79 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.348 1.059 . . . . 0.0 111.101 -177.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.81 -49.49 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.033 0.933 . . . . 0.0 111.876 -172.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.2 t -63.03 -4.97 2.56 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m 62.82 -12.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.935 2.494 . . . . 0.0 117.692 158.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.6 p -120.16 59.71 6.6 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.481 1.512 . . . . 0.0 113.663 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -58.04 84.11 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.832 3.022 . . . . 0.0 113.786 163.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.42 166.99 23.2 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 172.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.67 137.31 36.73 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.445 2.698 . . . . 0.0 108.32 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -102.77 -7.49 21.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.662 1.185 . . . . 0.0 112.962 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.25 170.77 11.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 130.17 3.388 . . . . 0.0 108.258 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -44.62 41.09 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.319 0.648 . . . . 0.0 111.794 167.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -66.76 -6.08 14.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.112 1.765 . . . . 0.0 114.429 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -73.58 101.56 3.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.42 1.009 . . . . 0.0 111.345 174.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 m -73.88 135.46 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.434 158.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -137.95 108.06 6.4 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.779 0.432 . . . . 0.0 110.828 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.58 121.63 25.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.283 1.433 . . . . 0.0 111.833 170.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mm -124.49 115.84 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 126.129 1.772 . . . . 0.0 110.188 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -67.58 127.95 34.63 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.405 1.082 . . . . 0.0 110.898 161.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 tp -141.4 145.19 35.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.359 2.263 . . . . 0.0 109.561 -171.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -113.73 101.05 53.39 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.162 1.385 . . . . 0.0 110.901 -171.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.66 168.91 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.348 3.365 . . . . 0.0 113.135 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.31 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.261 1.974 . . . . 0.0 110.857 162.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -76.32 75.4 3.11 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.087 -1.008 . . . . 0.0 111.748 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.94 -166.94 39.27 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.987 1.279 . . . . 0.0 112.492 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.99 135.67 47.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.961 1.304 . . . . 0.0 110.626 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -163.38 173.5 13.14 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.075 -1.015 . . . . 0.0 112.098 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.452 ' CG ' ' HE3' ' A' ' 56' ' ' LYS . 90.5 m-85 -125.67 105.0 8.68 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.743 0.817 . . . . 0.0 110.765 -165.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.95 129.86 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.976 1.711 . . . . 0.0 106.841 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.69 122.66 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.79 98.9 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.575 1.15 . . . . 0.0 109.223 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.56 -176.99 16.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.025 2.25 . . . . 0.0 111.279 -162.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -107.95 177.21 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.638 1.175 . . . . 0.0 111.57 176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.27 -17.18 5.42 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 117.675 1.83 . . . . 0.0 117.675 -170.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.39 6.36 44.47 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.514 1.657 . . . . 0.0 113.992 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 m -162.75 -1.23 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.57 114.88 3.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.512 1.525 . . . . 0.0 114.282 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.63 103.35 0.08 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 157.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 m -112.32 92.83 4.17 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -170.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -126.51 148.73 49.66 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.814 1.292 . . . . 0.0 113.908 -166.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 139.84 47.75 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.683 2.393 . . . . 0.0 114.132 -173.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -140.03 153.57 46.86 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.417 0.687 . . . . 0.0 110.718 156.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -124.48 115.45 20.92 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 165.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -66.65 134.35 52.1 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.24 0.473 . . . . 0.0 111.865 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.26 -29.94 0.05 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.56 30.18 10.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.747 2.118 . . . . 0.0 113.39 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -57.26 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 128.413 2.685 . . . . 0.0 113.42 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 p -143.42 -67.49 0.35 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.889 1.676 . . . . 0.0 110.472 -165.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 8.7 tp -67.56 -9.88 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 125.522 1.529 . . . . 0.0 113.576 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.02 144.46 16.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.734 1.159 . . . . 0.0 112.591 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 127.955 2.502 . . . . 0.0 111.346 -171.838 . . . . . . . . 2 2 . 1 stop_ save_